STRAIN_RGD_ID STRAIN_ONT_ID STRAIN_SYMBOL EXPERIMENT_COND_ONT_ID XCO_TERM EXP_COND_VALUE_MIN EXP_COND_VALUE_MAX EXP_COND_UNITS 70410 RS:0000007 AA XCO:0000069 standard diet 1549803 RS:0000029 ACI-Lystbg-Kyo/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1549803 RS:0000029 ACI-Lystbg-Kyo/Kyo XCO:0000102 fasting 1549803 RS:0000029 ACI-Lystbg-Kyo/Kyo XCO:0000087 specific pathogen-free condition 2292567 RS:0001158 ACI.COP-(D10Mgh8-D10Rat4)/Shul XCO:0000092 17 beta-estradiol 27.5 27.5 mg 2292567 RS:0001158 ACI.COP-(D10Mgh8-D10Rat4)/Shul XCO:0000099 control condition 2292565 RS:0001159 ACI.COP-(D3Mgh16-D3Rat119)/Shul XCO:0000092 17 beta-estradiol 27.5 27.5 mg 2292565 RS:0001159 ACI.COP-(D3Mgh16-D3Rat119)/Shul XCO:0000099 control condition 2292566 RS:0001160 ACI.COP-(D3Rat130-D3Rat114)/Shul XCO:0000092 17 beta-estradiol 27.5 27.5 mg 2292566 RS:0001160 ACI.COP-(D3Rat130-D3Rat114)/Shul XCO:0000099 control condition 2292564 RS:0001161 ACI.COP-(D6Rat80-D6Rat146)/Shul XCO:0000092 17 beta-estradiol 27.5 27.5 mg 2292564 RS:0001161 ACI.COP-(D6Rat80-D6Rat146)/Shul XCO:0000099 control condition 1547875 RS:0000016 ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur XCO:0000963 controlled NG-nitroarginine methyl ester content in acidified drinking water 8 13 mg/kg/d 1547875 RS:0000016 ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur XCO:0000963 controlled NG-nitroarginine methyl ester content in acidified drinking water 11 15 mg/kg/d 1547875 RS:0000016 ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur XCO:0000257 controlled hydrogen ion content drinking water 2.4 2.8 pH 1547875 RS:0000016 ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur XCO:0000112 unilateral nephrectomy 1598801 RS:0001162 ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur XCO:0000121 NG-nitroarginine methyl ester 9 16 mg/kg/d 1598801 RS:0001162 ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur XCO:0000121 NG-nitroarginine methyl ester 10 21 mg/kg/d 1598801 RS:0001162 ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur XCO:0000121 NG-nitroarginine methyl ester 10 21 ml/kg/d 1598801 RS:0001162 ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur XCO:0000099 control condition 1598801 RS:0001162 ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur XCO:0000087 specific pathogen-free condition 1598801 RS:0001162 ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur XCO:0000112 unilateral nephrectomy 5143942 RS:0002619 ACI.FHH-(D1Mit18-D1Rat90)(D14Mit11-D14Rat33)(D14Rat65-D14Rat90)/Eur XCO:0000022 controlled sodium content diet 0.4 0.4 % 5143942 RS:0002619 ACI.FHH-(D1Mit18-D1Rat90)(D14Mit11-D14Rat33)(D14Rat65-D14Rat90)/Eur XCO:0000113 right nephrectomy 5686832 RS:0003110 ACI.FHH-(D1Mit18-D1Rat90)(D3Got102-D3Got149)(D14Mit11-D14Rat33)(D14Rat65-D14Rat90)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 5686832 RS:0003110 ACI.FHH-(D1Mit18-D1Rat90)(D3Got102-D3Got149)(D14Mit11-D14Rat33)(D14Rat65-D14Rat90)/Mcwi XCO:0000113 right nephrectomy 5686829 RS:0003109 ACI.FHH-(D1Mit18-D1Rat90)(D3Rat6-D3Got149)(D14Mit11-D14Rat33)(D14Rat65-D14Rat90)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 5686829 RS:0003109 ACI.FHH-(D1Mit18-D1Rat90)(D3Rat6-D3Got149)(D14Mit11-D14Rat33)(D14Rat65-D14Rat90)/Mcwi XCO:0000113 right nephrectomy 1579695 RS:0001164 ACI.FHH-(D1Rat298-D1Rat90)/Eur XCO:0000121 NG-nitroarginine methyl ester 50 150 mg/l 1579695 RS:0001164 ACI.FHH-(D1Rat298-D1Rat90)/Eur XCO:0000099 control condition 1579695 RS:0001164 ACI.FHH-(D1Rat298-D1Rat90)/Eur XCO:0000113 right nephrectomy 1547871 RS:0000020 ACI.FHH-(D1Rat324-D1Rat156)/Eur XCO:0000963 controlled NG-nitroarginine methyl ester content in acidified drinking water 8 13 mg/kg/d 1547871 RS:0000020 ACI.FHH-(D1Rat324-D1Rat156)/Eur XCO:0000963 controlled NG-nitroarginine methyl ester content in acidified drinking water 11 15 mg/kg/d 1547871 RS:0000020 ACI.FHH-(D1Rat324-D1Rat156)/Eur XCO:0000257 controlled hydrogen ion content drinking water 2.4 2.8 pH 1547871 RS:0000020 ACI.FHH-(D1Rat324-D1Rat156)/Eur XCO:0000112 unilateral nephrectomy 1598800 RS:0001165 ACI.FHH-(D1Rat384-D1Rat156)/Eur XCO:0000121 NG-nitroarginine methyl ester 9 16 mg/kg/d 1598800 RS:0001165 ACI.FHH-(D1Rat384-D1Rat156)/Eur XCO:0000121 NG-nitroarginine methyl ester 10 21 mg/kg/d 1598800 RS:0001165 ACI.FHH-(D1Rat384-D1Rat156)/Eur XCO:0000121 NG-nitroarginine methyl ester 10 21 ml/kg/d 1598800 RS:0001165 ACI.FHH-(D1Rat384-D1Rat156)/Eur XCO:0000099 control condition 1598800 RS:0001165 ACI.FHH-(D1Rat384-D1Rat156)/Eur XCO:0000087 specific pathogen-free condition 1598800 RS:0001165 ACI.FHH-(D1Rat384-D1Rat156)/Eur XCO:0000112 unilateral nephrectomy 1598799 RS:0001166 ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur XCO:0000121 NG-nitroarginine methyl ester 9 16 mg/kg/d 1598799 RS:0001166 ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur XCO:0000121 NG-nitroarginine methyl ester 10 21 mg/kg/d 1598799 RS:0001166 ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur XCO:0000121 NG-nitroarginine methyl ester 10 21 ml/kg/d 1598799 RS:0001166 ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur XCO:0000099 control condition 1598799 RS:0001166 ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur XCO:0000087 specific pathogen-free condition 1598799 RS:0001166 ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur XCO:0000112 unilateral nephrectomy 1579700 RS:0001167 ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur XCO:0000121 NG-nitroarginine methyl ester 50 150 mg/l 1579700 RS:0001167 ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur XCO:0000099 control condition 1579700 RS:0001167 ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur XCO:0000113 right nephrectomy 1579678 RS:0001168 ACI.FHH-(D3Wox2-D3Rat59)/Eur XCO:0000121 NG-nitroarginine methyl ester 50 150 mg/l 1579678 RS:0001168 ACI.FHH-(D3Wox2-D3Rat59)/Eur XCO:0000099 control condition 1579678 RS:0001168 ACI.FHH-(D3Wox2-D3Rat59)/Eur XCO:0000113 right nephrectomy 14975244 RS:0004755 ACI.FHH-(rgdv393055223-rs107095981)/Mcwi XCO:0000121 NG-nitroarginine methyl ester 150 150 mg/l 14975244 RS:0004755 ACI.FHH-(rgdv393055223-rs107095981)/Mcwi XCO:0000112 unilateral nephrectomy 14975246 RS:0004757 ACI.FHH-(rgdv393055223-rs198076037)/Mcwi XCO:0000121 NG-nitroarginine methyl ester 150 150 mg/l 14975246 RS:0004757 ACI.FHH-(rgdv393055223-rs198076037)/Mcwi XCO:0000112 unilateral nephrectomy 14975245 RS:0004756 ACI.FHH-(rgdv393055223-rs198922144)/Mcwi XCO:0000121 NG-nitroarginine methyl ester 150 150 mg/l 14975245 RS:0004756 ACI.FHH-(rgdv393055223-rs198922144)/Mcwi XCO:0000112 unilateral nephrectomy 14975247 RS:0004758 ACI.FHH-(rs105373896-rgdv253272372)/Mcwi XCO:0000121 NG-nitroarginine methyl ester 150 150 mg/l 14975247 RS:0004758 ACI.FHH-(rs105373896-rgdv253272372)/Mcwi XCO:0000112 unilateral nephrectomy 14975242 RS:0004753 ACI.FHH-(rs105487995-rs105373896)/Mcwi XCO:0000121 NG-nitroarginine methyl ester 150 150 mg/l 14975242 RS:0004753 ACI.FHH-(rs105487995-rs105373896)/Mcwi XCO:0000112 unilateral nephrectomy 14975243 RS:0004754 ACI.FHH-(rs105487995-rs106411696)/Mcwi XCO:0000121 NG-nitroarginine methyl ester 150 150 mg/l 14975243 RS:0004754 ACI.FHH-(rs105487995-rs106411696)/Mcwi XCO:0000112 unilateral nephrectomy 14975248 RS:0004759 ACI.FHH-(rs198076037-rs105278863)/Mcwi XCO:0000121 NG-nitroarginine methyl ester 150 150 mg/l 14975248 RS:0004759 ACI.FHH-(rs198076037-rs105278863)/Mcwi XCO:0000112 unilateral nephrectomy 1547869 RS:0000021 ACI/Eur XCO:0000121 NG-nitroarginine methyl ester 9 16 mg/kg/d 1547869 RS:0000021 ACI/Eur XCO:0000121 NG-nitroarginine methyl ester 10 21 mg/kg/d 1547869 RS:0000021 ACI/Eur XCO:0000121 NG-nitroarginine methyl ester 10 21 ml/kg/d 1547869 RS:0000021 ACI/Eur XCO:0000121 NG-nitroarginine methyl ester 50 150 mg/l 1547869 RS:0000021 ACI/Eur XCO:0000360 arterial catheter implantation 1547869 RS:0000021 ACI/Eur XCO:0000099 control condition 1547869 RS:0000021 ACI/Eur XCO:0000963 controlled NG-nitroarginine methyl ester content in acidified drinking water 8 13 mg/kg/d 1547869 RS:0000021 ACI/Eur XCO:0000963 controlled NG-nitroarginine methyl ester content in acidified drinking water 11 15 mg/kg/d 1547869 RS:0000021 ACI/Eur XCO:0000257 controlled hydrogen ion content drinking water 2.4 2.8 pH 1547869 RS:0000021 ACI/Eur XCO:0000113 right nephrectomy 1547869 RS:0000021 ACI/Eur XCO:0000087 specific pathogen-free condition 1547869 RS:0000021 ACI/Eur XCO:0000112 unilateral nephrectomy 7364991 RS:0003549 ACI/EurMcwi XCO:0000121 NG-nitroarginine methyl ester 150 150 mg/l 7364991 RS:0003549 ACI/EurMcwi XCO:0000099 control condition 7364991 RS:0003549 ACI/EurMcwi XCO:0000112 unilateral nephrectomy 10000 RS:0000023 ACI/N XCO:0000099 control condition 1302717 RS:0000026 ACI/NHok XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302717 RS:0000026 ACI/NHok XCO:0000102 fasting 1302717 RS:0000026 ACI/NHok XCO:0000087 specific pathogen-free condition 1549811 RS:0000366 ACI/NJcl XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1549811 RS:0000366 ACI/NJcl XCO:0000355 controlled N-methyl-N'-nitro-N-nitrosoguanidine content drinking water 83 83 mg/l 1549811 RS:0000366 ACI/NJcl XCO:0000102 fasting 1549811 RS:0000366 ACI/NJcl XCO:0000087 specific pathogen-free condition 1302643 RS:0000028 ACI/NKyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302643 RS:0000028 ACI/NKyo XCO:0000102 fasting 1302643 RS:0000028 ACI/NKyo XCO:0000087 specific pathogen-free condition 1302688 RS:0000030 ACI/NMna XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302688 RS:0000030 ACI/NMna XCO:0000102 fasting 1302688 RS:0000030 ACI/NMna XCO:0000087 specific pathogen-free condition 1302670 RS:0000031 ACI/NSlc XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302670 RS:0000031 ACI/NSlc XCO:0000102 fasting 1302670 RS:0000031 ACI/NSlc XCO:0000087 specific pathogen-free condition 737892 RS:0000032 ACI/SegHsd XCO:0000393 1,2-dimethylhydrazine 20 20 mg/kg/week 737892 RS:0000032 ACI/SegHsd XCO:0000092 17 beta-estradiol 27.5 27.5 mg 737892 RS:0000032 ACI/SegHsd XCO:0000266 Freund's complete adjuvant 100 100 ul 737892 RS:0000032 ACI/SegHsd XCO:0000265 Freund's incomplete adjuvant 50 50 % 737892 RS:0000032 ACI/SegHsd XCO:0000360 arterial catheter implantation 737892 RS:0000032 ACI/SegHsd XCO:0000095 bilateral ovariectomy 737892 RS:0000032 ACI/SegHsd XCO:0000099 control condition 737892 RS:0000032 ACI/SegHsd XCO:0000812 controlled hemorrhage 737892 RS:0000032 ACI/SegHsd XCO:0000295 diethylstilbestrol 5 5 mg 737892 RS:0000032 ACI/SegHsd XCO:0000195 myelin oligodendrocyte glycoprotein 0.25 0.25 mg/ml 737892 RS:0000032 ACI/SegHsd XCO:0000291 peripheral myelin protein 2 peptide 58-81 100 100 ug 737892 RS:0000032 ACI/SegHsd XCO:0000292 peripheral nerve myelin 2 2 mg 737892 RS:0000032 ACI/SegHsd XCO:0000100 sham surgical control condition 737892 RS:0000032 ACI/SegHsd XCO:0000027 surgical implantation 1302691 RS:0000040 ALB/Hok XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302691 RS:0000040 ALB/Hok XCO:0000102 fasting 1302691 RS:0000040 ALB/Hok XCO:0000087 specific pathogen-free condition 6480218 RS:0003208 AR-Ednrbsl/Hkv XCO:0000087 specific pathogen-free condition 67958 RS:0000055 AS XCO:0000268 balloon angioplasty 6902893 RS:0003214 BB.SHR-(Acsm3-Igf2)/K XCO:0000099 control condition 1357980 RS:0000063 BB.SHR-(D4Got41-Tacr1)/K XCO:0000099 control condition 1357346 RS:0000371 BB.SHR-(D4Mit6-Spr)/K XCO:0000099 control condition 1549799 RS:0000372 BB.SHR-(D6Rat184-D6Rat3)/K XCO:0000099 control condition 631700 RS:0000069 BB.SHR-(Gnal-D18Mit9)/K XCO:0000099 control condition 1358922 RS:0000066 BB.WOKW-(D4Got41-Fabp1)/K XCO:0000099 control condition 61107 RS:0000067 BB/OK XCO:0000099 control condition 1599675 RS:0001174 BBDP.WF-(D13Rat124-D13Mgh5)/Sunn XCO:0000099 control condition 1641857 RS:0001175 BBDP.WF-(D8Rat16-D8Sunn1467)/Sunn XCO:0000099 control condition 1599674 RS:0001176 BBDP.WF-(D8Rat59-D8Sunn1467)/Sunn XCO:0000099 control condition 1641870 RS:0001177 BBDP.WF-(D8Rat73-D8Rat121)/Sunn XCO:0000099 control condition 1641855 RS:0001178 BBDP.WF-(D8Rat73-D8Rat20)/Sunn XCO:0000099 control condition 1641874 RS:0001179 BBDP.WF-(D8Rat73-D8Rat90)/Sunn XCO:0000099 control condition 7241811 RS:0003422 BBDP.WF-(D8Rat73-D8Sunn1467)(D13Rat124-D13Mgh5)/Sunn XCO:0000099 control condition 1641876 RS:0001180 BBDP.WF-(D8Rat73-D8Sunn1467)/Sunn XCO:0000099 control condition 1642018 RS:0001182 BBDP/WorBrm XCO:0000099 control condition 2306529 RS:0001772 BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw XCO:0000087 specific pathogen-free condition 2306541 RS:0001782 BBDR.F344-(D4Rat153-D4Rhw6),BBDP-(D4Rhw6-D4Rhw10)/Rhw XCO:0000087 specific pathogen-free condition 10003 RS:0000073 BBDR/Rhw XCO:0000265 Freund's incomplete adjuvant 50 50 % 10003 RS:0000073 BBDR/Rhw XCO:0000235 Poly I:C 5 5 ug/g 10003 RS:0000073 BBDR/Rhw XCO:0000231 anti-RT6.1 antibody 2 2 ml 10003 RS:0000073 BBDR/Rhw XCO:0000087 specific pathogen-free condition 10003 RS:0000073 BBDR/Rhw XCO:0000281 type II collagen 2 2 mg/kg 10003 RS:0000073 BBDR/Rhw XCO:0000281 type II collagen 100 100 ug 1304487 RS:0000076 BBDR/Wor XCO:0000238 Kilham rat virus 10000000 10000000 PFU 1304487 RS:0000076 BBDR/Wor XCO:0000235 Poly I:C 1 1 ug/g 1304487 RS:0000076 BBDR/Wor XCO:0000231 anti-RT6.1 antibody 25 25 ug 10004 RS:0000082 BC/CpbU XCO:0000099 control condition 10004 RS:0000082 BC/CpbU XCO:0000246 controlled cholesterol content diet 2 2 % 10004 RS:0000082 BC/CpbU XCO:0000247 controlled olive oil content diet 5 5 % 10004 RS:0000082 BC/CpbU XCO:0000102 fasting 67978 RS:0000089 BDIV XCO:0000345 N-ethyl-N-nitrosourea 80 80 mg/kg 67978 RS:0000089 BDIV XCO:0000345 N-ethyl-N-nitrosourea 80 80 ug/g 737921 RS:0000090 BDIV/lfz XCO:0000345 N-ethyl-N-nitrosourea 80 80 ug/g 61002 RS:0000091 BDIX XCO:0000345 N-ethyl-N-nitrosourea 80 80 mg/kg 61002 RS:0000091 BDIX XCO:0000345 N-ethyl-N-nitrosourea 80 80 ug/g 11554329 RS:0004258 BDIX.BDIV-D10Got1-D10Rat45/Zte XCO:0000345 N-ethyl-N-nitrosourea 80 80 ug/g 11554327 RS:0004257 BDIX.BDIV-D10Mit3-D10Mgh16/Zte XCO:0000345 N-ethyl-N-nitrosourea 80 80 ug/g 12738372 RS:0004304 BDIX.BDIV-D6Mit1-D6Mgh2/Zte XCO:0000345 N-ethyl-N-nitrosourea 80 80 mg/kg 12738372 RS:0004304 BDIX.BDIV-D6Mit1-D6Mgh2/Zte XCO:0000345 N-ethyl-N-nitrosourea 80 80 ug/g 12738394 RS:0004306 BDIX.BDIV-D6Mit8-D6Rat229/Zte XCO:0000345 N-ethyl-N-nitrosourea 80 80 mg/kg 12738394 RS:0004306 BDIX.BDIV-D6Mit8-D6Rat229/Zte XCO:0000345 N-ethyl-N-nitrosourea 80 80 ug/g 12738388 RS:0004305 BDIX.BDIV-D6Rat132-D6Mgh3/Zte XCO:0000345 N-ethyl-N-nitrosourea 80 80 mg/kg 12738388 RS:0004305 BDIX.BDIV-D6Rat132-D6Mgh3/Zte XCO:0000345 N-ethyl-N-nitrosourea 80 80 ug/g 32716420 RS:0004790 BDIX.BDIV-D6Rat132-D6Rat229/Zte XCO:0000345 N-ethyl-N-nitrosourea 80 80 mg/kg 32716420 RS:0004790 BDIX.BDIV-D6Rat132-D6Rat229/Zte XCO:0000345 N-ethyl-N-nitrosourea 80 80 ug/g 2311074 RS:0001789 BDIX/CrCrl XCO:0000710 DHD/K12/TRb cells 1 1 x 10E6 cells 2311074 RS:0001789 BDIX/CrCrl XCO:0000710 DHD/K12/TRb cells 1.5 1.5 X 10E6 2311074 RS:0001789 BDIX/CrCrl XCO:0000866 anal sphincter myotomy 2311074 RS:0001789 BDIX/CrCrl XCO:0000360 arterial catheter implantation 2311074 RS:0001789 BDIX/CrCrl XCO:0000099 control condition 2311074 RS:0001789 BDIX/CrCrl XCO:0000812 controlled hemorrhage 2311074 RS:0001789 BDIX/CrCrl XCO:0000733 sanguinarine 5 5 mg/kg/d 2311074 RS:0001789 BDIX/CrCrl XCO:0000733 sanguinarine 5 5 ml/kg/d 2311074 RS:0001789 BDIX/CrCrl XCO:0000711 taurolidine 2 2 % 2311074 RS:0001789 BDIX/CrCrl XCO:0000101 vehicle control condition 1 1 ml 10005 RS:0000092 BDIX/Han XCO:0000739 housing in trios 10005 RS:0000092 BDIX/Han XCO:0000744 housing with Haemophilus H21-infected subject 10005 RS:0000092 BDIX/Han XCO:0000745 housing with Haemophilus H35-infected subject 10005 RS:0000092 BDIX/Han XCO:0000746 housing with Pasteurella pneumotropica-infected subject 10005 RS:0000092 BDIX/Han XCO:0000747 housing with Pasteurellaceae-infected subject 10401918 RS:0004058 BDIX/HanHsd XCO:0000873 DHD/K12/TRb - Sp-5 cells 1 1 X 10E6 10401918 RS:0004058 BDIX/HanHsd XCO:0000876 floxuridine 1 1 mg/kg/d 10401918 RS:0004058 BDIX/HanHsd XCO:0000923 isolated lung perfusion with Hespan buffer 1 1 ml/min 10401918 RS:0004058 BDIX/HanHsd XCO:0000924 isolated lung perfusion with floxuridine 3.5 3.5 mg/ml 10401918 RS:0004058 BDIX/HanHsd XCO:0000924 isolated lung perfusion with floxuridine 7 7 mg/ml 10401918 RS:0004058 BDIX/HanHsd XCO:0000924 isolated lung perfusion with floxuridine 14 14 mg/ml 2307318 RS:0001790 BDIX/Ifz XCO:0000345 N-ethyl-N-nitrosourea 80 80 ug/g 127338474 RS:0004962 BDIX/Nem XCO:0000099 control condition 127338474 RS:0004962 BDIX/Nem XCO:0000884 trypan blue 0 0 mg/kg 127338474 RS:0004962 BDIX/Nem XCO:0000884 trypan blue 60 60 mg/kg 127338474 RS:0004962 BDIX/Nem XCO:0000884 trypan blue 120 120 mg/kg 737902 RS:0000093 BDIX/Orl XCO:0000156 0.9% sodium chloride solution 0.4 0.4 ml 737902 RS:0000093 BDIX/Orl XCO:0000156 0.9% sodium chloride solution 1 1 ml 737902 RS:0000093 BDIX/Orl XCO:0000646 Azoxymethane 15 15 mg/kg 737902 RS:0000093 BDIX/Orl XCO:0000099 control condition 2312473 RS:0001792 BDIX/OrlCrl XCO:0000156 0.9% sodium chloride solution 2 2 ml 2312473 RS:0001792 BDIX/OrlCrl XCO:0000871 5-fluorouracil 100 100 mg/kg 2312473 RS:0001792 BDIX/OrlCrl XCO:0000835 BT4C cells 0.01 0.01 x 10E6 cells 2312473 RS:0001792 BDIX/OrlCrl XCO:0000710 DHD/K12/TRb cells 0.5 0.5 X 10E6 2312473 RS:0001792 BDIX/OrlCrl XCO:0000710 DHD/K12/TRb cells 1 1 X 10E6 2312473 RS:0001792 BDIX/OrlCrl XCO:0000710 DHD/K12/TRb cells 1 1 x 10E6 cells 2312473 RS:0001792 BDIX/OrlCrl XCO:0000710 DHD/K12/TRb cells 1.5 1.5 X 10E6 2312473 RS:0001792 BDIX/OrlCrl XCO:0000710 DHD/K12/TRb cells 1.5 1.5 x 10E6 cells 2312473 RS:0001792 BDIX/OrlCrl XCO:0000710 DHD/K12/TRb cells 2 2 X 10E6 2312473 RS:0001792 BDIX/OrlCrl XCO:0000710 DHD/K12/TRb cells 3 3 X 10E6 2312473 RS:0001792 BDIX/OrlCrl XCO:0000710 DHD/K12/TRb cells 9 9 X 10E6 2312473 RS:0001792 BDIX/OrlCrl XCO:0000099 control condition 2312473 RS:0001792 BDIX/OrlCrl XCO:0000656 ganciclovir 50 50 mg/kg/d 2312473 RS:0001792 BDIX/OrlCrl XCO:0000837 gene transfer of the 15-LO-1 gene using an adenovirus vector 5 5 ul 2312473 RS:0001792 BDIX/OrlCrl XCO:0000837 gene transfer of the 15-LO-1 gene using an adenovirus vector 7.5 7.5 ul 2312473 RS:0001792 BDIX/OrlCrl XCO:0000836 gene transfer of the HSV-tk gene using an adenovirus vector 5 5 ul 2312473 RS:0001792 BDIX/OrlCrl XCO:0000836 gene transfer of the HSV-tk gene using an adenovirus vector 10 10 ul 2312473 RS:0001792 BDIX/OrlCrl XCO:0000864 hepatic portal vein occlusion 2312473 RS:0001792 BDIX/OrlCrl XCO:0000784 interleukin-2 75000 75000 U/d 2312473 RS:0001792 BDIX/OrlCrl XCO:0000210 partial hepatectomy 30 30 % 2312473 RS:0001792 BDIX/OrlCrl XCO:0000210 partial hepatectomy 70 70 % 2312473 RS:0001792 BDIX/OrlCrl XCO:0000445 phosphate buffered saline 0.1 0.1 ml 2312473 RS:0001792 BDIX/OrlCrl XCO:0000445 phosphate buffered saline 0.2 0.2 ml 2312473 RS:0001792 BDIX/OrlCrl XCO:0000100 sham surgical control condition 0 0 % 2312473 RS:0001792 BDIX/OrlCrl XCO:0000727 splenectomy 2312473 RS:0001792 BDIX/OrlCrl XCO:0000872 thymosin alpha-1 200 200 ug/kg 150527860 RS:0005125 BDIX/OrlIco XCO:0000785 PROb cells 2 2 x 10E6 cells 150527860 RS:0005125 BDIX/OrlIco XCO:0000786 PRObR1 cells 2 2 x 10E6 cells 150527860 RS:0005125 BDIX/OrlIco XCO:0000784 interleukin-2 45 45 x 10E4 IU/kg 150527860 RS:0005125 BDIX/OrlIco XCO:0000445 phosphate buffered saline 1 1 ml 150527860 RS:0005125 BDIX/OrlIco XCO:0000787 sodium butyrate 20 20 mmol/l 1566456 RS:0001189 BDIX/Zte XCO:0000345 N-ethyl-N-nitrosourea 80 80 ug/g 60985 RS:0000113 BN XCO:0000391 5-bromo-2'-deoxyuridine 50 50 mg/kg 60985 RS:0000113 BN XCO:0000266 Freund's complete adjuvant 50 50 % 60985 RS:0000113 BN XCO:0000206 N-nitrosodiethylamine 150 150 mg/kg 60985 RS:0000113 BN XCO:0000353 central nervous system myelin 5 5 mg/ml 60985 RS:0000113 BN XCO:0000099 control condition 60985 RS:0000113 BN XCO:0000442 controlled 2-acetamidofluorene content diet 0.02 0.02 % 60985 RS:0000113 BN XCO:0000030 controlled protein content diet 60985 RS:0000113 BN XCO:0000164 controlled sodium content drinking water 1 1 % 60985 RS:0000113 BN XCO:0000102 fasting 60985 RS:0000113 BN XCO:0000103 glucose solution 2 2 g/kg 60985 RS:0000113 BN XCO:0000103 glucose solution 60985 RS:0000113 BN XCO:0000210 partial hepatectomy 6480866 RS:0003219 BN-Chr 13LH/MavRrrc XCO:0000099 control condition 6480866 RS:0003219 BN-Chr 13LH/MavRrrc XCO:0000790 controlled sodium chloride content drinking water 1 1 % 6480866 RS:0003219 BN-Chr 13LH/MavRrrc XCO:0000790 controlled sodium chloride content drinking water 2 2 % 6480866 RS:0003219 BN-Chr 13LH/MavRrrc XCO:0000021 water 2303972 RS:0001797 BN-Chr 13SS/Mcwi XCO:0000522 common peroneal nerve direct electrical stimulation 3 3 V 2303972 RS:0001797 BN-Chr 13SS/Mcwi XCO:0000099 control condition 1642270 RS:0001193 BN-Lcatm3Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1642270 RS:0001193 BN-Lcatm3Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1642270 RS:0001193 BN-Lcatm3Mcwi XCO:0000152 drug dose time series 1642270 RS:0001193 BN-Lcatm3Mcwi XCO:0000102 fasting 1642270 RS:0001193 BN-Lcatm3Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1642270 RS:0001193 BN-Lcatm3Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1642270 RS:0001193 BN-Lcatm3Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1642270 RS:0001193 BN-Lcatm3Mcwi XCO:0000150 potassium ion 80 80 mmol/l 61113 RS:0000114 BN-Lx XCO:0000099 control condition 61113 RS:0000114 BN-Lx XCO:0000245 insulin 50000 50000 pmol/l 61113 RS:0000114 BN-Lx XCO:0000256 isoproterenol 200 200 nmol/l 61117 RS:0000116 BN-Lx/Cub XCO:0000099 control condition 61117 RS:0000116 BN-Lx/Cub XCO:0000246 controlled cholesterol content diet 2 2 % 61117 RS:0000116 BN-Lx/Cub XCO:0000247 controlled olive oil content diet 5 5 % 61117 RS:0000116 BN-Lx/Cub XCO:0000298 controlled saccharin content drinking water 0.1 0.1 % 61117 RS:0000116 BN-Lx/Cub XCO:0000102 fasting 61117 RS:0000116 BN-Lx/Cub XCO:0000297 fluid deprivation 61117 RS:0000116 BN-Lx/Cub XCO:0000302 lithium chloride solution 0.15 0.15 mol/l 1579688 RS:0001123 BN-Tgfbr2m1Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1579688 RS:0001123 BN-Tgfbr2m1Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1579688 RS:0001123 BN-Tgfbr2m1Mcwi XCO:0000152 drug dose time series 1579688 RS:0001123 BN-Tgfbr2m1Mcwi XCO:0000102 fasting 1579688 RS:0001123 BN-Tgfbr2m1Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1579688 RS:0001123 BN-Tgfbr2m1Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1579688 RS:0001123 BN-Tgfbr2m1Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1579688 RS:0001123 BN-Tgfbr2m1Mcwi XCO:0000150 potassium ion 80 80 mmol/l 2301937 RS:0001665 BN.GH-(D18Rat41-D18Mgh4)/Mcwi XCO:0000191 angiotensin II 5 50 ng/kg/min 2301937 RS:0001665 BN.GH-(D18Rat41-D18Mgh4)/Mcwi XCO:0000099 control condition 2301937 RS:0001665 BN.GH-(D18Rat41-D18Mgh4)/Mcwi XCO:0000127 norepinephrine 0.1 1 ug/kg/min 2301937 RS:0001665 BN.GH-(D18Rat41-D18Mgh4)/Mcwi XCO:0000145 phenylephrine 4 4 ug/kg 2301986 RS:0001669 BN.GH-(D2Rat22-D2Mgh11)(D18Rat41-D18Mgh4)/Mcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 2301986 RS:0001669 BN.GH-(D2Rat22-D2Mgh11)(D18Rat41-D18Mgh4)/Mcwi XCO:0000795 controlled sodium chloride content diet 4 4 % 2301989 RS:0001672 BN.GH-(D2Rat22-D2Mgh11)(D6Mit12-D6Rat15)(D18Rat41-D18Mgh4)/Mcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 2301989 RS:0001672 BN.GH-(D2Rat22-D2Mgh11)(D6Mit12-D6Rat15)(D18Rat41-D18Mgh4)/Mcwi XCO:0000795 controlled sodium chloride content diet 4 4 % 2301987 RS:0001670 BN.GH-(D2Rat22-D2Mgh11)(D6Mit12-D6Rat15)/Mcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 2301987 RS:0001670 BN.GH-(D2Rat22-D2Mgh11)(D6Mit12-D6Rat15)/Mcwi XCO:0000795 controlled sodium chloride content diet 4 4 % 2301939 RS:0001668 BN.GH-(D2Rat22-D2Mgh11)/Mcwi XCO:0000191 angiotensin II 5 50 ng/kg/min 2301939 RS:0001668 BN.GH-(D2Rat22-D2Mgh11)/Mcwi XCO:0000099 control condition 2301939 RS:0001668 BN.GH-(D2Rat22-D2Mgh11)/Mcwi XCO:0000127 norepinephrine 0.1 1 ug/kg/min 2301939 RS:0001668 BN.GH-(D2Rat22-D2Mgh11)/Mcwi XCO:0000145 phenylephrine 4 4 ug/kg 2301988 RS:0001671 BN.GH-(D6Mit12-D6Rat15)(D18Rat41-D18Mgh4)/Mcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 2301988 RS:0001671 BN.GH-(D6Mit12-D6Rat15)(D18Rat41-D18Mgh4)/Mcwi XCO:0000795 controlled sodium chloride content diet 4 4 % 2301938 RS:0001667 BN.GH-(D6Mit12-D6Rat15)/Mcwi XCO:0000191 angiotensin II 5 50 ng/kg/min 2301938 RS:0001667 BN.GH-(D6Mit12-D6Rat15)/Mcwi XCO:0000099 control condition 2301938 RS:0001667 BN.GH-(D6Mit12-D6Rat15)/Mcwi XCO:0000127 norepinephrine 0.1 1 ug/kg/min 2301938 RS:0001667 BN.GH-(D6Mit12-D6Rat15)/Mcwi XCO:0000145 phenylephrine 4 4 ug/kg 4143459 RS:0001459 BN.GK-(D2Rat40-D2Got149)/Ox XCO:0000099 control condition 4143459 RS:0001459 BN.GK-(D2Rat40-D2Got149)/Ox XCO:0000102 fasting 4143457 RS:0002465 BN.GK-(D2Rat40-D2Wox35)/Ox XCO:0000099 control condition 4143457 RS:0002465 BN.GK-(D2Rat40-D2Wox35)/Ox XCO:0000102 fasting 4143456 RS:0002464 BN.GK-(D2Wox30-D2Wox68)/Ox XCO:0000099 control condition 4143456 RS:0002464 BN.GK-(D2Wox30-D2Wox68)/Ox XCO:0000102 fasting 4143458 RS:0002463 BN.GK-(D2Wox49-D2Rat70)/Ox XCO:0000099 control condition 4143458 RS:0002463 BN.GK-(D2Wox49-D2Rat70)/Ox XCO:0000102 fasting 1331814 RS:0000117 BN.GK-(D8Got302-D8Got130)/Ox XCO:0000099 control condition 1331814 RS:0000117 BN.GK-(D8Got302-D8Got130)/Ox XCO:0000102 fasting 1331814 RS:0000117 BN.GK-(D8Got302-D8Got130)/Ox XCO:0000103 glucose solution 0.8 0.8 g/kg 1331813 RS:0000119 BN.GK-(D8Rat29-D8Got130)/Ox XCO:0000099 control condition 1331813 RS:0000119 BN.GK-(D8Rat29-D8Got130)/Ox XCO:0000102 fasting 1331813 RS:0000119 BN.GK-(D8Rat29-D8Got130)/Ox XCO:0000103 glucose solution 0.8 0.8 g/kg 1578712 RS:0001202 BN.LEW-(D10Mco17-D10Mco14)/Ciml XCO:0000365 Toxoplasma gondii cysts 20 20 1578714 RS:0001201 BN.LEW-(D10Mco17-D10Rat80)/Ciml XCO:0000365 Toxoplasma gondii cysts 20 20 1331817 RS:0000122 BN.LEW-(D10Rat32-D10Mgh4)/Rj XCO:0000365 Toxoplasma gondii cysts 20 20 8549599 RS:0003637 BN.LEW-(D10Rat32-D10Rat133)/Ciml XCO:0000365 Toxoplasma gondii cysts 20 20 1549802 RS:0001206 BN/1Hok XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1549802 RS:0001206 BN/1Hok XCO:0000102 fasting 1549802 RS:0001206 BN/1Hok XCO:0000087 specific pathogen-free condition 737972 RS:0000134 BN/Crl XCO:0000360 arterial catheter implantation 737972 RS:0000134 BN/Crl XCO:0000099 control condition 737972 RS:0000134 BN/Crl XCO:0000812 controlled hemorrhage 737972 RS:0000134 BN/Crl XCO:0000102 fasting 737972 RS:0000134 BN/Crl XCO:0000103 glucose solution 0.8 0.8 g/kg 634367 RS:0000133 BN/CrlCrlj XCO:0000030 controlled protein content diet 634367 RS:0000133 BN/CrlCrlj XCO:0000102 fasting 634367 RS:0000133 BN/CrlCrlj XCO:0000103 glucose solution 737691 RS:0000135 BN/Crli XCO:0000208 2-acetamidofluorene 0.02 0.02 % 737691 RS:0000135 BN/Crli XCO:0000206 N-nitrosodiethylamine 150 150 mg/kg 737691 RS:0000135 BN/Crli XCO:0000210 partial hepatectomy 737899 RS:0000136 BN/Cub XCO:0000099 control condition 737899 RS:0000136 BN/Cub XCO:0000211 controlled sucrose content diet 737899 RS:0000136 BN/Cub XCO:0000372 dexamethasone 0.03 0.03 mg/ml 737899 RS:0000136 BN/Cub XCO:0000102 fasting 631602 RS:0000137 BN/Elh XCO:0000191 angiotensin II 5 50 ng/kg/min 631602 RS:0000137 BN/Elh XCO:0000099 control condition 631602 RS:0000137 BN/Elh XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 631602 RS:0000137 BN/Elh XCO:0000795 controlled sodium chloride content diet 4 4 % 631602 RS:0000137 BN/Elh XCO:0000127 norepinephrine 0.1 1 ug/kg/min 631602 RS:0000137 BN/Elh XCO:0000145 phenylephrine 4 4 ug/kg 2313222 RS:0001805 BN/HsdMcwiCrl XCO:0000360 arterial catheter implantation 2313222 RS:0001805 BN/HsdMcwiCrl XCO:0000099 control condition 2313222 RS:0001805 BN/HsdMcwiCrl XCO:0000812 controlled hemorrhage 1549809 RS:0001209 BN/KtsSlc XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1549809 RS:0001209 BN/KtsSlc XCO:0000102 fasting 1549809 RS:0001209 BN/KtsSlc XCO:0000087 specific pathogen-free condition 1549800 RS:0001208 BN/KunKtsSlc XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1549800 RS:0001208 BN/KunKtsSlc XCO:0000102 fasting 1549800 RS:0001208 BN/KunKtsSlc XCO:0000087 specific pathogen-free condition 61498 RS:0000145 BN/NHsdMcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 61498 RS:0000145 BN/NHsdMcwi XCO:0000116 Kreb's solution perfusate 61498 RS:0000145 BN/NHsdMcwi XCO:0000121 NG-nitroarginine methyl ester 5 5 mg/kg 61498 RS:0000145 BN/NHsdMcwi XCO:0000143 acetylcholine 0 30 umol/l 61498 RS:0000145 BN/NHsdMcwi XCO:0000143 acetylcholine 0.1 0.1 ug/kg/min 61498 RS:0000145 BN/NHsdMcwi XCO:0000143 acetylcholine 0.2 0.2 ug/kg/min 61498 RS:0000145 BN/NHsdMcwi XCO:0000012 air carbon dioxide content 7 7 % 61498 RS:0000145 BN/NHsdMcwi XCO:0000012 air carbon dioxide content 7 % 61498 RS:0000145 BN/NHsdMcwi XCO:0000126 angiotensin 5 5 ng/kg/min 61498 RS:0000145 BN/NHsdMcwi XCO:0000126 angiotensin 10 10 ng/kg/min 61498 RS:0000145 BN/NHsdMcwi XCO:0000126 angiotensin 25 25 ng/kg/min 61498 RS:0000145 BN/NHsdMcwi XCO:0000126 angiotensin 50 50 ng/kg/min 61498 RS:0000145 BN/NHsdMcwi XCO:0000191 angiotensin II 20 20 ng/kg/min 61498 RS:0000145 BN/NHsdMcwi XCO:0000191 angiotensin II 100 100 ng/kg/min 61498 RS:0000145 BN/NHsdMcwi XCO:0000191 angiotensin II 200 200 ng/kg/min 61498 RS:0000145 BN/NHsdMcwi XCO:0000099 control condition 61498 RS:0000145 BN/NHsdMcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 61498 RS:0000145 BN/NHsdMcwi XCO:0000010 controlled air oxygen content 12 12 % 61498 RS:0000145 BN/NHsdMcwi XCO:0000010 controlled air oxygen content 12 % 61498 RS:0000145 BN/NHsdMcwi XCO:0000182 controlled exposure to ambient light 61498 RS:0000145 BN/NHsdMcwi XCO:0000183 controlled exposure to darkness 61498 RS:0000145 BN/NHsdMcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 61498 RS:0000145 BN/NHsdMcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 61498 RS:0000145 BN/NHsdMcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 61498 RS:0000145 BN/NHsdMcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 61498 RS:0000145 BN/NHsdMcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 61498 RS:0000145 BN/NHsdMcwi XCO:0000790 controlled sodium chloride content drinking water 1 1 % 61498 RS:0000145 BN/NHsdMcwi XCO:0000790 controlled sodium chloride content drinking water 2 2 % 61498 RS:0000145 BN/NHsdMcwi XCO:0000022 controlled sodium content diet 0 % 61498 RS:0000145 BN/NHsdMcwi XCO:0000022 controlled sodium content diet 0.1 0.1 % 61498 RS:0000145 BN/NHsdMcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 61498 RS:0000145 BN/NHsdMcwi XCO:0000022 controlled sodium content diet 4 4 % 61498 RS:0000145 BN/NHsdMcwi XCO:0000022 controlled sodium content diet 8 8 % 61498 RS:0000145 BN/NHsdMcwi XCO:0000152 drug dose time series 61498 RS:0000145 BN/NHsdMcwi XCO:0000102 fasting 61498 RS:0000145 BN/NHsdMcwi XCO:0000124 furosemide 10 10 mg/kg 61498 RS:0000145 BN/NHsdMcwi XCO:0000134 methacholine 0 11.06 mg/kg 61498 RS:0000145 BN/NHsdMcwi XCO:0000138 methylene blue 10 10 umol/l 61498 RS:0000145 BN/NHsdMcwi XCO:0000127 norepinephrine 0.1 0.1 ng/kg/min 61498 RS:0000145 BN/NHsdMcwi XCO:0000127 norepinephrine 0.2 0.2 ng/kg/min 61498 RS:0000145 BN/NHsdMcwi XCO:0000127 norepinephrine 0.5 0.5 ng/kg/min 61498 RS:0000145 BN/NHsdMcwi XCO:0000127 norepinephrine 0.5 0.5 ug/kg/min 61498 RS:0000145 BN/NHsdMcwi XCO:0000127 norepinephrine 1 1 ng/kg/min 61498 RS:0000145 BN/NHsdMcwi XCO:0000127 norepinephrine 1 1 ug/kg/min 61498 RS:0000145 BN/NHsdMcwi XCO:0000127 norepinephrine 3 3 ug/kg/min 61498 RS:0000145 BN/NHsdMcwi XCO:0000118 perfusate suspended 61498 RS:0000145 BN/NHsdMcwi XCO:0000145 phenylephrine 0 300 umol/l 61498 RS:0000145 BN/NHsdMcwi XCO:0000145 phenylephrine 1 1 umol/l 61498 RS:0000145 BN/NHsdMcwi XCO:0000145 phenylephrine 10 10 umol/l 61498 RS:0000145 BN/NHsdMcwi XCO:0000150 potassium ion 80 80 mmol/l 61498 RS:0000145 BN/NHsdMcwi XCO:0000003 resting on treadmill 61498 RS:0000145 BN/NHsdMcwi XCO:0000005 running on treadmill 1.6 1.6 m/min 61498 RS:0000145 BN/NHsdMcwi XCO:0000153 sample resting period 61498 RS:0000145 BN/NHsdMcwi XCO:0000142 sodium nitroprusside 0 3 umol/l 61498 RS:0000145 BN/NHsdMcwi XCO:0000055 tactile electric shock exposure 2 2 % 61498 RS:0000145 BN/NHsdMcwi XCO:0000004 walking on treadmill 0.8 0.8 m/min 61498 RS:0000145 BN/NHsdMcwi XCO:0000021 water 737964 RS:0000146 BN/OlaHsd XCO:0000266 Freund's complete adjuvant 100 100 ul 737964 RS:0000146 BN/OlaHsd XCO:0000291 peripheral myelin protein 2 peptide 58-81 100 100 ug 737964 RS:0000146 BN/OlaHsd XCO:0000292 peripheral nerve myelin 2 2 mg 1354669 RS:0000148 BN/OrlIcoCrlf XCO:0000099 control condition 1354669 RS:0000148 BN/OrlIcoCrlf XCO:0000102 fasting 1354669 RS:0000148 BN/OrlIcoCrlf XCO:0000739 housing in trios 1354669 RS:0000148 BN/OrlIcoCrlf XCO:0000744 housing with Haemophilus H21-infected subject 1354669 RS:0000148 BN/OrlIcoCrlf XCO:0000745 housing with Haemophilus H35-infected subject 1354669 RS:0000148 BN/OrlIcoCrlf XCO:0000746 housing with Pasteurella pneumotropica-infected subject 1354669 RS:0000148 BN/OrlIcoCrlf XCO:0000747 housing with Pasteurellaceae-infected subject 1354669 RS:0000148 BN/OrlIcoCrlf XCO:0000189 physical restraint on immobilization board 5508393 RS:0002938 BN/RijHsd XCO:0000743 Haemophilus 631594 RS:0000152 BN/Rj XCO:0000099 control condition 1549801 RS:0000430 BN/Seac XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1549801 RS:0000430 BN/Seac XCO:0000099 control condition 1549801 RS:0000430 BN/Seac XCO:0000246 controlled cholesterol content diet 1 1 % 1549801 RS:0000430 BN/Seac XCO:0000247 controlled olive oil content diet 10 10 % 1549801 RS:0000430 BN/Seac XCO:0000102 fasting 1549801 RS:0000430 BN/Seac XCO:0000103 glucose solution 2 2 g/kg 1549801 RS:0000430 BN/Seac XCO:0000087 specific pathogen-free condition 61115 RS:0000154 BN/SsN XCO:0000265 Freund's incomplete adjuvant 50 50 % 61115 RS:0000154 BN/SsN XCO:0000099 control condition 61115 RS:0000154 BN/SsN XCO:0000103 glucose solution 2 2 g/kg 61115 RS:0000154 BN/SsN XCO:0000281 type II collagen 2 2 mg/kg 61115 RS:0000154 BN/SsN XCO:0000281 type II collagen 100 100 ug 10008 RS:0000155 BN/SsNHsd XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 10008 RS:0000155 BN/SsNHsd XCO:0000092 17 beta-estradiol 27.5 27.5 mg 10008 RS:0000155 BN/SsNHsd XCO:0000208 2-acetamidofluorene 0.02 0.02 % 10008 RS:0000155 BN/SsNHsd XCO:0000208 2-acetamidofluorene 0.02 0.02 mg/kg 10008 RS:0000155 BN/SsNHsd XCO:0000206 N-nitrosodiethylamine 150 150 mg/kg 10008 RS:0000155 BN/SsNHsd XCO:0000268 balloon angioplasty 10008 RS:0000155 BN/SsNHsd XCO:0000099 control condition 10008 RS:0000155 BN/SsNHsd XCO:0000295 diethylstilbestrol 5 5 mg 10008 RS:0000155 BN/SsNHsd XCO:0000102 fasting 10008 RS:0000155 BN/SsNHsd XCO:0000210 partial hepatectomy 10008 RS:0000155 BN/SsNHsd XCO:0000100 sham surgical control condition 10008 RS:0000155 BN/SsNHsd XCO:0000087 specific pathogen-free condition 10008 RS:0000155 BN/SsNHsd XCO:0000027 surgical implantation 1302631 RS:0000156 BN/SsNSlc XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302631 RS:0000156 BN/SsNSlc XCO:0000099 control condition 1302631 RS:0000156 BN/SsNSlc XCO:0000102 fasting 1302631 RS:0000156 BN/SsNSlc XCO:0000087 specific pathogen-free condition 1302613 RS:0000157 BN/fMaiHok XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302613 RS:0000157 BN/fMaiHok XCO:0000102 fasting 1302613 RS:0000157 BN/fMaiHok XCO:0000087 specific pathogen-free condition 2314655 RS:0002019 BRAT-Avpdi/BluHsd XCO:0000713 desmopressin 100 100 ug/kg 2314655 RS:0002019 BRAT-Avpdi/BluHsd XCO:0000155 sodium chloride solution 1 1 ml 61118 RS:0000165 BUF/Mna XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 61118 RS:0000165 BUF/Mna XCO:0000099 control condition 61118 RS:0000165 BUF/Mna XCO:0000102 fasting 61118 RS:0000165 BUF/Mna XCO:0000087 specific pathogen-free condition 60986 RS:0000166 BUF/N XCO:0000099 control condition 60986 RS:0000166 BUF/N XCO:0000103 glucose solution 2 2 g/kg 1358998 RS:0000167 BUF/NHsd XCO:0000099 control condition 1549804 RS:0000467 BUF/NacJcl XCO:0000355 controlled N-methyl-N'-nitro-N-nitrosoguanidine content drinking water 83 83 mg/l 2307359 RS:0001813 BUF/SimRijHsd XCO:0000743 Haemophilus 2307121 RS:0001819 BXH2/Cub XCO:0000025 controlled fat content diet 10.4 10.4 % of calories 2307121 RS:0001819 BXH2/Cub XCO:0000030 controlled protein content diet 19.6 19.6 % of calories 2307121 RS:0001819 BXH2/Cub XCO:0000211 controlled sucrose content diet 70 70 % of calories 2307121 RS:0001819 BXH2/Cub XCO:0000102 fasting 5508398 RS:0002943 BluHsd:LE XCO:0000397 bisphenol A 2.5 2.5 ug/kg 5508398 RS:0002943 BluHsd:LE XCO:0000397 bisphenol A 25 25 ug/kg 5508398 RS:0002943 BluHsd:LE XCO:0000025 controlled fat content diet 21.2 21.2 % 5508398 RS:0002943 BluHsd:LE XCO:0000420 controlled in utero environment 5508398 RS:0002943 BluHsd:LE XCO:0000415 maternal milk 5508398 RS:0002943 BluHsd:LE XCO:0000101 vehicle control condition 1357191 RS:0000181 CDS/Ygl XCO:0000099 control condition 60998 RS:0000184 COP XCO:0000208 2-acetamidofluorene 0.02 0.02 % 60998 RS:0000184 COP XCO:0000266 Freund's complete adjuvant 100 100 ul 60998 RS:0000184 COP XCO:0000206 N-nitrosodiethylamine 150 150 mg/kg 60998 RS:0000184 COP XCO:0000030 controlled protein content diet 60998 RS:0000184 COP XCO:0000210 partial hepatectomy 60998 RS:0000184 COP XCO:0000291 peripheral myelin protein 2 peptide 58-81 100 100 ug 60998 RS:0000184 COP XCO:0000292 peripheral nerve myelin 2 2 mg 1599764 RS:0001215 COP.DA-(D16Rat12-D16Rat90)/Mco XCO:0000099 control condition 1599764 RS:0001215 COP.DA-(D16Rat12-D16Rat90)/Mco XCO:0000102 fasting 1599764 RS:0001215 COP.DA-(D16Rat12-D16Rat90)/Mco XCO:0000005 running on treadmill 10 10 m/min 1599769 RS:0001216 COP.DA-(D3Rat233-D3Mgh14)/Mco XCO:0000099 control condition 1599769 RS:0001216 COP.DA-(D3Rat233-D3Mgh14)/Mco XCO:0000102 fasting 1599769 RS:0001216 COP.DA-(D3Rat233-D3Mgh14)/Mco XCO:0000005 running on treadmill 10 10 m/min 1358153 RS:0000185 COP/CrCrl XCO:0000092 17 beta-estradiol 27.5 27.5 mg 1358153 RS:0000185 COP/CrCrl XCO:0000099 control condition 1358153 RS:0000185 COP/CrCrl XCO:0000295 diethylstilbestrol 5 5 mg 1358153 RS:0000185 COP/CrCrl XCO:0000100 sham surgical control condition 1358153 RS:0000185 COP/CrCrl XCO:0000027 surgical implantation 10011 RS:0000186 COP/OlaHsd XCO:0000092 17 beta-estradiol 27.5 27.5 mg 10011 RS:0000186 COP/OlaHsd XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 10011 RS:0000186 COP/OlaHsd XCO:0000360 arterial catheter implantation 10011 RS:0000186 COP/OlaHsd XCO:0000099 control condition 10011 RS:0000186 COP/OlaHsd XCO:0000812 controlled hemorrhage 10011 RS:0000186 COP/OlaHsd XCO:0000102 fasting 10011 RS:0000186 COP/OlaHsd XCO:0000296 running on inclined treadmill 10 10 m/min 10011 RS:0000186 COP/OlaHsd XCO:0000005 running on treadmill 10 10 m/min 734476 RS:0000064 Crl:CD(SD) XCO:0000090 7,12-dimethyltetraphene (DMBA) 30 30 mg/kg 734476 RS:0000064 Crl:CD(SD) XCO:0000606 AMG-8718 10 10 mg/kg 734476 RS:0000064 Crl:CD(SD) XCO:0000606 AMG-8718 100 100 mg/kg 734476 RS:0000064 Crl:CD(SD) XCO:0000606 AMG-8718 600 600 mg/kg 734476 RS:0000064 Crl:CD(SD) XCO:0000137 FAPGG 0.6 0.6 mmol/l 734476 RS:0000064 Crl:CD(SD) XCO:0000116 Kreb's solution perfusate 734476 RS:0000064 Crl:CD(SD) XCO:0000388 acetaminophen 300 300 mg/kg 734476 RS:0000064 Crl:CD(SD) XCO:0000388 acetaminophen 500 500 mg/kg 734476 RS:0000064 Crl:CD(SD) XCO:0000143 acetylcholine 0 30 umol/l 734476 RS:0000064 Crl:CD(SD) XCO:0000012 air carbon dioxide content 7 7 % 734476 RS:0000064 Crl:CD(SD) XCO:0000012 air carbon dioxide content 7 % 734476 RS:0000064 Crl:CD(SD) XCO:0000126 angiotensin 5 5 ng/kg/min 734476 RS:0000064 Crl:CD(SD) XCO:0000126 angiotensin 10 10 ng/kg/min 734476 RS:0000064 Crl:CD(SD) XCO:0000126 angiotensin 25 25 ng/kg/min 734476 RS:0000064 Crl:CD(SD) XCO:0000126 angiotensin 50 50 ng/kg/min 734476 RS:0000064 Crl:CD(SD) XCO:0000397 bisphenol A 25 25 ug/kg 734476 RS:0000064 Crl:CD(SD) XCO:0000397 bisphenol A 250 250 ug/kg 734476 RS:0000064 Crl:CD(SD) XCO:0000099 control condition 734476 RS:0000064 Crl:CD(SD) XCO:0000010 controlled air oxygen content 12 12 % 734476 RS:0000064 Crl:CD(SD) XCO:0000010 controlled air oxygen content 12 % 734476 RS:0000064 Crl:CD(SD) XCO:0000146 controlled oxygen content Kreb's solution perfusate 734476 RS:0000064 Crl:CD(SD) XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 734476 RS:0000064 Crl:CD(SD) XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 734476 RS:0000064 Crl:CD(SD) XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 734476 RS:0000064 Crl:CD(SD) XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 734476 RS:0000064 Crl:CD(SD) XCO:0000022 controlled sodium content diet 0 % 734476 RS:0000064 Crl:CD(SD) XCO:0000022 controlled sodium content diet 0.4 0.4 % 734476 RS:0000064 Crl:CD(SD) XCO:0000022 controlled sodium content diet 4 4 % 734476 RS:0000064 Crl:CD(SD) XCO:0000152 drug dose time series 734476 RS:0000064 Crl:CD(SD) XCO:0000102 fasting 734476 RS:0000064 Crl:CD(SD) XCO:0000124 furosemide 10 10 mg/kg 734476 RS:0000064 Crl:CD(SD) XCO:0000415 maternal milk 734476 RS:0000064 Crl:CD(SD) XCO:0000134 methacholine 0 11.06 mg/kg 734476 RS:0000064 Crl:CD(SD) XCO:0000138 methylene blue 10 10 umol/l 734476 RS:0000064 Crl:CD(SD) XCO:0000127 norepinephrine 0.1 0.1 ng/kg/min 734476 RS:0000064 Crl:CD(SD) XCO:0000127 norepinephrine 0.2 0.2 ng/kg/min 734476 RS:0000064 Crl:CD(SD) XCO:0000127 norepinephrine 0.5 0.5 ng/kg/min 734476 RS:0000064 Crl:CD(SD) XCO:0000127 norepinephrine 1 1 ng/kg/min 734476 RS:0000064 Crl:CD(SD) XCO:0000118 perfusate suspended 734476 RS:0000064 Crl:CD(SD) XCO:0000145 phenylephrine 0 300 umol/l 734476 RS:0000064 Crl:CD(SD) XCO:0000145 phenylephrine 1 1 umol/l 734476 RS:0000064 Crl:CD(SD) XCO:0000145 phenylephrine 10 10 umol/l 734476 RS:0000064 Crl:CD(SD) XCO:0000150 potassium ion 80 80 mmol/l 734476 RS:0000064 Crl:CD(SD) XCO:0000003 resting on treadmill 734476 RS:0000064 Crl:CD(SD) XCO:0000461 restricted feeding 4 4 h 734476 RS:0000064 Crl:CD(SD) XCO:0000005 running on treadmill 1.6 1.6 m/min 734476 RS:0000064 Crl:CD(SD) XCO:0000153 sample resting period 734476 RS:0000064 Crl:CD(SD) XCO:0000142 sodium nitroprusside 0 3 umol/l 734476 RS:0000064 Crl:CD(SD) XCO:0000069 standard diet 734476 RS:0000064 Crl:CD(SD) XCO:0000101 vehicle control condition 0 0 mg/kg 734476 RS:0000064 Crl:CD(SD) XCO:0000101 vehicle control condition ml/kg/d 734476 RS:0000064 Crl:CD(SD) XCO:0000101 vehicle control condition 734476 RS:0000064 Crl:CD(SD) XCO:0000004 walking on treadmill 0.8 0.8 m/min 2308852 RS:0001827 Crl:LE XCO:0000099 control condition 2308852 RS:0001827 Crl:LE XCO:0000102 fasting 737891 RS:0000695 Crl:SD XCO:0000519 anti-Shiga toxin 1 beta monoclonal antibody 13C4 0.5 0.5 mg/kg/d 737891 RS:0000695 Crl:SD XCO:0000517 anti-transforming growth factor beta antibody 0.5 0.5 mg/kg/d 737891 RS:0000695 Crl:SD XCO:0000360 arterial catheter implantation 737891 RS:0000695 Crl:SD XCO:0000099 control condition 737891 RS:0000695 Crl:SD XCO:0000406 controlled bisphenol A content drinking water 0.025 0.025 mg/l 737891 RS:0000695 Crl:SD XCO:0000406 controlled bisphenol A content drinking water 0.25 0.25 mg/l 737891 RS:0000695 Crl:SD XCO:0000406 controlled bisphenol A content drinking water 2.5 2.5 mg/l 737891 RS:0000695 Crl:SD XCO:0000023 controlled ethanol content drinking water 1 1 % 737891 RS:0000695 Crl:SD XCO:0000244 controlled fructose content diet 66 66 % 737891 RS:0000695 Crl:SD XCO:0000429 controlled fructose content drinking water 5 5 % 737891 RS:0000695 Crl:SD XCO:0000812 controlled hemorrhage 737891 RS:0000695 Crl:SD XCO:0000409 controlled metformin content drinking water 350 500 mg/kg/d 737891 RS:0000695 Crl:SD XCO:0000030 controlled protein content diet 20 20 % 737891 RS:0000695 Crl:SD XCO:0000542 enalapril 15 15 mg/l 737891 RS:0000695 Crl:SD XCO:0000245 insulin 2 2 U/kg/d 737891 RS:0000695 Crl:SD XCO:0000245 insulin 737891 RS:0000695 Crl:SD XCO:0000588 perindopril 1 1 mg/kg/d 737891 RS:0000695 Crl:SD XCO:0000241 streptozotocin 60 60 mg/kg/d 737891 RS:0000695 Crl:SD XCO:0000021 water 737929 RS:0001011 Crl:WI XCO:0000099 control condition 737929 RS:0001011 Crl:WI XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 20 20 mg/kg/d 737929 RS:0001011 Crl:WI XCO:0000962 controlled ex vivo heart perfusion 737929 RS:0001011 Crl:WI XCO:0000148 controlled oxygen content physiological salt solution perfusate 40 40 mmHg 737929 RS:0001011 Crl:WI XCO:0000942 controlled saxagliptin content diet 10 10 mg/kg/d 737929 RS:0001011 Crl:WI XCO:0000839 finerenone 10 10 mg/kg/d 737929 RS:0001011 Crl:WI XCO:0000839 finerenone 10 10 737929 RS:0001011 Crl:WI XCO:0000839 finerenone 737929 RS:0001011 Crl:WI XCO:0000245 insulin 4 4 IU/kg 737929 RS:0001011 Crl:WI XCO:0000005 running on treadmill 0 10 m/min 737929 RS:0001011 Crl:WI XCO:0000005 running on treadmill 15 15 m/min 737929 RS:0001011 Crl:WI XCO:0000069 standard diet 737929 RS:0001011 Crl:WI XCO:0000241 streptozotocin 55 55 mg/kg 737929 RS:0001011 Crl:WI XCO:0000101 vehicle control condition 10 10 mg/kg/d 737929 RS:0001011 Crl:WI XCO:0000101 vehicle control condition 2308816 RS:0001833 Crl:WI(Han) XCO:0000095 bilateral ovariectomy 2308816 RS:0001833 Crl:WI(Han) XCO:0000102 fasting 2308816 RS:0001833 Crl:WI(Han) XCO:0000100 sham surgical control condition 2312472 RS:0001834 Crl:WI(WU) XCO:0000597 abdominal aortic constriction 2312472 RS:0001834 Crl:WI(WU) XCO:0000590 icatibant 0.4 0.4 mg/kg/d 2312472 RS:0001834 Crl:WI(WU) XCO:0000161 losartan 3 3 mg/kg/d 2312472 RS:0001834 Crl:WI(WU) XCO:0000591 quinapril 2 2 mg/kg/d 2312472 RS:0001834 Crl:WI(WU) XCO:0000100 sham surgical control condition 2312472 RS:0001834 Crl:WI(WU) XCO:0000598 thoracic aortic constriction 11040548 RS:0004102 CrlCembe:WI XCO:0000099 control condition 2312504 RS:0001840 Crlj:WI XCO:0000121 NG-nitroarginine methyl ester 50 50 mg/kg 2312504 RS:0001840 Crlj:WI XCO:0000143 acetylcholine 5 5 ug/kg/min 2312504 RS:0001840 Crlj:WI XCO:0000099 control condition 2312504 RS:0001840 Crlj:WI XCO:0000010 controlled air oxygen content 5 5 % 2312504 RS:0001840 Crlj:WI XCO:0000010 controlled air oxygen content 21 21 % 2312504 RS:0001840 Crlj:WI XCO:0000102 fasting 2312504 RS:0001840 Crlj:WI XCO:0000275 glucose 2 2 g/kg 2312504 RS:0001840 Crlj:WI XCO:0000564 meclofenamate 3 3 mg/kg 2312504 RS:0001840 Crlj:WI XCO:0000142 sodium nitroprusside 5 5 ug/kg/min 2312504 RS:0001840 Crlj:WI XCO:0000101 vehicle control condition 0.15 0.15 ml 8547938 RS:0000696 CrljJcl:SD XCO:0000406 controlled bisphenol A content drinking water 0.01 0.01 mg/l 8547938 RS:0000696 CrljJcl:SD XCO:0000406 controlled bisphenol A content drinking water 0.1 0.1 mg/l 8547938 RS:0000696 CrljJcl:SD XCO:0000406 controlled bisphenol A content drinking water 1 1 mg/l 8547938 RS:0000696 CrljJcl:SD XCO:0000420 controlled in utero environment 8547938 RS:0000696 CrljJcl:SD XCO:0000298 controlled saccharin content drinking water 0.25 0.25 % 8547938 RS:0000696 CrljJcl:SD XCO:0000298 controlled saccharin content drinking water 0.5 0.5 % 8547938 RS:0000696 CrljJcl:SD XCO:0000433 controlled sucrose content drinking water 15 15 % 8547938 RS:0000696 CrljJcl:SD XCO:0000412 gestation 8547938 RS:0000696 CrljJcl:SD XCO:0000414 lactation 8547938 RS:0000696 CrljJcl:SD XCO:0000415 maternal milk 8547938 RS:0000696 CrljJcl:SD XCO:0000021 water 14394619 RS:0004703 DA-Tph2em2Mcwi+/+ XCO:0000099 control condition 14394620 RS:0004704 DA-Tph2em2Mcwi+/- XCO:0000099 control condition 14394621 RS:0004705 DA-Tph2em2Mcwi-/- XCO:0000099 control condition 14394616 RS:0004697 DA-Tph2em3Mcwi+/+ XCO:0000099 control condition 14394617 RS:0004702 DA-Tph2em3Mcwi+/- XCO:0000099 control condition 14394618 RS:0004701 DA-Tph2em3Mcwi-/- XCO:0000099 control condition 1331827 RS:0000196 DA.ACI-(D10Rat10-D10Rat142) XCO:0000195 myelin oligodendrocyte glycoprotein 200 200 ul 1331828 RS:0000197 DA.ACI-(D10Rat12-D10Rat144) XCO:0000195 myelin oligodendrocyte glycoprotein 200 200 ul 1331833 RS:0000198 DA.ACI-(D10Rat15-D10Rat29) XCO:0000195 myelin oligodendrocyte glycoprotein 200 200 ul 1331816 RS:0000199 DA.ACI-(D10Rat2-D10Rat29)/Kini XCO:0000195 myelin oligodendrocyte glycoprotein 20 20 ug 1331816 RS:0000199 DA.ACI-(D10Rat2-D10Rat29)/Kini XCO:0000195 myelin oligodendrocyte glycoprotein 200 200 ul 1331822 RS:0000200 DA.ACI-(D10Rat2-D10Rat6) XCO:0000195 myelin oligodendrocyte glycoprotein 200 200 ul 1331824 RS:0000201 DA.ACI-(D10Rat219-D10Rat29) XCO:0000195 myelin oligodendrocyte glycoprotein 200 200 ul 7244380 RS:0003430 DA.F344(Cia3c)/Arb XCO:0000182 controlled exposure to ambient light 7244381 RS:0003431 DA.F344(Cia3e)/Arb XCO:0000182 controlled exposure to ambient light 631282 RS:0000209 DA.F344-(D10Arb20-D10Arb22)/Arb XCO:0000265 Freund's incomplete adjuvant 50 50 % 631282 RS:0000209 DA.F344-(D10Arb20-D10Arb22)/Arb XCO:0000182 controlled exposure to ambient light 631282 RS:0000209 DA.F344-(D10Arb20-D10Arb22)/Arb XCO:0000281 type II collagen 2 2 mg/kg 631283 RS:0000210 DA.F344-(D10Arb21-D10Arb22)/Arb XCO:0000182 controlled exposure to ambient light 1299877 RS:0001225 DA.F344-(D10Rat204-D10Arb22)/Arb XCO:0000265 Freund's incomplete adjuvant 50 50 % 1299877 RS:0001225 DA.F344-(D10Rat204-D10Arb22)/Arb XCO:0000281 type II collagen 2 2 mg/kg 1299871 RS:0000212 DA.F344-(D20Arb2-D20Arb8)/Arb XCO:0000182 controlled exposure to ambient light 1299878 RS:0000213 DA.F344-(D4Arb30-D4Arb4)/Arb XCO:0000182 controlled exposure to ambient light 7243955 RS:0003425 DA.F344-(D4Got44-D4Arb21)/Arb XCO:0000182 controlled exposure to ambient light 7243960 RS:0003426 DA.F344-(D4Got44-D4Rat128)/Arb XCO:0000182 controlled exposure to ambient light 7243963 RS:0003427 DA.F344-(D4Uia2-D4Wox21)/Arb XCO:0000182 controlled exposure to ambient light 1299875 RS:0000214 DA.F344-(D7Rat22-D7Mit2)/Nsi XCO:0000273 carrageenan 1 1 ml 1299875 RS:0000214 DA.F344-(D7Rat22-D7Mit2)/Nsi XCO:0000058 room temperature 10 10 ml 1299875 RS:0000214 DA.F344-(D7Rat22-D7Mit2)/Nsi XCO:0000058 room temperature 14 14 ml 1299872 RS:0000216 DA.F344-(D8Arb15-D8Arb22)/Arb XCO:0000273 carrageenan 1 1 ml 1299872 RS:0000216 DA.F344-(D8Arb15-D8Arb22)/Arb XCO:0000058 room temperature 10 10 ml 1299872 RS:0000216 DA.F344-(D8Arb15-D8Arb22)/Arb XCO:0000058 room temperature 14 14 ml 629491 RS:0000221 DA.F344-Aia1/2 XCO:0000182 controlled exposure to ambient light 8551864 RS:0003683 DA.LEW.1AV1-(D4Mgh17-D4Mgh21)/Kiru XCO:0000265 Freund's incomplete adjuvant 200 200 ul 731193 RS:0000225 DA.PVG-(D4Rat141-D4Mgh11) XCO:0000265 Freund's incomplete adjuvant 200 200 ul 4889890 RS:0002506 DA.PVG.1AV1-(D17Rat8-D17Rat37)/Kini XCO:0000265 Freund's incomplete adjuvant 100 100 ul 4889890 RS:0002506 DA.PVG.1AV1-(D17Rat8-D17Rat37)/Kini XCO:0000099 control condition 4889890 RS:0002506 DA.PVG.1AV1-(D17Rat8-D17Rat37)/Kini XCO:0000195 myelin oligodendrocyte glycoprotein 0.1 0.1 ug/g 4889890 RS:0002506 DA.PVG.1AV1-(D17Rat8-D17Rat37)/Kini XCO:0000195 myelin oligodendrocyte glycoprotein 15 20 ug 4889890 RS:0002506 DA.PVG.1AV1-(D17Rat8-D17Rat37)/Kini XCO:0000195 myelin oligodendrocyte glycoprotein 15 22 ug 4889890 RS:0002506 DA.PVG.1AV1-(D17Rat8-D17Rat37)/Kini XCO:0000195 myelin oligodendrocyte glycoprotein 30 30 ug 7349357 RS:0003524 DA.PVG.1AV1-(D4Got126-D4Got136) XCO:0000265 Freund's incomplete adjuvant 200 200 ul 7349357 RS:0003524 DA.PVG.1AV1-(D4Got126-D4Got136) XCO:0000195 myelin oligodendrocyte glycoprotein 20 20 ug/200 ul 8551887 RS:0003694 DA.PVG.1AV1-(D4Got126-D4Rat203)/Kiru XCO:0000265 Freund's incomplete adjuvant 200 200 ul 2317599 RS:0002389 DA.PVG.1AV1-(D4Got211-D4Mit12)/Kini XCO:0000195 myelin oligodendrocyte glycoprotein 13 85 ug/200 ul 2317791 RS:0002390 DA.PVG.1AV1-(D4Got60-D4Kini1)/Kini XCO:0000195 myelin oligodendrocyte glycoprotein 13 85 ug/200 ul 737859 RS:0000226 DA.PVG.1AV1-(D4Mgh17-D4Rat56) XCO:0000265 Freund's incomplete adjuvant 100 100 ul 737859 RS:0000226 DA.PVG.1AV1-(D4Mgh17-D4Rat56) XCO:0000265 Freund's incomplete adjuvant 200 200 ul 737859 RS:0000226 DA.PVG.1AV1-(D4Mgh17-D4Rat56) XCO:0000281 type II collagen 500 500 ug 8551885 RS:0003693 DA.PVG.1AV1-(D4Mit22-D4Rat84)/Kiru XCO:0000265 Freund's incomplete adjuvant 200 200 ul 2317596 RS:0002387 DA.PVG.1AV1-(D4Rat103-D4Mit12)/Kini XCO:0000195 myelin oligodendrocyte glycoprotein 13 85 ug/200 ul 7240512 RS:0003371 DA.PVG.1AV1-(D4Rat113-D4Kiru80)/Kiru XCO:0000265 Freund's incomplete adjuvant 200 200 ul 7240510 RS:0003370 DA.PVG.1AV1-(D4Rat113-D4Kiru96)/Kiru XCO:0000265 Freund's incomplete adjuvant 200 200 ul 8551892 RS:0003696 DA.PVG.1AV1-(D4Rat113-D4Rat62)/Kiru XCO:0000265 Freund's incomplete adjuvant 200 200 ul 8551872 RS:0003688 DA.PVG.1AV1-(D4Rat155-D4Rat113)/Kiru XCO:0000265 Freund's incomplete adjuvant 200 200 ul 737857 RS:0000227 DA.PVG.1AV1-(D4Rat155-D4Rat84) XCO:0000266 Freund's complete adjuvant 100 100 ul 737857 RS:0000227 DA.PVG.1AV1-(D4Rat155-D4Rat84) XCO:0000265 Freund's incomplete adjuvant 100 100 ul 737857 RS:0000227 DA.PVG.1AV1-(D4Rat155-D4Rat84) XCO:0000265 Freund's incomplete adjuvant 200 200 ul 737857 RS:0000227 DA.PVG.1AV1-(D4Rat155-D4Rat84) XCO:0000263 pristane 150 150 ul 737857 RS:0000227 DA.PVG.1AV1-(D4Rat155-D4Rat84) XCO:0000280 squalene 200 200 ul 737857 RS:0000227 DA.PVG.1AV1-(D4Rat155-D4Rat84) XCO:0000281 type II collagen 500 500 ug 737858 RS:0000228 DA.PVG.1AV1-(D4Rat155-Spr) XCO:0000265 Freund's incomplete adjuvant 100 100 ul 737858 RS:0000228 DA.PVG.1AV1-(D4Rat155-Spr) XCO:0000265 Freund's incomplete adjuvant 200 200 ul 737858 RS:0000228 DA.PVG.1AV1-(D4Rat155-Spr) XCO:0000263 pristane 150 150 ul 737858 RS:0000228 DA.PVG.1AV1-(D4Rat155-Spr) XCO:0000281 type II collagen 500 500 ug 8551876 RS:0003690 DA.PVG.1AV1-(D4Rat203-D4Got130)/Kiru XCO:0000265 Freund's incomplete adjuvant 200 200 ul 8551882 RS:0003692 DA.PVG.1AV1-(D4Rat203-D4Mit22)/Kiru XCO:0000265 Freund's incomplete adjuvant 200 200 ul 2317595 RS:0002386 DA.PVG.1AV1-(D4Rat23-D4Mit12)/Kini XCO:0000195 myelin oligodendrocyte glycoprotein 13 85 ug/200 ul 2317590 RS:0002385 DA.PVG.1AV1-(D4Rat23-D4Rat108)/Kini XCO:0000195 myelin oligodendrocyte glycoprotein 13 85 ug/200 ul 2317598 RS:0002388 DA.PVG.1AV1-(D4Rat231-D4Mit12)/Kini XCO:0000265 Freund's incomplete adjuvant 200 200 ul 2317598 RS:0002388 DA.PVG.1AV1-(D4Rat231-D4Mit12)/Kini XCO:0000195 myelin oligodendrocyte glycoprotein 13 85 ug/200 ul 8551889 RS:0003695 DA.PVG.1AV1-(D4Rat62-D4Got136)/Kiru XCO:0000265 Freund's incomplete adjuvant 200 200 ul 737861 RS:0000229 DA.PVG.1AV1-(D4Rat63-D4Rat203) XCO:0000265 Freund's incomplete adjuvant 100 100 ul 737861 RS:0000229 DA.PVG.1AV1-(D4Rat63-D4Rat203) XCO:0000265 Freund's incomplete adjuvant 200 200 ul 737861 RS:0000229 DA.PVG.1AV1-(D4Rat63-D4Rat203) XCO:0000263 pristane 150 150 ul 737861 RS:0000229 DA.PVG.1AV1-(D4Rat63-D4Rat203) XCO:0000280 squalene 200 200 ul 737861 RS:0000229 DA.PVG.1AV1-(D4Rat63-D4Rat203) XCO:0000281 type II collagen 500 500 ug 8551880 RS:0003691 DA.PVG.1AV1-(D4Rat63-D4Rat203)/Kiru XCO:0000265 Freund's incomplete adjuvant 200 200 ul 8551874 RS:0003689 DA.PVG.1AV1-(D4Rat63-D4Rat84)/Kiru XCO:0000265 Freund's incomplete adjuvant 200 200 ul 61114 RS:0000239 DA/Bkl XCO:0000156 0.9% sodium chloride solution 0.1 0.1 ml 61114 RS:0000239 DA/Bkl XCO:0000265 Freund's incomplete adjuvant 0.1 0.1 ml 61114 RS:0000239 DA/Bkl XCO:0000265 Freund's incomplete adjuvant 50 50 % 61114 RS:0000239 DA/Bkl XCO:0000360 arterial catheter implantation 61114 RS:0000239 DA/Bkl XCO:0000182 controlled exposure to ambient light 61114 RS:0000239 DA/Bkl XCO:0000281 type II collagen 2 2 mg/kg 1600340 RS:0001227 DA/BklArbNsi XCO:0000273 carrageenan 1 1 ml 1600340 RS:0001227 DA/BklArbNsi XCO:0000099 control condition 1600340 RS:0001227 DA/BklArbNsi XCO:0000058 room temperature 10 10 ml 1600340 RS:0001227 DA/BklArbNsi XCO:0000058 room temperature 14 14 ml 1357345 RS:0000243 DA/K XCO:0000099 control condition 1357345 RS:0000243 DA/K XCO:0000103 glucose solution 2 2 g/kg 734475 RS:0000244 DA/OlaHsd XCO:0000360 arterial catheter implantation 734475 RS:0000244 DA/OlaHsd XCO:0000268 balloon angioplasty 734475 RS:0000244 DA/OlaHsd XCO:0000099 control condition 734475 RS:0000244 DA/OlaHsd XCO:0000812 controlled hemorrhage 734475 RS:0000244 DA/OlaHsd XCO:0000296 running on inclined treadmill 10 10 m/min 734475 RS:0000244 DA/OlaHsd XCO:0000005 running on treadmill 10 10 m/min 61111 RS:0000247 DA/Slc XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 61111 RS:0000247 DA/Slc XCO:0000255 anti-glomerular basement membrane antibody 500 500 ul 61111 RS:0000247 DA/Slc XCO:0000395 controlled 4-nitroquinoline N-oxide content drinking water 0.001 0.001 % 61111 RS:0000247 DA/Slc XCO:0000395 controlled 4-nitroquinoline N-oxide content drinking water 10 10 mg/l 61111 RS:0000247 DA/Slc XCO:0000102 fasting 61111 RS:0000247 DA/Slc XCO:0000087 specific pathogen-free condition 737950 RS:0000242 DA/Ztm XCO:0000266 Freund's complete adjuvant 100 100 ul 737950 RS:0000242 DA/Ztm XCO:0000265 Freund's incomplete adjuvant 50 50 % 737950 RS:0000242 DA/Ztm XCO:0000265 Freund's incomplete adjuvant 100 100 ul 737950 RS:0000242 DA/Ztm XCO:0000195 myelin oligodendrocyte glycoprotein 0.25 0.25 mg/ml 737950 RS:0000242 DA/Ztm XCO:0000263 pristane 150 150 ul 737950 RS:0000242 DA/Ztm XCO:0000356 spinal cord homogenate 10 10 mg 737950 RS:0000242 DA/Ztm XCO:0000280 squalene 200 200 ul 737950 RS:0000242 DA/Ztm XCO:0000280 squalene 860 860 mg/ml 737950 RS:0000242 DA/Ztm XCO:0000281 type II collagen 500 500 ug 2307156 RS:0001858 DA/ZtmKini XCO:0000266 Freund's complete adjuvant 100 100 ul 2307156 RS:0001858 DA/ZtmKini XCO:0000265 Freund's incomplete adjuvant 100 100 ul 2307156 RS:0001858 DA/ZtmKini XCO:0000265 Freund's incomplete adjuvant 200 200 ul 2307156 RS:0001858 DA/ZtmKini XCO:0000099 control condition 2307156 RS:0001858 DA/ZtmKini XCO:0000195 myelin oligodendrocyte glycoprotein 0.09 0.09 ug/g 2307156 RS:0001858 DA/ZtmKini XCO:0000195 myelin oligodendrocyte glycoprotein 13 85 ug/200 ul 2307156 RS:0001858 DA/ZtmKini XCO:0000195 myelin oligodendrocyte glycoprotein 15 20 ug 2307156 RS:0001858 DA/ZtmKini XCO:0000195 myelin oligodendrocyte glycoprotein 15 22 ug 2307156 RS:0001858 DA/ZtmKini XCO:0000195 myelin oligodendrocyte glycoprotein 20 20 ug 2307156 RS:0001858 DA/ZtmKini XCO:0000195 myelin oligodendrocyte glycoprotein 20 20 ug/200 ul 2307156 RS:0001858 DA/ZtmKini XCO:0000195 myelin oligodendrocyte glycoprotein 30 30 ug 2307156 RS:0001858 DA/ZtmKini XCO:0000195 myelin oligodendrocyte glycoprotein 200 200 ul 2307156 RS:0001858 DA/ZtmKini XCO:0000291 peripheral myelin protein 2 peptide 58-81 100 100 ug 2307156 RS:0001858 DA/ZtmKini XCO:0000292 peripheral nerve myelin 2 2 mg 634373 RS:0001675 DA/ZtmRhd XCO:0000263 pristane 150 150 ul 2304037 RS:0001859 DDI/Ddia XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2304037 RS:0001859 DDI/Ddia XCO:0000102 fasting 2304037 RS:0001859 DDI/Ddia XCO:0000087 specific pathogen-free condition 1302645 RS:0000252 DMY/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302645 RS:0000252 DMY/Kyo XCO:0000102 fasting 1302645 RS:0000252 DMY/Kyo XCO:0000087 specific pathogen-free condition 2304286 RS:0001860 DMYC/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2304286 RS:0001860 DMYC/Kyo XCO:0000102 fasting 2304286 RS:0001860 DMYC/Kyo XCO:0000087 specific pathogen-free condition 2304305 RS:0001861 DOB/Oda XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2304305 RS:0001861 DOB/Oda XCO:0000102 fasting 2304305 RS:0001861 DOB/Oda XCO:0000087 specific pathogen-free condition 1302719 RS:0000378 DON/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302719 RS:0000378 DON/Kyo XCO:0000102 fasting 1302719 RS:0000378 DON/Kyo XCO:0000087 specific pathogen-free condition 2304125 RS:0001862 DRH.F344-(D1Mgh8-D1Mgh12)/Shigm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2304125 RS:0001862 DRH.F344-(D1Mgh8-D1Mgh12)/Shigm XCO:0000440 controlled 3-methyl-4'-dimethylaminoazobenzene content diet 0.06 0.06 % 2304125 RS:0001862 DRH.F344-(D1Mgh8-D1Mgh12)/Shigm XCO:0000102 fasting 2304125 RS:0001862 DRH.F344-(D1Mgh8-D1Mgh12)/Shigm XCO:0000087 specific pathogen-free condition 625659 RS:0000249 DRH/Seac XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 625659 RS:0000249 DRH/Seac XCO:0000440 controlled 3-methyl-4'-dimethylaminoazobenzene content diet 0.06 0.06 % 625659 RS:0000249 DRH/Seac XCO:0000102 fasting 625659 RS:0000249 DRH/Seac XCO:0000087 specific pathogen-free condition 60995 RS:0000250 DRY XCO:0000099 control condition 631158 RS:0000382 DXE1/Ztm XCO:0000263 pristane 150 150 ul 631160 RS:0000383 DXE2/Ztm XCO:0000263 pristane 150 150 ul 631161 RS:0000384 DXE3/Ztm XCO:0000263 pristane 150 150 ul 61013 RS:0000202 E3 XCO:0000263 pristane 150 150 ul 737913 RS:0000261 E3/Ztm XCO:0000356 spinal cord homogenate 10 10 mg 634374 RS:0000208 E3/ZtmRhd XCO:0000263 pristane 150 150 ul 1302711 RS:0000269 ExHC/Seac XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302711 RS:0000269 ExHC/Seac XCO:0000099 control condition 1302711 RS:0000269 ExHC/Seac XCO:0000246 controlled cholesterol content diet 1 1 % 1302711 RS:0000269 ExHC/Seac XCO:0000247 controlled olive oil content diet 10 10 % 1302711 RS:0000269 ExHC/Seac XCO:0000102 fasting 1302711 RS:0000269 ExHC/Seac XCO:0000087 specific pathogen-free condition 2306090 RS:0001867 ExHC/Ta XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2306090 RS:0001867 ExHC/Ta XCO:0000102 fasting 2306090 RS:0001867 ExHC/Ta XCO:0000087 specific pathogen-free condition 60994 RS:0000215 F344 XCO:0000609 4-methyl-2-(piperidin-1-yl)-quinoline 0.15 0.15 mg/kg 60994 RS:0000215 F344 XCO:0000609 4-methyl-2-(piperidin-1-yl)-quinoline 0.5 0.5 mg/kg 60994 RS:0000215 F344 XCO:0000609 4-methyl-2-(piperidin-1-yl)-quinoline 0.75 0.75 mg/kg 60994 RS:0000215 F344 XCO:0000609 4-methyl-2-(piperidin-1-yl)-quinoline 1 1 mg/g 60994 RS:0000215 F344 XCO:0000609 4-methyl-2-(piperidin-1-yl)-quinoline 1 1 mg/kg 60994 RS:0000215 F344 XCO:0000608 Allyl isothiocyanate 0.5 0.5 % 60994 RS:0000215 F344 XCO:0000608 Allyl isothiocyanate 0.5 0.5 60994 RS:0000215 F344 XCO:0000099 control condition 60994 RS:0000215 F344 XCO:0000109 isoflurane 1.5 1.5 % 60994 RS:0000215 F344 XCO:0000348 middle cerebral artery occlusion 60994 RS:0000215 F344 XCO:0000614 rolipram 3 3 mg/kg 60994 RS:0000215 F344 XCO:0000432 sucrose 10 10 % 60994 RS:0000215 F344 XCO:0000101 vehicle control condition 2290141 RS:0001234 F344-AbatTn(sb-T2/Bart3)2.163Mcwi XCO:0000143 acetylcholine 0 30 umol/l 2290141 RS:0001234 F344-AbatTn(sb-T2/Bart3)2.163Mcwi XCO:0000022 controlled sodium content diet 4 4 % 2290141 RS:0001234 F344-AbatTn(sb-T2/Bart3)2.163Mcwi XCO:0000152 drug dose time series 2290141 RS:0001234 F344-AbatTn(sb-T2/Bart3)2.163Mcwi XCO:0000102 fasting 2290141 RS:0001234 F344-AbatTn(sb-T2/Bart3)2.163Mcwi XCO:0000145 phenylephrine 0 300 umol/l 2290141 RS:0001234 F344-AbatTn(sb-T2/Bart3)2.163Mcwi XCO:0000145 phenylephrine 1 1 umol/l 2290141 RS:0001234 F344-AbatTn(sb-T2/Bart3)2.163Mcwi XCO:0000145 phenylephrine 10 10 umol/l 2290141 RS:0001234 F344-AbatTn(sb-T2/Bart3)2.163Mcwi XCO:0000150 potassium ion 80 80 mmol/l 2306036 RS:0001868 F344-Apcm1Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2306036 RS:0001868 F344-Apcm1Kyo XCO:0000102 fasting 2306036 RS:0001868 F344-Apcm1Kyo XCO:0000087 specific pathogen-free condition 2290082 RS:0001246 F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi XCO:0000143 acetylcholine 0 30 umol/l 2290082 RS:0001246 F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi XCO:0000022 controlled sodium content diet 4 4 % 2290082 RS:0001246 F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi XCO:0000152 drug dose time series 2290082 RS:0001246 F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi XCO:0000102 fasting 2290082 RS:0001246 F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi XCO:0000145 phenylephrine 0 300 umol/l 2290082 RS:0001246 F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi XCO:0000145 phenylephrine 1 1 umol/l 2290082 RS:0001246 F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi XCO:0000145 phenylephrine 10 10 umol/l 2290082 RS:0001246 F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi XCO:0000150 potassium ion 80 80 mmol/l 2299140 RS:0001626 F344-DccTn(sb-T2/Bart3)2.205Mcwi XCO:0000143 acetylcholine 0 30 umol/l 2299140 RS:0001626 F344-DccTn(sb-T2/Bart3)2.205Mcwi XCO:0000022 controlled sodium content diet 4 4 % 2299140 RS:0001626 F344-DccTn(sb-T2/Bart3)2.205Mcwi XCO:0000152 drug dose time series 2299140 RS:0001626 F344-DccTn(sb-T2/Bart3)2.205Mcwi XCO:0000102 fasting 2299140 RS:0001626 F344-DccTn(sb-T2/Bart3)2.205Mcwi XCO:0000145 phenylephrine 0 300 umol/l 2299140 RS:0001626 F344-DccTn(sb-T2/Bart3)2.205Mcwi XCO:0000145 phenylephrine 1 1 umol/l 2299140 RS:0001626 F344-DccTn(sb-T2/Bart3)2.205Mcwi XCO:0000145 phenylephrine 10 10 umol/l 2299140 RS:0001626 F344-DccTn(sb-T2/Bart3)2.205Mcwi XCO:0000150 potassium ion 80 80 mmol/l 2314170 RS:0001870 F344-Egrm1Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2314170 RS:0001870 F344-Egrm1Kyo XCO:0000102 fasting 2314170 RS:0001870 F344-Egrm1Kyo XCO:0000087 specific pathogen-free condition 2290056 RS:0001280 F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi XCO:0000143 acetylcholine 0 30 umol/l 2290056 RS:0001280 F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi XCO:0000022 controlled sodium content diet 4 4 % 2290056 RS:0001280 F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi XCO:0000152 drug dose time series 2290056 RS:0001280 F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi XCO:0000102 fasting 2290056 RS:0001280 F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi XCO:0000145 phenylephrine 0 300 umol/l 2290056 RS:0001280 F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi XCO:0000145 phenylephrine 1 1 umol/l 2290056 RS:0001280 F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi XCO:0000145 phenylephrine 10 10 umol/l 2290056 RS:0001280 F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi XCO:0000150 potassium ion 80 80 mmol/l 2299137 RS:0001623 F344-Erbb4Tn(sb-T2/Bart3)2.208Mcwi XCO:0000143 acetylcholine 0 30 umol/l 2299137 RS:0001623 F344-Erbb4Tn(sb-T2/Bart3)2.208Mcwi XCO:0000022 controlled sodium content diet 4 4 % 2299137 RS:0001623 F344-Erbb4Tn(sb-T2/Bart3)2.208Mcwi XCO:0000152 drug dose time series 2299137 RS:0001623 F344-Erbb4Tn(sb-T2/Bart3)2.208Mcwi XCO:0000102 fasting 2299137 RS:0001623 F344-Erbb4Tn(sb-T2/Bart3)2.208Mcwi XCO:0000145 phenylephrine 0 300 umol/l 2299137 RS:0001623 F344-Erbb4Tn(sb-T2/Bart3)2.208Mcwi XCO:0000145 phenylephrine 1 1 umol/l 2299137 RS:0001623 F344-Erbb4Tn(sb-T2/Bart3)2.208Mcwi XCO:0000145 phenylephrine 10 10 umol/l 2299137 RS:0001623 F344-Erbb4Tn(sb-T2/Bart3)2.208Mcwi XCO:0000150 potassium ion 80 80 mmol/l 2290113 RS:0001264 F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi XCO:0000143 acetylcholine 0 30 umol/l 2290113 RS:0001264 F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi XCO:0000022 controlled sodium content diet 4 4 % 2290113 RS:0001264 F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi XCO:0000152 drug dose time series 2290113 RS:0001264 F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi XCO:0000102 fasting 2290113 RS:0001264 F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi XCO:0000145 phenylephrine 0 300 umol/l 2290113 RS:0001264 F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi XCO:0000145 phenylephrine 1 1 umol/l 2290113 RS:0001264 F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi XCO:0000145 phenylephrine 10 10 umol/l 2290113 RS:0001264 F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi XCO:0000150 potassium ion 80 80 mmol/l 2314230 RS:0001882 F344-HrKrh/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2314230 RS:0001882 F344-HrKrh/Kyo XCO:0000102 fasting 2314230 RS:0001882 F344-HrKrh/Kyo XCO:0000087 specific pathogen-free condition 13800557 RS:0004656 F344-Hsd11b2em1Jmul+/+ XCO:0000022 controlled sodium content diet 0.03 0.03 % 13800557 RS:0004656 F344-Hsd11b2em1Jmul+/+ XCO:0000022 controlled sodium content diet 0.3 0.3 % 13800557 RS:0004656 F344-Hsd11b2em1Jmul+/+ XCO:0000022 controlled sodium content diet 3 3 % 13800557 RS:0004656 F344-Hsd11b2em1Jmul+/+ XCO:0000016 standard rat chow 13800556 RS:0004653 F344-Hsd11b2em1Jmul-/- XCO:0000022 controlled sodium content diet 0.03 0.03 % 13800556 RS:0004653 F344-Hsd11b2em1Jmul-/- XCO:0000022 controlled sodium content diet 0.3 0.3 % 13800556 RS:0004653 F344-Hsd11b2em1Jmul-/- XCO:0000022 controlled sodium content diet 3 3 % 13800556 RS:0004653 F344-Hsd11b2em1Jmul-/- XCO:0000016 standard rat chow 2290162 RS:0001260 F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi XCO:0000143 acetylcholine 0 30 umol/l 2290162 RS:0001260 F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi XCO:0000022 controlled sodium content diet 4 4 % 2290162 RS:0001260 F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi XCO:0000152 drug dose time series 2290162 RS:0001260 F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi XCO:0000102 fasting 2290162 RS:0001260 F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi XCO:0000145 phenylephrine 0 300 umol/l 2290162 RS:0001260 F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi XCO:0000145 phenylephrine 1 1 umol/l 2290162 RS:0001260 F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi XCO:0000145 phenylephrine 10 10 umol/l 2290162 RS:0001260 F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi XCO:0000150 potassium ion 80 80 mmol/l 2314167 RS:0001873 F344-Kmch/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2314167 RS:0001873 F344-Kmch/Kyo XCO:0000102 fasting 2314167 RS:0001873 F344-Kmch/Kyo XCO:0000087 specific pathogen-free condition 2314164 RS:0001875 F344-Kuru2/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2314164 RS:0001875 F344-Kuru2/Kyo XCO:0000102 fasting 2314164 RS:0001875 F344-Kuru2/Kyo XCO:0000087 specific pathogen-free condition 2290110 RS:0001278 F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi XCO:0000143 acetylcholine 0 30 umol/l 2290110 RS:0001278 F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi XCO:0000022 controlled sodium content diet 4 4 % 2290110 RS:0001278 F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi XCO:0000152 drug dose time series 2290110 RS:0001278 F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi XCO:0000102 fasting 2290110 RS:0001278 F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi XCO:0000145 phenylephrine 0 300 umol/l 2290110 RS:0001278 F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi XCO:0000145 phenylephrine 1 1 umol/l 2290110 RS:0001278 F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi XCO:0000145 phenylephrine 10 10 umol/l 2290110 RS:0001278 F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi XCO:0000150 potassium ion 80 80 mmol/l 2290078 RS:0001269 F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi XCO:0000143 acetylcholine 0 30 umol/l 2290078 RS:0001269 F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi XCO:0000022 controlled sodium content diet 4 4 % 2290078 RS:0001269 F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi XCO:0000152 drug dose time series 2290078 RS:0001269 F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi XCO:0000102 fasting 2290078 RS:0001269 F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi XCO:0000145 phenylephrine 0 300 umol/l 2290078 RS:0001269 F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi XCO:0000145 phenylephrine 1 1 umol/l 2290078 RS:0001269 F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi XCO:0000145 phenylephrine 10 10 umol/l 2290078 RS:0001269 F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi XCO:0000150 potassium ion 80 80 mmol/l 2290103 RS:0001271 F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi XCO:0000143 acetylcholine 0 30 umol/l 2290103 RS:0001271 F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi XCO:0000022 controlled sodium content diet 4 4 % 2290103 RS:0001271 F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi XCO:0000152 drug dose time series 2290103 RS:0001271 F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi XCO:0000102 fasting 2290103 RS:0001271 F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi XCO:0000145 phenylephrine 0 300 umol/l 2290103 RS:0001271 F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi XCO:0000145 phenylephrine 1 1 umol/l 2290103 RS:0001271 F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi XCO:0000145 phenylephrine 10 10 umol/l 2290103 RS:0001271 F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi XCO:0000150 potassium ion 80 80 mmol/l 2314162 RS:0001876 F344-Oune/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2314162 RS:0001876 F344-Oune/Kyo XCO:0000102 fasting 2314162 RS:0001876 F344-Oune/Kyo XCO:0000087 specific pathogen-free condition 2302652 RS:0001696 F344-Pde4dTn(sb-T2/Bart3)2.285Mcwi XCO:0000109 isoflurane 1.5 1.5 % 2302652 RS:0001696 F344-Pde4dTn(sb-T2/Bart3)2.285Mcwi XCO:0000348 middle cerebral artery occlusion 2302652 RS:0001696 F344-Pde4dTn(sb-T2/Bart3)2.285Mcwi XCO:0000101 vehicle control condition 2290166 RS:0001273 F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi XCO:0000143 acetylcholine 0 30 umol/l 2290166 RS:0001273 F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi XCO:0000022 controlled sodium content diet 4 4 % 2290166 RS:0001273 F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi XCO:0000152 drug dose time series 2290166 RS:0001273 F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi XCO:0000102 fasting 2290166 RS:0001273 F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi XCO:0000145 phenylephrine 0 300 umol/l 2290166 RS:0001273 F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi XCO:0000145 phenylephrine 1 1 umol/l 2290166 RS:0001273 F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi XCO:0000145 phenylephrine 10 10 umol/l 2290166 RS:0001273 F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi XCO:0000150 potassium ion 80 80 mmol/l 2290146 RS:0001274 F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi XCO:0000143 acetylcholine 0 30 umol/l 2290146 RS:0001274 F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi XCO:0000022 controlled sodium content diet 4 4 % 2290146 RS:0001274 F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi XCO:0000152 drug dose time series 2290146 RS:0001274 F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi XCO:0000102 fasting 2290146 RS:0001274 F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi XCO:0000145 phenylephrine 0 300 umol/l 2290146 RS:0001274 F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi XCO:0000145 phenylephrine 1 1 umol/l 2290146 RS:0001274 F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi XCO:0000145 phenylephrine 10 10 umol/l 2290146 RS:0001274 F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi XCO:0000150 potassium ion 80 80 mmol/l 2306042 RS:0001877 F344-Scn1am1Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2306042 RS:0001877 F344-Scn1am1Kyo XCO:0000102 fasting 2306042 RS:0001877 F344-Scn1am1Kyo XCO:0000087 specific pathogen-free condition 2306041 RS:0001878 F344-Scn1am2Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2306041 RS:0001878 F344-Scn1am2Kyo XCO:0000102 fasting 2306041 RS:0001878 F344-Scn1am2Kyo XCO:0000087 specific pathogen-free condition 2292451 RS:0001287 F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi XCO:0000143 acetylcholine 0 30 umol/l 2292451 RS:0001287 F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi XCO:0000022 controlled sodium content diet 4 4 % 2292451 RS:0001287 F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi XCO:0000152 drug dose time series 2292451 RS:0001287 F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi XCO:0000102 fasting 2292451 RS:0001287 F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi XCO:0000145 phenylephrine 0 300 umol/l 2292451 RS:0001287 F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi XCO:0000145 phenylephrine 1 1 umol/l 2292451 RS:0001287 F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi XCO:0000145 phenylephrine 10 10 umol/l 2292451 RS:0001287 F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi XCO:0000150 potassium ion 80 80 mmol/l 7800671 RS:0003622 F344-Sv2am1Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 7800671 RS:0003622 F344-Sv2am1Kyo XCO:0000102 fasting 7800671 RS:0003622 F344-Sv2am1Kyo XCO:0000087 specific pathogen-free condition 2314168 RS:0001879 F344-Tbr1/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2314168 RS:0001879 F344-Tbr1/Kyo XCO:0000102 fasting 2314168 RS:0001879 F344-Tbr1/Kyo XCO:0000087 specific pathogen-free condition 2314368 RS:0001881 F344-Trdk/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2314368 RS:0001881 F344-Trdk/Kyo XCO:0000102 fasting 2314368 RS:0001881 F344-Trdk/Kyo XCO:0000087 specific pathogen-free condition 2290064 RS:0001295 F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi XCO:0000143 acetylcholine 0 30 umol/l 2290064 RS:0001295 F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi XCO:0000022 controlled sodium content diet 4 4 % 2290064 RS:0001295 F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi XCO:0000152 drug dose time series 2290064 RS:0001295 F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi XCO:0000102 fasting 2290064 RS:0001295 F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi XCO:0000145 phenylephrine 0 300 umol/l 2290064 RS:0001295 F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi XCO:0000145 phenylephrine 1 1 umol/l 2290064 RS:0001295 F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi XCO:0000145 phenylephrine 10 10 umol/l 2290064 RS:0001295 F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi XCO:0000150 potassium ion 80 80 mmol/l 14696721 RS:0004750 F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi-/+ XCO:0000608 Allyl isothiocyanate 0.5 0.5 % 14696720 RS:0004749 F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi-/- XCO:0000609 4-methyl-2-(piperidin-1-yl)-quinoline 1 1 mg/g 14696720 RS:0004749 F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi-/- XCO:0000609 4-methyl-2-(piperidin-1-yl)-quinoline 1 1 mg/kg 14696720 RS:0004749 F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi-/- XCO:0000608 Allyl isothiocyanate 0.5 0.5 % 14696720 RS:0004749 F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi-/- XCO:0000099 control condition 6480223 RS:0003210 F344.AR-EdnrbslHkv XCO:0000087 specific pathogen-free condition 1599755 RS:0001296 F344.BN-(D16Mit5-D16Rat75) XCO:0000092 17 beta-estradiol 3.3 3.3 mg/kg 1599755 RS:0001296 F344.BN-(D16Mit5-D16Rat75) XCO:0000092 17 beta-estradiol 10 10 mg/kg 1599755 RS:0001296 F344.BN-(D16Mit5-D16Rat75) XCO:0000206 N-nitrosodiethylamine 200 200 mg/kg 1599755 RS:0001296 F344.BN-(D16Mit5-D16Rat75) XCO:0000201 orchiectomy 1599755 RS:0001296 F344.BN-(D16Mit5-D16Rat75) XCO:0000094 ovariectomy 1599755 RS:0001296 F344.BN-(D16Mit5-D16Rat75) XCO:0000204 testosterone 3.3 3.3 mg/kg 1599755 RS:0001296 F344.BN-(D16Mit5-D16Rat75) XCO:0000204 testosterone 10 10 mg/kg 728146 RS:0000273 F344.BN-(D3Mgh13-D3Mgh7)/Dlw XCO:0000099 control condition 728146 RS:0000273 F344.BN-(D3Mgh13-D3Mgh7)/Dlw XCO:0000295 diethylstilbestrol 5 5 mg 728146 RS:0000273 F344.BN-(D3Mgh13-D3Mgh7)/Dlw XCO:0000027 surgical implantation 1331830 RS:0001297 F344.BN-(D5Rat1-D5Mit5)/Dlw XCO:0000295 diethylstilbestrol 5 5 mg 1331830 RS:0001297 F344.BN-(D5Rat1-D5Mit5)/Dlw XCO:0000027 surgical implantation 2304017 RS:0001926 F344.CVD-Unc5ccvd/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2304017 RS:0001926 F344.CVD-Unc5ccvd/Kyo XCO:0000102 fasting 2304017 RS:0001926 F344.CVD-Unc5ccvd/Kyo XCO:0000087 specific pathogen-free condition 7800661 RS:0003617 F344.Cg-Du, TyrCKyo+/+ XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 7800661 RS:0003617 F344.Cg-Du, TyrCKyo+/+ XCO:0000102 fasting 7800661 RS:0003617 F344.Cg-Du, TyrCKyo+/+ XCO:0000087 specific pathogen-free condition 7800659 RS:0003614 F344.Cg-Du, TyrC/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 7800659 RS:0003614 F344.Cg-Du, TyrC/Kyo XCO:0000102 fasting 7800659 RS:0003614 F344.Cg-Du, TyrC/Kyo XCO:0000087 specific pathogen-free condition 2303996 RS:0001927 F344.Cg-Foxn1rnu/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2303996 RS:0001927 F344.Cg-Foxn1rnu/Kyo XCO:0000102 fasting 2303996 RS:0001927 F344.Cg-Foxn1rnu/Kyo XCO:0000087 specific pathogen-free condition 7800667 RS:0003620 F344.Cg-Foxn1rnuKyo-/+ XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 7800667 RS:0003620 F344.Cg-Foxn1rnuKyo-/+ XCO:0000102 fasting 7800667 RS:0003620 F344.Cg-Foxn1rnuKyo-/+ XCO:0000087 specific pathogen-free condition 631294 RS:0000280 F344.GK-(D1Arb42a-D1Rat90)/Swe XCO:0000099 control condition 631294 RS:0000280 F344.GK-(D1Arb42a-D1Rat90)/Swe XCO:0000102 fasting 631294 RS:0000280 F344.GK-(D1Arb42a-D1Rat90)/Swe XCO:0000103 glucose solution 2 2 g/kg 1600342 RS:0001290 F344.GK-(D1Got250-D1Rat90)/Swe XCO:0000099 control condition 1600342 RS:0001290 F344.GK-(D1Got250-D1Rat90)/Swe XCO:0000102 fasting 1600342 RS:0001290 F344.GK-(D1Got250-D1Rat90)/Swe XCO:0000103 glucose solution 2 2 g/kg 634370 RS:0000281 F344.GK-(D1Mgh10-D1Rat119)/Swe XCO:0000099 control condition 634370 RS:0000281 F344.GK-(D1Mgh10-D1Rat119)/Swe XCO:0000102 fasting 634370 RS:0000281 F344.GK-(D1Mgh10-D1Rat119)/Swe XCO:0000103 glucose solution 2 2 g/kg 1600337 RS:0001298 F344.GK-(D1Mgh14-D1Rat90)/Swe XCO:0000099 control condition 1600337 RS:0001298 F344.GK-(D1Mgh14-D1Rat90)/Swe XCO:0000102 fasting 1600337 RS:0001298 F344.GK-(D1Mgh14-D1Rat90)/Swe XCO:0000103 glucose solution 2 2 g/kg 1600344 RS:0001300 F344.GK-(D1Rat175-D1Rat90)/Swe XCO:0000099 control condition 1600344 RS:0001300 F344.GK-(D1Rat175-D1Rat90)/Swe XCO:0000102 fasting 1600344 RS:0001300 F344.GK-(D1Rat175-D1Rat90)/Swe XCO:0000103 glucose solution 2 2 g/kg 1600345 RS:0001301 F344.GK-(D1Rat83-D1Rat376)/Swe XCO:0000099 control condition 1600345 RS:0001301 F344.GK-(D1Rat83-D1Rat376)/Swe XCO:0000102 fasting 1600345 RS:0001301 F344.GK-(D1Rat83-D1Rat376)/Swe XCO:0000103 glucose solution 2 2 g/kg 1600346 RS:0001302 F344.GK-(D1Swe4-D1Rat85)/Swe XCO:0000099 control condition 1600346 RS:0001302 F344.GK-(D1Swe4-D1Rat85)/Swe XCO:0000102 fasting 1600346 RS:0001302 F344.GK-(D1Swe4-D1Rat85)/Swe XCO:0000103 glucose solution 2 2 g/kg 2304293 RS:0001930 F344.LEC-xhs1/1Nrs XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2304293 RS:0001930 F344.LEC-xhs1/1Nrs XCO:0000102 fasting 2304293 RS:0001930 F344.LEC-xhs1/1Nrs XCO:0000087 specific pathogen-free condition 2304316 RS:0001931 F344.LEC-xhs1/2Nrs XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2304316 RS:0001931 F344.LEC-xhs1/2Nrs XCO:0000102 fasting 2304316 RS:0001931 F344.LEC-xhs1/2Nrs XCO:0000087 specific pathogen-free condition 2306035 RS:0001936 F344.NER-(D1Mgh6-D1Rat73)(D5Mgh4-D5Rat36)/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2306035 RS:0001936 F344.NER-(D1Mgh6-D1Rat73)(D5Mgh4-D5Rat36)/Kyo XCO:0000102 fasting 2306035 RS:0001936 F344.NER-(D1Mgh6-D1Rat73)(D5Mgh4-D5Rat36)/Kyo XCO:0000087 specific pathogen-free condition 2314316 RS:0001934 F344.NER-(D1Mgh6-D1Rat73)/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2314316 RS:0001934 F344.NER-(D1Mgh6-D1Rat73)/Kyo XCO:0000102 fasting 2314316 RS:0001934 F344.NER-(D1Mgh6-D1Rat73)/Kyo XCO:0000087 specific pathogen-free condition 2314315 RS:0001935 F344.NER-(D5Mgh4-D5Rat36)/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2314315 RS:0001935 F344.NER-(D5Mgh4-D5Rat36)/Kyo XCO:0000102 fasting 2314315 RS:0001935 F344.NER-(D5Mgh4-D5Rat36)/Kyo XCO:0000087 specific pathogen-free condition 1302630 RS:0000286 F344.OLETF-(D10Wox7-D10Wox6)/Tj XCO:0000102 fasting 1302630 RS:0000286 F344.OLETF-(D10Wox7-D10Wox6)/Tj XCO:0000104 glucose solution, 2.8M 2 2 g/kg 2306016 RS:0001937 F344.OLETF-(D11Mgh4-D11Mgh1)/2Tj XCO:0000102 fasting 2306016 RS:0001937 F344.OLETF-(D11Mgh4-D11Mgh1)/2Tj XCO:0000104 glucose solution, 2.8M 2 2 g/kg 2304000 RS:0001940 F344.OLETF-(D12Wox5-D12Rat21)/Tj XCO:0000102 fasting 2304000 RS:0001940 F344.OLETF-(D12Wox5-D12Rat21)/Tj XCO:0000104 glucose solution, 2.8M 2 2 g/kg 1302661 RS:0000289 F344.OLETF-(D14Rat23-D14Rat12)/Tj XCO:0000099 control condition 1302661 RS:0000289 F344.OLETF-(D14Rat23-D14Rat12)/Tj XCO:0000102 fasting 1302661 RS:0000289 F344.OLETF-(D14Rat23-D14Rat12)/Tj XCO:0000104 glucose solution, 2.8M 2 2 g/kg 1302661 RS:0000289 F344.OLETF-(D14Rat23-D14Rat12)/Tj XCO:0000087 specific pathogen-free condition 2306013 RS:0001958 F344.OLETF-(D14Rat8-D14Rat26)/2Tj XCO:0000102 fasting 2306013 RS:0001958 F344.OLETF-(D14Rat8-D14Rat26)/2Tj XCO:0000104 glucose solution, 2.8M 2 2 g/kg 1302685 RS:0000290 F344.OLETF-(D14Rat8-D14Rat26)/Tj XCO:0000102 fasting 1302685 RS:0000290 F344.OLETF-(D14Rat8-D14Rat26)/Tj XCO:0000104 glucose solution, 2.8M 2 2 g/kg 1302625 RS:0000291 F344.OLETF-(D16Wox4-D16Rat13)/Tj XCO:0000102 fasting 1302625 RS:0000291 F344.OLETF-(D16Wox4-D16Rat13)/Tj XCO:0000104 glucose solution, 2.8M 2 2 g/kg 2306019 RS:0001964 F344.OLETF-(D1Mit20-D1Mgh26)/2Tj XCO:0000102 fasting 2306019 RS:0001964 F344.OLETF-(D1Mit20-D1Mgh26)/2Tj XCO:0000104 glucose solution, 2.8M 2 2 g/kg 1358995 RS:0000292 F344.OLETF-(D1Rat166-D1Rat90)/Tj XCO:0000099 control condition 1358995 RS:0000292 F344.OLETF-(D1Rat166-D1Rat90)/Tj XCO:0000102 fasting 1358995 RS:0000292 F344.OLETF-(D1Rat166-D1Rat90)/Tj XCO:0000104 glucose solution, 2.8M 2 2 g/kg 2303994 RS:0001969 F344.OLETF-(D5Mgh4-D5Rat21)/Tj XCO:0000102 fasting 2303994 RS:0001969 F344.OLETF-(D5Mgh4-D5Rat21)/Tj XCO:0000104 glucose solution, 2.8M 2 2 g/kg 1302647 RS:0000478 F344.OLETF-(D5Rat166-D5Rat90)/Tj XCO:0000099 control condition 1302654 RS:0001734 F344.OLETF-(D7Mgh16-D7Mgh20)/Tj XCO:0000102 fasting 1302654 RS:0001734 F344.OLETF-(D7Mgh16-D7Mgh20)/Tj XCO:0000104 glucose solution, 2.8M 2 2 g/kg 1302654 RS:0001734 F344.OLETF-(D7Mgh16-D7Mgh20)/Tj XCO:0000087 specific pathogen-free condition 1643010 RS:0001303 F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj XCO:0000102 fasting 1643010 RS:0001303 F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj XCO:0000104 glucose solution, 2.8M 2 2 g/kg 1643010 RS:0001303 F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj XCO:0000087 specific pathogen-free condition 2306014 RS:0001738 F344.OLETF-(D8Rat54-D8Mgh17)/2Tj XCO:0000102 fasting 2306014 RS:0001738 F344.OLETF-(D8Rat54-D8Mgh17)/2Tj XCO:0000104 glucose solution, 2.8M 2 2 g/kg 1302713 RS:0000296 F344.OLETF-(D8Rat58-D8Mgh17)/Tj XCO:0000099 control condition 1302713 RS:0000296 F344.OLETF-(D8Rat58-D8Mgh17)/Tj XCO:0000102 fasting 1302713 RS:0000296 F344.OLETF-(D8Rat58-D8Mgh17)/Tj XCO:0000104 glucose solution, 2.8M 2 2 g/kg 2306018 RS:0001987 F344.OLETF-(D9Mgh8-D9Mit2)/2Tj XCO:0000102 fasting 2306018 RS:0001987 F344.OLETF-(D9Mgh8-D9Mit2)/2Tj XCO:0000104 glucose solution, 2.8M 2 2 g/kg 10755350 RS:0004089 F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj XCO:0000099 control condition 11532753 RS:0004218 F344.ZUC-(Leprfa),OLETF-(D5Rat166-D5Rat90)/Tj XCO:0000099 control condition 2304047 RS:0001991 F344.ZUC-Leprfa/Tj XCO:0000099 control condition 737690 RS:0000307 F344/Crli XCO:0000208 2-acetamidofluorene 0.02 0.02 % 737690 RS:0000307 F344/Crli XCO:0000206 N-nitrosodiethylamine 150 150 mg/kg 737690 RS:0000307 F344/Crli XCO:0000210 partial hepatectomy 734478 RS:0000179 F344/DuCrl XCO:0000137 FAPGG 0.6 0.6 mmol/l 734478 RS:0000179 F344/DuCrl XCO:0000116 Kreb's solution perfusate 734478 RS:0000179 F344/DuCrl XCO:0000143 acetylcholine 0 30 umol/l 734478 RS:0000179 F344/DuCrl XCO:0000012 air carbon dioxide content 7 7 % 734478 RS:0000179 F344/DuCrl XCO:0000012 air carbon dioxide content 7 % 734478 RS:0000179 F344/DuCrl XCO:0000126 angiotensin 5 5 ng/kg/min 734478 RS:0000179 F344/DuCrl XCO:0000126 angiotensin 10 10 ng/kg/min 734478 RS:0000179 F344/DuCrl XCO:0000126 angiotensin 25 25 ng/kg/min 734478 RS:0000179 F344/DuCrl XCO:0000126 angiotensin 50 50 ng/kg/min 734478 RS:0000179 F344/DuCrl XCO:0000099 control condition 734478 RS:0000179 F344/DuCrl XCO:0000010 controlled air oxygen content 12 12 % 734478 RS:0000179 F344/DuCrl XCO:0000010 controlled air oxygen content 12 % 734478 RS:0000179 F344/DuCrl XCO:0000146 controlled oxygen content Kreb's solution perfusate 734478 RS:0000179 F344/DuCrl XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 734478 RS:0000179 F344/DuCrl XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 734478 RS:0000179 F344/DuCrl XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 734478 RS:0000179 F344/DuCrl XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 734478 RS:0000179 F344/DuCrl XCO:0000022 controlled sodium content diet 0 % 734478 RS:0000179 F344/DuCrl XCO:0000022 controlled sodium content diet 0.4 0.4 % 734478 RS:0000179 F344/DuCrl XCO:0000022 controlled sodium content diet 4 4 % 734478 RS:0000179 F344/DuCrl XCO:0000152 drug dose time series 734478 RS:0000179 F344/DuCrl XCO:0000102 fasting 734478 RS:0000179 F344/DuCrl XCO:0000124 furosemide 10 10 mg/kg 734478 RS:0000179 F344/DuCrl XCO:0000104 glucose solution, 2.8M 2 2 g/kg 734478 RS:0000179 F344/DuCrl XCO:0000134 methacholine 0 11.06 mg/kg 734478 RS:0000179 F344/DuCrl XCO:0000138 methylene blue 10 10 umol/l 734478 RS:0000179 F344/DuCrl XCO:0000127 norepinephrine 0.1 0.1 ng/kg/min 734478 RS:0000179 F344/DuCrl XCO:0000127 norepinephrine 0.2 0.2 ng/kg/min 734478 RS:0000179 F344/DuCrl XCO:0000127 norepinephrine 0.5 0.5 ng/kg/min 734478 RS:0000179 F344/DuCrl XCO:0000127 norepinephrine 1 1 ng/kg/min 734478 RS:0000179 F344/DuCrl XCO:0000118 perfusate suspended 734478 RS:0000179 F344/DuCrl XCO:0000145 phenylephrine 0 300 umol/l 734478 RS:0000179 F344/DuCrl XCO:0000145 phenylephrine 1 1 umol/l 734478 RS:0000179 F344/DuCrl XCO:0000145 phenylephrine 10 10 umol/l 734478 RS:0000179 F344/DuCrl XCO:0000150 potassium ion 80 80 mmol/l 734478 RS:0000179 F344/DuCrl XCO:0000003 resting on treadmill 734478 RS:0000179 F344/DuCrl XCO:0000005 running on treadmill 1.6 1.6 m/min 734478 RS:0000179 F344/DuCrl XCO:0000153 sample resting period 734478 RS:0000179 F344/DuCrl XCO:0000142 sodium nitroprusside 0 3 umol/l 734478 RS:0000179 F344/DuCrl XCO:0000004 walking on treadmill 0.8 0.8 m/min 69643 RS:0000305 F344/DuCrlCrlj XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 69643 RS:0000305 F344/DuCrlCrlj XCO:0000099 control condition 69643 RS:0000305 F344/DuCrlCrlj XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 69643 RS:0000305 F344/DuCrlCrlj XCO:0000102 fasting 69643 RS:0000305 F344/DuCrlCrlj XCO:0000103 glucose solution 2 2 g/kg 69643 RS:0000305 F344/DuCrlCrlj XCO:0000103 glucose solution 69643 RS:0000305 F344/DuCrlCrlj XCO:0000104 glucose solution, 2.8M 2 2 g/kg 69643 RS:0000305 F344/DuCrlCrlj XCO:0000243 partial pancreatectomy 70 70 % 69643 RS:0000305 F344/DuCrlCrlj XCO:0000243 partial pancreatectomy 69643 RS:0000305 F344/DuCrlCrlj XCO:0000087 specific pathogen-free condition 2302067 RS:0001673 F344/DuCrlSwe XCO:0000099 control condition 1354670 RS:0000311 F344/IcoCrlf XCO:0000015 controlled calorie content diet 2.9 2.9 kcal/g 1354670 RS:0000311 F344/IcoCrlf XCO:0000102 fasting 1354670 RS:0000311 F344/IcoCrlf XCO:0000739 housing in trios 1354670 RS:0000311 F344/IcoCrlf XCO:0000744 housing with Haemophilus H21-infected subject 1354670 RS:0000311 F344/IcoCrlf XCO:0000745 housing with Haemophilus H35-infected subject 1354670 RS:0000311 F344/IcoCrlf XCO:0000746 housing with Pasteurella pneumotropica-infected subject 1354670 RS:0000311 F344/IcoCrlf XCO:0000747 housing with Pasteurellaceae-infected subject 1547866 RS:0000312 F344/Jcl XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1547866 RS:0000312 F344/Jcl XCO:0000099 control condition 1547866 RS:0000312 F344/Jcl XCO:0000102 fasting 1547866 RS:0000312 F344/Jcl XCO:0000087 specific pathogen-free condition 737926 RS:0000306 F344/NCrl XCO:0000102 fasting 737926 RS:0000306 F344/NCrl XCO:0000103 glucose solution 2 2 g/kg 61109 RS:0000363 F344/NHsd XCO:0000156 0.9% sodium chloride solution 0.4 0.4 ml 61109 RS:0000363 F344/NHsd XCO:0000156 0.9% sodium chloride solution 1 1 ml 61109 RS:0000363 F344/NHsd XCO:0000208 2-acetamidofluorene 0.02 0.02 % 61109 RS:0000363 F344/NHsd XCO:0000208 2-acetamidofluorene 0.02 0.02 mg/kg 61109 RS:0000363 F344/NHsd XCO:0000646 Azoxymethane 15 15 mg/kg 61109 RS:0000363 F344/NHsd XCO:0000266 Freund's complete adjuvant 100 100 ul 61109 RS:0000363 F344/NHsd XCO:0000265 Freund's incomplete adjuvant 50 50 % 61109 RS:0000363 F344/NHsd XCO:0000206 N-nitrosodiethylamine 150 150 mg/kg 61109 RS:0000363 F344/NHsd XCO:0000388 acetaminophen 1 1 g/kg 61109 RS:0000363 F344/NHsd XCO:0000388 acetaminophen 1.5 1.5 g/kg 61109 RS:0000363 F344/NHsd XCO:0000388 acetaminophen 800 800 mg/kg 61109 RS:0000363 F344/NHsd XCO:0000143 acetylcholine 0 30 umol/l 61109 RS:0000363 F344/NHsd XCO:0000360 arterial catheter implantation 61109 RS:0000363 F344/NHsd XCO:0000268 balloon angioplasty 61109 RS:0000363 F344/NHsd XCO:0000273 carrageenan 1 1 ml 61109 RS:0000363 F344/NHsd XCO:0000099 control condition 61109 RS:0000363 F344/NHsd XCO:0000010 controlled air oxygen content 10 10 % 61109 RS:0000363 F344/NHsd XCO:0000031 controlled calcium content diet 0.6 0.6 % 61109 RS:0000363 F344/NHsd XCO:0000182 controlled exposure to ambient light 61109 RS:0000363 F344/NHsd XCO:0000812 controlled hemorrhage 61109 RS:0000363 F344/NHsd XCO:0000022 controlled sodium content diet 4 4 % 61109 RS:0000363 F344/NHsd XCO:0000295 diethylstilbestrol 5 5 mg 61109 RS:0000363 F344/NHsd XCO:0000152 drug dose time series 61109 RS:0000363 F344/NHsd XCO:0000102 fasting 61109 RS:0000363 F344/NHsd XCO:0000103 glucose solution 2 2 g/kg 61109 RS:0000363 F344/NHsd XCO:0000210 partial hepatectomy 61109 RS:0000363 F344/NHsd XCO:0000291 peripheral myelin protein 2 peptide 58-81 100 100 ug 61109 RS:0000363 F344/NHsd XCO:0000292 peripheral nerve myelin 2 2 mg 61109 RS:0000363 F344/NHsd XCO:0000145 phenylephrine 0 300 umol/l 61109 RS:0000363 F344/NHsd XCO:0000145 phenylephrine 1 1 umol/l 61109 RS:0000363 F344/NHsd XCO:0000145 phenylephrine 10 10 umol/l 61109 RS:0000363 F344/NHsd XCO:0000157 physical restraint 61109 RS:0000363 F344/NHsd XCO:0000159 physical restraint in tube type rodent restrainer 61109 RS:0000363 F344/NHsd XCO:0000150 potassium ion 80 80 mmol/l 61109 RS:0000363 F344/NHsd XCO:0000058 room temperature 10 10 ml 61109 RS:0000363 F344/NHsd XCO:0000058 room temperature 14 14 ml 61109 RS:0000363 F344/NHsd XCO:0000155 sodium chloride solution 61109 RS:0000363 F344/NHsd XCO:0000027 surgical implantation 61109 RS:0000363 F344/NHsd XCO:0000281 type II collagen 2 2 mg/kg 61109 RS:0000363 F344/NHsd XCO:0000101 vehicle control condition 70509 RS:0000313 F344/NRrrc XCO:0000208 2-acetamidofluorene 0.02 0.02 % 70509 RS:0000313 F344/NRrrc XCO:0000391 5-bromo-2'-deoxyuridine 50 50 mg/kg 70509 RS:0000313 F344/NRrrc XCO:0000206 N-nitrosodiethylamine 150 150 mg/kg 70509 RS:0000313 F344/NRrrc XCO:0000099 control condition 70509 RS:0000313 F344/NRrrc XCO:0000442 controlled 2-acetamidofluorene content diet 0.02 0.02 % 70509 RS:0000313 F344/NRrrc XCO:0000440 controlled 3-methyl-4'-dimethylaminoazobenzene content diet 0.06 0.06 % 70509 RS:0000313 F344/NRrrc XCO:0000030 controlled protein content diet 70509 RS:0000313 F344/NRrrc XCO:0000102 fasting 70509 RS:0000313 F344/NRrrc XCO:0000103 glucose solution 2 2 g/kg 70509 RS:0000313 F344/NRrrc XCO:0000210 partial hepatectomy 1302627 RS:0000364 F344/NSlc XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302627 RS:0000364 F344/NSlc XCO:0000099 control condition 1302627 RS:0000364 F344/NSlc XCO:0000102 fasting 1302627 RS:0000364 F344/NSlc XCO:0000103 glucose solution 2 2 g/kg 1302627 RS:0000364 F344/NSlc XCO:0000104 glucose solution, 2.8M 2 2 g/kg 1302627 RS:0000364 F344/NSlc XCO:0000087 specific pathogen-free condition 1358919 RS:0000427 F344/Seac XCO:0000440 controlled 3-methyl-4'-dimethylaminoazobenzene content diet 0.06 0.06 % 1556748 RS:0001304 F344/Snk XCO:0000099 control condition 1302686 RS:0000428 F344/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302686 RS:0000428 F344/Stm XCO:0000099 control condition 1302686 RS:0000428 F344/Stm XCO:0000295 diethylstilbestrol 17 17 mg 1302686 RS:0000428 F344/Stm XCO:0000102 fasting 1302686 RS:0000428 F344/Stm XCO:0000087 specific pathogen-free condition 1302696 RS:0000317 FH/HamSlc XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302696 RS:0000317 FH/HamSlc XCO:0000102 fasting 1302696 RS:0000317 FH/HamSlc XCO:0000087 specific pathogen-free condition 60993 RS:0000017 FHH XCO:0000099 control condition 1579711 RS:0001134 FHH-Adipoqm1Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1579711 RS:0001134 FHH-Adipoqm1Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1579711 RS:0001134 FHH-Adipoqm1Mcwi XCO:0000152 drug dose time series 1579711 RS:0001134 FHH-Adipoqm1Mcwi XCO:0000102 fasting 1579711 RS:0001134 FHH-Adipoqm1Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1579711 RS:0001134 FHH-Adipoqm1Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1579711 RS:0001134 FHH-Adipoqm1Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1579711 RS:0001134 FHH-Adipoqm1Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1579707 RS:0001133 FHH-Adipoqm2Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1579707 RS:0001133 FHH-Adipoqm2Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1579707 RS:0001133 FHH-Adipoqm2Mcwi XCO:0000152 drug dose time series 1579707 RS:0001133 FHH-Adipoqm2Mcwi XCO:0000102 fasting 1579707 RS:0001133 FHH-Adipoqm2Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1579707 RS:0001133 FHH-Adipoqm2Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1579707 RS:0001133 FHH-Adipoqm2Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1579707 RS:0001133 FHH-Adipoqm2Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1579906 RS:0001135 FHH-Adipoqm3Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1579906 RS:0001135 FHH-Adipoqm3Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1579906 RS:0001135 FHH-Adipoqm3Mcwi XCO:0000152 drug dose time series 1579906 RS:0001135 FHH-Adipoqm3Mcwi XCO:0000102 fasting 1579906 RS:0001135 FHH-Adipoqm3Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1579906 RS:0001135 FHH-Adipoqm3Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1579906 RS:0001135 FHH-Adipoqm3Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1579906 RS:0001135 FHH-Adipoqm3Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1579698 RS:0001128 FHH-Adra1am1Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1579698 RS:0001128 FHH-Adra1am1Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1579698 RS:0001128 FHH-Adra1am1Mcwi XCO:0000152 drug dose time series 1579698 RS:0001128 FHH-Adra1am1Mcwi XCO:0000102 fasting 1579698 RS:0001128 FHH-Adra1am1Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1579698 RS:0001128 FHH-Adra1am1Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1579698 RS:0001128 FHH-Adra1am1Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1579698 RS:0001128 FHH-Adra1am1Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1579704 RS:0001130 FHH-Agtr1bm1Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1579704 RS:0001130 FHH-Agtr1bm1Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1579704 RS:0001130 FHH-Agtr1bm1Mcwi XCO:0000152 drug dose time series 1579704 RS:0001130 FHH-Agtr1bm1Mcwi XCO:0000102 fasting 1579704 RS:0001130 FHH-Agtr1bm1Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1579704 RS:0001130 FHH-Agtr1bm1Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1579704 RS:0001130 FHH-Agtr1bm1Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1579704 RS:0001130 FHH-Agtr1bm1Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1579910 RS:0001140 FHH-Ccr2m1Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1579910 RS:0001140 FHH-Ccr2m1Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1579910 RS:0001140 FHH-Ccr2m1Mcwi XCO:0000152 drug dose time series 1579910 RS:0001140 FHH-Ccr2m1Mcwi XCO:0000102 fasting 1579910 RS:0001140 FHH-Ccr2m1Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1579910 RS:0001140 FHH-Ccr2m1Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1579910 RS:0001140 FHH-Ccr2m1Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1579910 RS:0001140 FHH-Ccr2m1Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000116 Kreb's solution perfusate 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000099 control condition 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000152 drug dose time series 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000118 perfusate suspended 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1547876 RS:0000319 FHH-Chr 10BN/Mcwi XCO:0000153 sample resting period 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000116 Kreb's solution perfusate 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000099 control condition 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000152 drug dose time series 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000118 perfusate suspended 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1358173 RS:0000320 FHH-Chr 11BN/Mcwi XCO:0000153 sample resting period 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000116 Kreb's solution perfusate 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000099 control condition 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000152 drug dose time series 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000118 perfusate suspended 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000153 sample resting period 629512 RS:0000321 FHH-Chr 12BN/Mcwi XCO:0000142 sodium nitroprusside 0 3 umol/l 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000116 Kreb's solution perfusate 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000099 control condition 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000152 drug dose time series 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000118 perfusate suspended 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1358179 RS:0000322 FHH-Chr 13BN/Mcwi XCO:0000153 sample resting period 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000116 Kreb's solution perfusate 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000099 control condition 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000152 drug dose time series 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000118 perfusate suspended 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1547870 RS:0000323 FHH-Chr 14BN/Mcwi XCO:0000153 sample resting period 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000116 Kreb's solution perfusate 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000099 control condition 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000152 drug dose time series 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000118 perfusate suspended 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1547873 RS:0000324 FHH-Chr 15BN/Mcwi XCO:0000153 sample resting period 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000116 Kreb's solution perfusate 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000099 control condition 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000152 drug dose time series 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000118 perfusate suspended 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1358158 RS:0000325 FHH-Chr 16BN/Mcwi XCO:0000153 sample resting period 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000116 Kreb's solution perfusate 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000099 control condition 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000152 drug dose time series 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000118 perfusate suspended 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1358164 RS:0000326 FHH-Chr 17BN/Mcwi XCO:0000153 sample resting period 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000116 Kreb's solution perfusate 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000099 control condition 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000152 drug dose time series 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000118 perfusate suspended 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1358176 RS:0000327 FHH-Chr 18BN/Mcwi XCO:0000153 sample resting period 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000116 Kreb's solution perfusate 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000099 control condition 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000152 drug dose time series 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000118 perfusate suspended 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1358180 RS:0000328 FHH-Chr 19BN/Mcwi XCO:0000153 sample resting period 5688109 RS:0003185 FHH-Chr 1BN-Sorcs1em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688107 RS:0003156 FHH-Chr 1BN-Sorcs1em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000116 Kreb's solution perfusate 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000099 control condition 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000168 controlled in situ renal perfusion pressure 100 140 mmHg 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000152 drug dose time series 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000118 perfusate suspended 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000003 resting on treadmill 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000005 running on treadmill 1.6 1.6 m/min 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000153 sample resting period 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000142 sodium nitroprusside 0 3 umol/l 629520 RS:0000329 FHH-Chr 1BN/Mcwi XCO:0000004 walking on treadmill 0.8 0.8 m/min 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000116 Kreb's solution perfusate 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000099 control condition 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000152 drug dose time series 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000118 perfusate suspended 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1358175 RS:0000330 FHH-Chr 20BN/Mcwi XCO:0000153 sample resting period 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000116 Kreb's solution perfusate 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000099 control condition 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000152 drug dose time series 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000118 perfusate suspended 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1547868 RS:0000331 FHH-Chr 2BN/Mcwi XCO:0000153 sample resting period 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000116 Kreb's solution perfusate 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000099 control condition 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000152 drug dose time series 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000118 perfusate suspended 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1547865 RS:0000332 FHH-Chr 3BN/Mcwi XCO:0000153 sample resting period 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000116 Kreb's solution perfusate 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000099 control condition 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000152 drug dose time series 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000118 perfusate suspended 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1547867 RS:0000333 FHH-Chr 4BN/Mcwi XCO:0000153 sample resting period 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000116 Kreb's solution perfusate 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000099 control condition 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000152 drug dose time series 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000118 perfusate suspended 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1358170 RS:0000334 FHH-Chr 5BN/Mcwi XCO:0000153 sample resting period 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000116 Kreb's solution perfusate 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000099 control condition 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000152 drug dose time series 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000118 perfusate suspended 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1358159 RS:0000335 FHH-Chr 6BN/Mcwi XCO:0000153 sample resting period 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000116 Kreb's solution perfusate 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000099 control condition 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000152 drug dose time series 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000118 perfusate suspended 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1358157 RS:0000336 FHH-Chr 7BN/Mcwi XCO:0000153 sample resting period 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000116 Kreb's solution perfusate 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000099 control condition 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000152 drug dose time series 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000118 perfusate suspended 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1358151 RS:0000337 FHH-Chr 8BN/Mcwi XCO:0000153 sample resting period 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000116 Kreb's solution perfusate 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000099 control condition 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000152 drug dose time series 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000118 perfusate suspended 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1566448 RS:0001110 FHH-Chr 9BN/Mcwi XCO:0000153 sample resting period 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000116 Kreb's solution perfusate 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000099 control condition 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000152 drug dose time series 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000118 perfusate suspended 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1547872 RS:0000338 FHH-Chr XBN/Mcwi XCO:0000153 sample resting period 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000116 Kreb's solution perfusate 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000099 control condition 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000152 drug dose time series 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000118 perfusate suspended 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1547874 RS:0000339 FHH-Chr YBN/Mcwi XCO:0000153 sample resting period 1579694 RS:0001127 FHH-Egln3m1Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1579694 RS:0001127 FHH-Egln3m1Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1579694 RS:0001127 FHH-Egln3m1Mcwi XCO:0000152 drug dose time series 1579694 RS:0001127 FHH-Egln3m1Mcwi XCO:0000102 fasting 1579694 RS:0001127 FHH-Egln3m1Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1579694 RS:0001127 FHH-Egln3m1Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1579694 RS:0001127 FHH-Egln3m1Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1579694 RS:0001127 FHH-Egln3m1Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1579689 RS:0001124 FHH-F10m1Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1579689 RS:0001124 FHH-F10m1Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1579689 RS:0001124 FHH-F10m1Mcwi XCO:0000152 drug dose time series 1579689 RS:0001124 FHH-F10m1Mcwi XCO:0000102 fasting 1579689 RS:0001124 FHH-F10m1Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1579689 RS:0001124 FHH-F10m1Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1579689 RS:0001124 FHH-F10m1Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1579689 RS:0001124 FHH-F10m1Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1579912 RS:0001142 FHH-F10m2Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1579912 RS:0001142 FHH-F10m2Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1579912 RS:0001142 FHH-F10m2Mcwi XCO:0000152 drug dose time series 1579912 RS:0001142 FHH-F10m2Mcwi XCO:0000102 fasting 1579912 RS:0001142 FHH-F10m2Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1579912 RS:0001142 FHH-F10m2Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1579912 RS:0001142 FHH-F10m2Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1579912 RS:0001142 FHH-F10m2Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1579683 RS:0001119 FHH-Ghsrm1Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1579683 RS:0001119 FHH-Ghsrm1Mcwi XCO:0000152 drug dose time series 1579683 RS:0001119 FHH-Ghsrm1Mcwi XCO:0000102 fasting 1579683 RS:0001119 FHH-Ghsrm1Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1579683 RS:0001119 FHH-Ghsrm1Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1579683 RS:0001119 FHH-Ghsrm1Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1581644 RS:0001151 FHH-Htr1am1Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1581644 RS:0001151 FHH-Htr1am1Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1581644 RS:0001151 FHH-Htr1am1Mcwi XCO:0000152 drug dose time series 1581644 RS:0001151 FHH-Htr1am1Mcwi XCO:0000102 fasting 1581644 RS:0001151 FHH-Htr1am1Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1581644 RS:0001151 FHH-Htr1am1Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1581644 RS:0001151 FHH-Htr1am1Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1581644 RS:0001151 FHH-Htr1am1Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1579692 RS:0001126 FHH-Lcatm1Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1579692 RS:0001126 FHH-Lcatm1Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1579692 RS:0001126 FHH-Lcatm1Mcwi XCO:0000152 drug dose time series 1579692 RS:0001126 FHH-Lcatm1Mcwi XCO:0000102 fasting 1579692 RS:0001126 FHH-Lcatm1Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1579692 RS:0001126 FHH-Lcatm1Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1579692 RS:0001126 FHH-Lcatm1Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1579692 RS:0001126 FHH-Lcatm1Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1579705 RS:0001131 FHH-Nr0b2m1Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1579705 RS:0001131 FHH-Nr0b2m1Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1579705 RS:0001131 FHH-Nr0b2m1Mcwi XCO:0000152 drug dose time series 1579705 RS:0001131 FHH-Nr0b2m1Mcwi XCO:0000102 fasting 1579705 RS:0001131 FHH-Nr0b2m1Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1579705 RS:0001131 FHH-Nr0b2m1Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1579705 RS:0001131 FHH-Nr0b2m1Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1579705 RS:0001131 FHH-Nr0b2m1Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1579706 RS:0001132 FHH-Nr4a1m1Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1579706 RS:0001132 FHH-Nr4a1m1Mcwi XCO:0000099 control condition 1579706 RS:0001132 FHH-Nr4a1m1Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1579706 RS:0001132 FHH-Nr4a1m1Mcwi XCO:0000152 drug dose time series 1579706 RS:0001132 FHH-Nr4a1m1Mcwi XCO:0000102 fasting 1579706 RS:0001132 FHH-Nr4a1m1Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1579706 RS:0001132 FHH-Nr4a1m1Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1579706 RS:0001132 FHH-Nr4a1m1Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1579706 RS:0001132 FHH-Nr4a1m1Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1579687 RS:0001122 FHH-Procm1Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1579687 RS:0001122 FHH-Procm1Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1579687 RS:0001122 FHH-Procm1Mcwi XCO:0000152 drug dose time series 1579687 RS:0001122 FHH-Procm1Mcwi XCO:0000102 fasting 1579687 RS:0001122 FHH-Procm1Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1579687 RS:0001122 FHH-Procm1Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1579687 RS:0001122 FHH-Procm1Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1579687 RS:0001122 FHH-Procm1Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1579684 RS:0001120 FHH-Slc8a2m1Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1579684 RS:0001120 FHH-Slc8a2m1Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1579684 RS:0001120 FHH-Slc8a2m1Mcwi XCO:0000152 drug dose time series 1579684 RS:0001120 FHH-Slc8a2m1Mcwi XCO:0000102 fasting 1579684 RS:0001120 FHH-Slc8a2m1Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1579684 RS:0001120 FHH-Slc8a2m1Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1579684 RS:0001120 FHH-Slc8a2m1Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1579684 RS:0001120 FHH-Slc8a2m1Mcwi XCO:0000150 potassium ion 80 80 mmol/l 5687688 RS:0003111 FHH-Tg(CAG-Rab38)1Mcwi XCO:0000099 control condition 1579685 RS:0001121 FHH-Tgfbr2m2Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1579685 RS:0001121 FHH-Tgfbr2m2Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1579685 RS:0001121 FHH-Tgfbr2m2Mcwi XCO:0000152 drug dose time series 1579685 RS:0001121 FHH-Tgfbr2m2Mcwi XCO:0000102 fasting 1579685 RS:0001121 FHH-Tgfbr2m2Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1579685 RS:0001121 FHH-Tgfbr2m2Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1579685 RS:0001121 FHH-Tgfbr2m2Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1579685 RS:0001121 FHH-Tgfbr2m2Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1579682 RS:0001116 FHH-Tlr4m1Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1579682 RS:0001116 FHH-Tlr4m1Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1579682 RS:0001116 FHH-Tlr4m1Mcwi XCO:0000152 drug dose time series 1579682 RS:0001116 FHH-Tlr4m1Mcwi XCO:0000102 fasting 1579682 RS:0001116 FHH-Tlr4m1Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1579682 RS:0001116 FHH-Tlr4m1Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1579682 RS:0001116 FHH-Tlr4m1Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1579682 RS:0001116 FHH-Tlr4m1Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1357959 RS:0000341 FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi XCO:0000099 control condition 5688090 RS:0003181 FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688087 RS:0003152 FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi-/- XCO:0000099 control condition 5688087 RS:0003152 FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 1582193 RS:0001306 FHH.FHH.1BN-(D1Mgh13-D1Rat89)/Mcwi XCO:0000168 controlled in situ renal perfusion pressure 100 140 mmHg 1582195 RS:0001307 FHH.FHH.1BN-(D1Rat173F6B-D1Rat84)/Mcwi XCO:0000168 controlled in situ renal perfusion pressure 100 140 mmHg 1582186 RS:0001308 FHH.FHH.1BN-(D1Rat183-D1Rat76)/Mcwi XCO:0000168 controlled in situ renal perfusion pressure 100 140 mmHg 1582196 RS:0001309 FHH.FHH.1BN-(D1Rat234-D1Rat265)/Mcwi XCO:0000168 controlled in situ renal perfusion pressure 100 140 mmHg 1582191 RS:0001310 FHH.FHH.1BN-(D1Rat287-D1Rat84)/Mcwi XCO:0000168 controlled in situ renal perfusion pressure 100 140 mmHg 5147594 RS:0002296 FHH.PCK-(D9Rat35-D9Rat70)/Mcwi XCO:0000099 control condition 10015 RS:0000018 FHH/Eur XCO:0000257 controlled hydrogen ion content drinking water 2.4 2.8 pH 10015 RS:0000018 FHH/Eur XCO:0000112 unilateral nephrectomy 629509 RS:0000342 FHH/EurMcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 629509 RS:0000342 FHH/EurMcwi XCO:0000116 Kreb's solution perfusate 629509 RS:0000342 FHH/EurMcwi XCO:0000143 acetylcholine 0 30 umol/l 629509 RS:0000342 FHH/EurMcwi XCO:0000012 air carbon dioxide content 7 7 % 629509 RS:0000342 FHH/EurMcwi XCO:0000012 air carbon dioxide content 7 % 629509 RS:0000342 FHH/EurMcwi XCO:0000126 angiotensin 5 5 ng/kg/min 629509 RS:0000342 FHH/EurMcwi XCO:0000126 angiotensin 10 10 ng/kg/min 629509 RS:0000342 FHH/EurMcwi XCO:0000126 angiotensin 25 25 ng/kg/min 629509 RS:0000342 FHH/EurMcwi XCO:0000126 angiotensin 50 50 ng/kg/min 629509 RS:0000342 FHH/EurMcwi XCO:0000099 control condition 629509 RS:0000342 FHH/EurMcwi XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 12.5 12.5 mg/l 629509 RS:0000342 FHH/EurMcwi XCO:0000010 controlled air oxygen content 12 12 % 629509 RS:0000342 FHH/EurMcwi XCO:0000010 controlled air oxygen content 12 % 629509 RS:0000342 FHH/EurMcwi XCO:0000168 controlled in situ renal perfusion pressure 100 100 mmHg 629509 RS:0000342 FHH/EurMcwi XCO:0000168 controlled in situ renal perfusion pressure 100 140 mmHg 629509 RS:0000342 FHH/EurMcwi XCO:0000168 controlled in situ renal perfusion pressure 140 140 mmHg 629509 RS:0000342 FHH/EurMcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 629509 RS:0000342 FHH/EurMcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 629509 RS:0000342 FHH/EurMcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 629509 RS:0000342 FHH/EurMcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 629509 RS:0000342 FHH/EurMcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 629509 RS:0000342 FHH/EurMcwi XCO:0000022 controlled sodium content diet 0 % 629509 RS:0000342 FHH/EurMcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 629509 RS:0000342 FHH/EurMcwi XCO:0000022 controlled sodium content diet 4 4 % 629509 RS:0000342 FHH/EurMcwi XCO:0000022 controlled sodium content diet 8 8 % 629509 RS:0000342 FHH/EurMcwi XCO:0000152 drug dose time series 629509 RS:0000342 FHH/EurMcwi XCO:0000102 fasting 629509 RS:0000342 FHH/EurMcwi XCO:0000124 furosemide 10 10 mg/kg 629509 RS:0000342 FHH/EurMcwi XCO:0000134 methacholine 0 11.06 mg/kg 629509 RS:0000342 FHH/EurMcwi XCO:0000138 methylene blue 10 10 umol/l 629509 RS:0000342 FHH/EurMcwi XCO:0000127 norepinephrine 0.1 0.1 ng/kg/min 629509 RS:0000342 FHH/EurMcwi XCO:0000127 norepinephrine 0.2 0.2 ng/kg/min 629509 RS:0000342 FHH/EurMcwi XCO:0000127 norepinephrine 0.5 0.5 ng/kg/min 629509 RS:0000342 FHH/EurMcwi XCO:0000127 norepinephrine 1 1 ng/kg/min 629509 RS:0000342 FHH/EurMcwi XCO:0000118 perfusate suspended 629509 RS:0000342 FHH/EurMcwi XCO:0000145 phenylephrine 0 300 umol/l 629509 RS:0000342 FHH/EurMcwi XCO:0000145 phenylephrine 1 1 umol/l 629509 RS:0000342 FHH/EurMcwi XCO:0000145 phenylephrine 10 10 umol/l 629509 RS:0000342 FHH/EurMcwi XCO:0000150 potassium ion 80 80 mmol/l 629509 RS:0000342 FHH/EurMcwi XCO:0000003 resting on treadmill 629509 RS:0000342 FHH/EurMcwi XCO:0000005 running on treadmill 1.6 1.6 m/min 629509 RS:0000342 FHH/EurMcwi XCO:0000153 sample resting period 629509 RS:0000342 FHH/EurMcwi XCO:0000142 sodium nitroprusside 0 3 umol/l 629509 RS:0000342 FHH/EurMcwi XCO:0000004 walking on treadmill 0.8 0.8 m/min 2311072 RS:0000178 FHH/EurMcwiCrl XCO:0000360 arterial catheter implantation 2311072 RS:0000178 FHH/EurMcwiCrl XCO:0000099 control condition 2311072 RS:0000178 FHH/EurMcwiCrl XCO:0000812 controlled hemorrhage 2306024 RS:0001994 FOK/Ncu XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2306024 RS:0001994 FOK/Ncu XCO:0000102 fasting 2306024 RS:0001994 FOK/Ncu XCO:0000087 specific pathogen-free condition 1302602 RS:0000349 FXLE12/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302602 RS:0000349 FXLE12/Stm XCO:0000102 fasting 1302602 RS:0000349 FXLE12/Stm XCO:0000087 specific pathogen-free condition 1302665 RS:0000350 FXLE13/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302665 RS:0000350 FXLE13/Stm XCO:0000102 fasting 1302665 RS:0000350 FXLE13/Stm XCO:0000087 specific pathogen-free condition 1302615 RS:0000351 FXLE14/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302615 RS:0000351 FXLE14/Stm XCO:0000102 fasting 1302615 RS:0000351 FXLE14/Stm XCO:0000087 specific pathogen-free condition 1302673 RS:0000352 FXLE15/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302673 RS:0000352 FXLE15/Stm XCO:0000102 fasting 1302673 RS:0000352 FXLE15/Stm XCO:0000087 specific pathogen-free condition 1302619 RS:0000353 FXLE16/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302619 RS:0000353 FXLE16/Stm XCO:0000102 fasting 1302619 RS:0000353 FXLE16/Stm XCO:0000087 specific pathogen-free condition 1302708 RS:0000354 FXLE17/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302708 RS:0000354 FXLE17/Stm XCO:0000102 fasting 1302708 RS:0000354 FXLE17/Stm XCO:0000087 specific pathogen-free condition 1302682 RS:0000355 FXLE18/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302682 RS:0000355 FXLE18/Stm XCO:0000102 fasting 1302682 RS:0000355 FXLE18/Stm XCO:0000087 specific pathogen-free condition 1302690 RS:0000356 FXLE19/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302690 RS:0000356 FXLE19/Stm XCO:0000102 fasting 1302690 RS:0000356 FXLE19/Stm XCO:0000087 specific pathogen-free condition 1302633 RS:0000357 FXLE20/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302633 RS:0000357 FXLE20/Stm XCO:0000102 fasting 1302633 RS:0000357 FXLE20/Stm XCO:0000087 specific pathogen-free condition 1302607 RS:0000358 FXLE21/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302607 RS:0000358 FXLE21/Stm XCO:0000102 fasting 1302607 RS:0000358 FXLE21/Stm XCO:0000087 specific pathogen-free condition 1302683 RS:0000359 FXLE22/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302683 RS:0000359 FXLE22/Stm XCO:0000102 fasting 1302683 RS:0000359 FXLE22/Stm XCO:0000087 specific pathogen-free condition 1302601 RS:0000360 FXLE23/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302601 RS:0000360 FXLE23/Stm XCO:0000102 fasting 1302601 RS:0000360 FXLE23/Stm XCO:0000087 specific pathogen-free condition 1302611 RS:0000361 FXLE24/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302611 RS:0000361 FXLE24/Stm XCO:0000102 fasting 1302611 RS:0000361 FXLE24/Stm XCO:0000087 specific pathogen-free condition 1302603 RS:0001313 FXLE25/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302603 RS:0001313 FXLE25/Stm XCO:0000102 fasting 1302603 RS:0001313 FXLE25/Stm XCO:0000087 specific pathogen-free condition 1302598 RS:0001314 FXLE26/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302598 RS:0001314 FXLE26/Stm XCO:0000102 fasting 1302598 RS:0001314 FXLE26/Stm XCO:0000087 specific pathogen-free condition 1554304 RS:0000481 GAERS/Mave XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1554304 RS:0000481 GAERS/Mave XCO:0000099 control condition 1554304 RS:0000481 GAERS/Mave XCO:0000102 fasting 1554304 RS:0000481 GAERS/Mave XCO:0000087 specific pathogen-free condition 60984 RS:0000318 GH XCO:0000099 control condition 10016 RS:0000374 GH/Omr XCO:0000191 angiotensin II 5 50 ng/kg/min 10016 RS:0000374 GH/Omr XCO:0000099 control condition 10016 RS:0000374 GH/Omr XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 10016 RS:0000374 GH/Omr XCO:0000795 controlled sodium chloride content diet 4 4 % 10016 RS:0000374 GH/Omr XCO:0000127 norepinephrine 0.1 1 ug/kg/min 10016 RS:0000374 GH/Omr XCO:0000145 phenylephrine 4 4 ug/kg 1579686 RS:0001108 GH/OmrMcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1579686 RS:0001108 GH/OmrMcwi XCO:0000116 Kreb's solution perfusate 1579686 RS:0001108 GH/OmrMcwi XCO:0000143 acetylcholine 0 30 umol/l 1579686 RS:0001108 GH/OmrMcwi XCO:0000012 air carbon dioxide content 7 7 % 1579686 RS:0001108 GH/OmrMcwi XCO:0000012 air carbon dioxide content 7 % 1579686 RS:0001108 GH/OmrMcwi XCO:0000126 angiotensin 5 5 ng/kg/min 1579686 RS:0001108 GH/OmrMcwi XCO:0000126 angiotensin 10 10 ng/kg/min 1579686 RS:0001108 GH/OmrMcwi XCO:0000126 angiotensin 25 25 ng/kg/min 1579686 RS:0001108 GH/OmrMcwi XCO:0000126 angiotensin 50 50 ng/kg/min 1579686 RS:0001108 GH/OmrMcwi XCO:0000099 control condition 1579686 RS:0001108 GH/OmrMcwi XCO:0000010 controlled air oxygen content 12 12 % 1579686 RS:0001108 GH/OmrMcwi XCO:0000010 controlled air oxygen content 12 % 1579686 RS:0001108 GH/OmrMcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1579686 RS:0001108 GH/OmrMcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 1579686 RS:0001108 GH/OmrMcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 1579686 RS:0001108 GH/OmrMcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 1579686 RS:0001108 GH/OmrMcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 1579686 RS:0001108 GH/OmrMcwi XCO:0000022 controlled sodium content diet 0 % 1579686 RS:0001108 GH/OmrMcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 1579686 RS:0001108 GH/OmrMcwi XCO:0000022 controlled sodium content diet 4 4 % 1579686 RS:0001108 GH/OmrMcwi XCO:0000152 drug dose time series 1579686 RS:0001108 GH/OmrMcwi XCO:0000124 furosemide 10 10 mg/kg 1579686 RS:0001108 GH/OmrMcwi XCO:0000134 methacholine 0 11.06 mg/kg 1579686 RS:0001108 GH/OmrMcwi XCO:0000138 methylene blue 10 10 umol/l 1579686 RS:0001108 GH/OmrMcwi XCO:0000127 norepinephrine 0.1 0.1 ng/kg/min 1579686 RS:0001108 GH/OmrMcwi XCO:0000127 norepinephrine 0.2 0.2 ng/kg/min 1579686 RS:0001108 GH/OmrMcwi XCO:0000127 norepinephrine 0.5 0.5 ng/kg/min 1579686 RS:0001108 GH/OmrMcwi XCO:0000127 norepinephrine 1 1 ng/kg/min 1579686 RS:0001108 GH/OmrMcwi XCO:0000118 perfusate suspended 1579686 RS:0001108 GH/OmrMcwi XCO:0000145 phenylephrine 0 300 umol/l 1579686 RS:0001108 GH/OmrMcwi XCO:0000145 phenylephrine 1 1 umol/l 1579686 RS:0001108 GH/OmrMcwi XCO:0000145 phenylephrine 10 10 umol/l 1579686 RS:0001108 GH/OmrMcwi XCO:0000150 potassium ion 80 80 mmol/l 1579686 RS:0001108 GH/OmrMcwi XCO:0000003 resting on treadmill 1579686 RS:0001108 GH/OmrMcwi XCO:0000005 running on treadmill 1.6 1.6 m/min 1579686 RS:0001108 GH/OmrMcwi XCO:0000153 sample resting period 1579686 RS:0001108 GH/OmrMcwi XCO:0000142 sodium nitroprusside 0 3 umol/l 1579686 RS:0001108 GH/OmrMcwi XCO:0000004 walking on treadmill 0.8 0.8 m/min 634372 RS:0001315 GHS XCO:0000031 controlled calcium content diet 0.6 0.6 % 13506737 RS:0001299 GK XCO:0000121 NG-nitroarginine methyl ester 50 50 mg/kg 13506737 RS:0001299 GK XCO:0000143 acetylcholine 5 5 ug/kg/min 13506737 RS:0001299 GK XCO:0000095 bilateral ovariectomy 13506737 RS:0001299 GK XCO:0000099 control condition 13506737 RS:0001299 GK XCO:0000010 controlled air oxygen content 5 5 % 13506737 RS:0001299 GK XCO:0000010 controlled air oxygen content 21 21 % 13506737 RS:0001299 GK XCO:0000910 controlled dehydroepiandrosterone content diet 0.2 0.2 % 13506737 RS:0001299 GK XCO:0000463 dark phase of controlled light/dark cycle 13506737 RS:0001299 GK XCO:0000102 fasting 13506737 RS:0001299 GK XCO:0000275 glucose 1 1 g/kg 13506737 RS:0001299 GK XCO:0000275 glucose 2 2 g/kg 13506737 RS:0001299 GK XCO:0000103 glucose solution 2.8 2.8 mmol/l 13506737 RS:0001299 GK XCO:0000103 glucose solution 16.7 16.7 mmol/l 13506737 RS:0001299 GK XCO:0000549 left anterior descending coronary artery occlusion 13506737 RS:0001299 GK XCO:0000462 light phase of controlled light/dark cycle 13506737 RS:0001299 GK XCO:0000564 meclofenamate 3 3 mg/kg 13506737 RS:0001299 GK XCO:0000641 myocardial reperfusion 13506737 RS:0001299 GK XCO:0000002 resting 13506737 RS:0001299 GK XCO:0000008 running 3.91 3.91 km/d 13506737 RS:0001299 GK XCO:0000005 running on treadmill 15 15 m/min 13506737 RS:0001299 GK XCO:0000562 salidroside 40 40 mg/kg 13506737 RS:0001299 GK XCO:0000100 sham surgical control condition 13506737 RS:0001299 GK XCO:0000142 sodium nitroprusside 5 5 ug/kg/min 13506737 RS:0001299 GK XCO:0000101 vehicle control condition 0.15 0.15 ml 13506737 RS:0001299 GK XCO:0000101 vehicle control condition 13506737 RS:0001299 GK XCO:0000857 vildagliptin 30 30 mg/kg/d 39128239 RS:0004817 GK/CskCrlj XCO:0000686 Intralipid 20 10 10 ml/kg 39128239 RS:0004817 GK/CskCrlj XCO:0000099 control condition 39128239 RS:0004817 GK/CskCrlj XCO:0000102 fasting 39128239 RS:0004817 GK/CskCrlj XCO:0000275 glucose 2 2 g/kg 39128239 RS:0004817 GK/CskCrlj XCO:0000789 methylcellulose 0.5 0.5 % 39128239 RS:0004817 GK/CskCrlj XCO:0000684 nateglinide 50 50 mg/kg 2308885 RS:0001995 GK/CskCrljCrl XCO:0000099 control condition 1579710 RS:0001316 GK/Far XCO:0000099 control condition 1579710 RS:0001316 GK/Far XCO:0000102 fasting 13506739 RS:0004580 GK/Jcl XCO:0000563 Omacor 400 400 mg/kg/d 13506739 RS:0004580 GK/Jcl XCO:0000099 control condition 13506739 RS:0004580 GK/Jcl XCO:0000895 controlled cyclodextrin (CD)-clathrated hesperetin content diet 4.6 4.6 % 13506739 RS:0004580 GK/Jcl XCO:0000894 controlled hesperidin content diet 1 1 % 13506739 RS:0004580 GK/Jcl XCO:0000102 fasting 13506739 RS:0004580 GK/Jcl XCO:0000103 glucose solution 2 2 g/kg 13506739 RS:0004580 GK/Jcl XCO:0000069 standard diet 13506739 RS:0004580 GK/Jcl XCO:0000857 vildagliptin 30 30 mg/kg/d 41404660 RS:0004851 GK/Jpe XCO:0000099 control condition 41404660 RS:0004851 GK/Jpe XCO:0000246 controlled cholesterol content diet 1.25 1.25 % 41404660 RS:0004851 GK/Jpe XCO:0000246 controlled cholesterol content diet 1.25 1.25 41404660 RS:0004851 GK/Jpe XCO:0000772 controlled cocoa butter content diet 7.5 7.5 % 41404660 RS:0004851 GK/Jpe XCO:0000772 controlled cocoa butter content diet 7.5 7.5 g/kg 41404660 RS:0004851 GK/Jpe XCO:0000772 controlled cocoa butter content diet 7.5 7.5 41404660 RS:0004851 GK/Jpe XCO:0000102 fasting 2 2 ml/kg 41404660 RS:0004851 GK/Jpe XCO:0000102 fasting 41404660 RS:0004851 GK/Jpe XCO:0000103 glucose solution 1.75 1.75 g/kg 41404660 RS:0004851 GK/Jpe XCO:0000777 lipoic acid 50 50 mg/kg 41404660 RS:0004851 GK/Jpe XCO:0000775 soybean oil 2 2 ml/kg 10017 RS:0000118 GK/KyoSwe XCO:0000099 control condition 10017 RS:0000118 GK/KyoSwe XCO:0000102 fasting 10017 RS:0000118 GK/KyoSwe XCO:0000104 glucose solution, 2.8M 2 2 g/kg 1566447 RS:0001317 GK/MolTac XCO:0000811 A23187 10 10 umol/l 1566447 RS:0001317 GK/MolTac XCO:0000796 U46619 0.3 0.3 umol/l 1566447 RS:0001317 GK/MolTac XCO:0000860 anti-rh-VEGF165 monoclonal antibody 1 1 mg 1566447 RS:0001317 GK/MolTac XCO:0000861 control IgG monoclonal antibody 1 1 mg 1566447 RS:0001317 GK/MolTac XCO:0000099 control condition 1566447 RS:0001317 GK/MolTac XCO:0000942 controlled saxagliptin content diet 10 10 mg/kg/d 1566447 RS:0001317 GK/MolTac XCO:0000102 fasting 1566447 RS:0001317 GK/MolTac XCO:0000275 glucose 1566447 RS:0001317 GK/MolTac XCO:0000103 glucose solution 2 2 g/kg 1566447 RS:0001317 GK/MolTac XCO:0000883 pantoprazole 100 100 umol/kg 1566447 RS:0001317 GK/MolTac XCO:0000602 rosiglitazone 5 5 mg/kg 1566447 RS:0001317 GK/MolTac XCO:0000602 rosiglitazone 10 10 mg/kg 1566447 RS:0001317 GK/MolTac XCO:0000005 running on treadmill 0 10 m/min 1566447 RS:0001317 GK/MolTac XCO:0000005 running on treadmill 15 15 m/min 1566447 RS:0001317 GK/MolTac XCO:0000100 sham surgical control condition 1566447 RS:0001317 GK/MolTac XCO:0000882 sleeve gastrectomy 1566447 RS:0001317 GK/MolTac XCO:0000911 sodium bicarbonate 8.4 8.4 % 1566447 RS:0001317 GK/MolTac XCO:0000911 sodium bicarbonate 8.5 8.5 % 1566447 RS:0001317 GK/MolTac XCO:0000155 sodium chloride solution 4889464 RS:0002495 GK/Ox XCO:0000102 fasting 13506738 RS:0004579 GK/Par XCO:0000099 control condition 13506738 RS:0004579 GK/Par XCO:0000915 controlled ethanol content drinking water used as vehicle 1 1 % 13506738 RS:0004579 GK/Par XCO:0000904 controlled resveratrol content drinking water 1 1 mg/kg/d 1554306 RS:0000482 GK/Slc XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1554306 RS:0000482 GK/Slc XCO:0000566 controlled ipragliflozin content diet 0.008 0.008 % 1554306 RS:0000482 GK/Slc XCO:0000102 fasting 1554306 RS:0000482 GK/Slc XCO:0000087 specific pathogen-free condition 1554306 RS:0000482 GK/Slc XCO:0000101 vehicle control condition 127284837 RS:0004950 GK/Wnsm XCO:0000099 control condition 127284837 RS:0004950 GK/Wnsm XCO:0000962 controlled ex vivo heart perfusion 127284837 RS:0004950 GK/Wnsm XCO:0000148 controlled oxygen content physiological salt solution perfusate 40 40 mmHg 1599759 RS:0001318 GRY/Idr XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1599759 RS:0001318 GRY/Idr XCO:0000102 fasting 1599759 RS:0001318 GRY/Idr XCO:0000087 specific pathogen-free condition 1554308 RS:0001320 Gunn-Ugt1a1jSlc XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1554308 RS:0001320 Gunn-Ugt1a1jSlc XCO:0000102 fasting 1554308 RS:0001320 Gunn-Ugt1a1jSlc XCO:0000087 specific pathogen-free condition 1300432 RS:0000388 HAA/FDSC XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1300432 RS:0000388 HAA/FDSC XCO:0000102 fasting 1300432 RS:0000388 HAA/FDSC XCO:0000087 specific pathogen-free condition 738038 RS:0000392 HEP XCO:0000023 controlled ethanol content drinking water 10 10 % 738038 RS:0000392 HEP XCO:0000325 ethanol 20 20 % 738038 RS:0000392 HEP XCO:0000021 water 1554302 RS:0000486 HOB-Unc5chob/Snk XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1554302 RS:0000486 HOB-Unc5chob/Snk XCO:0000102 fasting 1554302 RS:0000486 HOB-Unc5chob/Snk XCO:0000087 specific pathogen-free condition 1302700 RS:0000395 HOB/Snk XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302700 RS:0000395 HOB/Snk XCO:0000102 fasting 1302700 RS:0000395 HOB/Snk XCO:0000087 specific pathogen-free condition 1302795 RS:0000397 HTG XCO:0000121 NG-nitroarginine methyl ester 30 30 mg/kg 1302795 RS:0000397 HTG XCO:0000099 control condition 1302795 RS:0000397 HTG XCO:0000246 controlled cholesterol content diet 1 1 % 1302795 RS:0000397 HTG XCO:0000102 fasting 1302795 RS:0000397 HTG XCO:0000161 losartan 10 10 mg/kg 1302795 RS:0000397 HTG XCO:0000162 pentolinium 5 5 mg/kg 1302795 RS:0000397 HTG XCO:0000189 physical restraint on immobilization board 1302795 RS:0000397 HTG XCO:0000069 standard diet 1302600 RS:0000399 HTX/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302600 RS:0000399 HTX/Kyo XCO:0000102 fasting 1302600 RS:0000399 HTX/Kyo XCO:0000087 specific pathogen-free condition 1302718 RS:0000400 HWY/Slc XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302718 RS:0000400 HWY/Slc XCO:0000102 fasting 1302718 RS:0000400 HWY/Slc XCO:0000087 specific pathogen-free condition 1566433 RS:0001592 HanTac:WH XCO:0000811 A23187 10 10 umol/l 1566433 RS:0001592 HanTac:WH XCO:0000796 U46619 0.3 0.3 umol/l 1566433 RS:0001592 HanTac:WH XCO:0000860 anti-rh-VEGF165 monoclonal antibody 1 1 mg 1566433 RS:0001592 HanTac:WH XCO:0000397 bisphenol A 0.025 0.025 mg/kg/d 1566433 RS:0001592 HanTac:WH XCO:0000397 bisphenol A 0.25 0.25 mg/kg/d 1566433 RS:0001592 HanTac:WH XCO:0000397 bisphenol A 5 5 mg/kg/d 1566433 RS:0001592 HanTac:WH XCO:0000397 bisphenol A 50 50 mg/kg/d 1566433 RS:0001592 HanTac:WH XCO:0000861 control IgG monoclonal antibody 1 1 mg 1566433 RS:0001592 HanTac:WH XCO:0000099 control condition 1566433 RS:0001592 HanTac:WH XCO:0000101 vehicle control condition 737903 RS:0000698 Hsd:SD XCO:0000600 2,3,7,8-tetrachlorodibenzo-p-dioxin 3 3 ng/kg/d 737903 RS:0000698 Hsd:SD XCO:0000600 2,3,7,8-tetrachlorodibenzo-p-dioxin 22 22 ng/kg/d 737903 RS:0000698 Hsd:SD XCO:0000600 2,3,7,8-tetrachlorodibenzo-p-dioxin 100 100 ng/kg/d 737903 RS:0000698 Hsd:SD XCO:0000600 2,3,7,8-tetrachlorodibenzo-p-dioxin 300 300 ng/kg/d 737903 RS:0000698 Hsd:SD XCO:0000600 2,3,7,8-tetrachlorodibenzo-p-dioxin 1000 1000 ng/kg/d 737903 RS:0000698 Hsd:SD XCO:0000137 FAPGG 0.6 0.6 mmol/l 737903 RS:0000698 Hsd:SD XCO:0000116 Kreb's solution perfusate 737903 RS:0000698 Hsd:SD XCO:0000388 acetaminophen 1 1 g/kg 737903 RS:0000698 Hsd:SD XCO:0000388 acetaminophen 2 2 g/kg 737903 RS:0000698 Hsd:SD XCO:0000143 acetylcholine 0 30 umol/l 737903 RS:0000698 Hsd:SD XCO:0000012 air carbon dioxide content 7 7 % 737903 RS:0000698 Hsd:SD XCO:0000012 air carbon dioxide content 7 % 737903 RS:0000698 Hsd:SD XCO:0000126 angiotensin 5 5 ng/kg/min 737903 RS:0000698 Hsd:SD XCO:0000126 angiotensin 10 10 ng/kg/min 737903 RS:0000698 Hsd:SD XCO:0000126 angiotensin 25 25 ng/kg/min 737903 RS:0000698 Hsd:SD XCO:0000126 angiotensin 50 50 ng/kg/min 737903 RS:0000698 Hsd:SD XCO:0000268 balloon angioplasty 737903 RS:0000698 Hsd:SD XCO:0000398 cisplatin 15 15 mg/kg 737903 RS:0000698 Hsd:SD XCO:0000099 control condition 737903 RS:0000698 Hsd:SD XCO:0000010 controlled air oxygen content 12 12 % 737903 RS:0000698 Hsd:SD XCO:0000010 controlled air oxygen content 12 % 737903 RS:0000698 Hsd:SD XCO:0000183 controlled exposure to darkness 737903 RS:0000698 Hsd:SD XCO:0000025 controlled fat content diet 42 42 % 737903 RS:0000698 Hsd:SD XCO:0000146 controlled oxygen content Kreb's solution perfusate 737903 RS:0000698 Hsd:SD XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 737903 RS:0000698 Hsd:SD XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 737903 RS:0000698 Hsd:SD XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 737903 RS:0000698 Hsd:SD XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 737903 RS:0000698 Hsd:SD XCO:0000022 controlled sodium content diet 0 % 737903 RS:0000698 Hsd:SD XCO:0000022 controlled sodium content diet 0.4 0.4 % 737903 RS:0000698 Hsd:SD XCO:0000022 controlled sodium content diet 4 4 % 737903 RS:0000698 Hsd:SD XCO:0000181 controlled visible light condition 30 30 cd x s/m2 737903 RS:0000698 Hsd:SD XCO:0000152 drug dose time series 737903 RS:0000698 Hsd:SD XCO:0000102 fasting 737903 RS:0000698 Hsd:SD XCO:0000124 furosemide 10 10 mg/kg 737903 RS:0000698 Hsd:SD XCO:0000678 gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector 4 4 x 10E8 vg 737903 RS:0000698 Hsd:SD XCO:0000678 gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector 40 40 x 10E8 vg 737903 RS:0000698 Hsd:SD XCO:0000134 methacholine 0 11.06 mg/kg 737903 RS:0000698 Hsd:SD XCO:0000138 methylene blue 10 10 umol/l 737903 RS:0000698 Hsd:SD XCO:0000127 norepinephrine 0.1 0.1 ng/kg/min 737903 RS:0000698 Hsd:SD XCO:0000127 norepinephrine 0.2 0.2 ng/kg/min 737903 RS:0000698 Hsd:SD XCO:0000127 norepinephrine 0.5 0.5 ng/kg/min 737903 RS:0000698 Hsd:SD XCO:0000127 norepinephrine 1 1 ng/kg/min 737903 RS:0000698 Hsd:SD XCO:0000118 perfusate suspended 737903 RS:0000698 Hsd:SD XCO:0000145 phenylephrine 0 300 umol/l 737903 RS:0000698 Hsd:SD XCO:0000145 phenylephrine 1 1 umol/l 737903 RS:0000698 Hsd:SD XCO:0000145 phenylephrine 10 10 umol/l 737903 RS:0000698 Hsd:SD XCO:0000150 potassium ion 80 80 mmol/l 737903 RS:0000698 Hsd:SD XCO:0000003 resting on treadmill 737903 RS:0000698 Hsd:SD XCO:0000005 running on treadmill 1.6 1.6 m/min 737903 RS:0000698 Hsd:SD XCO:0000153 sample resting period 737903 RS:0000698 Hsd:SD XCO:0000142 sodium nitroprusside 0 3 umol/l 737903 RS:0000698 Hsd:SD XCO:0000069 standard diet 737903 RS:0000698 Hsd:SD XCO:0000423 thymoquinone 40 40 mg/kg/d 737903 RS:0000698 Hsd:SD XCO:0000101 vehicle control condition 2 2 ul 737903 RS:0000698 Hsd:SD XCO:0000101 vehicle control condition 5 5 ml/kg 737903 RS:0000698 Hsd:SD XCO:0000101 vehicle control condition 737903 RS:0000698 Hsd:SD XCO:0000283 visible light stimulus 5 5 cd/m2 737903 RS:0000698 Hsd:SD XCO:0000283 visible light stimulus 12 12 cd/m2 737903 RS:0000698 Hsd:SD XCO:0000004 walking on treadmill 0.8 0.8 m/min 737960 RS:0001014 Hsd:WI XCO:0000156 0.9% sodium chloride solution 3 3 mg/kg/d 737960 RS:0001014 Hsd:WI XCO:0000156 0.9% sodium chloride solution 14 14 ml 737960 RS:0001014 Hsd:WI XCO:0000426 1H-pyrazole 10 10 mg/kg/d 737960 RS:0001014 Hsd:WI XCO:0000388 acetaminophen 500 500 mg/kg 737960 RS:0001014 Hsd:WI XCO:0000424 benfotiamine 100 100 mg/kg/d 737960 RS:0001014 Hsd:WI XCO:0000397 bisphenol A 125 125 mg/kg/d 737960 RS:0001014 Hsd:WI XCO:0000397 bisphenol A 250 250 mg/kg/d 737960 RS:0001014 Hsd:WI XCO:0000398 cisplatin 3 3 mg/kg 737960 RS:0001014 Hsd:WI XCO:0000398 cisplatin 7 7 mg/kg 737960 RS:0001014 Hsd:WI XCO:0000398 cisplatin 7.5 7.5 mg/kg 737960 RS:0001014 Hsd:WI XCO:0000099 control condition 737960 RS:0001014 Hsd:WI XCO:0000102 fasting 737960 RS:0001014 Hsd:WI XCO:0000425 lactotransferrin 300 300 mg/kg/d 737960 RS:0001014 Hsd:WI XCO:0000427 lycopene 6 6 mg/kg/d 737960 RS:0001014 Hsd:WI XCO:0000434 octylphenol 125 125 mg/kg/d 737960 RS:0001014 Hsd:WI XCO:0000434 octylphenol 250 250 mg/kg/d 737960 RS:0001014 Hsd:WI XCO:0000445 phosphate buffered saline 737960 RS:0001014 Hsd:WI XCO:0000430 silymarin 50 50 mg/kg/d 737960 RS:0001014 Hsd:WI XCO:0000423 thymoquinone 15 15 mg/kg 737960 RS:0001014 Hsd:WI XCO:0000101 vehicle control condition 38548927 RS:0004793 HsdCpb:WU XCO:0000099 control condition 38548927 RS:0004793 HsdCpb:WU XCO:0000893 controlled ramipril content drinking water 1 1 mg/kg/d 38548927 RS:0004793 HsdCpb:WU XCO:0000893 controlled ramipril content drinking water 1 1 ml/kg/d 38548927 RS:0004793 HsdCpb:WU XCO:0000549 left anterior descending coronary artery occlusion 38548927 RS:0004793 HsdCpb:WU XCO:0000114 left nephrectomy 38548927 RS:0004793 HsdCpb:WU XCO:0000100 sham surgical control condition 631285 RS:0000405 IER/Ihr XCO:0000099 control condition 10018 RS:0000410 IS/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 10018 RS:0000410 IS/Kyo XCO:0000102 fasting 10018 RS:0000410 IS/Kyo XCO:0000087 specific pathogen-free condition 2292168 RS:0001334 ISIAH XCO:0000099 control condition 2292168 RS:0001334 ISIAH XCO:0000912 controlled exposure to red light 20 20 W 2292168 RS:0001334 ISIAH XCO:0000799 ether 2292168 RS:0001334 ISIAH XCO:0000738 lipopolysaccharide 500 500 mg/kg 2292168 RS:0001334 ISIAH XCO:0000738 lipopolysaccharide 500 500 ug/kg 2292168 RS:0001334 ISIAH XCO:0000158 physical restraint in mechanical restrainer 2292168 RS:0001334 ISIAH XCO:0000159 physical restraint in tube type rodent restrainer 2292168 RS:0001334 ISIAH XCO:0000101 vehicle control condition 2 2 ml/kg 631844 RS:0000389 Iusm:HAD1 XCO:0000099 control condition 631844 RS:0000389 Iusm:HAD1 XCO:0000023 controlled ethanol content drinking water 10 10 % 731187 RS:0000390 Iusm:HAD2 XCO:0000099 control condition 631845 RS:0000423 Iusm:LAD1 XCO:0000099 control condition 631845 RS:0000423 Iusm:LAD1 XCO:0000023 controlled ethanol content drinking water 10 10 % 731188 RS:0000425 Iusm:LAD2 XCO:0000099 control condition 1641873 RS:0001375 Iusm:NP XCO:0000099 control condition 1641867 RS:0001377 Iusm:P XCO:0000099 control condition 12879431 RS:0004409 Jcl:WI XCO:0000563 Omacor 400 400 mg/kg/d 12879431 RS:0004409 Jcl:WI XCO:0000099 control condition 12879431 RS:0004409 Jcl:WI XCO:0000102 fasting 12879431 RS:0004409 Jcl:WI XCO:0000103 glucose solution 2 2 g/kg 12879431 RS:0004409 Jcl:WI XCO:0000069 standard diet 12879431 RS:0004409 Jcl:WI XCO:0000857 vildagliptin 30 30 mg/kg/d 2304296 RS:0002024 KB/Oda XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2304296 RS:0002024 KB/Oda XCO:0000102 fasting 2304296 RS:0002024 KB/Oda XCO:0000087 specific pathogen-free condition 2306022 RS:0002025 KCI/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2306022 RS:0002025 KCI/Kyo XCO:0000102 fasting 2306022 RS:0002025 KCI/Kyo XCO:0000087 specific pathogen-free condition 2314365 RS:0002031 KFRS2/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2314365 RS:0002031 KFRS2/Kyo XCO:0000102 fasting 2314365 RS:0002031 KFRS2/Kyo XCO:0000087 specific pathogen-free condition 7800673 RS:0003623 KFRS2/Kyo-/+ XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 7800673 RS:0003623 KFRS2/Kyo-/+ XCO:0000102 fasting 7800673 RS:0003623 KFRS2/Kyo-/+ XCO:0000087 specific pathogen-free condition 2314383 RS:0002032 KFRS3A/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2314383 RS:0002032 KFRS3A/Kyo XCO:0000102 fasting 2314383 RS:0002032 KFRS3A/Kyo XCO:0000087 specific pathogen-free condition 7800676 RS:0003626 KFRS3A/Kyo+/+ XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 7800676 RS:0003626 KFRS3A/Kyo+/+ XCO:0000102 fasting 7800676 RS:0003626 KFRS3A/Kyo+/+ XCO:0000087 specific pathogen-free condition 2314377 RS:0002033 KFRS3B/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2314377 RS:0002033 KFRS3B/Kyo XCO:0000102 fasting 2314377 RS:0002033 KFRS3B/Kyo XCO:0000087 specific pathogen-free condition 2314376 RS:0002034 KFRS4/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2314376 RS:0002034 KFRS4/Kyo XCO:0000102 fasting 2314376 RS:0002034 KFRS4/Kyo XCO:0000087 specific pathogen-free condition 2314379 RS:0002039 KFRS6/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2314379 RS:0002039 KFRS6/Kyo XCO:0000102 fasting 2314379 RS:0002039 KFRS6/Kyo XCO:0000087 specific pathogen-free condition 1302639 RS:0000415 KHR/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302639 RS:0000415 KHR/Kyo XCO:0000102 fasting 1302639 RS:0000415 KHR/Kyo XCO:0000087 specific pathogen-free condition 7800705 RS:0003629 KHR/Kyo-/+ XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 7800705 RS:0003629 KHR/Kyo-/+ XCO:0000102 fasting 7800705 RS:0003629 KHR/Kyo-/+ XCO:0000087 specific pathogen-free condition 7800702 RS:0003634 KHR/Kyo-/- XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 7800702 RS:0003634 KHR/Kyo-/- XCO:0000102 fasting 7800702 RS:0003634 KHR/Kyo-/- XCO:0000087 specific pathogen-free condition 68061 RS:0000434 KYN/Hok XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 68061 RS:0000434 KYN/Hok XCO:0000102 fasting 68061 RS:0000434 KYN/Hok XCO:0000087 specific pathogen-free condition 1302693 RS:0001336 KZ-LeprfaTky XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302693 RS:0001336 KZ-LeprfaTky XCO:0000102 fasting 1302693 RS:0001336 KZ-LeprfaTky XCO:0000087 specific pathogen-free condition 1300433 RS:0000424 LAA/FDSC XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1300433 RS:0000424 LAA/FDSC XCO:0000102 fasting 1300433 RS:0000424 LAA/FDSC XCO:0000087 specific pathogen-free condition 7241056 RS:0003393 LE-Lrrk2em1Sage-/- XCO:0000099 control condition 7241056 RS:0003393 LE-Lrrk2em1Sage-/- XCO:0000102 fasting 631163 RS:0000436 LE/BluGill XCO:0000137 FAPGG 0.6 0.6 mmol/l 631163 RS:0000436 LE/BluGill XCO:0000116 Kreb's solution perfusate 631163 RS:0000436 LE/BluGill XCO:0000143 acetylcholine 0 30 umol/l 631163 RS:0000436 LE/BluGill XCO:0000012 air carbon dioxide content 7 7 % 631163 RS:0000436 LE/BluGill XCO:0000012 air carbon dioxide content 7 % 631163 RS:0000436 LE/BluGill XCO:0000099 control condition 631163 RS:0000436 LE/BluGill XCO:0000010 controlled air oxygen content 12 12 % 631163 RS:0000436 LE/BluGill XCO:0000010 controlled air oxygen content 12 % 631163 RS:0000436 LE/BluGill XCO:0000146 controlled oxygen content Kreb's solution perfusate 631163 RS:0000436 LE/BluGill XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 631163 RS:0000436 LE/BluGill XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 631163 RS:0000436 LE/BluGill XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 631163 RS:0000436 LE/BluGill XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 631163 RS:0000436 LE/BluGill XCO:0000022 controlled sodium content diet 0 % 631163 RS:0000436 LE/BluGill XCO:0000022 controlled sodium content diet 4 4 % 631163 RS:0000436 LE/BluGill XCO:0000022 controlled sodium content diet 8 8 % 631163 RS:0000436 LE/BluGill XCO:0000152 drug dose time series 631163 RS:0000436 LE/BluGill XCO:0000134 methacholine 0 11.06 mg/kg 631163 RS:0000436 LE/BluGill XCO:0000138 methylene blue 10 10 umol/l 631163 RS:0000436 LE/BluGill XCO:0000118 perfusate suspended 631163 RS:0000436 LE/BluGill XCO:0000145 phenylephrine 0 300 umol/l 631163 RS:0000436 LE/BluGill XCO:0000145 phenylephrine 1 1 umol/l 631163 RS:0000436 LE/BluGill XCO:0000145 phenylephrine 10 10 umol/l 631163 RS:0000436 LE/BluGill XCO:0000150 potassium ion 80 80 mmol/l 631163 RS:0000436 LE/BluGill XCO:0000003 resting on treadmill 631163 RS:0000436 LE/BluGill XCO:0000005 running on treadmill 1.6 1.6 m/min 631163 RS:0000436 LE/BluGill XCO:0000153 sample resting period 631163 RS:0000436 LE/BluGill XCO:0000142 sodium nitroprusside 0 3 umol/l 631163 RS:0000436 LE/BluGill XCO:0000004 walking on treadmill 0.8 0.8 m/min 629485 RS:0000431 LE/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 629485 RS:0000431 LE/Stm XCO:0000099 control condition 629485 RS:0000431 LE/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 629485 RS:0000431 LE/Stm XCO:0000295 diethylstilbestrol 17 17 mg 629485 RS:0000431 LE/Stm XCO:0000102 fasting 629485 RS:0000431 LE/Stm XCO:0000087 specific pathogen-free condition 1302642 RS:0000441 LEA/Hkm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302642 RS:0000441 LEA/Hkm XCO:0000102 fasting 1302642 RS:0000441 LEA/Hkm XCO:0000087 specific pathogen-free condition 1302656 RS:0000442 LEA/Hok XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302656 RS:0000442 LEA/Hok XCO:0000099 control condition 1302656 RS:0000442 LEA/Hok XCO:0000102 fasting 1302656 RS:0000442 LEA/Hok XCO:0000087 specific pathogen-free condition 1302729 RS:0000444 LEA/Tj XCO:0000099 control condition 1302648 RS:0000446 LEC/Hok XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302648 RS:0000446 LEC/Hok XCO:0000099 control condition 1302648 RS:0000446 LEC/Hok XCO:0000102 fasting 1302648 RS:0000446 LEC/Hok XCO:0000087 specific pathogen-free condition 6480220 RS:0003209 LEH/Hkv XCO:0000087 specific pathogen-free condition 68074 RS:0001349 LETO XCO:0000099 control condition mg/kg/d 68074 RS:0001349 LETO XCO:0000102 fasting 68074 RS:0001349 LETO XCO:0000103 glucose solution 60999 RS:0000121 LEW XCO:0000266 Freund's complete adjuvant 50 50 % 60999 RS:0000121 LEW XCO:0000121 NG-nitroarginine methyl ester 30 30 mg/kg 60999 RS:0000121 LEW XCO:0000353 central nervous system myelin 5 5 mg/ml 60999 RS:0000121 LEW XCO:0000099 control condition 60999 RS:0000121 LEW XCO:0000022 controlled sodium content diet 0.2 0.2 % 60999 RS:0000121 LEW XCO:0000022 controlled sodium content diet 2 2 % 60999 RS:0000121 LEW XCO:0000161 losartan 10 10 mg/kg 60999 RS:0000121 LEW XCO:0000162 pentolinium 5 5 mg/kg 1578716 RS:0001352 LEW.1AR1/Ztm XCO:0000266 Freund's complete adjuvant 100 100 ul 1578716 RS:0001352 LEW.1AR1/Ztm XCO:0000291 peripheral myelin protein 2 peptide 58-81 100 100 ug 1578716 RS:0001352 LEW.1AR1/Ztm XCO:0000292 peripheral nerve myelin 2 2 mg 737657 RS:0000491 LEW.1AV1 XCO:0000280 squalene 860 860 mg/ml 631598 RS:0000492 LEW.1AV1.DA-(D10Got154-D10Rat135)/Ubc XCO:0000280 squalene 860 860 mg/ml 631595 RS:0000494 LEW.1AV1.DA-(D10Rat92-D10Rat135)/Ubc XCO:0000280 squalene 860 860 mg/ml 631596 RS:0000495 LEW.1AV1.DA-(D10Rat92-D10Wox17)/Ubc XCO:0000280 squalene 860 860 mg/ml 631597 RS:0000496 LEW.1AV1.DA-(D10Wox17-D10Rat135)/Ubc XCO:0000280 squalene 860 860 mg/ml 8551866 RS:0003684 LEW.1AV1.DA-(D4Mgh17-D4Rat203)/Kiru XCO:0000265 Freund's incomplete adjuvant 200 200 ul 2307300 RS:0002061 LEW.1AV1/Kini XCO:0000266 Freund's complete adjuvant 100 100 ul 2307300 RS:0002061 LEW.1AV1/Kini XCO:0000265 Freund's incomplete adjuvant 200 200 ul 2307300 RS:0002061 LEW.1AV1/Kini XCO:0000291 peripheral myelin protein 2 peptide 58-81 100 100 ug 2307300 RS:0002061 LEW.1AV1/Kini XCO:0000292 peripheral nerve myelin 2 2 mg 631581 RS:0000497 LEW.1F XCO:0000266 Freund's complete adjuvant 100 100 ul 631581 RS:0000497 LEW.1F XCO:0000291 peripheral myelin protein 2 peptide 58-81 100 100 ug 631581 RS:0000497 LEW.1F XCO:0000292 peripheral nerve myelin 2 2 mg 631581 RS:0000497 LEW.1F XCO:0000263 pristane 150 150 ul 2312352 RS:0002062 LEW.1N XCO:0000266 Freund's complete adjuvant 100 100 ul 2312352 RS:0002062 LEW.1N XCO:0000291 peripheral myelin protein 2 peptide 58-81 100 100 ug 2312352 RS:0002062 LEW.1N XCO:0000292 peripheral nerve myelin 2 2 mg 2312352 RS:0002062 LEW.1N XCO:0000263 pristane 150 150 ul 2313181 RS:0002063 LEW.1WR1/WorBrm XCO:0000266 Freund's complete adjuvant 100 100 ul 2313181 RS:0002063 LEW.1WR1/WorBrm XCO:0000291 peripheral myelin protein 2 peptide 58-81 100 100 ug 2313181 RS:0002063 LEW.1WR1/WorBrm XCO:0000292 peripheral nerve myelin 2 2 mg 1578705 RS:0001355 LEW.BN-(D10Arb4-D10Rat133)/Ciml XCO:0000365 Toxoplasma gondii cysts 20 20 1578706 RS:0001356 LEW.BN-(D10Mco17-D10Mco14)/Ciml XCO:0000365 Toxoplasma gondii cysts 20 20 1578711 RS:0001357 LEW.BN-(D10Mco17-D10Rat133)/Ciml XCO:0000365 Toxoplasma gondii cysts 20 20 1578693 RS:0001358 LEW.BN-(D10Mco17-D10Rat221)/Ciml XCO:0000365 Toxoplasma gondii cysts 20 20 1578708 RS:0001359 LEW.BN-(D10Mgh7-D10Rat221)/Ciml XCO:0000365 Toxoplasma gondii cysts 20 20 1578702 RS:0001360 LEW.BN-(D10Rat32-D10Rat133)/Ciml XCO:0000365 Toxoplasma gondii cysts 20 20 1331818 RS:0000505 LEW.BN-(D10Rat43-D10Mco4)/Rj XCO:0000365 Toxoplasma gondii cysts 20 20 10402839 RS:0004074 LEW.SS-((D10Mgh6-D10Mgh1)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 10402839 RS:0004074 LEW.SS-((D10Mgh6-D10Mgh1)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 10402842 RS:0004075 LEW.SS-(D17Rat15-D17Rat51)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 10402842 RS:0004075 LEW.SS-(D17Rat15-D17Rat51)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 4142800 RS:0002461 LEW.SS-(D18Chm31-D18Mit8)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 4142800 RS:0002461 LEW.SS-(D18Chm31-D18Mit8)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 4142799 RS:0002462 LEW.SS-(D2Uia5-D2Rat143)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 4142799 RS:0002462 LEW.SS-(D2Uia5-D2Rat143)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 10402852 RS:0004077 LEW.SS-(D7Rat27-D7Mgh1)(D17Rat15-D17Rat51)(D10Mgh6-D10Mgh1)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 10402852 RS:0004077 LEW.SS-(D7Rat27-D7Mgh1)(D17Rat15-D17Rat51)(D10Mgh6-D10Mgh1)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 10402850 RS:0004076 LEW.SS-(D7Rat27-D7Mgh1)(D17Rat15-D17Rat51)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 10402850 RS:0004076 LEW.SS-(D7Rat27-D7Mgh1)(D17Rat15-D17Rat51)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 4891051 RS:0000301 LEW.SS-(D7Rat73-D7Rat128)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 4891051 RS:0000301 LEW.SS-(D7Rat73-D7Rat128)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 10402836 RS:0004073 LEW.SS-(D8Chm12-D8Rat15)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 10402836 RS:0004073 LEW.SS-(D8Chm12-D8Rat15)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 737932 RS:0000509 LEW/Crl XCO:0000137 FAPGG 0.6 0.6 mmol/l 737932 RS:0000509 LEW/Crl XCO:0000116 Kreb's solution perfusate 737932 RS:0000509 LEW/Crl XCO:0000143 acetylcholine 0 30 umol/l 737932 RS:0000509 LEW/Crl XCO:0000012 air carbon dioxide content 7 7 % 737932 RS:0000509 LEW/Crl XCO:0000012 air carbon dioxide content 7 % 737932 RS:0000509 LEW/Crl XCO:0000126 angiotensin 5 5 ng/kg/min 737932 RS:0000509 LEW/Crl XCO:0000126 angiotensin 10 10 ng/kg/min 737932 RS:0000509 LEW/Crl XCO:0000126 angiotensin 25 25 ng/kg/min 737932 RS:0000509 LEW/Crl XCO:0000126 angiotensin 50 50 ng/kg/min 737932 RS:0000509 LEW/Crl XCO:0000099 control condition 737932 RS:0000509 LEW/Crl XCO:0000010 controlled air oxygen content 12 12 % 737932 RS:0000509 LEW/Crl XCO:0000010 controlled air oxygen content 12 % 737932 RS:0000509 LEW/Crl XCO:0000146 controlled oxygen content Kreb's solution perfusate 737932 RS:0000509 LEW/Crl XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 737932 RS:0000509 LEW/Crl XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 737932 RS:0000509 LEW/Crl XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 737932 RS:0000509 LEW/Crl XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 737932 RS:0000509 LEW/Crl XCO:0000022 controlled sodium content diet 0 % 737932 RS:0000509 LEW/Crl XCO:0000022 controlled sodium content diet 0.2 0.2 % 737932 RS:0000509 LEW/Crl XCO:0000022 controlled sodium content diet 0.4 0.4 % 737932 RS:0000509 LEW/Crl XCO:0000022 controlled sodium content diet 2 2 % 737932 RS:0000509 LEW/Crl XCO:0000022 controlled sodium content diet 4 4 % 737932 RS:0000509 LEW/Crl XCO:0000152 drug dose time series 737932 RS:0000509 LEW/Crl XCO:0000124 furosemide 10 10 mg/kg 737932 RS:0000509 LEW/Crl XCO:0000739 housing in trios 737932 RS:0000509 LEW/Crl XCO:0000744 housing with Haemophilus H21-infected subject 737932 RS:0000509 LEW/Crl XCO:0000745 housing with Haemophilus H35-infected subject 737932 RS:0000509 LEW/Crl XCO:0000746 housing with Pasteurella pneumotropica-infected subject 737932 RS:0000509 LEW/Crl XCO:0000747 housing with Pasteurellaceae-infected subject 737932 RS:0000509 LEW/Crl XCO:0000134 methacholine 0 11.06 mg/kg 737932 RS:0000509 LEW/Crl XCO:0000138 methylene blue 10 10 umol/l 737932 RS:0000509 LEW/Crl XCO:0000127 norepinephrine 0.1 0.1 ng/kg/min 737932 RS:0000509 LEW/Crl XCO:0000127 norepinephrine 0.2 0.2 ng/kg/min 737932 RS:0000509 LEW/Crl XCO:0000127 norepinephrine 0.5 0.5 ng/kg/min 737932 RS:0000509 LEW/Crl XCO:0000127 norepinephrine 1 1 ng/kg/min 737932 RS:0000509 LEW/Crl XCO:0000118 perfusate suspended 737932 RS:0000509 LEW/Crl XCO:0000145 phenylephrine 0 300 umol/l 737932 RS:0000509 LEW/Crl XCO:0000145 phenylephrine 1 1 umol/l 737932 RS:0000509 LEW/Crl XCO:0000145 phenylephrine 10 10 umol/l 737932 RS:0000509 LEW/Crl XCO:0000150 potassium ion 80 80 mmol/l 737932 RS:0000509 LEW/Crl XCO:0000003 resting on treadmill 737932 RS:0000509 LEW/Crl XCO:0000005 running on treadmill 1.6 1.6 m/min 737932 RS:0000509 LEW/Crl XCO:0000153 sample resting period 737932 RS:0000509 LEW/Crl XCO:0000142 sodium nitroprusside 0 3 umol/l 737932 RS:0000509 LEW/Crl XCO:0000004 walking on treadmill 0.8 0.8 m/min 631576 RS:0000510 LEW/CrlCrlj XCO:0000099 control condition 1559045 RS:0000816 LEW/Crlc XCO:0000337 air-jet exposure 2 2 lb/in2 1559045 RS:0000816 LEW/Crlc XCO:0000022 controlled sodium content diet 0.2 0.2 % 1559045 RS:0000816 LEW/Crlc XCO:0000022 controlled sodium content diet 2 2 % 1559045 RS:0000816 LEW/Crlc XCO:0000022 controlled sodium content diet 8 8 % 1559045 RS:0000816 LEW/Crlc XCO:0000145 phenylephrine 5 50 ug/min 1559045 RS:0000816 LEW/Crlc XCO:0000254 sodium ion solution 800 800 mmol/l 1559045 RS:0000816 LEW/Crlc XCO:0000142 sodium nitroprusside 10 100 ug/min 737963 RS:0000511 LEW/Cub XCO:0000121 NG-nitroarginine methyl ester 30 30 mg/kg 737963 RS:0000511 LEW/Cub XCO:0000161 losartan 10 10 mg/kg 737963 RS:0000511 LEW/Cub XCO:0000162 pentolinium 5 5 mg/kg 737919 RS:0000513 LEW/Han XCO:0000266 Freund's complete adjuvant 100 100 ul 737919 RS:0000513 LEW/Han XCO:0000291 peripheral myelin protein 2 peptide 58-81 100 100 ug 737919 RS:0000513 LEW/Han XCO:0000292 peripheral nerve myelin 2 2 mg 737919 RS:0000513 LEW/Han XCO:0000263 pristane 150 150 ul 1357957 RS:0001362 LEW/HanHfr XCO:0000743 Haemophilus 2303504 RS:0002065 LEW/JmsNgs XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2303504 RS:0002065 LEW/JmsNgs XCO:0000102 fasting 2303504 RS:0002065 LEW/JmsNgs XCO:0000087 specific pathogen-free condition 1359003 RS:0000516 LEW/Jr XCO:0000022 controlled sodium content diet 0.2 0.2 % 1359003 RS:0000516 LEW/Jr XCO:0000022 controlled sodium content diet 2 2 % 737905 RS:0000518 LEW/Maas XCO:0000282 anti-Thy1 antibody 2 2 mg/kg 1331815 RS:0000519 LEW/Mol XCO:0000282 anti-Thy1 antibody 2 2 mg/kg 1331815 RS:0000519 LEW/Mol XCO:0000795 controlled sodium chloride content diet 8 8 % 1331815 RS:0000519 LEW/Mol XCO:0000069 standard diet 61104 RS:0000520 LEW/NCrl XCO:0000022 controlled sodium content diet 0.2 0.2 % 61104 RS:0000520 LEW/NCrl XCO:0000022 controlled sodium content diet 8 8 % 634363 RS:0000523 LEW/NIcoCrlf XCO:0000099 control condition 634363 RS:0000523 LEW/NIcoCrlf XCO:0000159 physical restraint in tube type rodent restrainer 631579 RS:0000525 LEW/OlaHsd XCO:0000099 control condition 631579 RS:0000525 LEW/OlaHsd XCO:0000246 controlled cholesterol content diet 2 2 % 631579 RS:0000525 LEW/OlaHsd XCO:0000247 controlled olive oil content diet 5 5 % 631579 RS:0000525 LEW/OlaHsd XCO:0000102 fasting 631593 RS:0000528 LEW/Rj XCO:0000099 control condition 724570 RS:0000529 LEW/Rkb XCO:0000099 control condition 2325206 RS:0002367 LEW/Seac XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2325206 RS:0002367 LEW/Seac XCO:0000102 fasting 2325206 RS:0002367 LEW/Seac XCO:0000087 specific pathogen-free condition 737922 RS:0000531 LEW/SsNHsd XCO:0000156 0.9% sodium chloride solution 0.1 0.1 ml 737922 RS:0000531 LEW/SsNHsd XCO:0000265 Freund's incomplete adjuvant 0.1 0.1 ml 737922 RS:0000531 LEW/SsNHsd XCO:0000360 arterial catheter implantation 737922 RS:0000531 LEW/SsNHsd XCO:0000268 balloon angioplasty 737922 RS:0000531 LEW/SsNHsd XCO:0000099 control condition 737922 RS:0000531 LEW/SsNHsd XCO:0000812 controlled hemorrhage 1302701 RS:0000532 LEW/SsNSlc XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302701 RS:0000532 LEW/SsNSlc XCO:0000102 fasting 1302701 RS:0000532 LEW/SsNSlc XCO:0000087 specific pathogen-free condition 737930 RS:0000533 LEW/Ztm XCO:0000099 control condition 1302621 RS:0000535 LEXF10A/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302621 RS:0000535 LEXF10A/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302621 RS:0000535 LEXF10A/Stm XCO:0000102 fasting 1302621 RS:0000535 LEXF10A/Stm XCO:0000087 specific pathogen-free condition 1302616 RS:0000536 LEXF10B/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302616 RS:0000536 LEXF10B/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302616 RS:0000536 LEXF10B/Stm XCO:0000102 fasting 1302616 RS:0000536 LEXF10B/Stm XCO:0000087 specific pathogen-free condition 1302612 RS:0000537 LEXF10C/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302612 RS:0000537 LEXF10C/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302612 RS:0000537 LEXF10C/Stm XCO:0000102 fasting 1302612 RS:0000537 LEXF10C/Stm XCO:0000087 specific pathogen-free condition 1302638 RS:0000538 LEXF11/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302638 RS:0000538 LEXF11/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302638 RS:0000538 LEXF11/Stm XCO:0000102 fasting 1302638 RS:0000538 LEXF11/Stm XCO:0000087 specific pathogen-free condition 1302641 RS:0000539 LEXF1A/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302641 RS:0000539 LEXF1A/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302641 RS:0000539 LEXF1A/Stm XCO:0000102 fasting 1302641 RS:0000539 LEXF1A/Stm XCO:0000087 specific pathogen-free condition 4140413 RS:0002455 LEXF1B/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302666 RS:0000540 LEXF1C/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302666 RS:0000540 LEXF1C/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302666 RS:0000540 LEXF1C/Stm XCO:0000102 fasting 1302666 RS:0000540 LEXF1C/Stm XCO:0000087 specific pathogen-free condition 1302605 RS:0000541 LEXF2A/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302605 RS:0000541 LEXF2A/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302605 RS:0000541 LEXF2A/Stm XCO:0000102 fasting 1302605 RS:0000541 LEXF2A/Stm XCO:0000087 specific pathogen-free condition 1302710 RS:0000542 LEXF2B/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302710 RS:0000542 LEXF2B/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302710 RS:0000542 LEXF2B/Stm XCO:0000102 fasting 1302710 RS:0000542 LEXF2B/Stm XCO:0000087 specific pathogen-free condition 1302646 RS:0000543 LEXF2C/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302646 RS:0000543 LEXF2C/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302646 RS:0000543 LEXF2C/Stm XCO:0000102 fasting 1302646 RS:0000543 LEXF2C/Stm XCO:0000087 specific pathogen-free condition 7349321 RS:0003521 LEXF2D/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302707 RS:0000544 LEXF3/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302707 RS:0000544 LEXF3/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302707 RS:0000544 LEXF3/Stm XCO:0000102 fasting 1302707 RS:0000544 LEXF3/Stm XCO:0000087 specific pathogen-free condition 1302604 RS:0000545 LEXF4/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302604 RS:0000545 LEXF4/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302604 RS:0000545 LEXF4/Stm XCO:0000102 fasting 1302604 RS:0000545 LEXF4/Stm XCO:0000087 specific pathogen-free condition 1302723 RS:0000546 LEXF5/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302723 RS:0000546 LEXF5/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302723 RS:0000546 LEXF5/Stm XCO:0000102 fasting 1302723 RS:0000546 LEXF5/Stm XCO:0000087 specific pathogen-free condition 4140405 RS:0002447 LEXF6A/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302617 RS:0000547 LEXF6B/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302617 RS:0000547 LEXF6B/Stm XCO:0000102 fasting 1302617 RS:0000547 LEXF6B/Stm XCO:0000087 specific pathogen-free condition 1302652 RS:0000548 LEXF7A/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302652 RS:0000548 LEXF7A/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302652 RS:0000548 LEXF7A/Stm XCO:0000102 fasting 1302652 RS:0000548 LEXF7A/Stm XCO:0000087 specific pathogen-free condition 1302649 RS:0000549 LEXF7B/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302649 RS:0000549 LEXF7B/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302649 RS:0000549 LEXF7B/Stm XCO:0000102 fasting 1302649 RS:0000549 LEXF7B/Stm XCO:0000087 specific pathogen-free condition 1302597 RS:0000550 LEXF7C/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302597 RS:0000550 LEXF7C/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302597 RS:0000550 LEXF7C/Stm XCO:0000102 fasting 1302597 RS:0000550 LEXF7C/Stm XCO:0000087 specific pathogen-free condition 1302653 RS:0000551 LEXF8A/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302653 RS:0000551 LEXF8A/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302653 RS:0000551 LEXF8A/Stm XCO:0000102 fasting 1302653 RS:0000551 LEXF8A/Stm XCO:0000087 specific pathogen-free condition 7349322 RS:0003523 LEXF8B/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 4140408 RS:0002450 LEXF8C/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302699 RS:0000552 LEXF8D/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302699 RS:0000552 LEXF8D/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302699 RS:0000552 LEXF8D/Stm XCO:0000102 fasting 1302699 RS:0000552 LEXF8D/Stm XCO:0000087 specific pathogen-free condition 1302618 RS:0000553 LEXF9/Stm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302618 RS:0000553 LEXF9/Stm XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water 400 400 mg/l 1302618 RS:0000553 LEXF9/Stm XCO:0000102 fasting 1302618 RS:0000553 LEXF9/Stm XCO:0000087 specific pathogen-free condition 2313343 RS:0002068 LH-Chr 13BN/Mav XCO:0000099 control condition 2313343 RS:0002068 LH-Chr 13BN/Mav XCO:0000790 controlled sodium chloride content drinking water 1 1 % 2313343 RS:0002068 LH-Chr 13BN/Mav XCO:0000790 controlled sodium chloride content drinking water 2 2 % 2313343 RS:0002068 LH-Chr 13BN/Mav XCO:0000021 water 12903251 RS:0004422 LH-Chr 17LN/Aek XCO:0000022 controlled sodium content diet 0.3 0.3 % 12903251 RS:0004422 LH-Chr 17LN/Aek XCO:0000022 controlled sodium content diet 4 4 % 12903257 RS:0004421 LH.LH-Chr 17LN-(rs199194111-rs105876746)/Aek XCO:0000022 controlled sodium content diet 0.3 0.3 % 12903257 RS:0004421 LH.LH-Chr 17LN-(rs199194111-rs105876746)/Aek XCO:0000022 controlled sodium content diet 4 4 % 10021 RS:0000556 LH/Mav XCO:0000156 0.9% sodium chloride solution 330 330 ul/kg/min 10021 RS:0000556 LH/Mav XCO:0000597 abdominal aortic constriction 10021 RS:0000556 LH/Mav XCO:0000599 aldosterone 66 66 ng/kg/min 10021 RS:0000556 LH/Mav XCO:0000933 argipressin 0.17 0.17 ng/kg/min 10021 RS:0000556 LH/Mav XCO:0000304 bilateral adrenalectomy mg/kg 10021 RS:0000556 LH/Mav XCO:0000304 bilateral adrenalectomy 10021 RS:0000556 LH/Mav XCO:0000934 bilateral renal denervation 10021 RS:0000556 LH/Mav XCO:0000938 bovine serum albumin 1 1 % 10021 RS:0000556 LH/Mav XCO:0000931 celiac artery and superior mesenteric artery constriction 10021 RS:0000556 LH/Mav XCO:0000099 control condition 10021 RS:0000556 LH/Mav XCO:0000552 controlled hydralazine content drinking water 15 15 mg/kg/d 10021 RS:0000556 LH/Mav XCO:0000552 controlled hydralazine content drinking water 75 75 mg/kg/d 10021 RS:0000556 LH/Mav XCO:0000900 controlled hydrochlorothiazide content drinking water 15 15 mg/kg/d 10021 RS:0000556 LH/Mav XCO:0000383 controlled losartan content drinking water 10 10 mg/kg/d 10021 RS:0000556 LH/Mav XCO:0000952 controlled perindopril content drinking water 0.4 0.4 mg/kg/d 10021 RS:0000556 LH/Mav XCO:0000952 controlled perindopril content drinking water 1.5 1.5 mg/kg/d 10021 RS:0000556 LH/Mav XCO:0000952 controlled perindopril content drinking water 3 3 mg/kg/d 10021 RS:0000556 LH/Mav XCO:0000953 controlled reserpine content drinking water 0.75 0.75 mg/kg/d 10021 RS:0000556 LH/Mav XCO:0000790 controlled sodium chloride content drinking water 1 1 % 10021 RS:0000556 LH/Mav XCO:0000790 controlled sodium chloride content drinking water 2 2 % 10021 RS:0000556 LH/Mav XCO:0000164 controlled sodium content drinking water 2 2 % 10021 RS:0000556 LH/Mav XCO:0000102 fasting 10021 RS:0000556 LH/Mav XCO:0000275 glucose 2 2 g/kg 10021 RS:0000556 LH/Mav XCO:0000551 hydralazine 75 75 mg/kg/d 10021 RS:0000556 LH/Mav XCO:0000633 hydrocortisone 33 33 ng/kg/min 10021 RS:0000556 LH/Mav XCO:0000130 ketamine 20 20 mg/kg 10021 RS:0000556 LH/Mav XCO:0000334 left adrenalectomy 10021 RS:0000556 LH/Mav XCO:0000936 left kidney denervation 10021 RS:0000556 LH/Mav XCO:0000611 nifedipine 50 50 mg/kg/d 10021 RS:0000556 LH/Mav XCO:0000127 norepinephrine 333 333 ng/kg/min 10021 RS:0000556 LH/Mav XCO:0000588 perindopril 0.01 0.01 mg/kg/d 10021 RS:0000556 LH/Mav XCO:0000588 perindopril 0.04 0.04 mg/kg/d 10021 RS:0000556 LH/Mav XCO:0000588 perindopril 0.1 0.1 mg/kg/d 10021 RS:0000556 LH/Mav XCO:0000588 perindopril 0.4 0.4 mg/kg/d 10021 RS:0000556 LH/Mav XCO:0000588 perindopril 1 1 mg/kg/d 10021 RS:0000556 LH/Mav XCO:0000588 perindopril 1.5 1.5 mg/kg/d 10021 RS:0000556 LH/Mav XCO:0000635 polyfructosan 1.25 1.25 % 10021 RS:0000556 LH/Mav XCO:0000550 reserpine 0.75 0.75 mg/kg/d 10021 RS:0000556 LH/Mav XCO:0000550 reserpine 0.75 0.75 ml/kg/d 10021 RS:0000556 LH/Mav XCO:0000335 right adrenalectomy 10021 RS:0000556 LH/Mav XCO:0000113 right nephrectomy 10021 RS:0000556 LH/Mav XCO:0000241 streptozotocin 75 75 mg/kg 10021 RS:0000556 LH/Mav XCO:0000624 thiobutabarbital 75 75 mg/kg 10021 RS:0000556 LH/Mav XCO:0000101 vehicle control condition 10021 RS:0000556 LH/Mav XCO:0000021 water 60990 RS:0000554 LH/MavRrrc XCO:0000099 control condition 60990 RS:0000554 LH/MavRrrc XCO:0000188 darodipine 200 200 ug/kg 60990 RS:0000554 LH/MavRrrc XCO:0000161 losartan 20 20 mg/kg 60990 RS:0000554 LH/MavRrrc XCO:0000187 trimethaphan camsylate 10 10 mg/kg 60990 RS:0000554 LH/MavRrrc XCO:0000101 vehicle control condition 10755352 RS:0004090 LH/MavRrrcAek XCO:0000795 controlled sodium chloride content diet 4 4 % 10755352 RS:0004090 LH/MavRrrcAek XCO:0000022 controlled sodium content diet 0.3 0.3 % 10755352 RS:0004090 LH/MavRrrcAek XCO:0000022 controlled sodium content diet 4 4 % 10755352 RS:0004090 LH/MavRrrcAek XCO:0000016 standard rat chow 1581645 RS:0001366 LL/Mav XCO:0000156 0.9% sodium chloride solution 330 330 ul/kg/min 1581645 RS:0001366 LL/Mav XCO:0000597 abdominal aortic constriction 1581645 RS:0001366 LL/Mav XCO:0000599 aldosterone 66 66 ng/kg/min 1581645 RS:0001366 LL/Mav XCO:0000933 argipressin 0.17 0.17 ng/kg/min 1581645 RS:0001366 LL/Mav XCO:0000304 bilateral adrenalectomy mg/kg 1581645 RS:0001366 LL/Mav XCO:0000304 bilateral adrenalectomy 1581645 RS:0001366 LL/Mav XCO:0000934 bilateral renal denervation 1581645 RS:0001366 LL/Mav XCO:0000938 bovine serum albumin 1 1 % 1581645 RS:0001366 LL/Mav XCO:0000931 celiac artery and superior mesenteric artery constriction 1581645 RS:0001366 LL/Mav XCO:0000099 control condition 1581645 RS:0001366 LL/Mav XCO:0000102 fasting 1581645 RS:0001366 LL/Mav XCO:0000275 glucose 2 2 g/kg 1581645 RS:0001366 LL/Mav XCO:0000633 hydrocortisone 33 33 ng/kg/min 1581645 RS:0001366 LL/Mav XCO:0000334 left adrenalectomy 1581645 RS:0001366 LL/Mav XCO:0000936 left kidney denervation 1581645 RS:0001366 LL/Mav XCO:0000127 norepinephrine 333 333 ng/kg/min 1581645 RS:0001366 LL/Mav XCO:0000635 polyfructosan 1.25 1.25 % 1581645 RS:0001366 LL/Mav XCO:0000335 right adrenalectomy 1581645 RS:0001366 LL/Mav XCO:0000113 right nephrectomy 1581645 RS:0001366 LL/Mav XCO:0000241 streptozotocin 100 100 mg/kg 1581645 RS:0001366 LL/Mav XCO:0000101 vehicle control condition 10022 RS:0000560 LN/Mav XCO:0000099 control condition 61015 RS:0000559 LN/MavRrrc XCO:0000099 control condition 61015 RS:0000559 LN/MavRrrc XCO:0000188 darodipine 200 200 ug/kg 61015 RS:0000559 LN/MavRrrc XCO:0000161 losartan 20 20 mg/kg 61015 RS:0000559 LN/MavRrrc XCO:0000187 trimethaphan camsylate 10 10 mg/kg 10755354 RS:0004091 LN/MavRrrcAek XCO:0000795 controlled sodium chloride content diet 4 4 % 10755354 RS:0004091 LN/MavRrrcAek XCO:0000016 standard rat chow 38456008 RS:0000563 LOU/C XCO:0000099 control condition 1357985 RS:0000565 LOU/Ins XCO:0000099 control condition 60988 RS:0000566 LOU/M XCO:0000266 Freund's complete adjuvant 0.05 0.1 ml 60988 RS:0000566 LOU/M XCO:0000846 Hu-S102-129 0.05 0.1 ml 60988 RS:0000566 LOU/M XCO:0000847 Hu-S110-129 0.05 0.1 ml 60988 RS:0000566 LOU/M XCO:0000768 Schistosoma mansoni cercariae 800 800 60988 RS:0000566 LOU/M XCO:0000768 Schistosoma mansoni cercariae 1500 1500 60988 RS:0000566 LOU/M XCO:0000398 cisplatin 0.25 0.25 mg/kg 60988 RS:0000566 LOU/M XCO:0000398 cisplatin 0.5 0.5 mg/kg 60988 RS:0000566 LOU/M XCO:0000398 cisplatin 1 1 mg/kg 60988 RS:0000566 LOU/M XCO:0000398 cisplatin 2 2 mg/kg 60988 RS:0000566 LOU/M XCO:0000398 cisplatin 4 4 mg/kg 60988 RS:0000566 LOU/M XCO:0000099 control condition 60988 RS:0000566 LOU/M XCO:0000825 cyclophosphamide 5 5 mg 60988 RS:0000566 LOU/M XCO:0000825 cyclophosphamide 8 8 mg 60988 RS:0000566 LOU/M XCO:0000539 doxorubicin 1 1 mg/kg 60988 RS:0000566 LOU/M XCO:0000828 human myelin basic protein 0.05 0.1 ml 60988 RS:0000566 LOU/M XCO:0000824 pertussis toxin 3.5 3.5 ug 60988 RS:0000566 LOU/M XCO:0000779 rat IgM immunocytoma cells 1 1 x 10E4 cells 60988 RS:0000566 LOU/M XCO:0000766 rat anti-26 kDa T cell line 10 15 x 10E6 cells 60988 RS:0000566 LOU/M XCO:0000771 rat anti-26 kDa antiserum 1 1 ml 60988 RS:0000566 LOU/M XCO:0000764 rat anti-Ab2 T cell line 10 15 x 10E6 cells 60988 RS:0000566 LOU/M XCO:0000762 rat anti-Ab2 T cells 10 15 x 10E6 cells 60988 RS:0000566 LOU/M XCO:0000770 rat anti-Ab2 antiserum 1 1 ml 60988 RS:0000566 LOU/M XCO:0000826 rat anti-Hu-MBP T cell line 9 9 x 10E6 cells 60988 RS:0000566 LOU/M XCO:0000827 rat anti-Hu-S102-129 T cell line 9 9 x 10E6 cells 60988 RS:0000566 LOU/M XCO:0000859 rat anti-control-Ab2 T cell line 10 15 x 10E6 cells 60988 RS:0000566 LOU/M XCO:0000858 rat anti-control-Ab2 T cells 10 15 x 10E6 cells 60988 RS:0000566 LOU/M XCO:0000853 rat serum from subject bearing a B48-14 IgE-producing hybridoma 0.5 0.5 ml 60988 RS:0000566 LOU/M XCO:0000778 spiroplatin 0.25 0.25 mg/kg 60988 RS:0000566 LOU/M XCO:0000778 spiroplatin 0.5 0.5 mg/kg 60988 RS:0000566 LOU/M XCO:0000778 spiroplatin 1 1 mg/kg 60988 RS:0000566 LOU/M XCO:0000778 spiroplatin 2 2 mg/kg 60988 RS:0000566 LOU/M XCO:0000778 spiroplatin 4 4 mg/kg 60988 RS:0000566 LOU/M XCO:0000778 spiroplatin 8 8 mg/kg 60988 RS:0000566 LOU/M XCO:0000778 spiroplatin 16 16 mg/kg 8662449 RS:0003786 LOU/MBbb XCO:0000099 control condition 126779578 RS:0004900 LOU/MWsl XCO:0000156 0.9% sodium chloride solution 126779578 RS:0004900 LOU/MWsl XCO:0000099 control condition 126779578 RS:0004900 LOU/MWsl XCO:0000539 doxorubicin 0.06 0.06 mg/kg 126779578 RS:0004900 LOU/MWsl XCO:0000539 doxorubicin 0.12 0.12 mg/kg 126779578 RS:0004900 LOU/MWsl XCO:0000539 doxorubicin 0.25 0.25 mg/kg 126779578 RS:0004900 LOU/MWsl XCO:0000539 doxorubicin 0.5 0.5 mg/kg 126779578 RS:0004900 LOU/MWsl XCO:0000539 doxorubicin 0.5 0.5 ml/kg 126779578 RS:0004900 LOU/MWsl XCO:0000539 doxorubicin 1 1 mg/kg 126779578 RS:0004900 LOU/MWsl XCO:0000539 doxorubicin 1 1 ml/kg 126779578 RS:0004900 LOU/MWsl XCO:0000539 doxorubicin 2 2 mg/kg 126779578 RS:0004900 LOU/MWsl XCO:0000539 doxorubicin 2 2 ml/kg 126779578 RS:0004900 LOU/MWsl XCO:0000848 negatively charged liposome-entrapped doxorubicin 0.5 0.5 mg/kg 126779578 RS:0004900 LOU/MWsl XCO:0000848 negatively charged liposome-entrapped doxorubicin 1 1 mg/kg 126779578 RS:0004900 LOU/MWsl XCO:0000848 negatively charged liposome-entrapped doxorubicin 2 2 mg/kg 126779578 RS:0004900 LOU/MWsl XCO:0000782 negatively charged liposomes 126779578 RS:0004900 LOU/MWsl XCO:0000849 positively charged liposome-entrapped doxorubicin 0.5 0.5 mg/kg 126779578 RS:0004900 LOU/MWsl XCO:0000849 positively charged liposome-entrapped doxorubicin 1 1 mg/kg 126779578 RS:0004900 LOU/MWsl XCO:0000781 positively charged liposomes 126779578 RS:0004900 LOU/MWsl XCO:0000779 rat IgM immunocytoma cells 0.01 0.01 x 10E6 cells 126779578 RS:0004900 LOU/MWsl XCO:0000779 rat IgM immunocytoma cells 1 1 x 10E4 cells 126779578 RS:0004900 LOU/MWsl XCO:0000101 vehicle control condition 1 1 ml/kg 7401261 RS:0003566 LOU/NimrOlaHsd XCO:0000015 controlled calorie content diet 2.9 2.9 kcal/g 7401261 RS:0003566 LOU/NimrOlaHsd XCO:0000102 fasting 10024 RS:0000573 M520/N XCO:0000099 control condition 1302728 RS:0000575 MES/Slc XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302728 RS:0000575 MES/Slc XCO:0000102 fasting 1302728 RS:0000575 MES/Slc XCO:0000087 specific pathogen-free condition 2307317 RS:0000577 MHS XCO:0000862 bendroflumethiazide 200 200 ug 2307317 RS:0000577 MHS XCO:0000099 control condition 2307317 RS:0000577 MHS XCO:0000466 controlled ex vivo artery perfusion pressure 60 60 mmHg 2307317 RS:0000577 MHS XCO:0000466 controlled ex vivo artery perfusion pressure 120 120 mmHg 2307317 RS:0000577 MHS XCO:0000245 insulin 2 2 IU/d 2307317 RS:0000577 MHS XCO:0000245 insulin 4 4 IU/kg 2307317 RS:0000577 MHS XCO:0000069 standard diet 2307317 RS:0000577 MHS XCO:0000241 streptozotocin 50 50 mg/kg 2307317 RS:0000577 MHS XCO:0000241 streptozotocin 55 55 mg/kg 2307317 RS:0000577 MHS XCO:0000241 streptozotocin 55 55 ml/kg 10025 RS:0000578 MHS/Gib XCO:0000099 control condition 10025 RS:0000578 MHS/Gib XCO:0000795 controlled sodium chloride content diet 2.5 2.5 g/kg 7800692 RS:0003627 MKO/Tami XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 7800692 RS:0003627 MKO/Tami XCO:0000102 fasting 7800692 RS:0003627 MKO/Tami XCO:0000087 specific pathogen-free condition 60992 RS:0000580 MNS XCO:0000862 bendroflumethiazide 200 200 ug 60992 RS:0000580 MNS XCO:0000099 control condition 60992 RS:0000580 MNS XCO:0000245 insulin 2 2 IU/d 60992 RS:0000580 MNS XCO:0000245 insulin 4 4 IU/kg 60992 RS:0000580 MNS XCO:0000069 standard diet 60992 RS:0000580 MNS XCO:0000241 streptozotocin 50 50 mg/kg 60992 RS:0000580 MNS XCO:0000241 streptozotocin 55 55 mg/kg 10028 RS:0000581 MNS/Gib XCO:0000099 control condition 10028 RS:0000581 MNS/Gib XCO:0000795 controlled sodium chloride content diet 2.5 2.5 g/kg 2325146 RS:0002408 MNS/NMco XCO:0000268 balloon angioplasty 70449 RS:0000589 MR/N XCO:0000099 control condition 1559043 RS:0001372 MV/Opu XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1559043 RS:0001372 MV/Opu XCO:0000102 fasting 1559043 RS:0001372 MV/Opu XCO:0000087 specific pathogen-free condition 68098 RS:0000592 MW XCO:0000536 angiotensin II receptor antagonist 20 20 mg/l 68098 RS:0000592 MW XCO:0000536 angiotensin II receptor antagonist 80 80 mg/l 68098 RS:0000592 MW XCO:0000270 captopril 30 30 mg/kg/d 68098 RS:0000592 MW XCO:0000270 captopril 500 500 mg/l 68098 RS:0000592 MW XCO:0000099 control condition 68098 RS:0000592 MW XCO:0000552 controlled hydralazine content drinking water 25 25 mg/l 68098 RS:0000592 MW XCO:0000539 doxorubicin 2 2 mg/kg 68098 RS:0000592 MW XCO:0000542 enalapril 20 20 mg/kg/d 68098 RS:0000592 MW XCO:0000542 enalapril 50 50 mg/l 68098 RS:0000592 MW XCO:0000551 hydralazine 80 80 mg/l 68098 RS:0000592 MW XCO:0000535 lisinopril 10 10 mg/kg/d 68098 RS:0000592 MW XCO:0000017 nephrectomy 68098 RS:0000592 MW XCO:0000593 puromycin aminonucleoside 40 40 mg/kg 68098 RS:0000592 MW XCO:0000593 puromycin aminonucleoside 100 100 mg/kg 68098 RS:0000592 MW XCO:0000550 reserpine 5 5 mg/l 68098 RS:0000592 MW XCO:0000113 right nephrectomy 68098 RS:0000592 MW XCO:0000100 sham surgical control condition 68098 RS:0000592 MW XCO:0000112 unilateral nephrectomy 68098 RS:0000592 MW XCO:0000101 vehicle control condition 68099 RS:0000594 MWF XCO:0000905 castor oil 68099 RS:0000594 MWF XCO:0000099 control condition 68099 RS:0000594 MWF XCO:0000677 controlled enalapril content drinking water 10 10 mg/kg 68099 RS:0000594 MWF XCO:0000555 controlled lisinopril content drinking water 80 100 mg/l 68099 RS:0000594 MWF XCO:0000637 cyclosporine A 50 50 mg/kg/d 68099 RS:0000594 MWF XCO:0000637 cyclosporine A 50 50 ml/kg/d 68099 RS:0000594 MWF XCO:0000539 doxorubicin 5 5 mg/kg 68099 RS:0000594 MWF XCO:0000839 finerenone 10 10 mg/kg/d 68099 RS:0000594 MWF XCO:0000833 lacidipine 1 1 mg/kg/d 68099 RS:0000594 MWF XCO:0000535 lisinopril 80 100 mg/l 1641831 RS:0001373 MWF-Chr 6SHR/Rkb XCO:0000099 control condition 2312609 RS:0002073 MWF-Chr 8SHR/Rkb XCO:0000099 control condition 731185 RS:0000595 MWF/Fub XCO:0000099 control condition 731185 RS:0000595 MWF/Fub XCO:0000795 controlled sodium chloride content diet 8 8 % 731185 RS:0000595 MWF/Fub XCO:0000022 controlled sodium content diet 8 8 % 731185 RS:0000595 MWF/Fub XCO:0000839 finerenone 10 10 mg/kg/d 731185 RS:0000595 MWF/Fub XCO:0000069 standard diet 724569 RS:0000596 MWF/FubRkb XCO:0000099 control condition 724569 RS:0000596 MWF/FubRkb XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 5 5 mg/kg/d 724569 RS:0000596 MWF/FubRkb XCO:0000893 controlled ramipril content drinking water 1 1 mg/kg/d 724569 RS:0000596 MWF/FubRkb XCO:0000893 controlled ramipril content drinking water 1 1 ml/kg/d 724569 RS:0000596 MWF/FubRkb XCO:0000839 finerenone 10 10 mg/kg/d 724569 RS:0000596 MWF/FubRkb XCO:0000839 finerenone 724569 RS:0000596 MWF/FubRkb XCO:0000114 left nephrectomy 724569 RS:0000596 MWF/FubRkb XCO:0000100 sham surgical control condition 724569 RS:0000596 MWF/FubRkb XCO:0000101 vehicle control condition 10 10 mg/kg/d 724569 RS:0000596 MWF/FubRkb XCO:0000101 vehicle control condition 737906 RS:0000593 MWF/Hsd XCO:0000360 arterial catheter implantation 737906 RS:0000593 MWF/Hsd XCO:0000099 control condition 737906 RS:0000593 MWF/Hsd XCO:0000812 controlled hemorrhage 737906 RS:0000593 MWF/Hsd XCO:0000549 left anterior descending coronary artery occlusion 737906 RS:0000593 MWF/Hsd XCO:0000100 sham surgical control condition 25314294 RS:0004778 MWF/Ztm XCO:0000360 arterial catheter implantation 25314294 RS:0004778 MWF/Ztm XCO:0000668 arterial catheter implantation and controlled hemorrhage 25314294 RS:0004778 MWF/Ztm XCO:0000592 cilazapril 15 15 mg/kg/d 25314294 RS:0004778 MWF/Ztm XCO:0000099 control condition 25314294 RS:0004778 MWF/Ztm XCO:0000555 controlled lisinopril content drinking water 40 40 mg/l 25314294 RS:0004778 MWF/Ztm XCO:0000555 controlled lisinopril content drinking water 50 50 mg/l 25314294 RS:0004778 MWF/Ztm XCO:0000555 controlled lisinopril content drinking water 80 80 mg/l 25314294 RS:0004778 MWF/Ztm XCO:0000069 standard diet 6482298 RS:0003240 MWF/ZtmRrrc XCO:0000099 control condition 6482298 RS:0003240 MWF/ZtmRrrc XCO:0000542 enalapril 50 50 mg/l 6482298 RS:0003240 MWF/ZtmRrrc XCO:0000101 vehicle control condition 2314001 RS:0002074 N:HS XCO:0000266 Freund's complete adjuvant 100 100 ul 2314001 RS:0002074 N:HS XCO:0000048 auditory stimulus 63 63 dB 2314001 RS:0002074 N:HS XCO:0000099 control condition 2314001 RS:0002074 N:HS XCO:0000103 glucose solution 2 2 g/kg 2314001 RS:0002074 N:HS XCO:0000195 myelin oligodendrocyte glycoprotein 50 120 ug 2314001 RS:0002074 N:HS XCO:0000283 visible light stimulus 7 7 W 1302678 RS:0000600 NAR/Slc XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302678 RS:0000600 NAR/Slc XCO:0000102 fasting 1302678 RS:0000600 NAR/Slc XCO:0000087 specific pathogen-free condition 2311073 RS:0002075 NBL/CrCrl XCO:0000360 arterial catheter implantation 2311073 RS:0002075 NBL/CrCrl XCO:0000099 control condition 2311073 RS:0002075 NBL/CrCrl XCO:0000812 controlled hemorrhage 1559031 RS:0001374 NE/Mave XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1559031 RS:0001374 NE/Mave XCO:0000102 fasting 1559031 RS:0001374 NE/Mave XCO:0000087 specific pathogen-free condition 2306034 RS:0002077 NER.F344-(D1Mgh6-D1Rat132)(D5Rat100-D5Rat234)/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2306034 RS:0002077 NER.F344-(D1Mgh6-D1Rat132)(D5Rat100-D5Rat234)/Kyo XCO:0000102 fasting 2306034 RS:0002077 NER.F344-(D1Mgh6-D1Rat132)(D5Rat100-D5Rat234)/Kyo XCO:0000087 specific pathogen-free condition 2314314 RS:0002078 NER.F344-(D1Mgh6-D1Rat132)/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2314314 RS:0002078 NER.F344-(D1Mgh6-D1Rat132)/Kyo XCO:0000102 fasting 2314314 RS:0002078 NER.F344-(D1Mgh6-D1Rat132)/Kyo XCO:0000087 specific pathogen-free condition 7800694 RS:0003628 NER.F344-(D1Rat132)(D5Rat100)/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 7800694 RS:0003628 NER.F344-(D1Rat132)(D5Rat100)/Kyo XCO:0000102 fasting 7800694 RS:0003628 NER.F344-(D1Rat132)(D5Rat100)/Kyo XCO:0000087 specific pathogen-free condition 2314313 RS:0002079 NER.F344-(D5Rat100-D5Rat234)/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2314313 RS:0002079 NER.F344-(D5Rat100-D5Rat234)/Kyo XCO:0000102 fasting 2314313 RS:0002079 NER.F344-(D5Rat100-D5Rat234)/Kyo XCO:0000087 specific pathogen-free condition 628486 RS:0000606 NER/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 628486 RS:0000606 NER/Kyo XCO:0000102 fasting 628486 RS:0000606 NER/Kyo XCO:0000087 specific pathogen-free condition 68104 RS:0002080 NIG-III/Hok XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 68104 RS:0002080 NIG-III/Hok XCO:0000102 fasting 68104 RS:0002080 NIG-III/Hok XCO:0000087 specific pathogen-free condition 38500209 RS:0004791 NISAG XCO:0000099 control condition 38500209 RS:0004791 NISAG XCO:0000159 physical restraint in tube type rodent restrainer 2314009 RS:0002539 NMcwi:HS XCO:0000099 control condition 2314009 RS:0002539 NMcwi:HS XCO:0000102 fasting 1641877 RS:0001376 NP.P-(D4Rat119-D4Rat55)/Iusm XCO:0000099 control condition 1641877 RS:0001376 NP.P-(D4Rat119-D4Rat55)/Iusm XCO:0000023 controlled ethanol content drinking water 10 10 % 1641877 RS:0001376 NP.P-(D4Rat119-D4Rat55)/Iusm XCO:0000021 water 1566440 RS:0001410 NTac:SD XCO:0000099 control condition 1566440 RS:0001410 NTac:SD XCO:0000102 fasting 1566440 RS:0001410 NTac:SD XCO:0000103 glucose solution 2 2 g/kg 4140404 RS:0002446 ODS-Gulood/od/ShiJcl XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 4140404 RS:0002446 ODS-Gulood/od/ShiJcl XCO:0000102 fasting 4140404 RS:0002446 ODS-Gulood/od/ShiJcl XCO:0000087 specific pathogen-free condition 61014 RS:0000284 OLETF XCO:0000099 control condition 61014 RS:0000284 OLETF XCO:0000102 fasting 61014 RS:0000284 OLETF XCO:0000103 glucose solution 2 2 g/kg 61014 RS:0000284 OLETF XCO:0000103 glucose solution 61014 RS:0000284 OLETF XCO:0000537 olmesartan medoxomil 0.35 0.35 mg/kg/d 61014 RS:0000284 OLETF XCO:0000537 olmesartan medoxomil 3.8 3.8 mg/kg/d 61014 RS:0000284 OLETF XCO:0000538 temocapril 3.9 3.9 mg/kg/d 734526 RS:0000625 OLETF/Got XCO:0000099 control condition 734526 RS:0000625 OLETF/Got XCO:0000102 fasting 734526 RS:0000625 OLETF/Got XCO:0000104 glucose solution, 2.8M 2 2 g/kg 734526 RS:0000625 OLETF/Got XCO:0000243 partial pancreatectomy 70 70 % 734526 RS:0000625 OLETF/Got XCO:0000243 partial pancreatectomy 1302716 RS:0000632 OM/NSlc XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302716 RS:0000632 OM/NSlc XCO:0000102 fasting 1302716 RS:0000632 OM/NSlc XCO:0000087 specific pathogen-free condition 2304038 RS:0001989 OP/Jtt XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2304038 RS:0001989 OP/Jtt XCO:0000102 fasting 2304038 RS:0001989 OP/Jtt XCO:0000087 specific pathogen-free condition 68114 RS:0000634 OXYS/Nov XCO:0000099 control condition 68114 RS:0000634 OXYS/Nov XCO:0000944 controlled alendronate content drinking water 0.84 0.84 mg/kg/d 68114 RS:0000634 OXYS/Nov XCO:0000955 controlled glucosamine - alendronate content drinking water 1.26 1.26 mg/kg/d 68114 RS:0000634 OXYS/Nov XCO:0000560 controlled melatonin content diet 0.04 0.04 mg/kg/d 68114 RS:0000634 OXYS/Nov XCO:0000945 controlled taxifolin content drinking water 5.06 5.06 mg/kg/d 68114 RS:0000634 OXYS/Nov XCO:0000101 vehicle control condition 1641856 RS:0001380 P.NP-(D4Rat119-D4Rat55)/Iusm XCO:0000099 control condition 1580542 RS:0001381 PCK-Pkhd1pck/CrljCrl XCO:0000099 control condition 1580542 RS:0001381 PCK-Pkhd1pck/CrljCrl XCO:0000677 controlled enalapril content drinking water 5 5 mg/kg/d 1580542 RS:0001381 PCK-Pkhd1pck/CrljCrl XCO:0000383 controlled losartan content drinking water 5 5 mg/kg/d 1580542 RS:0001381 PCK-Pkhd1pck/CrljCrl XCO:0000535 lisinopril 3 3 ml/kg/d 1580542 RS:0001381 PCK-Pkhd1pck/CrljCrl XCO:0000101 vehicle control condition ml/kg/d 728161 RS:0000126 PD/Cub XCO:0000099 control condition 728161 RS:0000126 PD/Cub XCO:0000211 controlled sucrose content diet 728161 RS:0000126 PD/Cub XCO:0000372 dexamethasone 0.03 0.03 mg/ml 728161 RS:0000126 PD/Cub XCO:0000102 fasting 61006 RS:0000224 PVG XCO:0000266 Freund's complete adjuvant 100 100 ul 61006 RS:0000224 PVG XCO:0000291 peripheral myelin protein 2 peptide 58-81 100 100 ug 61006 RS:0000224 PVG XCO:0000292 peripheral nerve myelin 2 2 mg 737658 RS:0000644 PVG.1AV1 XCO:0000266 Freund's complete adjuvant 100 100 ul 737658 RS:0000644 PVG.1AV1 XCO:0000265 Freund's incomplete adjuvant 100 100 ul 737658 RS:0000644 PVG.1AV1 XCO:0000291 peripheral myelin protein 2 peptide 58-81 100 100 ug 737658 RS:0000644 PVG.1AV1 XCO:0000292 peripheral nerve myelin 2 2 mg 737658 RS:0000644 PVG.1AV1 XCO:0000263 pristane 150 150 ul 737658 RS:0000644 PVG.1AV1 XCO:0000280 squalene 200 200 ul 737658 RS:0000644 PVG.1AV1 XCO:0000281 type II collagen 500 500 ug 8551868 RS:0003687 PVG.1AV1.DA-(D4Mgh17-D4Rat84)/Kiru XCO:0000265 Freund's incomplete adjuvant 200 200 ul 2307157 RS:0002085 PVG.1AV1/Kini XCO:0000265 Freund's incomplete adjuvant 200 200 ul 629486 RS:0000645 PVG/OlaHsd XCO:0000360 arterial catheter implantation 629486 RS:0000645 PVG/OlaHsd XCO:0000099 control condition 629486 RS:0000645 PVG/OlaHsd XCO:0000812 controlled hemorrhage 1302722 RS:0000647 PVG/Seac XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302722 RS:0000647 PVG/Seac XCO:0000102 fasting 1302722 RS:0000647 PVG/Seac XCO:0000087 specific pathogen-free condition 2307138 RS:0002086 PXO1/Cub XCO:0000025 controlled fat content diet 10.4 10.4 % of calories 2307138 RS:0002086 PXO1/Cub XCO:0000030 controlled protein content diet 19.6 19.6 % of calories 2307138 RS:0002086 PXO1/Cub XCO:0000211 controlled sucrose content diet 70 70 % of calories 2307138 RS:0002086 PXO1/Cub XCO:0000102 fasting 2307132 RS:0002089 PXO10/Cub XCO:0000025 controlled fat content diet 10.4 10.4 % of calories 2307132 RS:0002089 PXO10/Cub XCO:0000030 controlled protein content diet 19.6 19.6 % of calories 2307132 RS:0002089 PXO10/Cub XCO:0000211 controlled sucrose content diet 70 70 % of calories 2307132 RS:0002089 PXO10/Cub XCO:0000102 fasting 2307356 RS:0002090 PXO2/Cub XCO:0000025 controlled fat content diet 10.4 10.4 % of calories 2307356 RS:0002090 PXO2/Cub XCO:0000030 controlled protein content diet 19.6 19.6 % of calories 2307356 RS:0002090 PXO2/Cub XCO:0000211 controlled sucrose content diet 70 70 % of calories 2307356 RS:0002090 PXO2/Cub XCO:0000102 fasting 2307355 RS:0002091 PXO3-1/Cub XCO:0000025 controlled fat content diet 10.4 10.4 % of calories 2307355 RS:0002091 PXO3-1/Cub XCO:0000030 controlled protein content diet 19.6 19.6 % of calories 2307355 RS:0002091 PXO3-1/Cub XCO:0000211 controlled sucrose content diet 70 70 % of calories 2307355 RS:0002091 PXO3-1/Cub XCO:0000102 fasting 2307116 RS:0002092 PXO3-2/Cub XCO:0000025 controlled fat content diet 10.4 10.4 % of calories 2307116 RS:0002092 PXO3-2/Cub XCO:0000030 controlled protein content diet 19.6 19.6 % of calories 2307116 RS:0002092 PXO3-2/Cub XCO:0000211 controlled sucrose content diet 70 70 % of calories 2307116 RS:0002092 PXO3-2/Cub XCO:0000102 fasting 2307135 RS:0002093 PXO4/Cub XCO:0000025 controlled fat content diet 10.4 10.4 % of calories 2307135 RS:0002093 PXO4/Cub XCO:0000030 controlled protein content diet 19.6 19.6 % of calories 2307135 RS:0002093 PXO4/Cub XCO:0000211 controlled sucrose content diet 70 70 % of calories 2307135 RS:0002093 PXO4/Cub XCO:0000102 fasting 2307128 RS:0002094 PXO5-1/Cub XCO:0000025 controlled fat content diet 10.4 10.4 % of calories 2307128 RS:0002094 PXO5-1/Cub XCO:0000030 controlled protein content diet 19.6 19.6 % of calories 2307128 RS:0002094 PXO5-1/Cub XCO:0000211 controlled sucrose content diet 70 70 % of calories 2307128 RS:0002094 PXO5-1/Cub XCO:0000102 fasting 2307117 RS:0002095 PXO5-2/Cub XCO:0000025 controlled fat content diet 10.4 10.4 % of calories 2307117 RS:0002095 PXO5-2/Cub XCO:0000030 controlled protein content diet 19.6 19.6 % of calories 2307117 RS:0002095 PXO5-2/Cub XCO:0000211 controlled sucrose content diet 70 70 % of calories 2307117 RS:0002095 PXO5-2/Cub XCO:0000102 fasting 2307137 RS:0002096 PXO6-1/Cub XCO:0000025 controlled fat content diet 10.4 10.4 % of calories 2307137 RS:0002096 PXO6-1/Cub XCO:0000030 controlled protein content diet 19.6 19.6 % of calories 2307137 RS:0002096 PXO6-1/Cub XCO:0000211 controlled sucrose content diet 70 70 % of calories 2307137 RS:0002096 PXO6-1/Cub XCO:0000102 fasting 2307125 RS:0002097 PXO6-2/Cub XCO:0000025 controlled fat content diet 10.4 10.4 % of calories 2307125 RS:0002097 PXO6-2/Cub XCO:0000030 controlled protein content diet 19.6 19.6 % of calories 2307125 RS:0002097 PXO6-2/Cub XCO:0000211 controlled sucrose content diet 70 70 % of calories 2307125 RS:0002097 PXO6-2/Cub XCO:0000102 fasting 2307130 RS:0002098 PXO6-3/Cub XCO:0000025 controlled fat content diet 10.4 10.4 % of calories 2307130 RS:0002098 PXO6-3/Cub XCO:0000030 controlled protein content diet 19.6 19.6 % of calories 2307130 RS:0002098 PXO6-3/Cub XCO:0000211 controlled sucrose content diet 70 70 % of calories 2307130 RS:0002098 PXO6-3/Cub XCO:0000102 fasting 2307119 RS:0002099 PXO7-1/Cub XCO:0000025 controlled fat content diet 10.4 10.4 % of calories 2307119 RS:0002099 PXO7-1/Cub XCO:0000030 controlled protein content diet 19.6 19.6 % of calories 2307119 RS:0002099 PXO7-1/Cub XCO:0000211 controlled sucrose content diet 70 70 % of calories 2307119 RS:0002099 PXO7-1/Cub XCO:0000102 fasting 2307122 RS:0002101 PXO8-1/Cub XCO:0000025 controlled fat content diet 10.4 10.4 % of calories 2307122 RS:0002101 PXO8-1/Cub XCO:0000030 controlled protein content diet 19.6 19.6 % of calories 2307122 RS:0002101 PXO8-1/Cub XCO:0000211 controlled sucrose content diet 70 70 % of calories 2307122 RS:0002101 PXO8-1/Cub XCO:0000102 fasting 2307131 RS:0002102 PXO8-2/Cub XCO:0000025 controlled fat content diet 10.4 10.4 % of calories 2307131 RS:0002102 PXO8-2/Cub XCO:0000030 controlled protein content diet 19.6 19.6 % of calories 2307131 RS:0002102 PXO8-2/Cub XCO:0000211 controlled sucrose content diet 70 70 % of calories 2307131 RS:0002102 PXO8-2/Cub XCO:0000102 fasting 2307118 RS:0002103 PXO9/Cub XCO:0000025 controlled fat content diet 10.4 10.4 % of calories 2307118 RS:0002103 PXO9/Cub XCO:0000030 controlled protein content diet 19.6 19.6 % of calories 2307118 RS:0002103 PXO9/Cub XCO:0000211 controlled sucrose content diet 70 70 % of calories 2307118 RS:0002103 PXO9/Cub XCO:0000102 fasting 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000809 2-methyl-6-(phenylethynyl)pyridine 200 200 umol 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000841 GSK-812 2 2 ul 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000099 control condition 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000183 controlled exposure to darkness 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000531 gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector 5250000 5250000 PFU 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000794 gene transfer of the lin-28 homolog B gene using an adenovirus vector 5250000 5250000 PFU 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000821 gene transfer of the rat GDNF gene using the plasmid vector pVAX2 15 15 ug 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000821 gene transfer of the rat GDNF gene using the plasmid vector pVAX2 30 30 ug 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000820 gene transfer using empty plasmid vector pVAX2 30 30 ug 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000720 laser photocoagulation 22.5 22.5 um 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000720 laser photocoagulation 45 45 um 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000720 laser photocoagulation 67.5 67.5 um 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000720 laser photocoagulation 135 135 um 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000720 laser photocoagulation 180 180 um 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000720 laser photocoagulation 225 225 um 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000462 light phase of controlled light/dark cycle 0 5 lux 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000805 nondamaging retinal laser therapy 50 50 um 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000445 phosphate buffered saline 4 4 ul 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000803 subthreshold laser therapy 200 200 um 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000101 vehicle control condition 2 2 ul 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000283 visible light stimulus -4.5 -4.5 log(cd x m/s2) 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000283 visible light stimulus -2.5 -2.5 log(cd x m/s2) 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000283 visible light stimulus -0.5 -0.5 log(cd x m/s2) 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000283 visible light stimulus -0.02 -0.02 log(cd x m/s2) 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000283 visible light stimulus 0.5 0.5 log(cd x m/s2) 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000283 visible light stimulus 1 1 log(cd x m/s2) 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000283 visible light stimulus 3 3 cd x s/m2 1358259 RS:0000655 RCS-p+/LavRrrc XCO:0000283 visible light stimulus 25 25 cd x s/m2 1358278 RS:0000656 RCS-rdy+ p+/LavRrrc XCO:0000810 2-Chloro-5-hydroxyphenylglycine 200 200 umol 1358278 RS:0000656 RCS-rdy+ p+/LavRrrc XCO:0000809 2-methyl-6-(phenylethynyl)pyridine 200 200 umol 1358278 RS:0000656 RCS-rdy+ p+/LavRrrc XCO:0000808 DL-α-aminoadipate 70 70 ug/ul 1358278 RS:0000656 RCS-rdy+ p+/LavRrrc XCO:0000183 controlled exposure to darkness 1358278 RS:0000656 RCS-rdy+ p+/LavRrrc XCO:0000445 phosphate buffered saline 4 4 ul 1358278 RS:0000656 RCS-rdy+ p+/LavRrrc XCO:0000283 visible light stimulus -4.5 -4.5 log(cd x m/s2) 1358278 RS:0000656 RCS-rdy+ p+/LavRrrc XCO:0000283 visible light stimulus -2.5 -2.5 log(cd x m/s2) 1358278 RS:0000656 RCS-rdy+ p+/LavRrrc XCO:0000283 visible light stimulus -0.5 -0.5 log(cd x m/s2) 1358278 RS:0000656 RCS-rdy+ p+/LavRrrc XCO:0000283 visible light stimulus -0.02 -0.02 log(cd x m/s2) 1358278 RS:0000656 RCS-rdy+ p+/LavRrrc XCO:0000283 visible light stimulus 0.5 0.5 log(cd x m/s2) 1358278 RS:0000656 RCS-rdy+ p+/LavRrrc XCO:0000283 visible light stimulus 1 1 log(cd x m/s2) 1302660 RS:0000659 RCS/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302660 RS:0000659 RCS/Kyo XCO:0000102 fasting 1302660 RS:0000659 RCS/Kyo XCO:0000087 specific pathogen-free condition 1358258 RS:0000660 RCS/LavRrrc XCO:0000183 controlled exposure to darkness 1358258 RS:0000660 RCS/LavRrrc XCO:0000678 gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector 40 40 x 10E8 vg 1358258 RS:0000660 RCS/LavRrrc XCO:0000852 human periodontal ligament-derived stem cells 0.2 0.2 x 10E6 cells 1358258 RS:0000660 RCS/LavRrrc XCO:0000101 vehicle control condition 2 2 ul 1358258 RS:0000660 RCS/LavRrrc XCO:0000283 visible light stimulus 2.5 2.5 cd/m2 1358258 RS:0000660 RCS/LavRrrc XCO:0000283 visible light stimulus 68122 RS:0000652 RCS/N XCO:0000099 control condition 68122 RS:0000652 RCS/N XCO:0000183 controlled exposure to darkness 68122 RS:0000652 RCS/N XCO:0000181 controlled visible light condition 30 30 cd/m2 68122 RS:0000652 RCS/N XCO:0000284 controlled visible light exposure 68122 RS:0000652 RCS/N XCO:0000678 gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector 21.6 21.6 x 10E8 vg 68122 RS:0000652 RCS/N XCO:0000832 lensotomy 68122 RS:0000652 RCS/N XCO:0000283 visible light stimulus 0.01 0.01 cd x s/m2 68122 RS:0000652 RCS/N XCO:0000283 visible light stimulus 2.5 2.5 cd x s/m2 68122 RS:0000652 RCS/N XCO:0000283 visible light stimulus 10 10 cd x s/m2 68122 RS:0000652 RCS/N XCO:0000283 visible light stimulus 100 100 cd x s/m2 68123 RS:0000663 RHA/N XCO:0000048 auditory stimulus 63 63 dB 68123 RS:0000663 RHA/N XCO:0000099 control condition 68123 RS:0000663 RHA/N XCO:0000283 visible light stimulus 7 7 W 1302624 RS:0000667 RICO/Ngs XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302624 RS:0000667 RICO/Ngs XCO:0000102 fasting 1302624 RS:0000667 RICO/Ngs XCO:0000087 specific pathogen-free condition 68126 RS:0000671 RLA/N XCO:0000048 auditory stimulus 63 63 dB 68126 RS:0000671 RLA/N XCO:0000099 control condition 68126 RS:0000671 RLA/N XCO:0000283 visible light stimulus 7 7 W 38549341 RS:0004796 RP/AEurRijHsd XCO:0000743 Haemophilus 2314496 RS:0002108 SBH.SBN-(D1Mgh2-D1Mgh11)/Ygl XCO:0000099 control condition 2314496 RS:0002108 SBH.SBN-(D1Mgh2-D1Mgh11)/Ygl XCO:0000164 controlled sodium content drinking water 1 1 % 2314496 RS:0002108 SBH.SBN-(D1Mgh2-D1Mgh11)/Ygl XCO:0000192 deoxycorticosterone acetate 25 25 mg 2314500 RS:0002110 SBH.SBN-(D1Mgh2-D1Rat101)/Ygl XCO:0000099 control condition 2314500 RS:0002110 SBH.SBN-(D1Mgh2-D1Rat101)/Ygl XCO:0000164 controlled sodium content drinking water 1 1 % 2314500 RS:0002110 SBH.SBN-(D1Mgh2-D1Rat101)/Ygl XCO:0000192 deoxycorticosterone acetate 25 25 mg 2314493 RS:0002111 SBH.SBN-(D1Mgh2-D1Rat74)/Ygl XCO:0000099 control condition 2314493 RS:0002111 SBH.SBN-(D1Mgh2-D1Rat74)/Ygl XCO:0000164 controlled sodium content drinking water 1 1 % 2314493 RS:0002111 SBH.SBN-(D1Mgh2-D1Rat74)/Ygl XCO:0000192 deoxycorticosterone acetate 25 25 mg 2314494 RS:0002112 SBH.SBN-(D1Rat137-D1Rat123)/Ygl XCO:0000099 control condition 2314494 RS:0002112 SBH.SBN-(D1Rat137-D1Rat123)/Ygl XCO:0000164 controlled sodium content drinking water 1 1 % 2314494 RS:0002112 SBH.SBN-(D1Rat137-D1Rat123)/Ygl XCO:0000192 deoxycorticosterone acetate 25 25 mg 2314498 RS:0002113 SBH.SBN-(D1Rat137-D1Rat83)/Ygl XCO:0000099 control condition 2314498 RS:0002113 SBH.SBN-(D1Rat137-D1Rat83)/Ygl XCO:0000164 controlled sodium content drinking water 1 1 % 2314498 RS:0002113 SBH.SBN-(D1Rat137-D1Rat83)/Ygl XCO:0000192 deoxycorticosterone acetate 25 25 mg 2314501 RS:0002114 SBH.SBN-(D1Wox11-D1Rat137)/Ygl XCO:0000099 control condition 2314501 RS:0002114 SBH.SBN-(D1Wox11-D1Rat137)/Ygl XCO:0000164 controlled sodium content drinking water 1 1 % 2314501 RS:0002114 SBH.SBN-(D1Wox11-D1Rat137)/Ygl XCO:0000192 deoxycorticosterone acetate 25 25 mg 631572 RS:0000677 SBH/Ygl XCO:0000099 control condition 631572 RS:0000677 SBH/Ygl XCO:0000643 controlled exposure to a foster mother of a different strain within the same species. 631572 RS:0000677 SBH/Ygl XCO:0000795 controlled sodium chloride content diet 0.65 0.65 % 631572 RS:0000677 SBH/Ygl XCO:0000795 controlled sodium chloride content diet 8 8 % 631572 RS:0000677 SBH/Ygl XCO:0000164 controlled sodium content drinking water 1 1 % 631572 RS:0000677 SBH/Ygl XCO:0000192 deoxycorticosterone acetate 25 25 mg 631572 RS:0000677 SBH/Ygl XCO:0000192 deoxycorticosterone acetate 75 75 mg 631572 RS:0000677 SBH/Ygl XCO:0000245 insulin 10 10 ul 631572 RS:0000677 SBH/Ygl XCO:0000100 sham surgical control condition 631572 RS:0000677 SBH/Ygl XCO:0000016 standard rat chow 631572 RS:0000677 SBH/Ygl XCO:0000241 streptozotocin 60 60 mg/kg 631572 RS:0000677 SBH/Ygl XCO:0000112 unilateral nephrectomy 631572 RS:0000677 SBH/Ygl XCO:0000021 water 2314499 RS:0002116 SBN.SBH-(D1Mgh17-D1Mgh14)/Ygl XCO:0000099 control condition 2314499 RS:0002116 SBN.SBH-(D1Mgh17-D1Mgh14)/Ygl XCO:0000164 controlled sodium content drinking water 1 1 % 2314499 RS:0002116 SBN.SBH-(D1Mgh17-D1Mgh14)/Ygl XCO:0000192 deoxycorticosterone acetate 25 25 mg 2314497 RS:0002117 SBN.SBH-(D1Rat101-D1Rat74)/Ygl XCO:0000099 control condition 2314497 RS:0002117 SBN.SBH-(D1Rat101-D1Rat74)/Ygl XCO:0000164 controlled sodium content drinking water 1 1 % 2314497 RS:0002117 SBN.SBH-(D1Rat101-D1Rat74)/Ygl XCO:0000192 deoxycorticosterone acetate 25 25 mg 2314492 RS:0002118 SBN.SBH-(D1Rat148-D1Rat89)/Ygl XCO:0000099 control condition 2314492 RS:0002118 SBN.SBH-(D1Rat148-D1Rat89)/Ygl XCO:0000164 controlled sodium content drinking water 1 1 % 2314492 RS:0002118 SBN.SBH-(D1Rat148-D1Rat89)/Ygl XCO:0000192 deoxycorticosterone acetate 25 25 mg 2314495 RS:0002119 SBN.SBH-(D1Rat27-D1Mit7)/Ygl XCO:0000099 control condition 2314495 RS:0002119 SBN.SBH-(D1Rat27-D1Mit7)/Ygl XCO:0000164 controlled sodium content drinking water 1 1 % 2314495 RS:0002119 SBN.SBH-(D1Rat27-D1Mit7)/Ygl XCO:0000192 deoxycorticosterone acetate 25 25 mg 631573 RS:0000679 SBN/Ygl XCO:0000099 control condition 631573 RS:0000679 SBN/Ygl XCO:0000643 controlled exposure to a foster mother of a different strain within the same species. 631573 RS:0000679 SBN/Ygl XCO:0000164 controlled sodium content drinking water 1 1 % 631573 RS:0000679 SBN/Ygl XCO:0000647 darusentan 50 50 mg/kg/d 631573 RS:0000679 SBN/Ygl XCO:0000192 deoxycorticosterone acetate 25 25 mg 631573 RS:0000679 SBN/Ygl XCO:0000192 deoxycorticosterone acetate 75 75 mg 631573 RS:0000679 SBN/Ygl XCO:0000100 sham surgical control condition 631573 RS:0000679 SBN/Ygl XCO:0000016 standard rat chow 631573 RS:0000679 SBN/Ygl XCO:0000112 unilateral nephrectomy 631573 RS:0000679 SBN/Ygl XCO:0000021 water 70508 RS:0000681 SD XCO:0000600 2,3,7,8-tetrachlorodibenzo-p-dioxin 1000 1000 ng/kg/d 70508 RS:0000681 SD XCO:0000604 Aprotinin 12000 12000 kIU 70508 RS:0000681 SD XCO:0000589 Moexipril 30 35 mg/kg/d 70508 RS:0000681 SD XCO:0000388 acetaminophen 250 250 mg/kg 70508 RS:0000681 SD XCO:0000388 acetaminophen 500 500 mg/kg 70508 RS:0000681 SD XCO:0000388 acetaminophen 1000 1000 mg/kg 70508 RS:0000681 SD XCO:0000607 acetic acid 70508 RS:0000681 SD XCO:0000599 aldosterone 30 40 mg/kg/d 70508 RS:0000681 SD XCO:0000599 aldosterone 35 35 mg/kg/d 70508 RS:0000681 SD XCO:0000519 anti-Shiga toxin 1 beta monoclonal antibody 13C4 5 5 mg/kg 70508 RS:0000681 SD XCO:0000517 anti-transforming growth factor beta antibody 0.5 0.5 mg/kg 70508 RS:0000681 SD XCO:0000517 anti-transforming growth factor beta antibody 5 5 mg/kg 70508 RS:0000681 SD XCO:0000319 artificial aortocaval fistula 70508 RS:0000681 SD XCO:0000507 carprofen 5 5 mg/kg 70508 RS:0000681 SD XCO:0000099 control condition 70508 RS:0000681 SD XCO:0000031 controlled calcium content diet 0.6 0.6 % 70508 RS:0000681 SD XCO:0000031 controlled calcium content diet 1 1 % 70508 RS:0000681 SD XCO:0000014 controlled content diet 0.9 0.9 % 70508 RS:0000681 SD XCO:0000014 controlled content diet 1 1 % 70508 RS:0000681 SD XCO:0000014 controlled content diet 1.2 1.2 % 70508 RS:0000681 SD XCO:0000677 controlled enalapril content drinking water 5 5 mg/kg/d 70508 RS:0000681 SD XCO:0000383 controlled losartan content drinking water 5 5 mg/kg/d 70508 RS:0000681 SD XCO:0000829 corn oil 70508 RS:0000681 SD XCO:0000504 coronal plane rotational acceleration of the head 140 140 rad/s2 70508 RS:0000681 SD XCO:0000504 coronal plane rotational acceleration of the head 210 210 krad/s2 70508 RS:0000681 SD XCO:0000504 coronal plane rotational acceleration of the head 250 250 rad/s2 70508 RS:0000681 SD XCO:0000504 coronal plane rotational acceleration of the head 360 360 krad/s2 70508 RS:0000681 SD XCO:0000504 coronal plane rotational acceleration of the head 380 380 rad/s2 70508 RS:0000681 SD XCO:0000504 coronal plane rotational acceleration of the head 500 500 krad/s2 70508 RS:0000681 SD XCO:0000504 coronal plane rotational acceleration of the head 615 615 rad/s2 70508 RS:0000681 SD XCO:0000513 dibutyl phthalate 850 850 mg/kg/d 70508 RS:0000681 SD XCO:0000619 digoxin 0.01 0.01 mmol/l 70508 RS:0000681 SD XCO:0000539 doxorubicin 5 5 mg/kg 70508 RS:0000681 SD XCO:0000542 enalapril 25 25 mg/l 70508 RS:0000681 SD XCO:0000542 enalapril 50 50 mg/l 70508 RS:0000681 SD XCO:0000102 fasting 70508 RS:0000681 SD XCO:0000421 in utero condition 70508 RS:0000681 SD XCO:0000245 insulin 70508 RS:0000681 SD XCO:0000109 isoflurane 4 4 % 70508 RS:0000681 SD XCO:0000130 ketamine 80 80 mg/kg 70508 RS:0000681 SD XCO:0000549 left anterior descending coronary artery occlusion 70508 RS:0000681 SD XCO:0000114 left nephrectomy 70508 RS:0000681 SD XCO:0000161 losartan 180 180 mg/l 70508 RS:0000681 SD XCO:0000514 metoprolol 100 100 mg/kg/d 70508 RS:0000681 SD XCO:0000514 metoprolol 70508 RS:0000681 SD XCO:0000516 metoprolol succinate 100 100 mg/kg/d 70508 RS:0000681 SD XCO:0000017 nephrectomy 70508 RS:0000681 SD XCO:0000611 nifedipine 200 200 ug/kg 70508 RS:0000681 SD XCO:0000547 paricalcitol 0.1 0.1 ug/kg 70508 RS:0000681 SD XCO:0000547 paricalcitol 0.3 0.3 ug/kg 70508 RS:0000681 SD XCO:0000547 paricalcitol 0.8 0.8 mg/kg 70508 RS:0000681 SD XCO:0000159 physical restraint in tube type rodent restrainer 70508 RS:0000681 SD XCO:0000533 puromycin 40 40 mg/kg 70508 RS:0000681 SD XCO:0000533 puromycin 80 80 mg/kg 70508 RS:0000681 SD XCO:0000533 puromycin 100 100 mg/kg 70508 RS:0000681 SD XCO:0000617 quinidine 10 10 mmol/l 70508 RS:0000681 SD XCO:0000100 sham surgical control condition 70508 RS:0000681 SD XCO:0000627 spironolactone 5.56 5.56 mg/kg/d 70508 RS:0000681 SD XCO:0000241 streptozotocin 60 60 mg/kg 70508 RS:0000681 SD XCO:0000623 tritiated digoxin 10 10 uCi 70508 RS:0000681 SD XCO:0000622 tritiated quinidine 10 10 uCi 70508 RS:0000681 SD XCO:0000621 tritiated verapamil 10 10 uCi 70508 RS:0000681 SD XCO:0000112 unilateral nephrectomy 70508 RS:0000681 SD XCO:0000101 vehicle control condition 100 100 ul 70508 RS:0000681 SD XCO:0000101 vehicle control condition 70508 RS:0000681 SD XCO:0000616 verapamil 3 3 mmol/l 70508 RS:0000681 SD XCO:0000620 vinblastine 1 1 mmol/l 70508 RS:0000681 SD XCO:0000131 xylazine 10 10 mg/kg 12904730 RS:0004437 SD-Abcb11em1Sage XCO:0000099 control condition 12904057 RS:0004432 SD-Abcb1aem1Sage-/- XCO:0000619 digoxin 0.01 0.01 mmol/l 12904057 RS:0004432 SD-Abcb1aem1Sage-/- XCO:0000617 quinidine 10 10 mmol/l 12904057 RS:0004432 SD-Abcb1aem1Sage-/- XCO:0000623 tritiated digoxin 10 10 uCi 12904057 RS:0004432 SD-Abcb1aem1Sage-/- XCO:0000622 tritiated quinidine 10 10 uCi 12904057 RS:0004432 SD-Abcb1aem1Sage-/- XCO:0000621 tritiated verapamil 10 10 uCi 12904057 RS:0004432 SD-Abcb1aem1Sage-/- XCO:0000101 vehicle control condition 12904057 RS:0004432 SD-Abcb1aem1Sage-/- XCO:0000616 verapamil 1 1 mmol/l 12904057 RS:0004432 SD-Abcb1aem1Sage-/- XCO:0000616 verapamil 3 3 mmol/l 12904057 RS:0004432 SD-Abcb1aem1Sage-/- XCO:0000620 vinblastine 1 1 mmol/l 13792683 RS:0004628 SD-Abcc6em2Qlju+/+ XCO:0000069 standard diet 13792682 RS:0004627 SD-Abcc6em2Qlju+/- XCO:0000069 standard diet 10413852 RS:0004085 SD-Abcc6em2Qlju-/- XCO:0000069 standard diet 12903250 RS:0004428 SD-Ahrem1Sage XCO:0000025 controlled fat content diet 42 42 % 13838845 RS:0004674 SD-Ahrem2Sage XCO:0000600 2,3,7,8-tetrachlorodibenzo-p-dioxin 3 3 ng/kg/d 13838845 RS:0004674 SD-Ahrem2Sage XCO:0000600 2,3,7,8-tetrachlorodibenzo-p-dioxin 22 22 ng/kg/d 13838845 RS:0004674 SD-Ahrem2Sage XCO:0000600 2,3,7,8-tetrachlorodibenzo-p-dioxin 100 100 ng/kg/d 13838845 RS:0004674 SD-Ahrem2Sage XCO:0000600 2,3,7,8-tetrachlorodibenzo-p-dioxin 300 300 ng/kg/d 13838845 RS:0004674 SD-Ahrem2Sage XCO:0000600 2,3,7,8-tetrachlorodibenzo-p-dioxin 1000 1000 ng/kg/d 13838845 RS:0004674 SD-Ahrem2Sage XCO:0000099 control condition 13838845 RS:0004674 SD-Ahrem2Sage XCO:0000101 vehicle control condition 5 5 ml/kg 12880021 RS:0004423 SD-Apoeem1Sage XCO:0000099 control condition 12880021 RS:0004423 SD-Apoeem1Sage XCO:0000626 removal of maxillary molar crown 13792607 RS:0004626 SD-Cd59em1Ask+/+ XCO:0000099 control condition 13792606 RS:0004625 SD-Cd59em1Ask-/- XCO:0000099 control condition 151356958 RS:0005134 SD-Cftrem1Apb XCO:0000099 control condition 14392817 RS:0004682 SD-Cftrem1Sage+/+ XCO:0000099 control condition 14392815 RS:0004681 SD-Cftrem1Sage-/- XCO:0000099 control condition 151356959 RS:0005135 SD-Cftrem2Apb XCO:0000099 control condition 151356959 RS:0005135 SD-Cftrem2Apb XCO:0000929 controlled ColonLYTELY content drinking water 4.5 4.5 % 14696722 RS:0004751 SD-Cyp3a23/3a1em1Myliu,Cyp3a2em1Myliu XCO:0000611 nifedipine 200 200 ug/kg 13792795 RS:0004633 SD-Fhem1+/+ XCO:0000099 control condition 13792794 RS:0004632 SD-Fhem1+/- XCO:0000099 control condition 14696715 RS:0004746 SD-Htr7em1Msu XCO:0000099 control condition 12910101 RS:0004461 SD-Ldlrem1 XCO:0000099 control condition 12910101 RS:0004461 SD-Ldlrem1 XCO:0000025 controlled fat content diet 42 42 % 12910101 RS:0004461 SD-Ldlrem1 XCO:0000069 standard diet 12904908 RS:0004448 SD-Ldlrem1Sage XCO:0000025 controlled fat content diet 42 42 % 12904908 RS:0004448 SD-Ldlrem1Sage XCO:0000069 standard diet 13792575 RS:0004621 SD-Lepem1Sage+/+ XCO:0000099 control condition 13792575 RS:0004621 SD-Lepem1Sage+/+ XCO:0000102 fasting 13792575 RS:0004621 SD-Lepem1Sage+/+ XCO:0000069 standard diet 12904912 RS:0004449 SD-Lepem1Sage-/- XCO:0000099 control condition 12904912 RS:0004449 SD-Lepem1Sage-/- XCO:0000102 fasting 12904912 RS:0004449 SD-Lepem1Sage-/- XCO:0000103 glucose solution 2 2 g/kg 12904912 RS:0004449 SD-Lepem1Sage-/- XCO:0000069 standard diet 149735898 RS:0005005 SD-Myh7bem1Blar+/+ XCO:0000099 control condition 126925949 RS:0004946 SD-Myh7bem1Blar+/- XCO:0000099 control condition 126925952 RS:0004947 SD-Myh7bem1Blar-/- XCO:0000099 control condition 13208517 RS:0004500 SD-Nfe2l2em1Mcwi+/+ XCO:0000191 angiotensin II 100 100 ng/kg/min 13208517 RS:0004500 SD-Nfe2l2em1Mcwi+/+ XCO:0000316 calcium-free buffer solution 13208517 RS:0004500 SD-Nfe2l2em1Mcwi+/+ XCO:0000215 controlled calcium ion content physiological salt solution perfusate 0 0 % 13208517 RS:0004500 SD-Nfe2l2em1Mcwi+/+ XCO:0000022 controlled sodium content diet 0.4 0.4 % 13208517 RS:0004500 SD-Nfe2l2em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 13208517 RS:0004500 SD-Nfe2l2em1Mcwi+/+ XCO:0000147 physiological salt solution perfusate 13208517 RS:0004500 SD-Nfe2l2em1Mcwi+/+ XCO:0000101 vehicle control condition 13208518 RS:0004501 SD-Nfe2l2em1Mcwi-/- XCO:0000191 angiotensin II 100 100 ng/kg/min 13208518 RS:0004501 SD-Nfe2l2em1Mcwi-/- XCO:0000316 calcium-free buffer solution 13208518 RS:0004501 SD-Nfe2l2em1Mcwi-/- XCO:0000215 controlled calcium ion content physiological salt solution perfusate 0 0 % 13208518 RS:0004501 SD-Nfe2l2em1Mcwi-/- XCO:0000022 controlled sodium content diet 0.4 0.4 % 13208518 RS:0004501 SD-Nfe2l2em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 13208518 RS:0004501 SD-Nfe2l2em1Mcwi-/- XCO:0000147 physiological salt solution perfusate 13208518 RS:0004501 SD-Nfe2l2em1Mcwi-/- XCO:0000101 vehicle control condition 2304041 RS:0002122 SD-Tg(CAG-Rgn)Slc XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2304041 RS:0002122 SD-Tg(CAG-Rgn)Slc XCO:0000102 fasting 2304041 RS:0002122 SD-Tg(CAG-Rgn)Slc XCO:0000087 specific pathogen-free condition 629501 RS:0000687 SD-Tg(Ren2)27 XCO:0000099 control condition 13513909 RS:0004585 SD-Tg(Ren2)27-/- XCO:0000099 control condition 13792705 RS:0004630 SD-Trpv1em1Sage+/+ XCO:0000638 Capsazepine 3 3 mg/kg 13792705 RS:0004630 SD-Trpv1em1Sage+/+ XCO:0000639 V1-Cal 1 1 mg/kg 13792705 RS:0004630 SD-Trpv1em1Sage+/+ XCO:0000637 cyclosporine A 2.5 2.5 mg/kg 13792705 RS:0004630 SD-Trpv1em1Sage+/+ XCO:0000219 dihydrocapsaicin 0.1 0.1 mg/kg 13792705 RS:0004630 SD-Trpv1em1Sage+/+ XCO:0000219 dihydrocapsaicin 0.3 0.3 mg/kg 13792705 RS:0004630 SD-Trpv1em1Sage+/+ XCO:0000219 dihydrocapsaicin 1 1 mg/kg 13792705 RS:0004630 SD-Trpv1em1Sage+/+ XCO:0000219 dihydrocapsaicin 3 3 mg/kg 13792705 RS:0004630 SD-Trpv1em1Sage+/+ XCO:0000549 left anterior descending coronary artery occlusion 13792705 RS:0004630 SD-Trpv1em1Sage+/+ XCO:0000641 myocardial reperfusion 13792705 RS:0004630 SD-Trpv1em1Sage+/+ XCO:0000624 thiobutabarbital 100 100 mg/kg 13792701 RS:0004629 SD-Trpv1em1Sage-/- XCO:0000639 V1-Cal 1 1 mg/kg 13792701 RS:0004629 SD-Trpv1em1Sage-/- XCO:0000549 left anterior descending coronary artery occlusion 13792701 RS:0004629 SD-Trpv1em1Sage-/- XCO:0000641 myocardial reperfusion 13792701 RS:0004629 SD-Trpv1em1Sage-/- XCO:0000624 thiobutabarbital 100 100 mg/kg 68133 RS:0000704 SDJ/Hok XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 68133 RS:0000704 SDJ/Hok XCO:0000102 fasting 68133 RS:0000704 SDJ/Hok XCO:0000087 specific pathogen-free condition 629497 RS:0000709 SDT/Jcl XCO:0000031 controlled calcium content diet 1 1 % 631219 RS:0000709 SDT/Jcl XCO:0000031 controlled calcium content diet 1 1 % 629497 RS:0000709 SDT/Jcl XCO:0000014 controlled content diet 1 1 % 629497 RS:0000709 SDT/Jcl XCO:0000014 controlled content diet 1.2 1.2 % 631219 RS:0000709 SDT/Jcl XCO:0000014 controlled content diet 1 1 % 631219 RS:0000709 SDT/Jcl XCO:0000014 controlled content diet 1.2 1.2 % 629497 RS:0000709 SDT/Jcl XCO:0000102 fasting 631219 RS:0000709 SDT/Jcl XCO:0000102 fasting 629497 RS:0000709 SDT/Jcl XCO:0000103 glucose solution 2 2 g/kg 631219 RS:0000709 SDT/Jcl XCO:0000103 glucose solution 2 2 g/kg 629497 RS:0000709 SDT/Jcl XCO:0000017 nephrectomy 631219 RS:0000709 SDT/Jcl XCO:0000017 nephrectomy 629497 RS:0000709 SDT/Jcl XCO:0000547 paricalcitol 0.1 0.1 ug/kg 629497 RS:0000709 SDT/Jcl XCO:0000547 paricalcitol 0.3 0.3 ug/kg 631219 RS:0000709 SDT/Jcl XCO:0000547 paricalcitol 0.1 0.1 ug/kg 631219 RS:0000709 SDT/Jcl XCO:0000547 paricalcitol 0.3 0.3 ug/kg 629497 RS:0000709 SDT/Jcl XCO:0000087 specific pathogen-free condition 631219 RS:0000709 SDT/Jcl XCO:0000087 specific pathogen-free condition 1302695 RS:0000711 SER/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302695 RS:0000711 SER/Kyo XCO:0000102 fasting 1302695 RS:0000711 SER/Kyo XCO:0000087 specific pathogen-free condition 61000 RS:0000015 SHR XCO:0000099 control condition 61000 RS:0000015 SHR XCO:0000022 controlled sodium content diet 0.4 0.4 % 61000 RS:0000015 SHR XCO:0000022 controlled sodium content diet 1 1 % 61000 RS:0000015 SHR XCO:0000022 controlled sodium content diet 1.4 1.4 % 61000 RS:0000015 SHR XCO:0000164 controlled sodium content drinking water 1 1 % 61000 RS:0000015 SHR XCO:0000750 diclofenac 10 10 mg/kg 61000 RS:0000015 SHR XCO:0000750 diclofenac 20 20 mg/kg 61000 RS:0000015 SHR XCO:0000750 diclofenac 40 40 mg/kg 61000 RS:0000015 SHR XCO:0000449 diestrus 61000 RS:0000015 SHR XCO:0000447 estrus 61000 RS:0000015 SHR XCO:0000448 metestrus 61000 RS:0000015 SHR XCO:0000450 proestrus 2317891 RS:0002404 SHR-Chr 6MWF/Rkb XCO:0000099 control condition 2317891 RS:0002404 SHR-Chr 6MWF/Rkb XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 5 5 mg/kg/d 2317891 RS:0002404 SHR-Chr 6MWF/Rkb XCO:0000100 sham surgical control condition 6480210 RS:0003207 SHR-Chr 8MWF/Rkb XCO:0000100 sham surgical control condition 6480210 RS:0003207 SHR-Chr 8MWF/Rkb XCO:0000112 unilateral nephrectomy 1641875 RS:0001416 SHR-Chr YBN/Cub XCO:0000159 physical restraint in tube type rodent restrainer 7241265 RS:0003412 SHR-Chr YWKY/Akr XCO:0000159 physical restraint in tube type rodent restrainer 11040525 RS:0004100 SHR-Ndufc2em1Mcwi+/+ XCO:0000032 controlled potassium content diet 6.3 6.3 mg/g 11040525 RS:0004100 SHR-Ndufc2em1Mcwi+/+ XCO:0000030 controlled protein content diet 19.7 19.7 % 11040525 RS:0004100 SHR-Ndufc2em1Mcwi+/+ XCO:0000022 controlled sodium content diet 3.7 3.7 mg/g 11040519 RS:0004098 SHR-Ndufc2em1Mcwi-/+ XCO:0000032 controlled potassium content diet 6.3 6.3 mg/g 11040519 RS:0004098 SHR-Ndufc2em1Mcwi-/+ XCO:0000030 controlled protein content diet 19.7 19.7 % 11040519 RS:0004098 SHR-Ndufc2em1Mcwi-/+ XCO:0000022 controlled sodium content diet 3.7 3.7 mg/g 11040527 RS:0004101 SHR-Ndufc2em2Mcwi+/+ XCO:0000032 controlled potassium content diet 6.3 6.3 mg/g 11040527 RS:0004101 SHR-Ndufc2em2Mcwi+/+ XCO:0000030 controlled protein content diet 19.7 19.7 % 11040527 RS:0004101 SHR-Ndufc2em2Mcwi+/+ XCO:0000022 controlled sodium content diet 3.7 3.7 mg/g 11040521 RS:0004099 SHR-Ndufc2em2Mcwi-/+ XCO:0000032 controlled potassium content diet 6.3 6.3 mg/g 11040521 RS:0004099 SHR-Ndufc2em2Mcwi-/+ XCO:0000030 controlled protein content diet 19.7 19.7 % 11040521 RS:0004099 SHR-Ndufc2em2Mcwi-/+ XCO:0000022 controlled sodium content diet 3.7 3.7 mg/g 2300215 RS:0001638 SHR.BN-(D10Mgh3-D10Rat85)/Ipcv XCO:0000246 controlled cholesterol content diet 2 2 % 2300217 RS:0001637 SHR.BN-(D10Mgh3-Srebf1)/Ipcv XCO:0000246 controlled cholesterol content diet 2 2 % 2306893 RS:0002147 SHR.BN-(D16Rat87-D16Mgh1)/Jk XCO:0000099 control condition 2306893 RS:0002147 SHR.BN-(D16Rat87-D16Mgh1)/Jk XCO:0000022 controlled sodium content diet 1 1 % 2306893 RS:0002147 SHR.BN-(D16Rat87-D16Mgh1)/Jk XCO:0000164 controlled sodium content drinking water 1 1 % 628908 RS:0000721 SHR.BN-(D1Mit3-Igf2)/Ipcv XCO:0000099 control condition 2306892 RS:0002154 SHR.BN-(D2Rat114-D2Rat123)/Jk XCO:0000099 control condition 2306892 RS:0002154 SHR.BN-(D2Rat114-D2Rat123)/Jk XCO:0000022 controlled sodium content diet 1 1 % 2306892 RS:0002154 SHR.BN-(D2Rat114-D2Rat123)/Jk XCO:0000164 controlled sodium content drinking water 1 1 % 631578 RS:0000717 SHR.BN-(D2Rat171-D2Arb24)/Ipcv XCO:0000099 control condition 631578 RS:0000717 SHR.BN-(D2Rat171-D2Arb24)/Ipcv XCO:0000298 controlled saccharin content drinking water 0.1 0.1 % 631578 RS:0000717 SHR.BN-(D2Rat171-D2Arb24)/Ipcv XCO:0000297 fluid deprivation 631578 RS:0000717 SHR.BN-(D2Rat171-D2Arb24)/Ipcv XCO:0000302 lithium chloride solution 0.15 0.15 mol/l 2306895 RS:0002155 SHR.BN-(D2Rat226-D2Rat294)/Jk XCO:0000099 control condition 2306895 RS:0002155 SHR.BN-(D2Rat226-D2Rat294)/Jk XCO:0000022 controlled sodium content diet 1 1 % 2306895 RS:0002155 SHR.BN-(D2Rat226-D2Rat294)/Jk XCO:0000164 controlled sodium content drinking water 1 1 % 2316928 RS:0002378 SHR.BN-(D3Rat159-D3Rat1)(D6Rat40-D6Rat170)/Mco XCO:0000268 balloon angioplasty 2316928 RS:0002378 SHR.BN-(D3Rat159-D3Rat1)(D6Rat40-D6Rat170)/Mco XCO:0000099 control condition 2316925 RS:0002376 SHR.BN-(D3Rat159-D3Rat1)/Mco XCO:0000268 balloon angioplasty 2316925 RS:0002376 SHR.BN-(D3Rat159-D3Rat1)/Mco XCO:0000099 control condition 2306894 RS:0002156 SHR.BN-(D4Rat33-D4Rat54)/Jk XCO:0000099 control condition 2306894 RS:0002156 SHR.BN-(D4Rat33-D4Rat54)/Jk XCO:0000022 controlled sodium content diet 1 1 % 2306894 RS:0002156 SHR.BN-(D4Rat33-D4Rat54)/Jk XCO:0000164 controlled sodium content drinking water 1 1 % 634382 RS:0000723 SHR.BN-(D5Wox12-D5Wox20)/Ipcv XCO:0000099 control condition 2316927 RS:0002377 SHR.BN-(D6Rat40-D6Rat170)/Mco XCO:0000268 balloon angioplasty 2316927 RS:0002377 SHR.BN-(D6Rat40-D6Rat170)/Mco XCO:0000099 control condition 61106 RS:0000725 SHR.BN-(D8Mit5-D8Mgh6)/Ipcv XCO:0000246 controlled cholesterol content diet 2 2 % 61106 RS:0000725 SHR.BN-(D8Mit5-D8Mgh6)/Ipcv XCO:0000025 controlled fat content diet 10.4 10.4 % of calories 61106 RS:0000725 SHR.BN-(D8Mit5-D8Mgh6)/Ipcv XCO:0000247 controlled olive oil content diet 5 5 % 61106 RS:0000725 SHR.BN-(D8Mit5-D8Mgh6)/Ipcv XCO:0000030 controlled protein content diet 19.6 19.6 % of calories 61106 RS:0000725 SHR.BN-(D8Mit5-D8Mgh6)/Ipcv XCO:0000211 controlled sucrose content diet 70 70 % of calories 61106 RS:0000725 SHR.BN-(D8Mit5-D8Mgh6)/Ipcv XCO:0000102 fasting 628907 RS:0000728 SHR.BN-RT1n XCO:0000246 controlled cholesterol content diet 2 2 % 628907 RS:0000728 SHR.BN-RT1n XCO:0000247 controlled olive oil content diet 5 5 % 628907 RS:0000728 SHR.BN-RT1n XCO:0000102 fasting 1600338 RS:0001419 SHR.F344-(D12Mgh5-D12Mgh6)/Snk XCO:0000099 control condition 1559048 RS:0001420 SHR.ODS-Gulood/Shi XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1559048 RS:0001420 SHR.ODS-Gulood/Shi XCO:0000102 fasting 1559048 RS:0001420 SHR.ODS-Gulood/Shi XCO:0000087 specific pathogen-free condition 1641863 RS:0001422 SHR.PD-(D8Mgh9-D8Rat149)/Cub XCO:0000102 fasting 2314531 RS:0002162 SHR.SS-(D13Rat1-D13Mgh6)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 2314532 RS:0002163 SHR.SS-(D8Uia1-D8Rat90)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 1641850 RS:0001424 SHR.WKY-(D1Got158-D1Got161)/Njs XCO:0000099 control condition 1643002 RS:0001425 SHR.WKY-(D1Rat420-D1Got161)/Njs XCO:0000099 control condition 1641858 RS:0001426 SHR.WKY-(D1Rat420-D1Rat278)/Njs XCO:0000099 control condition 629487 RS:0000737 SHR.WKY-(D1Wox19-D1Wox34)/Njs XCO:0000099 control condition 631589 RS:0000740 SHR.WKY-(D1Wox34-D1Rat164)/Njs XCO:0000099 control condition 631590 RS:0000741 SHR.WKY-(D1Wox34-Sah)/Njs XCO:0000099 control condition 7241794 RS:0003421 SHR/Bbb XCO:0000099 control condition 7241794 RS:0003421 SHR/Bbb XCO:0000032 controlled potassium content diet 6.3 6.3 mg/g 7241794 RS:0003421 SHR/Bbb XCO:0000030 controlled protein content diet 19.7 19.7 % 7241794 RS:0003421 SHR/Bbb XCO:0000022 controlled sodium content diet 3.7 3.7 mg/g 7241794 RS:0003421 SHR/Bbb XCO:0000164 controlled sodium content drinking water 1 1 % 731186 RS:0000743 SHR/Fub XCO:0000099 control condition 731186 RS:0000743 SHR/Fub XCO:0000022 controlled sodium content diet 0.2 0.2 % 631696 RS:0000744 SHR/FubRkb XCO:0000099 control condition 631696 RS:0000744 SHR/FubRkb XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water 5 5 mg/kg/d 631696 RS:0000744 SHR/FubRkb XCO:0000100 sham surgical control condition 631696 RS:0000744 SHR/FubRkb XCO:0000112 unilateral nephrectomy 1302724 RS:0000745 SHR/Hcm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302724 RS:0000745 SHR/Hcm XCO:0000102 fasting 1302724 RS:0000745 SHR/Hcm XCO:0000087 specific pathogen-free condition 631577 RS:0000746 SHR/Izm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 631577 RS:0000746 SHR/Izm XCO:0000099 control condition 631577 RS:0000746 SHR/Izm XCO:0000025 controlled fat content diet 5 5 % 631577 RS:0000746 SHR/Izm XCO:0000025 controlled fat content diet 26 26 % 631577 RS:0000746 SHR/Izm XCO:0000032 controlled potassium content diet 0.44 0.44 % 631577 RS:0000746 SHR/Izm XCO:0000032 controlled potassium content diet 0.75 0.75 % 631577 RS:0000746 SHR/Izm XCO:0000032 controlled potassium content diet % 631577 RS:0000746 SHR/Izm XCO:0000102 fasting 631577 RS:0000746 SHR/Izm XCO:0000245 insulin 50000 50000 pmol/l 631577 RS:0000746 SHR/Izm XCO:0000256 isoproterenol 200 200 nmol/l 631577 RS:0000746 SHR/Izm XCO:0000087 specific pathogen-free condition 1302620 RS:0000747 SHR/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302620 RS:0000747 SHR/Kyo XCO:0000102 fasting 1302620 RS:0000747 SHR/Kyo XCO:0000087 specific pathogen-free condition 61110 RS:0000749 SHR/Mol XCO:0000099 control condition 728194 RS:0000729 SHR/N XCO:0000099 control condition 728195 RS:0000750 SHR/N-cp XCO:0000029 controlled carbohydrate content diet 54 54 % 728195 RS:0000750 SHR/N-cp XCO:0000552 controlled hydralazine content drinking water 30 30 mg/l 728195 RS:0000750 SHR/N-cp XCO:0000551 hydralazine 50 50 mg/l 728195 RS:0000750 SHR/N-cp XCO:0000588 perindopril 0.25 0.5 mg/kg/d 728195 RS:0000750 SHR/N-cp XCO:0000550 reserpine 4 4 mg/l 728195 RS:0000750 SHR/N-cp XCO:0000069 standard diet 1357994 RS:0000730 SHR/NCrl XCO:0000137 FAPGG 0.6 0.6 mmol/l 1357994 RS:0000730 SHR/NCrl XCO:0000116 Kreb's solution perfusate 1357994 RS:0000730 SHR/NCrl XCO:0000143 acetylcholine 0 30 umol/l 1357994 RS:0000730 SHR/NCrl XCO:0000012 air carbon dioxide content 7 7 % 1357994 RS:0000730 SHR/NCrl XCO:0000012 air carbon dioxide content 7 % 1357994 RS:0000730 SHR/NCrl XCO:0000126 angiotensin 5 5 ng/kg/min 1357994 RS:0000730 SHR/NCrl XCO:0000126 angiotensin 10 10 ng/kg/min 1357994 RS:0000730 SHR/NCrl XCO:0000126 angiotensin 25 25 ng/kg/min 1357994 RS:0000730 SHR/NCrl XCO:0000126 angiotensin 50 50 ng/kg/min 1357994 RS:0000730 SHR/NCrl XCO:0000099 control condition 1357994 RS:0000730 SHR/NCrl XCO:0000010 controlled air oxygen content 12 12 % 1357994 RS:0000730 SHR/NCrl XCO:0000010 controlled air oxygen content 12 % 1357994 RS:0000730 SHR/NCrl XCO:0000146 controlled oxygen content Kreb's solution perfusate 1357994 RS:0000730 SHR/NCrl XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 1357994 RS:0000730 SHR/NCrl XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 1357994 RS:0000730 SHR/NCrl XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 1357994 RS:0000730 SHR/NCrl XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 1357994 RS:0000730 SHR/NCrl XCO:0000022 controlled sodium content diet 0 % 1357994 RS:0000730 SHR/NCrl XCO:0000022 controlled sodium content diet 0.4 0.4 % 1357994 RS:0000730 SHR/NCrl XCO:0000022 controlled sodium content diet 4 4 % 1357994 RS:0000730 SHR/NCrl XCO:0000152 drug dose time series 1357994 RS:0000730 SHR/NCrl XCO:0000124 furosemide 10 10 mg/kg 1357994 RS:0000730 SHR/NCrl XCO:0000134 methacholine 0 11.06 mg/kg 1357994 RS:0000730 SHR/NCrl XCO:0000138 methylene blue 10 10 umol/l 1357994 RS:0000730 SHR/NCrl XCO:0000127 norepinephrine 0.1 0.1 ng/kg/min 1357994 RS:0000730 SHR/NCrl XCO:0000127 norepinephrine 0.2 0.2 ng/kg/min 1357994 RS:0000730 SHR/NCrl XCO:0000127 norepinephrine 0.5 0.5 ng/kg/min 1357994 RS:0000730 SHR/NCrl XCO:0000127 norepinephrine 1 1 ng/kg/min 1357994 RS:0000730 SHR/NCrl XCO:0000118 perfusate suspended 1357994 RS:0000730 SHR/NCrl XCO:0000145 phenylephrine 0 300 umol/l 1357994 RS:0000730 SHR/NCrl XCO:0000145 phenylephrine 1 1 umol/l 1357994 RS:0000730 SHR/NCrl XCO:0000145 phenylephrine 10 10 umol/l 1357994 RS:0000730 SHR/NCrl XCO:0000150 potassium ion 80 80 mmol/l 1357994 RS:0000730 SHR/NCrl XCO:0000003 resting on treadmill 1357994 RS:0000730 SHR/NCrl XCO:0000005 running on treadmill 1.6 1.6 m/min 1357994 RS:0000730 SHR/NCrl XCO:0000153 sample resting period 1357994 RS:0000730 SHR/NCrl XCO:0000142 sodium nitroprusside 0 3 umol/l 1357994 RS:0000730 SHR/NCrl XCO:0000004 walking on treadmill 0.8 0.8 m/min 629465 RS:0000752 SHR/NCrlCrlj XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 629465 RS:0000752 SHR/NCrlCrlj XCO:0000902 controlled candesartan content drinking water 1 1 mg/kg/d 629465 RS:0000752 SHR/NCrlCrlj XCO:0000901 controlled delapril content drinking water 30 30 mg/kg/d 629465 RS:0000752 SHR/NCrlCrlj XCO:0000552 controlled hydralazine content drinking water 15 15 mg/kg/d 629465 RS:0000752 SHR/NCrlCrlj XCO:0000102 fasting 629465 RS:0000752 SHR/NCrlCrlj XCO:0000087 specific pathogen-free condition 629465 RS:0000752 SHR/NCrlCrlj XCO:0000112 unilateral nephrectomy 629465 RS:0000752 SHR/NCrlCrlj XCO:0000101 vehicle control condition 61096 RS:0000753 SHR/NCruk XCO:0000099 control condition 61096 RS:0000753 SHR/NCruk XCO:0000245 insulin 50000 50000 pmol/l 61096 RS:0000753 SHR/NCruk XCO:0000256 isoproterenol 200 200 nmol/l 724574 RS:0000754 SHR/NHsd XCO:0000360 arterial catheter implantation 724574 RS:0000754 SHR/NHsd XCO:0000268 balloon angioplasty 724574 RS:0000754 SHR/NHsd XCO:0000099 control condition 724574 RS:0000754 SHR/NHsd XCO:0000812 controlled hemorrhage 724574 RS:0000754 SHR/NHsd XCO:0000022 controlled sodium content diet 0.3 0.3 % 724574 RS:0000754 SHR/NHsd XCO:0000022 controlled sodium content diet 4 4 % 724574 RS:0000754 SHR/NHsd XCO:0000022 controlled sodium content diet 724574 RS:0000754 SHR/NHsd XCO:0000100 sham surgical control condition 2325143 RS:0002406 SHR/NHsdMco XCO:0000099 control condition 2325143 RS:0002406 SHR/NHsdMco XCO:0000022 controlled sodium content diet 0.3 0.3 % 2325143 RS:0002406 SHR/NHsdMco XCO:0000022 controlled sodium content diet 2 2 % 634364 RS:0000755 SHR/NIcoCrlf XCO:0000099 control condition 634364 RS:0000755 SHR/NIcoCrlf XCO:0000159 physical restraint in tube type rodent restrainer 1559042 RS:0001428 SHR/Nig XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1559042 RS:0001428 SHR/Nig XCO:0000102 fasting 1559042 RS:0001428 SHR/Nig XCO:0000087 specific pathogen-free condition 61100 RS:0000402 SHR/Ola XCO:0000099 control condition 61100 RS:0000402 SHR/Ola XCO:0000245 insulin 50000 50000 pmol/l 61100 RS:0000402 SHR/Ola XCO:0000256 isoproterenol 200 200 nmol/l 61100 RS:0000402 SHR/Ola XCO:0000159 physical restraint in tube type rodent restrainer 631848 RS:0000715 SHR/OlaIpcv XCO:0000099 control condition 631848 RS:0000715 SHR/OlaIpcv XCO:0000246 controlled cholesterol content diet 2 2 % 631848 RS:0000715 SHR/OlaIpcv XCO:0000247 controlled olive oil content diet 5 5 % 631848 RS:0000715 SHR/OlaIpcv XCO:0000298 controlled saccharin content drinking water 0.1 0.1 % 631848 RS:0000715 SHR/OlaIpcv XCO:0000102 fasting 631848 RS:0000715 SHR/OlaIpcv XCO:0000297 fluid deprivation 631848 RS:0000715 SHR/OlaIpcv XCO:0000302 lithium chloride solution 0.15 0.15 mol/l 631604 RS:0000757 SHR/Snk XCO:0000099 control condition 1302680 RS:0000758 SHR/Ta XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302680 RS:0000758 SHR/Ta XCO:0000102 fasting 1302680 RS:0000758 SHR/Ta XCO:0000087 specific pathogen-free condition 61010 RS:0000759 SHRSP XCO:0000099 control condition 61010 RS:0000759 SHRSP XCO:0000382 controlled captopril content drinking water 100 400 mg/l 61010 RS:0000759 SHRSP XCO:0000022 controlled sodium content diet 0.4 0.4 % 61010 RS:0000759 SHRSP XCO:0000022 controlled sodium content diet 1.4 1.4 % 2307169 RS:0002537 SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb XCO:0000099 control condition 2307169 RS:0002537 SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb XCO:0000032 controlled potassium content diet 6.3 6.3 mg/g 2307169 RS:0002537 SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb XCO:0000022 controlled sodium content diet 3.7 3.7 mg/g 2307169 RS:0002537 SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb XCO:0000164 controlled sodium content drinking water 1 1 % 2307167 RS:0002536 SHRSP.SHRSR-(Klk1-D1Mit3)/Bbb XCO:0000099 control condition 2307167 RS:0002536 SHRSP.SHRSR-(Klk1-D1Mit3)/Bbb XCO:0000032 controlled potassium content diet 6.3 6.3 mg/g 2307167 RS:0002536 SHRSP.SHRSR-(Klk1-D1Mit3)/Bbb XCO:0000022 controlled sodium content diet 3.7 3.7 mg/g 2307167 RS:0002536 SHRSP.SHRSR-(Klk1-D1Mit3)/Bbb XCO:0000164 controlled sodium content drinking water 1 1 % 2307166 RS:0002535 SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb XCO:0000099 control condition 2307166 RS:0002535 SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb XCO:0000032 controlled potassium content diet 6.3 6.3 mg/g 2307166 RS:0002535 SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb XCO:0000022 controlled sodium content diet 3.7 3.7 mg/g 2307166 RS:0002535 SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb XCO:0000164 controlled sodium content drinking water 1 1 % 2302110 RS:0001683 SHRSP.WKY-(Apbb1-D1Arb21)/Izm XCO:0000307 cold ambient air exposure 4 4 degrees C 2302110 RS:0001683 SHRSP.WKY-(Apbb1-D1Arb21)/Izm XCO:0000099 control condition 2304098 RS:0002487 SHRSP.WKY-(D1Smu13-D1Arb21)/Izm XCO:0000307 cold ambient air exposure 4 4 degrees C 2304098 RS:0002487 SHRSP.WKY-(D1Smu13-D1Arb21)/Izm XCO:0000099 control condition 4889411 RS:0002492 SHRSP.WKY-(D1Smu13-D1Wox33)/Izm XCO:0000307 cold ambient air exposure 4 4 degrees C 4889411 RS:0002492 SHRSP.WKY-(D1Smu13-D1Wox33)/Izm XCO:0000099 control condition 4889411 RS:0002492 SHRSP.WKY-(D1Smu13-D1Wox33)/Izm XCO:0000183 controlled exposure to darkness 4889411 RS:0002492 SHRSP.WKY-(D1Smu13-D1Wox33)/Izm XCO:0000284 controlled visible light exposure 4889411 RS:0002492 SHRSP.WKY-(D1Smu13-D1Wox33)/Izm XCO:0000158 physical restraint in mechanical restrainer 1600343 RS:0001433 SHRSP.WKY-(D1Wox29-D1Arb21)/Izm XCO:0000191 angiotensin II 6 6 umol/l 1600343 RS:0001433 SHRSP.WKY-(D1Wox29-D1Arb21)/Izm XCO:0000307 cold ambient air exposure 4 4 degrees C 1600343 RS:0001433 SHRSP.WKY-(D1Wox29-D1Arb21)/Izm XCO:0000099 control condition 2301371 RS:0001653 SHRSP.WKY-(D2Mit21-D2Rat157)/Gcrc XCO:0000099 control condition 2301371 RS:0001653 SHRSP.WKY-(D2Mit21-D2Rat157)/Gcrc XCO:0000164 controlled sodium content drinking water 1 1 % 631279 RS:0000764 SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc XCO:0000099 control condition 631279 RS:0000764 SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc XCO:0000182 controlled exposure to ambient light 631279 RS:0000764 SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc XCO:0000183 controlled exposure to darkness 631279 RS:0000764 SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc XCO:0000164 controlled sodium content drinking water 1 1 % 631278 RS:0000763 SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc XCO:0000099 control condition 631278 RS:0000763 SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc XCO:0000182 controlled exposure to ambient light 631278 RS:0000763 SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc XCO:0000183 controlled exposure to darkness 631278 RS:0000763 SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc XCO:0000164 controlled sodium content drinking water 1 1 % 737863 RS:0000768 SHRSP.WKY-(D2Wox9-D2Mgh12)/Gcrc XCO:0000099 control condition 737863 RS:0000768 SHRSP.WKY-(D2Wox9-D2Mgh12)/Gcrc XCO:0000164 controlled sodium content drinking water 1 1 % 13432204 RS:0004558 SHRSP.WKY-(D3Mgh16-D3Mit10)/Gcrc XCO:0000155 sodium chloride solution 1 1 % 13432204 RS:0004558 SHRSP.WKY-(D3Mgh16-D3Mit10)/Gcrc XCO:0000101 vehicle control condition 7411676 RS:0003568 SHRSP.WKY-(D3Mgh16-D3Rat114)/Gcrc XCO:0000155 sodium chloride solution 1 1 % 7411676 RS:0003568 SHRSP.WKY-(D3Mgh16-D3Rat114)/Gcrc XCO:0000101 vehicle control condition 13432200 RS:0004554 SHRSP.WKY-(D3Mgh16-D3Rat80)/Gcrc XCO:0000155 sodium chloride solution 1 1 % 13432200 RS:0004554 SHRSP.WKY-(D3Mgh16-D3Rat80)/Gcrc XCO:0000101 vehicle control condition 13432201 RS:0004555 SHRSP.WKY-(D3Mgh16-D3Wox3)/Gcrc XCO:0000155 sodium chloride solution 1 1 % 13432201 RS:0004555 SHRSP.WKY-(D3Mgh16-D3Wox3)/Gcrc XCO:0000101 vehicle control condition 13432203 RS:0004557 SHRSP.WKY-(D3Mgh16-rs197649383)/Gcrc XCO:0000155 sodium chloride solution 1 1 % 13432203 RS:0004557 SHRSP.WKY-(D3Mgh16-rs197649383)/Gcrc XCO:0000101 vehicle control condition 13432202 RS:0004556 SHRSP.WKY-(D3Mgh16-rs65433898)/Gcrc XCO:0000155 sodium chloride solution 1 1 % 13432202 RS:0004556 SHRSP.WKY-(D3Mgh16-rs65433898)/Gcrc XCO:0000101 vehicle control condition 13432199 RS:0004553 SHRSP.WKY-(D3Wox20-D3Rat114)/Gcrc XCO:0000155 sodium chloride solution 1 1 % 13432199 RS:0004553 SHRSP.WKY-(D3Wox20-D3Rat114)/Gcrc XCO:0000101 vehicle control condition 731189 RS:0000772 SHRSP.WKY-(Klk1-D1Rat116)/Izm XCO:0000099 control condition 0 0 731189 RS:0000772 SHRSP.WKY-(Klk1-D1Rat116)/Izm XCO:0000099 control condition 731189 RS:0000772 SHRSP.WKY-(Klk1-D1Rat116)/Izm XCO:0000164 controlled sodium content drinking water 1 1 % 731189 RS:0000772 SHRSP.WKY-(Klk1-D1Rat116)/Izm XCO:0000102 fasting 0 0 2304120 RS:0000779 SHRSP/2Ta XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2304120 RS:0000779 SHRSP/2Ta XCO:0000102 fasting 2304120 RS:0000779 SHRSP/2Ta XCO:0000087 specific pathogen-free condition 61116 RS:0000773 SHRSP/A3 XCO:0000099 control condition 728184 RS:0000775 SHRSP/A3N XCO:0000099 control condition 728184 RS:0000775 SHRSP/A3N XCO:0000708 controlled carvedilol content diet 2400 2400 ppm 728184 RS:0000775 SHRSP/A3N XCO:0000731 controlled enrasentan content diet 1200 1200 ppm 728184 RS:0000775 SHRSP/A3N XCO:0000731 controlled enrasentan content diet 2400 2400 ppm 728184 RS:0000775 SHRSP/A3N XCO:0000025 controlled fat content diet 24.5 24.5 % 728184 RS:0000775 SHRSP/A3N XCO:0000552 controlled hydralazine content drinking water 100 100 mg/l 728184 RS:0000775 SHRSP/A3N XCO:0000552 controlled hydralazine content drinking water 200 200 mg/l 728184 RS:0000775 SHRSP/A3N XCO:0000900 controlled hydrochlorothiazide content drinking water 100 100 mg/l 728184 RS:0000775 SHRSP/A3N XCO:0000900 controlled hydrochlorothiazide content drinking water 200 200 mg/l 728184 RS:0000775 SHRSP/A3N XCO:0000790 controlled sodium chloride content drinking water 1 1 % 728184 RS:0000775 SHRSP/A3N XCO:0000164 controlled sodium content drinking water 1 1 % 728184 RS:0000775 SHRSP/A3N XCO:0000721 eprosartan 60 60 mg/kg/d 728184 RS:0000775 SHRSP/A3N XCO:0000411 reproduction condition 728184 RS:0000775 SHRSP/A3N XCO:0000791 standard condition 728184 RS:0000775 SHRSP/A3N XCO:0000101 vehicle control condition 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000756 Kolliphor HS 15 25 25 % 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000099 control condition 0 0 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000099 control condition 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000700 controlled BAY60-4552 content diet 0.3 0.3 mg/kg/d 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000700 controlled BAY60-4552 content diet 3 3 mg/kg/d 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000699 controlled GSK2181236A content diet 0.1 0.1 mg/kg/d 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000699 controlled GSK2181236A content diet 1 1 mg/kg/d 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000716 controlled SB-239063 content diet 1200 1200 ppm 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000025 controlled fat content diet 24.5 24.5 % 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000032 controlled potassium content diet 0.75 0.75 % 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000030 controlled protein content diet 16 16 % 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000795 controlled sodium chloride content diet 1 1 % 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000790 controlled sodium chloride content drinking water 1 1 % 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000022 controlled sodium content diet 4 4 % 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000164 controlled sodium content drinking water 1 1 % 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000755 dimethyl sulfoxide 30 30 % 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000752 right carotid artery occlusion 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000100 sham surgical control condition 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000069 standard diet 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000751 unilateral carotid artery occlusion 2311051 RS:0002538 SHRSP/A3NCrl XCO:0000101 vehicle control condition 1581618 RS:0001444 SHRSP/Bbb XCO:0000099 control condition 1581618 RS:0001444 SHRSP/Bbb XCO:0000032 controlled potassium content diet 6.3 6.3 mg/g 1581618 RS:0001444 SHRSP/Bbb XCO:0000030 controlled protein content diet 19.7 19.7 % 1581618 RS:0001444 SHRSP/Bbb XCO:0000022 controlled sodium content diet 3.7 3.7 mg/g 1581618 RS:0001444 SHRSP/Bbb XCO:0000164 controlled sodium content drinking water 1 1 % 1559047 RS:0001445 SHRSP/Ezo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1559047 RS:0001445 SHRSP/Ezo XCO:0000102 fasting 1559047 RS:0001445 SHRSP/Ezo XCO:0000087 specific pathogen-free condition 734759 RS:0000760 SHRSP/Gcrc XCO:0000099 control condition 734759 RS:0000760 SHRSP/Gcrc XCO:0000182 controlled exposure to ambient light 734759 RS:0000760 SHRSP/Gcrc XCO:0000183 controlled exposure to darkness 734759 RS:0000760 SHRSP/Gcrc XCO:0000164 controlled sodium content drinking water 1 1 % 734759 RS:0000760 SHRSP/Gcrc XCO:0000155 sodium chloride solution 1 1 % 734759 RS:0000760 SHRSP/Gcrc XCO:0000101 vehicle control condition 2325209 RS:0002368 SHRSP/Hos XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2325209 RS:0002368 SHRSP/Hos XCO:0000102 fasting 2325209 RS:0002368 SHRSP/Hos XCO:0000087 specific pathogen-free condition 631599 RS:0000770 SHRSP/Izm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 631599 RS:0000770 SHRSP/Izm XCO:0000337 air-jet exposure 631599 RS:0000770 SHRSP/Izm XCO:0000307 cold ambient air exposure 4 4 degrees C 631599 RS:0000770 SHRSP/Izm XCO:0000099 control condition 0 0 631599 RS:0000770 SHRSP/Izm XCO:0000099 control condition 631599 RS:0000770 SHRSP/Izm XCO:0000183 controlled exposure to darkness 631599 RS:0000770 SHRSP/Izm XCO:0000164 controlled sodium content drinking water 1 1 % 631599 RS:0000770 SHRSP/Izm XCO:0000284 controlled visible light exposure 631599 RS:0000770 SHRSP/Izm XCO:0000102 fasting 0 0 631599 RS:0000770 SHRSP/Izm XCO:0000102 fasting 631599 RS:0000770 SHRSP/Izm XCO:0000320 hexamethonium 40 40 mg/kg 631599 RS:0000770 SHRSP/Izm XCO:0000158 physical restraint in mechanical restrainer 631599 RS:0000770 SHRSP/Izm XCO:0000058 room temperature 631599 RS:0000770 SHRSP/Izm XCO:0000087 specific pathogen-free condition 1559041 RS:0001446 SHRSP/Ngsk XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1559041 RS:0001446 SHRSP/Ngsk XCO:0000102 fasting 1559041 RS:0001446 SHRSP/Ngsk XCO:0000087 specific pathogen-free condition 1302606 RS:0000778 SHRSP/Ta XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302606 RS:0000778 SHRSP/Ta XCO:0000102 fasting 1302606 RS:0000778 SHRSP/Ta XCO:0000087 specific pathogen-free condition 2307161 RS:0002193 SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb XCO:0000099 control condition 2307161 RS:0002193 SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb XCO:0000032 controlled potassium content diet 6.3 6.3 mg/g 2307161 RS:0002193 SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb XCO:0000022 controlled sodium content diet 3.7 3.7 mg/g 2307161 RS:0002193 SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb XCO:0000164 controlled sodium content drinking water 1 1 % 2307160 RS:0002194 SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb XCO:0000099 control condition 2307160 RS:0002194 SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb XCO:0000032 controlled potassium content diet 6.3 6.3 mg/g 2307160 RS:0002194 SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb XCO:0000022 controlled sodium content diet 3.7 3.7 mg/g 2307160 RS:0002194 SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb XCO:0000164 controlled sodium content drinking water 1 1 % 2307159 RS:0002195 SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb XCO:0000099 control condition 2307159 RS:0002195 SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb XCO:0000032 controlled potassium content diet 6.3 6.3 mg/g 2307159 RS:0002195 SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb XCO:0000022 controlled sodium content diet 3.7 3.7 mg/g 2307159 RS:0002195 SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb XCO:0000164 controlled sodium content drinking water 1 1 % 2307168 RS:0002192 SHRSR/Bbb XCO:0000099 control condition 2307168 RS:0002192 SHRSR/Bbb XCO:0000032 controlled potassium content diet 6.3 6.3 mg/g 2307168 RS:0002192 SHRSR/Bbb XCO:0000022 controlled sodium content diet 3.7 3.7 mg/g 2307168 RS:0002192 SHRSR/Bbb XCO:0000164 controlled sodium content drinking water 1 1 % 1302727 RS:0000780 SHRSR/Ta XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302727 RS:0000780 SHRSR/Ta XCO:0000099 control condition 1302727 RS:0000780 SHRSR/Ta XCO:0000102 fasting 1302727 RS:0000780 SHRSR/Ta XCO:0000087 specific pathogen-free condition 2303116 RS:0002196 SPRD.WKY-(D10Rat91-D10Rat135)/Ibmm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 1599760 RS:0001450 SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 1599760 RS:0001450 SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm XCO:0000099 control condition 2303117 RS:0002197 SPRD.WKY-(D5Rat190-D5Rat114)(D18Rat102-D18Rat44)/Ibmm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 1599763 RS:0001452 SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 1599763 RS:0001452 SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm XCO:0000099 control condition 737962 RS:0001449 SPRD/Ztm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 737962 RS:0001449 SPRD/Ztm XCO:0000099 control condition 70453 RS:0000784 SR XCO:0000022 controlled sodium content diet 0.3 0.3 % 70453 RS:0000784 SR XCO:0000022 controlled sodium content diet 6 6 % 70453 RS:0000784 SR XCO:0000022 controlled sodium content diet 8 8 % 70453 RS:0000784 SR XCO:0000107 pentobarbital 50 50 mg/kg 634366 RS:0000785 SR/Hsd XCO:0000218 4-alpha-phorbol 12,13-didecanoate 2.5 2.5 mg/kg 634366 RS:0000785 SR/Hsd XCO:0000586 Gnai2 antisense oligonucleotide 4.17 4.17 ug/d 634366 RS:0000785 SR/Hsd XCO:0000599 aldosterone 22.5 22.5 ng/hr 634366 RS:0000785 SR/Hsd XCO:0000226 apamin 100 100 ug/kg 634366 RS:0000785 SR/Hsd XCO:0000360 arterial catheter implantation 634366 RS:0000785 SR/Hsd XCO:0000957 artificial cerebrospinal fluid with 0.15 M sodium 4.4 4.6 ul/hr 634366 RS:0000785 SR/Hsd XCO:0000227 charybdotoxin 100 100 ug/kg 634366 RS:0000785 SR/Hsd XCO:0000099 control condition 0.15 0.15 % 634366 RS:0000785 SR/Hsd XCO:0000099 control condition 634366 RS:0000785 SR/Hsd XCO:0000812 controlled hemorrhage 634366 RS:0000785 SR/Hsd XCO:0000795 controlled sodium chloride content diet 8 8 % 634366 RS:0000785 SR/Hsd XCO:0000022 controlled sodium content diet 0.15 0.15 % 634366 RS:0000785 SR/Hsd XCO:0000022 controlled sodium content diet 0.3 0.3 % 634366 RS:0000785 SR/Hsd XCO:0000022 controlled sodium content diet 0.4 0.4 % 634366 RS:0000785 SR/Hsd XCO:0000022 controlled sodium content diet 4 4 % 634366 RS:0000785 SR/Hsd XCO:0000022 controlled sodium content diet 8 8 % 634366 RS:0000785 SR/Hsd XCO:0000219 dihydrocapsaicin 30 30 ug/kg 634366 RS:0000785 SR/Hsd XCO:0000102 fasting 634366 RS:0000785 SR/Hsd XCO:0000587 intracerebroventricular cannula implantation 634366 RS:0000785 SR/Hsd XCO:0000107 pentobarbital 50 50 mg/kg 634366 RS:0000785 SR/Hsd XCO:0000224 ruthenium red 3 3 mg/kg 634366 RS:0000785 SR/Hsd XCO:0000585 scrambled control oligodeoxynucleotide 4.17 4.17 ug/d 634366 RS:0000785 SR/Hsd XCO:0000100 sham surgical control condition 634366 RS:0000785 SR/Hsd XCO:0000069 standard diet 634366 RS:0000785 SR/Hsd XCO:0000373 surgical denervation 10040 RS:0000786 SR/Jr XCO:0000960 10% CO2, 20% O2, 70% N2 10 10 % 10040 RS:0000786 SR/Jr XCO:0000960 10% CO2, 20% O2, 70% N2 10040 RS:0000786 SR/Jr XCO:0000918 ambient air 10040 RS:0000786 SR/Jr XCO:0000631 atropine 1 1 mg/kg 10040 RS:0000786 SR/Jr XCO:0000268 balloon angioplasty 10040 RS:0000786 SR/Jr XCO:0000584 controlled cecal material content oral gavage 2 2 ml 10040 RS:0000786 SR/Jr XCO:0000182 controlled exposure to ambient light 10040 RS:0000786 SR/Jr XCO:0000183 controlled exposure to darkness 10040 RS:0000786 SR/Jr XCO:0000576 controlled meropenem content drinking water 50 50 mg/kg/d 10040 RS:0000786 SR/Jr XCO:0000583 controlled omeprazole content oral gavage 50 50 ml/kg/d 10040 RS:0000786 SR/Jr XCO:0000795 controlled sodium chloride content diet 0.3 0.3 % 10040 RS:0000786 SR/Jr XCO:0000795 controlled sodium chloride content diet 8 8 % 10040 RS:0000786 SR/Jr XCO:0000022 controlled sodium content diet 0.2 0.2 % 10040 RS:0000786 SR/Jr XCO:0000022 controlled sodium content diet 0.3 0.3 % 10040 RS:0000786 SR/Jr XCO:0000022 controlled sodium content diet 8 8 % 10040 RS:0000786 SR/Jr XCO:0000574 controlled vancomycin content drinking water 50 50 mg/kg/d 10040 RS:0000786 SR/Jr XCO:0000107 pentobarbital 20 20 mg/kg 10040 RS:0000786 SR/Jr XCO:0000108 pentobarbital, sodium 20 20 mg/kg 1582184 RS:0001454 SR/JrHsd XCO:0000092 17 beta-estradiol 5 5 mg 1582184 RS:0001454 SR/JrHsd XCO:0000092 17 beta-estradiol 10 10 ug/d 1582184 RS:0001454 SR/JrHsd XCO:0000095 bilateral ovariectomy 1582184 RS:0001454 SR/JrHsd XCO:0000099 control condition 1582184 RS:0001454 SR/JrHsd XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 1582184 RS:0001454 SR/JrHsd XCO:0000795 controlled sodium chloride content diet 4 4 % 1582184 RS:0001454 SR/JrHsd XCO:0000022 controlled sodium content diet 0.1 0.1 % 1582184 RS:0001454 SR/JrHsd XCO:0000022 controlled sodium content diet 0.3 0.3 % 1582184 RS:0001454 SR/JrHsd XCO:0000022 controlled sodium content diet 8 8 % 1582184 RS:0001454 SR/JrHsd XCO:0000917 distilled water 1582184 RS:0001454 SR/JrHsd XCO:0000102 fasting 1582184 RS:0001454 SR/JrHsd XCO:0000916 gelled diet 200 200 g/kg/d 1582184 RS:0001454 SR/JrHsd XCO:0000823 peanut oil 0.2 0.2 ml 1582184 RS:0001454 SR/JrHsd XCO:0000100 sham surgical control condition 737936 RS:0000787 SR/JrIpcv XCO:0000022 controlled sodium content diet 0.3 0.3 % 6903881 RS:0003329 SR/NEisSlc XCO:0000156 0.9% sodium chloride solution 6903881 RS:0003329 SR/NEisSlc XCO:0000795 controlled sodium chloride content diet 0.3 0.3 % 6903881 RS:0003329 SR/NEisSlc XCO:0000795 controlled sodium chloride content diet 8 8 % 6903881 RS:0003329 SR/NEisSlc XCO:0000022 controlled sodium content diet 0.3 0.3 % 6903881 RS:0003329 SR/NEisSlc XCO:0000022 controlled sodium content diet 8 8 % 6903881 RS:0003329 SR/NEisSlc XCO:0000107 pentobarbital 20 20 mg/kg 6903881 RS:0003329 SR/NEisSlc XCO:0000272 tempol 4 4 mol/l 69369 RS:0000789 SS XCO:0000795 controlled sodium chloride content diet 8 8 % 69369 RS:0000789 SS XCO:0000022 controlled sodium content diet 0.2 0.2 % 69369 RS:0000789 SS XCO:0000022 controlled sodium content diet 0.3 0.3 % 69369 RS:0000789 SS XCO:0000022 controlled sodium content diet 2 2 % 69369 RS:0000789 SS XCO:0000022 controlled sodium content diet 6 6 % 69369 RS:0000789 SS XCO:0000022 controlled sodium content diet 8 8 % 69369 RS:0000789 SS XCO:0000107 pentobarbital 50 50 mg/kg 69369 RS:0000789 SS XCO:0000069 standard diet 5687977 RS:0003160 SS-Acad10em2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5687979 RS:0003130 SS-Acad10em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 6484715 RS:0003284 SS-Adora2bem2Mcwi XCO:0000191 angiotensin II 200 200 ng/kg/min 6484715 RS:0003284 SS-Adora2bem2Mcwi XCO:0000099 control condition 6484715 RS:0003284 SS-Adora2bem2Mcwi XCO:0000102 fasting 6484715 RS:0003284 SS-Adora2bem2Mcwi XCO:0000109 isoflurane 1 2 % 5686302 RS:0003017 SS-Adra2aem1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686302 RS:0003017 SS-Adra2aem1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686300 RS:0003016 SS-Adra2aem1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686300 RS:0003016 SS-Adra2aem1Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686654 RS:0003044 SS-Agtr1aem1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686654 RS:0003044 SS-Agtr1aem1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686652 RS:0003043 SS-Agtr1aem1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686652 RS:0003043 SS-Agtr1aem1Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686657 RS:0003045 SS-Agtr1aem5Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686657 RS:0003045 SS-Agtr1aem5Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686306 RS:0003019 SS-Agtrapem4Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686306 RS:0003019 SS-Agtrapem4Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686304 RS:0003018 SS-Agtrapem4Mcwi-/- XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 5686304 RS:0003018 SS-Agtrapem4Mcwi-/- XCO:0000795 controlled sodium chloride content diet 4 4 % 5686304 RS:0003018 SS-Agtrapem4Mcwi-/- XCO:0000022 controlled sodium content diet 0.4 0.4 % 5686304 RS:0003018 SS-Agtrapem4Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686304 RS:0003018 SS-Agtrapem4Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686662 RS:0003047 SS-Agtrapem8Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686662 RS:0003047 SS-Agtrapem8Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686659 RS:0003046 SS-Agtrapem8Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686659 RS:0003046 SS-Agtrapem8Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686666 RS:0003049 SS-Aldh2em2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686666 RS:0003049 SS-Aldh2em2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686664 RS:0003048 SS-Aldh2em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686664 RS:0003048 SS-Aldh2em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5687983 RS:0003161 SS-Alms1em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5687981 RS:0003131 SS-Alms1em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5687985 RS:0003162 SS-Apoeem7Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5687987 RS:0003132 SS-Apoeem7Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5687992 RS:0003163 SS-Apoeem8Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5687989 RS:0003133 SS-Apoeem8Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5687994 RS:0003164 SS-Bcas3em4Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5687996 RS:0003134 SS-Bcas3em4Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686670 RS:0003051 SS-Cdh13em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686670 RS:0003051 SS-Cdh13em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686668 RS:0003050 SS-Cdh13em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686668 RS:0003050 SS-Cdh13em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 1358178 RS:0000790 SS-Chr 10BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358178 RS:0000790 SS-Chr 10BN/Mcwi XCO:0000116 Kreb's solution perfusate 1358178 RS:0000790 SS-Chr 10BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1358178 RS:0000790 SS-Chr 10BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1358178 RS:0000790 SS-Chr 10BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1358178 RS:0000790 SS-Chr 10BN/Mcwi XCO:0000099 control condition 1358178 RS:0000790 SS-Chr 10BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1358178 RS:0000790 SS-Chr 10BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1358178 RS:0000790 SS-Chr 10BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358178 RS:0000790 SS-Chr 10BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1358178 RS:0000790 SS-Chr 10BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358178 RS:0000790 SS-Chr 10BN/Mcwi XCO:0000152 drug dose time series 1358178 RS:0000790 SS-Chr 10BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1358178 RS:0000790 SS-Chr 10BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1358178 RS:0000790 SS-Chr 10BN/Mcwi XCO:0000118 perfusate suspended 1358178 RS:0000790 SS-Chr 10BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1358178 RS:0000790 SS-Chr 10BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1358178 RS:0000790 SS-Chr 10BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1358178 RS:0000790 SS-Chr 10BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1358178 RS:0000790 SS-Chr 10BN/Mcwi XCO:0000153 sample resting period 629521 RS:0000792 SS-Chr 11BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 629521 RS:0000792 SS-Chr 11BN/Mcwi XCO:0000116 Kreb's solution perfusate 629521 RS:0000792 SS-Chr 11BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 629521 RS:0000792 SS-Chr 11BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 629521 RS:0000792 SS-Chr 11BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 629521 RS:0000792 SS-Chr 11BN/Mcwi XCO:0000099 control condition 629521 RS:0000792 SS-Chr 11BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 629521 RS:0000792 SS-Chr 11BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 629521 RS:0000792 SS-Chr 11BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 629521 RS:0000792 SS-Chr 11BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 629521 RS:0000792 SS-Chr 11BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 629521 RS:0000792 SS-Chr 11BN/Mcwi XCO:0000152 drug dose time series 629521 RS:0000792 SS-Chr 11BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 629521 RS:0000792 SS-Chr 11BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 629521 RS:0000792 SS-Chr 11BN/Mcwi XCO:0000118 perfusate suspended 629521 RS:0000792 SS-Chr 11BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 629521 RS:0000792 SS-Chr 11BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 629521 RS:0000792 SS-Chr 11BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 629521 RS:0000792 SS-Chr 11BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 629521 RS:0000792 SS-Chr 11BN/Mcwi XCO:0000153 sample resting period 5683886 RS:0003040 SS-Chr 12BN.SS-(D12Arb13-D12Mit2)/Mcwi XCO:0000022 controlled sodium content diet 1 1 % 5683886 RS:0003040 SS-Chr 12BN.SS-(D12Arb13-D12Mit2)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 5683890 RS:0003042 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 20 20 mmHg 5683890 RS:0003042 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 40 40 mmHg 5683890 RS:0003042 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 60 60 mmHg 5683890 RS:0003042 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 80 80 mmHg 5683890 RS:0003042 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 100 100 mmHg 5683890 RS:0003042 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 120 120 mmHg 5683890 RS:0003042 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 140 140 mmHg 5683890 RS:0003042 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 160 160 mmHg 5683890 RS:0003042 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi XCO:0000022 controlled sodium content diet 0.3 0.3 % 5683890 RS:0003042 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi XCO:0000022 controlled sodium content diet 1 1 % 5683890 RS:0003042 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 5683888 RS:0003041 SS-Chr 12BN.SS-(D12Hmgc3-D12Rat79)/Mcwi XCO:0000022 controlled sodium content diet 1 1 % 5683888 RS:0003041 SS-Chr 12BN.SS-(D12Hmgc3-D12Rat79)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000116 Kreb's solution perfusate 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000099 control condition 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 20 20 mmHg 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 40 40 mmHg 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 60 60 mmHg 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 80 80 mmHg 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 100 100 mmHg 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 120 120 mmHg 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 140 140 mmHg 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 160 160 mmHg 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000022 controlled sodium content diet 0.3 0.3 % 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000022 controlled sodium content diet 1 1 % 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000152 drug dose time series 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000118 perfusate suspended 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1358162 RS:0000793 SS-Chr 12BN/Mcwi XCO:0000153 sample resting period 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000116 Kreb's solution perfusate 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000522 common peroneal nerve direct electrical stimulation 3 3 V 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000099 control condition 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000152 drug dose time series 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000118 perfusate suspended 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000003 resting on treadmill 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000005 running on treadmill 1.6 1.6 m/min 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000153 sample resting period 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000142 sodium nitroprusside 0 3 umol/l 629523 RS:0000794 SS-Chr 13BN/Mcwi XCO:0000004 walking on treadmill 0.8 0.8 m/min 2311082 RS:0002198 SS-Chr 13BN/McwiCrl XCO:0000438 candesartan 0.5 0.5 ug/min 2311082 RS:0002198 SS-Chr 13BN/McwiCrl XCO:0000795 controlled sodium chloride content diet 0.1 0.1 % 2311082 RS:0002198 SS-Chr 13BN/McwiCrl XCO:0000795 controlled sodium chloride content diet 8 8 % 2311082 RS:0002198 SS-Chr 13BN/McwiCrl XCO:0000654 kynurenate 0.14 0.14 ug/min 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000116 Kreb's solution perfusate 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000099 control condition 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000152 drug dose time series 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000118 perfusate suspended 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1358152 RS:0000795 SS-Chr 14BN/Mcwi XCO:0000153 sample resting period 1358163 RS:0000796 SS-Chr 15BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358163 RS:0000796 SS-Chr 15BN/Mcwi XCO:0000116 Kreb's solution perfusate 1358163 RS:0000796 SS-Chr 15BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1358163 RS:0000796 SS-Chr 15BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1358163 RS:0000796 SS-Chr 15BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1358163 RS:0000796 SS-Chr 15BN/Mcwi XCO:0000099 control condition 1358163 RS:0000796 SS-Chr 15BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1358163 RS:0000796 SS-Chr 15BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1358163 RS:0000796 SS-Chr 15BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358163 RS:0000796 SS-Chr 15BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1358163 RS:0000796 SS-Chr 15BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358163 RS:0000796 SS-Chr 15BN/Mcwi XCO:0000152 drug dose time series 1358163 RS:0000796 SS-Chr 15BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1358163 RS:0000796 SS-Chr 15BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1358163 RS:0000796 SS-Chr 15BN/Mcwi XCO:0000118 perfusate suspended 1358163 RS:0000796 SS-Chr 15BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1358163 RS:0000796 SS-Chr 15BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1358163 RS:0000796 SS-Chr 15BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1358163 RS:0000796 SS-Chr 15BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1358163 RS:0000796 SS-Chr 15BN/Mcwi XCO:0000153 sample resting period 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000116 Kreb's solution perfusate 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000126 angiotensin 5 5 ng/kg/min 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000126 angiotensin 10 10 ng/kg/min 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000126 angiotensin 25 25 ng/kg/min 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000126 angiotensin 50 50 ng/kg/min 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000099 control condition 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000022 controlled sodium content diet 0 % 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000152 drug dose time series 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000124 furosemide 10 10 mg/kg 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000127 norepinephrine 0.1 0.1 ng/kg/min 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000127 norepinephrine 0.2 0.2 ng/kg/min 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000127 norepinephrine 0.5 0.5 ng/kg/min 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000127 norepinephrine 1 1 ng/kg/min 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000118 perfusate suspended 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000003 resting on treadmill 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000005 running on treadmill 1.6 1.6 m/min 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000153 sample resting period 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000142 sodium nitroprusside 0 3 umol/l 629524 RS:0000797 SS-Chr 16BN/Mcwi XCO:0000004 walking on treadmill 0.8 0.8 m/min 1358171 RS:0000798 SS-Chr 17BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358171 RS:0000798 SS-Chr 17BN/Mcwi XCO:0000116 Kreb's solution perfusate 1358171 RS:0000798 SS-Chr 17BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1358171 RS:0000798 SS-Chr 17BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1358171 RS:0000798 SS-Chr 17BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1358171 RS:0000798 SS-Chr 17BN/Mcwi XCO:0000099 control condition 1358171 RS:0000798 SS-Chr 17BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1358171 RS:0000798 SS-Chr 17BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1358171 RS:0000798 SS-Chr 17BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358171 RS:0000798 SS-Chr 17BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1358171 RS:0000798 SS-Chr 17BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358171 RS:0000798 SS-Chr 17BN/Mcwi XCO:0000152 drug dose time series 1358171 RS:0000798 SS-Chr 17BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1358171 RS:0000798 SS-Chr 17BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1358171 RS:0000798 SS-Chr 17BN/Mcwi XCO:0000118 perfusate suspended 1358171 RS:0000798 SS-Chr 17BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1358171 RS:0000798 SS-Chr 17BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1358171 RS:0000798 SS-Chr 17BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1358171 RS:0000798 SS-Chr 17BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1358171 RS:0000798 SS-Chr 17BN/Mcwi XCO:0000153 sample resting period 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000116 Kreb's solution perfusate 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000126 angiotensin 5 5 ng/kg/min 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000126 angiotensin 10 10 ng/kg/min 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000126 angiotensin 25 25 ng/kg/min 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000126 angiotensin 50 50 ng/kg/min 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000099 control condition 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000022 controlled sodium content diet 0 % 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000152 drug dose time series 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000124 furosemide 10 10 mg/kg 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000127 norepinephrine 0.1 0.1 ng/kg/min 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000127 norepinephrine 0.2 0.2 ng/kg/min 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000127 norepinephrine 0.5 0.5 ng/kg/min 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000127 norepinephrine 1 1 ng/kg/min 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000118 perfusate suspended 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000003 resting on treadmill 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000005 running on treadmill 1.6 1.6 m/min 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000153 sample resting period 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000142 sodium nitroprusside 0 3 umol/l 629525 RS:0000799 SS-Chr 18BN/Mcwi XCO:0000004 walking on treadmill 0.8 0.8 m/min 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000116 Kreb's solution perfusate 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000099 control condition 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000152 drug dose time series 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000118 perfusate suspended 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1358174 RS:0000800 SS-Chr 19BN/Mcwi XCO:0000153 sample resting period 1641879 RS:0001456 SS-Chr 19SHR/Rkb XCO:0000022 controlled sodium content diet 0.2 0.2 % 1641879 RS:0001456 SS-Chr 19SHR/Rkb XCO:0000022 controlled sodium content diet 4 4 % 1600490 RS:0001457 SS-Chr 1BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1600490 RS:0001457 SS-Chr 1BN/Mcwi XCO:0000116 Kreb's solution perfusate 1600490 RS:0001457 SS-Chr 1BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1600490 RS:0001457 SS-Chr 1BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1600490 RS:0001457 SS-Chr 1BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1600490 RS:0001457 SS-Chr 1BN/Mcwi XCO:0000099 control condition 1600490 RS:0001457 SS-Chr 1BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1600490 RS:0001457 SS-Chr 1BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1600490 RS:0001457 SS-Chr 1BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1600490 RS:0001457 SS-Chr 1BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1600490 RS:0001457 SS-Chr 1BN/Mcwi XCO:0000152 drug dose time series 1600490 RS:0001457 SS-Chr 1BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1600490 RS:0001457 SS-Chr 1BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1600490 RS:0001457 SS-Chr 1BN/Mcwi XCO:0000118 perfusate suspended 1600490 RS:0001457 SS-Chr 1BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1600490 RS:0001457 SS-Chr 1BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1600490 RS:0001457 SS-Chr 1BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1600490 RS:0001457 SS-Chr 1BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1600490 RS:0001457 SS-Chr 1BN/Mcwi XCO:0000153 sample resting period 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000116 Kreb's solution perfusate 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000126 angiotensin 5 5 ng/kg/min 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000126 angiotensin 10 10 ng/kg/min 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000126 angiotensin 25 25 ng/kg/min 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000126 angiotensin 50 50 ng/kg/min 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000099 control condition 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000152 drug dose time series 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000124 furosemide 10 10 mg/kg 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000127 norepinephrine 0.1 0.1 ng/kg/min 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000127 norepinephrine 0.2 0.2 ng/kg/min 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000127 norepinephrine 0.5 0.5 ng/kg/min 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000127 norepinephrine 1 1 ng/kg/min 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000118 perfusate suspended 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000003 resting on treadmill 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000005 running on treadmill 1.6 1.6 m/min 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000153 sample resting period 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000142 sodium nitroprusside 0 3 umol/l 629522 RS:0000801 SS-Chr 20BN/Mcwi XCO:0000004 walking on treadmill 0.8 0.8 m/min 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000116 Kreb's solution perfusate 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000099 control condition 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 60 60 mmHg 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000795 controlled sodium chloride content diet 1 1 % 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000152 drug dose time series 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000118 perfusate suspended 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000003 resting on treadmill 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000005 running on treadmill 1.6 1.6 m/min 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000153 sample resting period 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000142 sodium nitroprusside 0 3 umol/l 629511 RS:0000802 SS-Chr 2BN/Mcwi XCO:0000004 walking on treadmill 0.8 0.8 m/min 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000116 Kreb's solution perfusate 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000099 control condition 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000152 drug dose time series 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000118 perfusate suspended 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1358154 RS:0000803 SS-Chr 3BN/Mcwi XCO:0000153 sample resting period 629513 RS:0000804 SS-Chr 4BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 629513 RS:0000804 SS-Chr 4BN/Mcwi XCO:0000116 Kreb's solution perfusate 629513 RS:0000804 SS-Chr 4BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 629513 RS:0000804 SS-Chr 4BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 629513 RS:0000804 SS-Chr 4BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 629513 RS:0000804 SS-Chr 4BN/Mcwi XCO:0000099 control condition 629513 RS:0000804 SS-Chr 4BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 629513 RS:0000804 SS-Chr 4BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 629513 RS:0000804 SS-Chr 4BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 629513 RS:0000804 SS-Chr 4BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 629513 RS:0000804 SS-Chr 4BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 629513 RS:0000804 SS-Chr 4BN/Mcwi XCO:0000152 drug dose time series 629513 RS:0000804 SS-Chr 4BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 629513 RS:0000804 SS-Chr 4BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 629513 RS:0000804 SS-Chr 4BN/Mcwi XCO:0000118 perfusate suspended 629513 RS:0000804 SS-Chr 4BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 629513 RS:0000804 SS-Chr 4BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 629513 RS:0000804 SS-Chr 4BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 629513 RS:0000804 SS-Chr 4BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 629513 RS:0000804 SS-Chr 4BN/Mcwi XCO:0000153 sample resting period 5688002 RS:0003166 SS-Chr 5BN-Cyp4a2em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688006 RS:0003125 SS-Chr 5BN-Cyp4a2em1Mcwi-/+ XCO:0000022 controlled sodium content diet 4 4 % 5688004 RS:0003136 SS-Chr 5BN-Cyp4a2em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 g/kg 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000116 Kreb's solution perfusate 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000099 control condition 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000152 drug dose time series 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000118 perfusate suspended 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1358114 RS:0000805 SS-Chr 5BN/Mcwi XCO:0000153 sample resting period 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000116 Kreb's solution perfusate 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000099 control condition 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000152 drug dose time series 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000118 perfusate suspended 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000003 resting on treadmill 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000005 running on treadmill 1.6 1.6 m/min 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000153 sample resting period 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000142 sodium nitroprusside 0 3 umol/l 629514 RS:0000806 SS-Chr 6BN/Mcwi XCO:0000004 walking on treadmill 0.8 0.8 m/min 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000116 Kreb's solution perfusate 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000099 control condition 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000152 drug dose time series 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000118 perfusate suspended 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000003 resting on treadmill 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000005 running on treadmill 1.6 1.6 m/min 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000153 sample resting period 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000142 sodium nitroprusside 0 3 umol/l 629515 RS:0000807 SS-Chr 7BN/Mcwi XCO:0000004 walking on treadmill 0.8 0.8 m/min 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000116 Kreb's solution perfusate 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000012 air carbon dioxide content 7 % 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000126 angiotensin 5 5 ng/kg/min 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000126 angiotensin 10 10 ng/kg/min 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000126 angiotensin 25 25 ng/kg/min 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000126 angiotensin 50 50 ng/kg/min 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000099 control condition 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000010 controlled air oxygen content 12 % 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000152 drug dose time series 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000124 furosemide 10 10 mg/kg 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000127 norepinephrine 0.1 0.1 ng/kg/min 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000127 norepinephrine 0.2 0.2 ng/kg/min 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000127 norepinephrine 0.5 0.5 ng/kg/min 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000127 norepinephrine 1 1 ng/kg/min 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000118 perfusate suspended 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000003 resting on treadmill 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000005 running on treadmill 1.6 1.6 m/min 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000153 sample resting period 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000142 sodium nitroprusside 0 3 umol/l 629518 RS:0000809 SS-Chr 9BN/Mcwi XCO:0000004 walking on treadmill 0.8 0.8 m/min 1566437 RS:0001109 SS-Chr XBN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1566437 RS:0001109 SS-Chr XBN/Mcwi XCO:0000116 Kreb's solution perfusate 1566437 RS:0001109 SS-Chr XBN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1566437 RS:0001109 SS-Chr XBN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1566437 RS:0001109 SS-Chr XBN/Mcwi XCO:0000012 air carbon dioxide content 7 % 1566437 RS:0001109 SS-Chr XBN/Mcwi XCO:0000099 control condition 1566437 RS:0001109 SS-Chr XBN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1566437 RS:0001109 SS-Chr XBN/Mcwi XCO:0000010 controlled air oxygen content 12 % 1566437 RS:0001109 SS-Chr XBN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1566437 RS:0001109 SS-Chr XBN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1566437 RS:0001109 SS-Chr XBN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1566437 RS:0001109 SS-Chr XBN/Mcwi XCO:0000152 drug dose time series 1566437 RS:0001109 SS-Chr XBN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1566437 RS:0001109 SS-Chr XBN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1566437 RS:0001109 SS-Chr XBN/Mcwi XCO:0000118 perfusate suspended 1566437 RS:0001109 SS-Chr XBN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1566437 RS:0001109 SS-Chr XBN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1566437 RS:0001109 SS-Chr XBN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1566437 RS:0001109 SS-Chr XBN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1566437 RS:0001109 SS-Chr XBN/Mcwi XCO:0000153 sample resting period 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000116 Kreb's solution perfusate 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000012 air carbon dioxide content 7 % 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000099 control condition 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000010 controlled air oxygen content 12 % 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000152 drug dose time series 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000138 methylene blue 10 10 umol/l 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000118 perfusate suspended 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000003 resting on treadmill 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000005 running on treadmill 1.6 1.6 m/min 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000153 sample resting period 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000142 sodium nitroprusside 0 3 umol/l 629517 RS:0000810 SS-Chr YBN/Mcwi XCO:0000004 walking on treadmill 0.8 0.8 m/min 6484573 RS:0003267 SS-Clcn6em2Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 6484573 RS:0003267 SS-Clcn6em2Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1642277 RS:0001463 SS-Cpt2m1Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1642277 RS:0001463 SS-Cpt2m1Mcwi XCO:0000022 controlled sodium content diet 1 1 % 1642277 RS:0001463 SS-Cpt2m1Mcwi XCO:0000152 drug dose time series 1642277 RS:0001463 SS-Cpt2m1Mcwi XCO:0000102 fasting 1642277 RS:0001463 SS-Cpt2m1Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1642277 RS:0001463 SS-Cpt2m1Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1642277 RS:0001463 SS-Cpt2m1Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1642277 RS:0001463 SS-Cpt2m1Mcwi XCO:0000150 potassium ion 80 80 mmol/l 5688000 RS:0003165 SS-Cybaem1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5687998 RS:0003135 SS-Cybaem1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686676 RS:0003053 SS-Cyp1a1em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686676 RS:0003053 SS-Cyp1a1em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686672 RS:0003052 SS-Cyp1a1em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686672 RS:0003052 SS-Cyp1a1em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686680 RS:0003055 SS-Cyp1a1em2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686680 RS:0003055 SS-Cyp1a1em2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686678 RS:0003054 SS-Cyp1a1em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686678 RS:0003054 SS-Cyp1a1em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686687 RS:0003057 SS-Cyp1a1em5Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686687 RS:0003057 SS-Cyp1a1em5Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686684 RS:0003056 SS-Cyp1a1em5Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686684 RS:0003056 SS-Cyp1a1em5Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5688008 RS:0003167 SS-Ets1em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688010 RS:0003126 SS-Ets1em1Mcwi-/+ XCO:0000022 controlled sodium content diet 4 4 % 1642364 RS:0001467 SS-Ghsrm3Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1642364 RS:0001467 SS-Ghsrm3Mcwi XCO:0000022 controlled sodium content diet 1 1 % 1642364 RS:0001467 SS-Ghsrm3Mcwi XCO:0000152 drug dose time series 1642364 RS:0001467 SS-Ghsrm3Mcwi XCO:0000102 fasting 1642364 RS:0001467 SS-Ghsrm3Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1642364 RS:0001467 SS-Ghsrm3Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1642364 RS:0001467 SS-Ghsrm3Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1642364 RS:0001467 SS-Ghsrm3Mcwi XCO:0000150 potassium ion 80 80 mmol/l 5688014 RS:0003168 SS-Gpr183em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688012 RS:0003137 SS-Gpr183em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5688018 RS:0003169 SS-Gpr183em2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688016 RS:0003138 SS-Gpr183em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5688022 RS:0003170 SS-Gpr183em3Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688020 RS:0003139 SS-Gpr183em3Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686311 RS:0003021 SS-Hexim2em4Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686311 RS:0003021 SS-Hexim2em4Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686308 RS:0003020 SS-Hexim2em4Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686308 RS:0003020 SS-Hexim2em4Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5688024 RS:0003171 SS-Itga9em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 13782280 RS:0004609 SS-Kcnj1em1Kasu+/+ XCO:0000099 control condition 13782351 RS:0004613 SS-Kcnj1em1Kasu+/- XCO:0000099 control condition 13782353 RS:0004614 SS-Kcnj1em1Kasu-/- XCO:0000099 control condition 5686702 RS:0003063 SS-Kcnq1em14Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686702 RS:0003063 SS-Kcnq1em14Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686700 RS:0003062 SS-Kcnq1em14Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686700 RS:0003062 SS-Kcnq1em14Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 1642271 RS:0001475 SS-Klf4m3Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1642271 RS:0001475 SS-Klf4m3Mcwi XCO:0000022 controlled sodium content diet 1 1 % 1642271 RS:0001475 SS-Klf4m3Mcwi XCO:0000152 drug dose time series 1642271 RS:0001475 SS-Klf4m3Mcwi XCO:0000102 fasting 1642271 RS:0001475 SS-Klf4m3Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1642271 RS:0001475 SS-Klf4m3Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1642271 RS:0001475 SS-Klf4m3Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1642271 RS:0001475 SS-Klf4m3Mcwi XCO:0000150 potassium ion 80 80 mmol/l 6484719 RS:0003288 SS-Leprem2Mcwi XCO:0000099 control condition 6484719 RS:0003288 SS-Leprem2Mcwi XCO:0000157 physical restraint 20 30 min/d 5688026 RS:0003172 SS-Mas1em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688028 RS:0003140 SS-Mas1em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5688032 RS:0003173 SS-Mmp2em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688030 RS:0003141 SS-Mmp2em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5688037 RS:0003174 SS-Mmp2em2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688034 RS:0003142 SS-Mmp2em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686706 RS:0003065 SS-Msraem3Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686706 RS:0003065 SS-Msraem3Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686704 RS:0003064 SS-Msraem3Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686704 RS:0003064 SS-Msraem3Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686710 RS:0003067 SS-Msraem4Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686710 RS:0003067 SS-Msraem4Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686708 RS:0003066 SS-Msraem4Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686708 RS:0003066 SS-Msraem4Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686715 RS:0003069 SS-Mstnem1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686715 RS:0003069 SS-Mstnem1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686713 RS:0003068 SS-Mstnem1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686713 RS:0003068 SS-Mstnem1Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686721 RS:0003071 SS-Mstnem3Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686721 RS:0003071 SS-Mstnem3Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686723 RS:0003072 SS-Mstnem3Mcwi-/+ XCO:0000022 controlled sodium content diet 4 4 % 5686723 RS:0003072 SS-Mstnem3Mcwi-/+ XCO:0000022 controlled sodium content diet 4 % 5686718 RS:0003070 SS-Mstnem3Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686718 RS:0003070 SS-Mstnem3Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5688039 RS:0003175 SS-Mthfrem1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688041 RS:0003127 SS-Mthfrem1Mcwi-/+ XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 5688041 RS:0003127 SS-Mthfrem1Mcwi-/+ XCO:0000795 controlled sodium chloride content diet 4 4 % 5688041 RS:0003127 SS-Mthfrem1Mcwi-/+ XCO:0000022 controlled sodium content diet 0.4 0.4 % 5688041 RS:0003127 SS-Mthfrem1Mcwi-/+ XCO:0000022 controlled sodium content diet 4 4 % 5688069 RS:0003179 SS-Ncf2em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688066 RS:0003149 SS-Ncf2em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5688045 RS:0003176 SS-Nckap5em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688043 RS:0003143 SS-Nckap5em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5688049 RS:0003177 SS-Nckap5em2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688047 RS:0003144 SS-Nckap5em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5688053 RS:0003178 SS-Nckap5em3Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688051 RS:0003145 SS-Nckap5em3Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5688077 RS:0003180 SS-Nox4em2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688080 RS:0003128 SS-Nox4em2Mcwi-/+ XCO:0000022 controlled sodium content diet 4 4 % 5688074 RS:0003150 SS-Nox4em2Mcwi-/- XCO:0000022 controlled sodium content diet 0.4 0.4 % 5688074 RS:0003150 SS-Nox4em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686728 RS:0003074 SS-Nppaem4Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686728 RS:0003074 SS-Nppaem4Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686725 RS:0003073 SS-Nppaem4Mcwi-/- XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 5686725 RS:0003073 SS-Nppaem4Mcwi-/- XCO:0000795 controlled sodium chloride content diet 4 4 % 5686725 RS:0003073 SS-Nppaem4Mcwi-/- XCO:0000022 controlled sodium content diet 0.4 0.4 % 5686725 RS:0003073 SS-Nppaem4Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686725 RS:0003073 SS-Nppaem4Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686732 RS:0003076 SS-Nppbem2Mcwi+/+ XCO:0000099 control condition 5686732 RS:0003076 SS-Nppbem2Mcwi+/+ XCO:0000795 controlled sodium chloride content diet % 5686732 RS:0003076 SS-Nppbem2Mcwi+/+ XCO:0000795 controlled sodium chloride content diet 5686732 RS:0003076 SS-Nppbem2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686732 RS:0003076 SS-Nppbem2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686732 RS:0003076 SS-Nppbem2Mcwi+/+ XCO:0000022 controlled sodium content diet % 5686732 RS:0003076 SS-Nppbem2Mcwi+/+ XCO:0000022 controlled sodium content diet 5686730 RS:0003075 SS-Nppbem2Mcwi-/- XCO:0000099 control condition 5686730 RS:0003075 SS-Nppbem2Mcwi-/- XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 5686730 RS:0003075 SS-Nppbem2Mcwi-/- XCO:0000795 controlled sodium chloride content diet 4 4 % 5686730 RS:0003075 SS-Nppbem2Mcwi-/- XCO:0000795 controlled sodium chloride content diet % 5686730 RS:0003075 SS-Nppbem2Mcwi-/- XCO:0000795 controlled sodium chloride content diet 5686730 RS:0003075 SS-Nppbem2Mcwi-/- XCO:0000022 controlled sodium content diet 0.4 0.4 % 5686730 RS:0003075 SS-Nppbem2Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686730 RS:0003075 SS-Nppbem2Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686730 RS:0003075 SS-Nppbem2Mcwi-/- XCO:0000022 controlled sodium content diet % 5686730 RS:0003075 SS-Nppbem2Mcwi-/- XCO:0000022 controlled sodium content diet 5686730 RS:0003075 SS-Nppbem2Mcwi-/- XCO:0000601 gene transfer of the rat natriuretic peptide B gene using an adenovirus vector 100000000000 100000000000 PFU 5686730 RS:0003075 SS-Nppbem2Mcwi-/- XCO:0000101 vehicle control condition 5686736 RS:0003078 SS-Nppbem4Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686736 RS:0003078 SS-Nppbem4Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686734 RS:0003077 SS-Nppbem4Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686734 RS:0003077 SS-Nppbem4Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686740 RS:0003080 SS-Plcd3em4Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686740 RS:0003080 SS-Plcd3em4Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686738 RS:0003079 SS-Plcd3em4Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686738 RS:0003079 SS-Plcd3em4Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686744 RS:0003082 SS-Plcd3em7Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686744 RS:0003082 SS-Plcd3em7Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686742 RS:0003081 SS-Plcd3em7Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686742 RS:0003081 SS-Plcd3em7Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686749 RS:0003084 SS-Plekha7em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686749 RS:0003084 SS-Plekha7em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686747 RS:0003083 SS-Plekha7em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686747 RS:0003083 SS-Plekha7em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686760 RS:0003089 SS-Plekha7em4Mcwi+/+ XCO:0000795 controlled sodium chloride content diet 8 8 % 5686760 RS:0003089 SS-Plekha7em4Mcwi+/+ XCO:0000022 controlled sodium content diet 0.4 0.4 % 5686760 RS:0003089 SS-Plekha7em4Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686760 RS:0003089 SS-Plekha7em4Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686760 RS:0003089 SS-Plekha7em4Mcwi+/+ XCO:0000022 controlled sodium content diet 8 8 % 5686758 RS:0003088 SS-Plekha7em4Mcwi-/- XCO:0000795 controlled sodium chloride content diet 8 8 % 5686758 RS:0003088 SS-Plekha7em4Mcwi-/- XCO:0000022 controlled sodium content diet 0.4 0.4 % 5686758 RS:0003088 SS-Plekha7em4Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686758 RS:0003088 SS-Plekha7em4Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686758 RS:0003088 SS-Plekha7em4Mcwi-/- XCO:0000022 controlled sodium content diet 8 8 % 5686764 RS:0003091 SS-Plod1em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686764 RS:0003091 SS-Plod1em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686762 RS:0003090 SS-Plod1em1Mcwi-/- XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 5686762 RS:0003090 SS-Plod1em1Mcwi-/- XCO:0000795 controlled sodium chloride content diet 4 4 % 5686762 RS:0003090 SS-Plod1em1Mcwi-/- XCO:0000022 controlled sodium content diet 0.4 0.4 % 5686762 RS:0003090 SS-Plod1em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686762 RS:0003090 SS-Plod1em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686692 RS:0003059 SS-Prokr1em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686689 RS:0003058 SS-Prokr1em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686689 RS:0003058 SS-Prokr1em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686697 RS:0003061 SS-Prokr1em2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686697 RS:0003061 SS-Prokr1em2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686695 RS:0003060 SS-Prokr1em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686695 RS:0003060 SS-Prokr1em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 4139884 RS:0002438 SS-Rag1em1Mcwi XCO:0000022 controlled sodium content diet 4 4 % 5688094 RS:0003182 SS-Rag1em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688092 RS:0003153 SS-Rag1em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 4139873 RS:0002427 SS-Rag1em2Mcwi XCO:0000022 controlled sodium content diet 4 4 % 5688098 RS:0003183 SS-Rag1em2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688096 RS:0003154 SS-Rag1em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686316 RS:0003023 SS-Rasgrp3em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686316 RS:0003023 SS-Rasgrp3em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686314 RS:0003022 SS-Rasgrp3em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686314 RS:0003022 SS-Rasgrp3em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5688100 RS:0003184 SS-Renem1Mcwi+/+ XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 5688100 RS:0003184 SS-Renem1Mcwi+/+ XCO:0000022 controlled sodium content diet 0.4 0.4 % 5688100 RS:0003184 SS-Renem1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 12743611 RS:0004313 SS-Renem1Mcwi+/- XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 12743611 RS:0004313 SS-Renem1Mcwi+/- XCO:0000022 controlled sodium content diet 0.4 0.4 % 5688102 RS:0003155 SS-Renem1Mcwi-/- XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 5688102 RS:0003155 SS-Renem1Mcwi-/- XCO:0000022 controlled sodium content diet 0.4 0.4 % 5688102 RS:0003155 SS-Renem1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686320 RS:0003025 SS-Sh2b3em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686322 RS:0003031 SS-Sh2b3em1Mcwi-/+ XCO:0000022 controlled sodium content diet 4 % 5686318 RS:0003024 SS-Sh2b3em1Mcwi-/- XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 5686318 RS:0003024 SS-Sh2b3em1Mcwi-/- XCO:0000795 controlled sodium chloride content diet 4 4 % 5686318 RS:0003024 SS-Sh2b3em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686318 RS:0003024 SS-Sh2b3em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686766 RS:0003092 SS-Sh2b3em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686766 RS:0003092 SS-Sh2b3em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 11553862 RS:0004231 SS-Shc1em1Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 60 60 mmHg 11553862 RS:0004231 SS-Shc1em1Mcwi XCO:0000795 controlled sodium chloride content diet 1 1 % 11553914 RS:0004233 SS-Shc1em4Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 60 60 mmHg 11553914 RS:0004233 SS-Shc1em4Mcwi XCO:0000795 controlled sodium chloride content diet 1 1 % 11553916 RS:0004234 SS-Shc1em5Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 60 60 mmHg 11553916 RS:0004234 SS-Shc1em5Mcwi XCO:0000795 controlled sodium chloride content diet 1 1 % 5686770 RS:0003094 SS-Slc30a8em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686770 RS:0003094 SS-Slc30a8em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686768 RS:0003093 SS-Slc30a8em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686768 RS:0003093 SS-Slc30a8em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686776 RS:0003096 SS-Slc30a8em2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686776 RS:0003096 SS-Slc30a8em2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686772 RS:0003095 SS-Slc30a8em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686772 RS:0003095 SS-Slc30a8em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 1599758 RS:0001480 SS-Sod3m1Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1599758 RS:0001480 SS-Sod3m1Mcwi XCO:0000022 controlled sodium content diet 1 1 % 1599758 RS:0001480 SS-Sod3m1Mcwi XCO:0000152 drug dose time series 1599758 RS:0001480 SS-Sod3m1Mcwi XCO:0000102 fasting 1599758 RS:0001480 SS-Sod3m1Mcwi XCO:0000642 monocrotaline 40 40 mg/kg 1599758 RS:0001480 SS-Sod3m1Mcwi XCO:0000642 monocrotaline 40 40 1599758 RS:0001480 SS-Sod3m1Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1599758 RS:0001480 SS-Sod3m1Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1599758 RS:0001480 SS-Sod3m1Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1599758 RS:0001480 SS-Sod3m1Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1599758 RS:0001480 SS-Sod3m1Mcwi XCO:0000101 vehicle control condition 5686780 RS:0003098 SS-Stk39em2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686780 RS:0003098 SS-Stk39em2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686782 RS:0003099 SS-Stk39em2Mcwi-/+ XCO:0000022 controlled sodium content diet 4 4 % 5686782 RS:0003099 SS-Stk39em2Mcwi-/+ XCO:0000022 controlled sodium content diet 4 % 5686778 RS:0003097 SS-Stk39em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686778 RS:0003097 SS-Stk39em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686786 RS:0003101 SS-Tcf7l2em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686786 RS:0003101 SS-Tcf7l2em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686788 RS:0003102 SS-Tcf7l2em1Mcwi-/+ XCO:0000022 controlled sodium content diet 4 4 % 5686788 RS:0003102 SS-Tcf7l2em1Mcwi-/+ XCO:0000022 controlled sodium content diet 4 % 5686784 RS:0003100 SS-Tcf7l2em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686784 RS:0003100 SS-Tcf7l2em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5688113 RS:0003186 SS-Tfdp2em2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688111 RS:0003157 SS-Tfdp2em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 2290429 RS:0001482 SS-Tg(ApoC3-CETP)53Opaz XCO:0000022 controlled sodium content diet 0.3 0.3 % 2290429 RS:0001482 SS-Tg(ApoC3-CETP)53Opaz XCO:0000102 fasting 5688119 RS:0003129 SS-Tgfb1em3Mcwi+/- XCO:0000022 controlled sodium content diet 4 4 % 5688123 RS:0003188 SS-Ube2q2em3Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688121 RS:0003158 SS-Ube2q2em3Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686792 RS:0003104 SS-Ulk3em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686792 RS:0003104 SS-Ulk3em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686794 RS:0003105 SS-Ulk3em1Mcwi-/+ XCO:0000022 controlled sodium content diet 4 4 % 5686794 RS:0003105 SS-Ulk3em1Mcwi-/+ XCO:0000022 controlled sodium content diet 4 % 5686790 RS:0003103 SS-Ulk3em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686790 RS:0003103 SS-Ulk3em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686328 RS:0003027 SS-Ulk3em4Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686328 RS:0003027 SS-Ulk3em4Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686330 RS:0003028 SS-Ulk3em4Mcwi-/+ XCO:0000022 controlled sodium content diet 4 4 % 5686330 RS:0003028 SS-Ulk3em4Mcwi-/+ XCO:0000022 controlled sodium content diet 4 % 5686326 RS:0003026 SS-Ulk3em4Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686326 RS:0003026 SS-Ulk3em4Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5688125 RS:0003159 SS-Ulk4em3Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686799 RS:0003107 SS-Wdr72em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686799 RS:0003107 SS-Wdr72em1Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686797 RS:0003106 SS-Wdr72em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686797 RS:0003106 SS-Wdr72em1Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 5686335 RS:0003030 SS-Wdr72em2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5686335 RS:0003030 SS-Wdr72em2Mcwi+/+ XCO:0000022 controlled sodium content diet 4 % 5686332 RS:0003029 SS-Wdr72em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 5686332 RS:0003029 SS-Wdr72em2Mcwi-/- XCO:0000022 controlled sodium content diet 4 % 12802367 RS:0004400 SS.BN-(2340-RN34_13048990782)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12802367 RS:0004400 SS.BN-(2340-RN34_13048990782)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000116 Kreb's solution perfusate 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000012 air carbon dioxide content 7 % 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000099 control condition 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000010 controlled air oxygen content 12 % 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000152 drug dose time series 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000138 methylene blue 10 10 umol/l 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000118 perfusate suspended 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000003 resting on treadmill 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000005 running on treadmill 1.6 1.6 m/min 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000153 sample resting period 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000142 sodium nitroprusside 0 3 umol/l 629510 RS:0000813 SS.BN-(D12Arb13-D12Rat79)/Mcwi XCO:0000004 walking on treadmill 0.8 0.8 m/min 7248456 RS:0000298 SS.BN-(D12Hmgc3- D12Got29)/Mcwi XCO:0000022 controlled sodium content diet 1 1 % 7248456 RS:0000298 SS.BN-(D12Hmgc3- D12Got29)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 7248453 RS:0000368 SS.BN-(D12Hmgc3-AU047911)/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 20 20 mmHg 7248453 RS:0000368 SS.BN-(D12Hmgc3-AU047911)/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 40 40 mmHg 7248453 RS:0000368 SS.BN-(D12Hmgc3-AU047911)/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 60 60 mmHg 7248453 RS:0000368 SS.BN-(D12Hmgc3-AU047911)/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 80 80 mmHg 7248453 RS:0000368 SS.BN-(D12Hmgc3-AU047911)/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 100 100 mmHg 7248453 RS:0000368 SS.BN-(D12Hmgc3-AU047911)/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 120 120 mmHg 7248453 RS:0000368 SS.BN-(D12Hmgc3-AU047911)/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 140 140 mmHg 7248453 RS:0000368 SS.BN-(D12Hmgc3-AU047911)/Mcwi XCO:0000466 controlled ex vivo artery perfusion pressure 160 160 mmHg 7248453 RS:0000368 SS.BN-(D12Hmgc3-AU047911)/Mcwi XCO:0000022 controlled sodium content diet 0.3 0.3 % 7248453 RS:0000368 SS.BN-(D12Hmgc3-AU047911)/Mcwi XCO:0000022 controlled sodium content diet 1 1 % 7248453 RS:0000368 SS.BN-(D12Hmgc3-AU047911)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 7248454 RS:0000132 SS.BN-(D12Hmgc7-D12Hmgc6)/Mcwi XCO:0000022 controlled sodium content diet 1 1 % 7248454 RS:0000132 SS.BN-(D12Hmgc7-D12Hmgc6)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12792944 RS:0004376 SS.BN-(D13Got42-D13Got45)/Mcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 12792944 RS:0004376 SS.BN-(D13Got42-D13Got45)/Mcwi XCO:0000795 controlled sodium chloride content diet 8 8 % 12792944 RS:0004376 SS.BN-(D13Got42-D13Got45)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12792944 RS:0004376 SS.BN-(D13Got42-D13Got45)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12792946 RS:0004378 SS.BN-(D13Got42-D13Hmgc354)/Mcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 12792946 RS:0004378 SS.BN-(D13Got42-D13Hmgc354)/Mcwi XCO:0000795 controlled sodium chloride content diet 8 8 % 12792946 RS:0004378 SS.BN-(D13Got42-D13Hmgc354)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12792946 RS:0004378 SS.BN-(D13Got42-D13Hmgc354)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12792947 RS:0004379 SS.BN-(D13Got42-D13Hmgc497)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12792947 RS:0004379 SS.BN-(D13Got42-D13Hmgc497)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12792949 RS:0004381 SS.BN-(D13Got42-D13Hmgc664)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12792949 RS:0004381 SS.BN-(D13Got42-D13Hmgc664)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12792948 RS:0004380 SS.BN-(D13Got42-D13Hmgc885)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12792948 RS:0004380 SS.BN-(D13Got42-D13Hmgc885)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12792945 RS:0004377 SS.BN-(D13Got42-D13Rat130)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12792945 RS:0004377 SS.BN-(D13Got42-D13Rat130)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12792939 RS:0004375 SS.BN-(D13Got42-D13Rat61)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12792939 RS:0004375 SS.BN-(D13Got42-D13Rat61)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12792226 RS:0004368 SS.BN-(D13Got45-D13Hmgc664)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12792226 RS:0004368 SS.BN-(D13Got45-D13Hmgc664)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12792954 RS:0004386 SS.BN-(D13Got45-D13Rat32)/Mcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 12792954 RS:0004386 SS.BN-(D13Got45-D13Rat32)/Mcwi XCO:0000795 controlled sodium chloride content diet 8 8 % 12792954 RS:0004386 SS.BN-(D13Got45-D13Rat32)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12792954 RS:0004386 SS.BN-(D13Got45-D13Rat32)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 2303010 RS:0001729 SS.BN-(D13Got51-D13Rat192)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 2303011 RS:0001730 SS.BN-(D13Got51-D13Rat57)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12792214 RS:0004372 SS.BN-(D13Hmgc1041-D13Hmgc664)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12792214 RS:0004372 SS.BN-(D13Hmgc1041-D13Hmgc664)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12792217 RS:0004374 SS.BN-(D13Hmgc1041-D13Hmgc885)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12792217 RS:0004374 SS.BN-(D13Hmgc1041-D13Hmgc885)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12792212 RS:0004370 SS.BN-(D13Hmgc1048-D13Hmgc1045)/Mcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 12792212 RS:0004370 SS.BN-(D13Hmgc1048-D13Hmgc1045)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12792212 RS:0004370 SS.BN-(D13Hmgc1048-D13Hmgc1045)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12792213 RS:0004371 SS.BN-(D13Hmgc1048-D13Hmgc1050)/Mcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 12792213 RS:0004371 SS.BN-(D13Hmgc1048-D13Hmgc1050)/Mcwi XCO:0000795 controlled sodium chloride content diet 8 8 % 12792213 RS:0004371 SS.BN-(D13Hmgc1048-D13Hmgc1050)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12792213 RS:0004371 SS.BN-(D13Hmgc1048-D13Hmgc1050)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12792211 RS:0004369 SS.BN-(D13Hmgc1048-D13Hmgc664)/Mcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 12792211 RS:0004369 SS.BN-(D13Hmgc1048-D13Hmgc664)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12792211 RS:0004369 SS.BN-(D13Hmgc1048-D13Hmgc664)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12798530 RS:0004388 SS.BN-(D13Hmgc115-D13Got22)/Mcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 12798530 RS:0004388 SS.BN-(D13Hmgc115-D13Got22)/Mcwi XCO:0000795 controlled sodium chloride content diet 8 8 % 12798530 RS:0004388 SS.BN-(D13Hmgc115-D13Got22)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12798530 RS:0004388 SS.BN-(D13Hmgc115-D13Got22)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12792952 RS:0004384 SS.BN-(D13Hmgc354-D13Rat32)/Mcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 12792952 RS:0004384 SS.BN-(D13Hmgc354-D13Rat32)/Mcwi XCO:0000795 controlled sodium chloride content diet 8 8 % 12792952 RS:0004384 SS.BN-(D13Hmgc354-D13Rat32)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12792952 RS:0004384 SS.BN-(D13Hmgc354-D13Rat32)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12798529 RS:0004387 SS.BN-(D13Hmgc37-D13Got22)/Mcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 12798529 RS:0004387 SS.BN-(D13Hmgc37-D13Got22)/Mcwi XCO:0000795 controlled sodium chloride content diet 8 8 % 12798529 RS:0004387 SS.BN-(D13Hmgc37-D13Got22)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12798529 RS:0004387 SS.BN-(D13Hmgc37-D13Got22)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12798532 RS:0004390 SS.BN-(D13Hmgc40-D13Got22)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12798532 RS:0004390 SS.BN-(D13Hmgc40-D13Got22)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 6907436 RS:0003364 SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi XCO:0000121 NG-nitroarginine methyl ester 100 100 umol/l 6907436 RS:0003364 SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi XCO:0000215 controlled calcium ion content physiological salt solution perfusate 0 0 % 6907436 RS:0003364 SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi XCO:0000382 controlled captopril content drinking water 100 100 mg/kg/d 6907436 RS:0003364 SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi XCO:0000383 controlled losartan content drinking water 20 20 mg/kg/d 6907436 RS:0003364 SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi XCO:0000384 controlled tempol content drinking water 15 15 mg/kg/d 6907436 RS:0003364 SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi XCO:0000147 physiological salt solution perfusate 12792951 RS:0004383 SS.BN-(D13Hmgc5885-D13Rat32)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12792951 RS:0004383 SS.BN-(D13Hmgc5885-D13Rat32)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12802366 RS:0004398 SS.BN-(D13Hmgc64-4582)/Mcwi XCO:0000522 common peroneal nerve direct electrical stimulation 3 3 V 12802366 RS:0004398 SS.BN-(D13Hmgc64-4582)/Mcwi XCO:0000099 control condition 12802366 RS:0004398 SS.BN-(D13Hmgc64-4582)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12802366 RS:0004398 SS.BN-(D13Hmgc64-4582)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12802365 RS:0004397 SS.BN-(D13Hmgc64-D13Hmgc23)/Mcwi XCO:0000522 common peroneal nerve direct electrical stimulation 3 3 V 12802365 RS:0004397 SS.BN-(D13Hmgc64-D13Hmgc23)/Mcwi XCO:0000099 control condition 12802365 RS:0004397 SS.BN-(D13Hmgc64-D13Hmgc23)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12802365 RS:0004397 SS.BN-(D13Hmgc64-D13Hmgc23)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 2293145 RS:0001486 SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 2293145 RS:0001486 SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi XCO:0000522 common peroneal nerve direct electrical stimulation 3 3 V 2293145 RS:0001486 SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi XCO:0000099 control condition 2293145 RS:0001486 SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 2293145 RS:0001486 SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi XCO:0000795 controlled sodium chloride content diet 8 8 % 2293145 RS:0001486 SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 2293145 RS:0001486 SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12798533 RS:0004391 SS.BN-(D13Hmgc85-D13Got22)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12798533 RS:0004391 SS.BN-(D13Hmgc85-D13Got22)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12798531 RS:0004389 SS.BN-(D13Hmgc86-D13Got22)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12798531 RS:0004389 SS.BN-(D13Hmgc86-D13Got22)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12792216 RS:0004373 SS.BN-(D13Hmgc885-D13Hmgc664)/Mcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 12792216 RS:0004373 SS.BN-(D13Hmgc885-D13Hmgc664)/Mcwi XCO:0000795 controlled sodium chloride content diet 8 8 % 12792216 RS:0004373 SS.BN-(D13Hmgc885-D13Hmgc664)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12792216 RS:0004373 SS.BN-(D13Hmgc885-D13Hmgc664)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12792950 RS:0004382 SS.BN-(D13Mit5-D13Rat32)/Mcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 12792950 RS:0004382 SS.BN-(D13Mit5-D13Rat32)/Mcwi XCO:0000795 controlled sodium chloride content diet 8 8 % 12792950 RS:0004382 SS.BN-(D13Mit5-D13Rat32)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12792950 RS:0004382 SS.BN-(D13Mit5-D13Rat32)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 2303006 RS:0001725 SS.BN-(D13Rat101-D13Rat46)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 2302985 RS:0001709 SS.BN-(D13Rat111-D13Got22)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 2302985 RS:0001709 SS.BN-(D13Rat111-D13Got22)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12798538 RS:0004396 SS.BN-(D13Rat111-D13Hmgc85)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12798538 RS:0004396 SS.BN-(D13Rat111-D13Hmgc85)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12798536 RS:0004394 SS.BN-(D13Rat111-D13Hmgc86)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12798536 RS:0004394 SS.BN-(D13Rat111-D13Hmgc86)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12798535 RS:0004393 SS.BN-(D13Rat111-D13Rat115)/Mcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 12798535 RS:0004393 SS.BN-(D13Rat111-D13Rat115)/Mcwi XCO:0000795 controlled sodium chloride content diet 8 8 % 12798535 RS:0004393 SS.BN-(D13Rat111-D13Rat115)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12798535 RS:0004393 SS.BN-(D13Rat111-D13Rat115)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 2303001 RS:0001720 SS.BN-(D13Rat111-D13Rat127)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12798537 RS:0004395 SS.BN-(D13Rat111-D13Rat20)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12798537 RS:0004395 SS.BN-(D13Rat111-D13Rat20)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 2303004 RS:0001723 SS.BN-(D13Rat115-D13Rat61)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 2303002 RS:0001721 SS.BN-(D13Rat123-D13Rat197)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 6907445 RS:0003366 SS.BN-(D13Rat124-D13Rat101)/Mcwi XCO:0000215 controlled calcium ion content physiological salt solution perfusate 0 0 % 6907445 RS:0003366 SS.BN-(D13Rat124-D13Rat101)/Mcwi XCO:0000147 physiological salt solution perfusate 2303007 RS:0001726 SS.BN-(D13Rat127-D13Rat46)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 2302994 RS:0001713 SS.BN-(D13Rat127-D13Rat61)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 2303005 RS:0001724 SS.BN-(D13Rat127-D13Rat77)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12792953 RS:0004385 SS.BN-(D13Rat130-D13Rat32)/Mcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 12792953 RS:0004385 SS.BN-(D13Rat130-D13Rat32)/Mcwi XCO:0000795 controlled sodium chloride content diet 8 8 % 12792953 RS:0004385 SS.BN-(D13Rat130-D13Rat32)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12792953 RS:0004385 SS.BN-(D13Rat130-D13Rat32)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 2302984 RS:0001711 SS.BN-(D13Rat151-D13Rat197)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 2302984 RS:0001711 SS.BN-(D13Rat151-D13Rat197)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 2302999 RS:0001718 SS.BN-(D13Rat178-D13Got45)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 2303009 RS:0001728 SS.BN-(D13Rat183-D13Rat192)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 2293146 RS:0001488 SS.BN-(D13Rat20-D13Got22)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 2293146 RS:0001488 SS.BN-(D13Rat20-D13Got22)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 5688061 RS:0003147 SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi+/+ XCO:0000022 controlled sodium content diet 4 4 % 5688063 RS:0003148 SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi-/+ XCO:0000022 controlled sodium content diet 4 4 % 5688059 RS:0003146 SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi-/- XCO:0000022 controlled sodium content diet 4 4 % 2293143 RS:0001489 SS.BN-(D13Rat20-D13Rat127)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12802362 RS:0004399 SS.BN-(D13Rat25-RN34_13048990782)/Mcwi XCO:0000522 common peroneal nerve direct electrical stimulation 3 3 V 12802362 RS:0004399 SS.BN-(D13Rat25-RN34_13048990782)/Mcwi XCO:0000099 control condition 12802362 RS:0004399 SS.BN-(D13Rat25-RN34_13048990782)/Mcwi XCO:0000383 controlled losartan content drinking water 50 50 mg/kg/d 12802362 RS:0004399 SS.BN-(D13Rat25-RN34_13048990782)/Mcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 12802362 RS:0004399 SS.BN-(D13Rat25-RN34_13048990782)/Mcwi XCO:0000795 controlled sodium chloride content diet 8 8 % 12802362 RS:0004399 SS.BN-(D13Rat25-RN34_13048990782)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12802362 RS:0004399 SS.BN-(D13Rat25-RN34_13048990782)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12802363 RS:0004401 SS.BN-(D13Rat25-rs106935835)/Mcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 12802363 RS:0004401 SS.BN-(D13Rat25-rs106935835)/Mcwi XCO:0000795 controlled sodium chloride content diet 8 8 % 12802363 RS:0004401 SS.BN-(D13Rat25-rs106935835)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12802363 RS:0004401 SS.BN-(D13Rat25-rs106935835)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12802364 RS:0004402 SS.BN-(D13Rat25-rs198199323)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12802364 RS:0004402 SS.BN-(D13Rat25-rs198199323)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 2302989 RS:0001712 SS.BN-(D13Rat57-D13Rat192)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 2303008 RS:0001727 SS.BN-(D13Rat61-D13GRat197)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 2303003 RS:0001722 SS.BN-(D13Rat7-D13Rat127)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 2302987 RS:0001708 SS.BN-(D13Rat7-D13Rat60)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 2302996 RS:0001715 SS.BN-(D13Rat7-D13Rat88)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 12798534 RS:0004392 SS.BN-(D13Rat77-D13Got22)/Mcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 12798534 RS:0004392 SS.BN-(D13Rat77-D13Got22)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 6907438 RS:0003365 SS.BN-(D13Rat77-D13Rat105)/Mcwi XCO:0000215 controlled calcium ion content physiological salt solution perfusate 0 0 % 6907438 RS:0003365 SS.BN-(D13Rat77-D13Rat105)/Mcwi XCO:0000147 physiological salt solution perfusate 2302997 RS:0001716 SS.BN-(D13Rat91-D13Got45)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 2293144 RS:0001490 SS.BN-(D13Rat91-D13Rat179)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 4145091 RS:0002482 SS.BN-(D6Rat149-D6Arb3)/Mcwi XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 4145090 RS:0002481 SS.BN-(D6Rat149-D6Got171)/Mcwi XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 4145089 RS:0002480 SS.BN-(D6Rat149-D6Rat18)/Mcwi XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000116 Kreb's solution perfusate 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000143 acetylcholine 0 30 umol/l 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000012 air carbon dioxide content 7 7 % 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000012 air carbon dioxide content 7 % 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000099 control condition 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000010 controlled air oxygen content 12 12 % 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000010 controlled air oxygen content 12 % 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000022 controlled sodium content diet 4 4 % 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000152 drug dose time series 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000134 methacholine 0 11.06 mg/kg 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000138 methylene blue 10 10 umol/l 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000118 perfusate suspended 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000145 phenylephrine 0 300 umol/l 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000145 phenylephrine 1 1 umol/l 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000145 phenylephrine 10 10 umol/l 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000150 potassium ion 80 80 mmol/l 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000003 resting on treadmill 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000005 running on treadmill 1.6 1.6 m/min 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000153 sample resting period 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000142 sodium nitroprusside 0 3 umol/l 1358160 RS:0000815 SS.BN-(D8Rat163-D8Rat81)/Mcwi XCO:0000004 walking on treadmill 0.8 0.8 m/min 631605 RS:0000846 SS.LEW-(D10Arb9-D10Got101)/Jr XCO:0000022 controlled sodium content diet 0.3 0.3 % 631605 RS:0000846 SS.LEW-(D10Arb9-D10Got101)/Jr XCO:0000022 controlled sodium content diet 2 2 % 1642287 RS:0001504 SS.LEW-(D10Arb9-D10Mco84)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 1642287 RS:0001504 SS.LEW-(D10Arb9-D10Mco84)/Mco XCO:0000022 controlled sodium content diet 2 2 % 1642279 RS:0001505 SS.LEW-(D10Arb9-D10Rat161)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 1642279 RS:0001505 SS.LEW-(D10Arb9-D10Rat161)/Mco XCO:0000022 controlled sodium content diet 2 2 % 1642285 RS:0001506 SS.LEW-(D10Arb9-D10Rat57)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 1642285 RS:0001506 SS.LEW-(D10Arb9-D10Rat57)/Mco XCO:0000022 controlled sodium content diet 2 2 % 2292389 RS:0001508 SS.LEW-(D10Chm10-D10Chm14)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 2292389 RS:0001508 SS.LEW-(D10Chm10-D10Chm14)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551714 RS:0003651 SS.LEW-(D10Chm10-D10Rat11)(D10Chm246-D10Chm257)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551714 RS:0003651 SS.LEW-(D10Chm10-D10Rat11)(D10Chm246-D10Chm257)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551718 RS:0003653 SS.LEW-(D10Chm10-D10Rat11)(D16Chm48-D16Chm60)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551718 RS:0003653 SS.LEW-(D10Chm10-D10Rat11)(D16Chm48-D16Chm60)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1579903 RS:0001507 SS.LEW-(D10Chm10-D10Rat11)/Ayd XCO:0000337 air-jet exposure 2 2 lb/in2 1579903 RS:0001507 SS.LEW-(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 1579903 RS:0001507 SS.LEW-(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1579903 RS:0001507 SS.LEW-(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 8 8 % 1579903 RS:0001507 SS.LEW-(D10Chm10-D10Rat11)/Ayd XCO:0000145 phenylephrine 5 50 ug/min 1579903 RS:0001507 SS.LEW-(D10Chm10-D10Rat11)/Ayd XCO:0000254 sodium ion solution 800 800 mmol/l 1579903 RS:0001507 SS.LEW-(D10Chm10-D10Rat11)/Ayd XCO:0000142 sodium nitroprusside 10 100 ug/min 1579898 RS:0001510 SS.LEW-(D10Chm128-D10Chm121)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1579907 RS:0001509 SS.LEW-(D10Chm128-D10Chm169)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2292386 RS:0001511 SS.LEW-(D10Chm155-D10Rat127)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 2292386 RS:0001511 SS.LEW-(D10Chm155-D10Rat127)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2292384 RS:0001512 SS.LEW-(D10Chm167-D10Chm257)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 2292384 RS:0001512 SS.LEW-(D10Chm167-D10Chm257)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1579913 RS:0001515 SS.LEW-(D10Chm224-D10Chm222)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2292387 RS:0001516 SS.LEW-(D10Chm224-D10Chm259)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 2292387 RS:0001516 SS.LEW-(D10Chm224-D10Chm259)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1579901 RS:0001513 SS.LEW-(D10Chm224-D10Chm6)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 1579901 RS:0001513 SS.LEW-(D10Chm224-D10Chm6)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2292388 RS:0001517 SS.LEW-(D10Chm246-D10Chm257)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 2292388 RS:0001517 SS.LEW-(D10Chm246-D10Chm257)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8657135 RS:0003776 SS.LEW-(D10Chm280-D10Chm216)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2325798 RS:0002417 SS.LEW-(D10Got112-Igfbp4)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 2325798 RS:0002417 SS.LEW-(D10Got112-Igfbp4)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 631220 RS:0000844 SS.LEW-(D10Mco1-D10Mco31)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1642970 RS:0001520 SS.LEW-(D10Mco113-D10Got93)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 1642970 RS:0001520 SS.LEW-(D10Mco113-D10Got93)/Mco XCO:0000022 controlled sodium content diet 2 2 % 728396 RS:0000845 SS.LEW-(D10Mco15-D10Mgh1)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 728396 RS:0000845 SS.LEW-(D10Mco15-D10Mgh1)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2292385 RS:0001521 SS.LEW-(D10Mco30-D10Got107)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 2292385 RS:0001521 SS.LEW-(D10Mco30-D10Got107)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1579914 RS:0001522 SS.LEW-(D10Mco30-D10Got92)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1641872 RS:0001523 SS.LEW-(D10Mco38-D10Mco41)/Jr XCO:0000022 controlled sodium content diet 2 2 % 1641853 RS:0001524 SS.LEW-(D10Mco38-D10Mgh1)/Jr XCO:0000022 controlled sodium content diet 2 2 % 1642272 RS:0001519 SS.LEW-(D10Mco84-D10Got93)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 1642272 RS:0001519 SS.LEW-(D10Mco84-D10Got93)/Mco XCO:0000022 controlled sodium content diet 2 2 % 1642971 RS:0001525 SS.LEW-(D10Mco84-D10Mco129)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 1642971 RS:0001525 SS.LEW-(D10Mco84-D10Mco129)/Mco XCO:0000022 controlled sodium content diet 2 2 % 1642969 RS:0001526 SS.LEW-(D10Mco84-D10Mco134)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 1642969 RS:0001526 SS.LEW-(D10Mco84-D10Mco134)/Mco XCO:0000022 controlled sodium content diet 2 2 % 1642972 RS:0001527 SS.LEW-(D10Mco84-D10Mco143)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 1642972 RS:0001527 SS.LEW-(D10Mco84-D10Mco143)/Mco XCO:0000022 controlled sodium content diet 2 2 % 1642968 RS:0001528 SS.LEW-(D10Mco84-D10Rat58)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 1642968 RS:0001528 SS.LEW-(D10Mco84-D10Rat58)/Mco XCO:0000022 controlled sodium content diet 2 2 % 1642288 RS:0001529 SS.LEW-(D10Mco89-D10Got101)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 1642288 RS:0001529 SS.LEW-(D10Mco89-D10Got101)/Mco XCO:0000022 controlled sodium content diet 2 2 % 1641849 RS:0001530 SS.LEW-(D10Mit1-D10Mgh1)/Jr XCO:0000022 controlled sodium content diet 2 2 % 734480 RS:0000884 SS.LEW-(D10Mit10-D10Mgh1)/Jr XCO:0000022 controlled sodium content diet 2 2 % 1641866 RS:0001531 SS.LEW-(D10Mit10-D10Rat24)/Jr XCO:0000022 controlled sodium content diet 2 2 % 728140 RS:0000819 SS.LEW-(D10Rat11-D10Mgh1)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 728388 RS:0000848 SS.LEW-(D10Rat119-D10Mgh1)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 728386 RS:0000849 SS.LEW-(D10Rat119-D10Rat133)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 728386 RS:0000849 SS.LEW-(D10Rat119-D10Rat133)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551711 RS:0003650 SS.LEW-(D10Rat194-D10Chm243)(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551711 RS:0003650 SS.LEW-(D10Rat194-D10Chm243)(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551716 RS:0003652 SS.LEW-(D10Rat194-D10Chm243)(D16Chm48-D16Chm60)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551716 RS:0003652 SS.LEW-(D10Rat194-D10Chm243)(D16Chm48-D16Chm60)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2292390 RS:0001514 SS.LEW-(D10Rat194-D10Chm243)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 2292390 RS:0001514 SS.LEW-(D10Rat194-D10Chm243)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1579894 RS:0001532 SS.LEW-(D10Rat204-D10Rat9)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 728384 RS:0000852 SS.LEW-(D10Rat24-Igfbp4)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 728384 RS:0000852 SS.LEW-(D10Rat24-Igfbp4)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 724577 RS:0000853 SS.LEW-(D10Rat27-Igfbp4)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 724577 RS:0000853 SS.LEW-(D10Rat27-Igfbp4)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1642283 RS:0001518 SS.LEW-(D10Rat29-D10Got93)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 1642283 RS:0001518 SS.LEW-(D10Rat29-D10Got93)/Mco XCO:0000022 controlled sodium content diet 2 2 % 1642275 RS:0001533 SS.LEW-(D10Rat29-D10Mco88)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 1642275 RS:0001533 SS.LEW-(D10Rat29-D10Mco88)/Mco XCO:0000022 controlled sodium content diet 2 2 % 728394 RS:0000854 SS.LEW-(D10Rat55-D10Rat13)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 728394 RS:0000854 SS.LEW-(D10Rat55-D10Rat13)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 724572 RS:0000856 SS.LEW-(D10Wox51-D10Rat27)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2325801 RS:0002418 SS.LEW-(D16Chm36-D16Mit2)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 2325801 RS:0002418 SS.LEW-(D16Chm36-D16Mit2)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551742 RS:0003663 SS.LEW-(D16Chm48-D16Chm60)(D18Rat101-D18Rat92)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551742 RS:0003663 SS.LEW-(D16Chm48-D16Chm60)(D18Rat101-D18Rat92)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 7421612 RS:0003583 SS.LEW-(D16Chm48-D16Chm60)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 7421612 RS:0003583 SS.LEW-(D16Chm48-D16Chm60)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2301247 RS:0001644 SS.LEW-(D16Got3-D16Rat112)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1358168 RS:0000857 SS.LEW-(D16Mit2-D16Chm23)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 631585 RS:0000822 SS.LEW-(D16Mit2-D16Rat12)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2325803 RS:0002419 SS.LEW-(D16Rat112-D16Chm60)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 2325803 RS:0002419 SS.LEW-(D16Rat112-D16Chm60)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1358150 RS:0000859 SS.LEW-(D16Rat12-D16Chm23)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1358161 RS:0000860 SS.LEW-(D16Rat38-D16Chm66)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 728148 RS:0000823 SS.LEW-(D16Uia2-D16Rat12)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551732 RS:0003659 SS.LEW-(D17Chm131-D17Chm93)(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551732 RS:0003659 SS.LEW-(D17Chm131-D17Chm93)(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551734 RS:0003660 SS.LEW-(D17Chm131-D17Chm93)(D17Rat84-D17Chm17)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551734 RS:0003660 SS.LEW-(D17Chm131-D17Chm93)(D17Rat84-D17Chm17)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 7421621 RS:0003586 SS.LEW-(D17Chm131-D17Chm93)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 7421621 RS:0003586 SS.LEW-(D17Chm131-D17Chm93)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1559035 RS:0001491 SS.LEW-(D17Chm14-D17Rat181)/Ayd XCO:0000337 air-jet exposure 2 2 lb/in2 1559035 RS:0001491 SS.LEW-(D17Chm14-D17Rat181)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1559035 RS:0001491 SS.LEW-(D17Chm14-D17Rat181)/Ayd XCO:0000022 controlled sodium content diet 8 8 % 1559035 RS:0001491 SS.LEW-(D17Chm14-D17Rat181)/Ayd XCO:0000145 phenylephrine 5 50 ug/min 1559035 RS:0001491 SS.LEW-(D17Chm14-D17Rat181)/Ayd XCO:0000254 sodium ion solution 800 800 mmol/l 1559035 RS:0001491 SS.LEW-(D17Chm14-D17Rat181)/Ayd XCO:0000142 sodium nitroprusside 10 100 ug/min 7421617 RS:0003584 SS.LEW-(D17Chm14-D17Rat65)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 7421617 RS:0003584 SS.LEW-(D17Chm14-D17Rat65)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1559034 RS:0001492 SS.LEW-(D17Chm14-D17Rat97)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 7421619 RS:0003585 SS.LEW-(D17Chm85-D17Chm71)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 7421619 RS:0003585 SS.LEW-(D17Chm85-D17Chm71)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1559037 RS:0001493 SS.LEW-(D17Chm9-D17Rat97)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 734473 RS:0000861 SS.LEW-(D17Mco3-D17Mco10)/Jr XCO:0000022 controlled sodium content diet 2 2 % 1559032 RS:0001494 SS.LEW-(D17Rat65-D17Chm2)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1559033 RS:0001495 SS.LEW-(D17Rat65-Prl)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 7421623 RS:0003587 SS.LEW-(D17Rat84-D17Chm17)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 7421623 RS:0003587 SS.LEW-(D17Rat84-D17Chm17)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8657079 RS:0003775 SS.LEW-(D18Chm124-D18Chm126)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8657079 RS:0003775 SS.LEW-(D18Chm124-D18Chm126)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2301383 RS:0001656 SS.LEW-(D18Chm31-D18Rat55)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 2301383 RS:0001656 SS.LEW-(D18Chm31-D18Rat55)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2301384 RS:0001657 SS.LEW-(D18Chm41-D18Rat45)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 2301384 RS:0001657 SS.LEW-(D18Chm41-D18Rat45)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2301381 RS:0001654 SS.LEW-(D18Chm41-D18Rat92)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 2301381 RS:0001654 SS.LEW-(D18Chm41-D18Rat92)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2301388 RS:0001661 SS.LEW-(D18Chm56-D18Rat55)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 2301388 RS:0001661 SS.LEW-(D18Chm56-D18Rat55)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551789 RS:0003681 SS.LEW-(D18Chm59-D18Rat1)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551789 RS:0003681 SS.LEW-(D18Chm59-D18Rat1)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551782 RS:0003678 SS.LEW-(D18Chm90-D18Chm4)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551782 RS:0003678 SS.LEW-(D18Chm90-D18Chm4)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2301382 RS:0001655 SS.LEW-(D18Chm91-D18Rat67)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 2301382 RS:0001655 SS.LEW-(D18Chm91-D18Rat67)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2301385 RS:0001658 SS.LEW-(D18Rat29-D18Rat55)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 2301385 RS:0001658 SS.LEW-(D18Rat29-D18Rat55)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2301249 RS:0001646 SS.LEW-(D18Rat30-D18Chm29)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551787 RS:0003680 SS.LEW-(D18Rat55-D18Mgh2)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551787 RS:0003680 SS.LEW-(D18Rat55-D18Mgh2)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2301386 RS:0001659 SS.LEW-(D18Rat61-D18Rat45)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 2301386 RS:0001659 SS.LEW-(D18Rat61-D18Rat45)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2301387 RS:0001660 SS.LEW-(D18Rat67-D18Rat55)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 2301387 RS:0001660 SS.LEW-(D18Rat67-D18Rat55)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551785 RS:0003679 SS.LEW-(D18Wox7-D18Rat67)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551785 RS:0003679 SS.LEW-(D18Wox7-D18Rat67)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551755 RS:0003668 SS.LEW-(D1Chm64-D1Rat19)(D10Rat194-D10Chm243)(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551755 RS:0003668 SS.LEW-(D1Chm64-D1Rat19)(D10Rat194-D10Chm243)(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 7421599 RS:0003578 SS.LEW-(D1Chm64-D1Rat19)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 7421599 RS:0003578 SS.LEW-(D1Chm64-D1Rat19)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2316653 RS:0002372 SS.LEW-(D1Mco102-D1Got46)/Mco XCO:0000022 controlled sodium content diet 0.4 0.4 % 2316653 RS:0002372 SS.LEW-(D1Mco102-D1Got46)/Mco XCO:0000022 controlled sodium content diet 2 2 % 2316654 RS:0002373 SS.LEW-(D1Mco102-D1Mco129)/1Mco XCO:0000022 controlled sodium content diet 0.4 0.4 % 2316655 RS:0002374 SS.LEW-(D1Mco102-D1Mco129)/2Mco XCO:0000022 controlled sodium content diet 0.4 0.4 % 9685797 RS:0003864 SS.LEW-(D1Mco134-D1Wox6)/Bj XCO:0000022 controlled sodium content diet 0.3 0.3 % 9685797 RS:0003864 SS.LEW-(D1Mco134-D1Wox6)/Bj XCO:0000022 controlled sodium content diet 2 2 % 9685797 RS:0003864 SS.LEW-(D1Mco134-D1Wox6)/Bj XCO:0000035 housing in pairs 734481 RS:0000862 SS.LEW-(D1Mco2-D1Mco35)/Jr XCO:0000022 controlled sodium content diet 2 2 % 734479 RS:0000863 SS.LEW-(D1Mco2-D1Rat49)/Jr XCO:0000022 controlled sodium content diet 0.3 0.3 % 734479 RS:0000863 SS.LEW-(D1Mco2-D1Rat49)/Jr XCO:0000022 controlled sodium content diet 2 2 % 2292653 RS:0001534 SS.LEW-(D1Mco36-D1Mco101)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 2292653 RS:0001534 SS.LEW-(D1Mco36-D1Mco101)/Mco XCO:0000022 controlled sodium content diet 2 2 % 2292653 RS:0001534 SS.LEW-(D1Mco36-D1Mco101)/Mco XCO:0000035 housing in pairs 9685785 RS:0003859 SS.LEW-(D1Mco36-D1Mco54)/Bj XCO:0000022 controlled sodium content diet 0.3 0.3 % 9685785 RS:0003859 SS.LEW-(D1Mco36-D1Mco54)/Bj XCO:0000022 controlled sodium content diet 2 2 % 9685785 RS:0003859 SS.LEW-(D1Mco36-D1Mco54)/Bj XCO:0000035 housing in pairs 9685791 RS:0003861 SS.LEW-(D1Mco36-D1Mco61)/Bj XCO:0000022 controlled sodium content diet 0.3 0.3 % 9685791 RS:0003861 SS.LEW-(D1Mco36-D1Mco61)/Bj XCO:0000022 controlled sodium content diet 2 2 % 9685791 RS:0003861 SS.LEW-(D1Mco36-D1Mco61)/Bj XCO:0000035 housing in pairs 2292648 RS:0001496 SS.LEW-(D1Mco36-D1Mco77)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 2292648 RS:0001496 SS.LEW-(D1Mco36-D1Mco77)/Mco XCO:0000022 controlled sodium content diet 2 2 % 2292647 RS:0001497 SS.LEW-(D1Mco36-D1Rat106)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 2292647 RS:0001497 SS.LEW-(D1Mco36-D1Rat106)/Mco XCO:0000022 controlled sodium content diet 2 2 % 2292649 RS:0001498 SS.LEW-(D1Mco36-D1Rat131)/1Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 2292649 RS:0001498 SS.LEW-(D1Mco36-D1Rat131)/1Mco XCO:0000022 controlled sodium content diet 2 2 % 2292650 RS:0001499 SS.LEW-(D1Mco36-D1Rat131)/2Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 2292650 RS:0001499 SS.LEW-(D1Mco36-D1Rat131)/2Mco XCO:0000022 controlled sodium content diet 2 2 % 9685787 RS:0003860 SS.LEW-(D1Mco36-D1Rat200)/Bj XCO:0000022 controlled sodium content diet 0.3 0.3 % 9685787 RS:0003860 SS.LEW-(D1Mco36-D1Rat200)/Bj XCO:0000022 controlled sodium content diet 2 2 % 9685787 RS:0003860 SS.LEW-(D1Mco36-D1Rat200)/Bj XCO:0000035 housing in pairs 728159 RS:0000830 SS.LEW-(D1Mco36-D1Rat49)/Jr XCO:0000022 controlled sodium content diet 0.3 0.3 % 728159 RS:0000830 SS.LEW-(D1Mco36-D1Rat49)/Jr XCO:0000022 controlled sodium content diet 2 2 % 728143 RS:0000827 SS.LEW-(D1Mco38-D1Rat49)/Jr XCO:0000022 controlled sodium content diet 0.3 0.3 % 728143 RS:0000827 SS.LEW-(D1Mco38-D1Rat49)/Jr XCO:0000022 controlled sodium content diet 2 2 % 1357975 RS:0000866 SS.LEW-(D1Mco4-D1Rat18)/Mco XCO:0000022 controlled sodium content diet 2 2 % 9685795 RS:0003863 SS.LEW-(D1Mco55-D1Wox6)/Bj XCO:0000022 controlled sodium content diet 0.3 0.3 % 9685795 RS:0003863 SS.LEW-(D1Mco55-D1Wox6)/Bj XCO:0000022 controlled sodium content diet 2 2 % 9685795 RS:0003863 SS.LEW-(D1Mco55-D1Wox6)/Bj XCO:0000035 housing in pairs 1357983 RS:0000867 SS.LEW-(D1Mco75-D1Rat18)/Mco XCO:0000022 controlled sodium content diet 2 2 % 1357977 RS:0000868 SS.LEW-(D1Mco8-D1Rat213)/Mco XCO:0000022 controlled sodium content diet 2 2 % 2292652 RS:0001500 SS.LEW-(D1Mco85-D1Rat49)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 2292652 RS:0001500 SS.LEW-(D1Mco85-D1Rat49)/Mco XCO:0000022 controlled sodium content diet 2 2 % 728162 RS:0000829 SS.LEW-(D1Mco87-D1Rat71)/Jr XCO:0000022 controlled sodium content diet 0.3 0.3 % 728162 RS:0000829 SS.LEW-(D1Mco87-D1Rat71)/Jr XCO:0000022 controlled sodium content diet 2 2 % 2292651 RS:0001501 SS.LEW-(D1Mco99-D1Rat49)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 2292651 RS:0001501 SS.LEW-(D1Mco99-D1Rat49)/Mco XCO:0000022 controlled sodium content diet 2 2 % 728165 RS:0000824 SS.LEW-(D1Rat196-D1Mco36)/Jr XCO:0000022 controlled sodium content diet 0.3 0.3 % 728165 RS:0000824 SS.LEW-(D1Rat196-D1Mco36)/Jr XCO:0000022 controlled sodium content diet 2 2 % 728152 RS:0000825 SS.LEW-(D1Rat196-D1Mgh7)/Jr XCO:0000022 controlled sodium content diet 0.3 0.3 % 728152 RS:0000825 SS.LEW-(D1Rat196-D1Mgh7)/Jr XCO:0000022 controlled sodium content diet 2 2 % 9685793 RS:0003862 SS.LEW-(D1Rat200-D1Mco136)/Bj XCO:0000022 controlled sodium content diet 0.3 0.3 % 9685793 RS:0003862 SS.LEW-(D1Rat200-D1Mco136)/Bj XCO:0000022 controlled sodium content diet 2 2 % 9685793 RS:0003862 SS.LEW-(D1Rat200-D1Mco136)/Bj XCO:0000035 housing in pairs 731190 RS:0000870 SS.LEW-(D1Rat211-D1Rat18)/Mco XCO:0000182 controlled exposure to ambient light 731190 RS:0000870 SS.LEW-(D1Rat211-D1Rat18)/Mco XCO:0000183 controlled exposure to darkness 731190 RS:0000870 SS.LEW-(D1Rat211-D1Rat18)/Mco XCO:0000022 controlled sodium content diet 2 2 % 8551752 RS:0003667 SS.LEW-(D1Rat320-D1Mgh32)(D10Rat194-D10Chm243)(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551752 RS:0003667 SS.LEW-(D1Rat320-D1Mgh32)(D10Rat194-D10Chm243)(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 7421603 RS:0003579 SS.LEW-(D1Rat320-D1Mgh32)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 7421603 RS:0003579 SS.LEW-(D1Rat320-D1Mgh32)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 728134 RS:0000831 SS.LEW-(D1Rat35-D1Rat49)/Jr XCO:0000022 controlled sodium content diet 0.3 0.3 % 728134 RS:0000831 SS.LEW-(D1Rat35-D1Rat49)/Jr XCO:0000022 controlled sodium content diet 2 2 % 728163 RS:0000828 SS.LEW-(D1Uia2-D1Rat49)/Jr XCO:0000022 controlled sodium content diet 0.3 0.3 % 728163 RS:0000828 SS.LEW-(D1Uia2-D1Rat49)/Jr XCO:0000022 controlled sodium content diet 2 2 % 8551750 RS:0003666 SS.LEW-(D1Uia4-D1Rat320)(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551750 RS:0003666 SS.LEW-(D1Uia4-D1Rat320)(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 7421606 RS:0003581 SS.LEW-(D1Uia4-D1Rat320)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 7421606 RS:0003581 SS.LEW-(D1Uia4-D1Rat320)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 631571 RS:0000871 SS.LEW-(D1Uia8-D1Mco38)/Jr XCO:0000022 controlled sodium content diet 0.3 0.3 % 631571 RS:0000871 SS.LEW-(D1Uia8-D1Mco38)/Jr XCO:0000022 controlled sodium content diet 2 2 % 4107063 RS:0002424 SS.LEW-(D1Uia8-D1Rat124)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 4107063 RS:0002424 SS.LEW-(D1Uia8-D1Rat124)/Mco XCO:0000022 controlled sodium content diet 2 2 % 1357987 RS:0000865 SS.LEW-(D1Uia8-D1Rat18)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 1357987 RS:0000865 SS.LEW-(D1Uia8-D1Rat18)/Mco XCO:0000022 controlled sodium content diet 2 2 % 1357986 RS:0000875 SS.LEW-(D1Uia8-D1Rat211)/Mco XCO:0000022 controlled sodium content diet 2 2 % 4107065 RS:0002425 SS.LEW-(D1Uia8-D1Rat213)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 4107065 RS:0002425 SS.LEW-(D1Uia8-D1Rat213)/Mco XCO:0000022 controlled sodium content diet 2 2 % 1579896 RS:0001535 SS.LEW-(D2Rat18-D2Chm277)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1549794 RS:0000876 SS.LEW-(D2Rat199-D2Mco17)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 1549794 RS:0000876 SS.LEW-(D2Rat199-D2Mco17)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551737 RS:0003661 SS.LEW-(D2Uia5-D2Mit6)(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551737 RS:0003661 SS.LEW-(D2Uia5-D2Mit6)(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551739 RS:0003662 SS.LEW-(D2Uia5-D2Mit6)(D10Rat194-D10Chm243)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551739 RS:0003662 SS.LEW-(D2Uia5-D2Mit6)(D10Rat194-D10Chm243)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 731194 RS:0000879 SS.LEW-(D3Chm64-D3Rat17)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 731194 RS:0000879 SS.LEW-(D3Chm64-D3Rat17)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2301248 RS:0001645 SS.LEW-(D3Got33-D3Chm68)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1357981 RS:0000880 SS.LEW-(D3Mco21-D3Rat17)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 1357981 RS:0000880 SS.LEW-(D3Mco21-D3Rat17)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551730 RS:0003658 SS.LEW-(D3Rat2-D3Chm79)(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551730 RS:0003658 SS.LEW-(D3Rat2-D3Chm79)(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551727 RS:0003657 SS.LEW-(D3Rat2-D3Chm79)(D10Rat194-D10Chm243)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551727 RS:0003657 SS.LEW-(D3Rat2-D3Chm79)(D10Rat194-D10Chm243)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2325796 RS:0002416 SS.LEW-(D3Rat52-D3Chm57)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 2325796 RS:0002416 SS.LEW-(D3Rat52-D3Chm57)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1357982 RS:0000881 SS.LEW-(D3Rat52-D3Chm63)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 1357982 RS:0000881 SS.LEW-(D3Rat52-D3Chm63)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 731192 RS:0000882 SS.LEW-(D3Rat52-D3Rat130)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 731192 RS:0000882 SS.LEW-(D3Rat52-D3Rat130)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1357988 RS:0000878 SS.LEW-(D3Rat52-D3Rat17)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 1357988 RS:0000878 SS.LEW-(D3Rat52-D3Rat17)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 2301246 RS:0001643 SS.LEW-(D3Rat61-D3Wox1)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 2301246 RS:0001643 SS.LEW-(D3Rat61-D3Wox1)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 7794706 RS:0003613 SS.LEW-(D5Mco39-D5Mco41)(D5Mco42-D5Mco47)/Mco XCO:0000022 controlled sodium content diet 2 2 % 7794700 RS:0003611 SS.LEW-(D5Mco39-D5Mco41)/Mco XCO:0000022 controlled sodium content diet 2 2 % 7777140 RS:0003604 SS.LEW-(D5Mco39-D5Mco57)(D5Mco41-D5Mco47)/Mco XCO:0000022 controlled sodium content diet 2 2 % 7794691 RS:0003607 SS.LEW-(D5Mco39-D5Mco57)(D5Mco42-D5Mco47)/Mco XCO:0000022 controlled sodium content diet 2 2 % 7794698 RS:0003610 SS.LEW-(D5Mco39-D5Mco57)(D5Mco43-D5Mco47)/Mco XCO:0000022 controlled sodium content diet 2 2 % 7777135 RS:0003602 SS.LEW-(D5Mco39-D5Mco57)/1Mco XCO:0000022 controlled sodium content diet 2 2 % 7777143 RS:0003605 SS.LEW-(D5Mco39-D5Mco57)/2Mco XCO:0000022 controlled sodium content diet 2 2 % 7794694 RS:0003608 SS.LEW-(D5Mco39-D5Mco57)/3Mco XCO:0000022 controlled sodium content diet 2 2 % 7777138 RS:0003603 SS.LEW-(D5Mco41-D5Mco47)/Mco XCO:0000022 controlled sodium content diet 2 2 % 7777180 RS:0003606 SS.LEW-(D5Mco42-D5Mco47)/1Mco XCO:0000022 controlled sodium content diet 2 2 % 7794704 RS:0003612 SS.LEW-(D5Mco42-D5Mco47)/2Mco XCO:0000022 controlled sodium content diet 2 2 % 7794696 RS:0003609 SS.LEW-(D5Mco43-D5Mco47)/Mco XCO:0000022 controlled sodium content diet 2 2 % 7421610 RS:0003582 SS.LEW-(D5Mit5-D5M4Mit14)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 7421610 RS:0003582 SS.LEW-(D5Mit5-D5M4Mit14)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 734474 RS:0000883 SS.LEW-(D5Mit9-D5Mco10)/Jr XCO:0000022 controlled sodium content diet 2 2 % 1579902 RS:0001536 SS.LEW-(D5Rat130-D5Rat108)/JrMcwi XCO:0000099 control condition 1579902 RS:0001536 SS.LEW-(D5Rat130-D5Rat108)/JrMcwi XCO:0000022 controlled sodium content diet 8 8 % 1579899 RS:0001537 SS.LEW-(D5Rat130-D5Rat31)/JrMcwi XCO:0000168 controlled in situ renal perfusion pressure 125 130 mmHg 1579899 RS:0001537 SS.LEW-(D5Rat130-D5Rat31)/JrMcwi XCO:0000168 controlled in situ renal perfusion pressure 150 150 mmHg 1579899 RS:0001537 SS.LEW-(D5Rat130-D5Rat31)/JrMcwi XCO:0000168 controlled in situ renal perfusion pressure 170 175 mmHg 1579899 RS:0001537 SS.LEW-(D5Rat130-D5Rat31)/JrMcwi XCO:0000022 controlled sodium content diet 8 8 % 1579911 RS:0001538 SS.LEW-(D5Rat130-D5Rat72)/Mcwi XCO:0000099 control condition 1579911 RS:0001538 SS.LEW-(D5Rat130-D5Rat72)/Mcwi XCO:0000022 controlled sodium content diet 8 8 % 4891048 RS:0000211 SS.LEW-(D7Rat73-D7Rat128)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 4891048 RS:0000211 SS.LEW-(D7Rat73-D7Rat128)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551757 RS:0003669 SS.LEW-(D7Uia3-D7Mgh1)(D10Rat194-D10Chm243)(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551757 RS:0003669 SS.LEW-(D7Uia3-D7Mgh1)(D10Rat194-D10Chm243)(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551725 RS:0003656 SS.LEW-(D8Chm12-D8Rat15)(D10Rat194-D10Chm243)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551725 RS:0003656 SS.LEW-(D8Chm12-D8Rat15)(D10Rat194-D10Chm243)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1357180 RS:0000841 SS.LEW-(D8Chm14-D8Rat16)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 1357180 RS:0000841 SS.LEW-(D8Chm14-D8Rat16)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1357189 RS:0000840 SS.LEW-(D8Rat56-D8Rat51)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 1357189 RS:0000840 SS.LEW-(D8Rat56-D8Rat51)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551721 RS:0003654 SS.LEW-(D8Rat58-D8Chm12)(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551721 RS:0003654 SS.LEW-(D8Rat58-D8Chm12)(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551723 RS:0003655 SS.LEW-(D8Rat58-D8Chm12)(D10Rat194-D10Chm243)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551723 RS:0003655 SS.LEW-(D8Rat58-D8Chm12)(D10Rat194-D10Chm243)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1549808 RS:0000885 SS.LEW-(Prlr-D2Rat143)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 1549808 RS:0000885 SS.LEW-(Prlr-D2Rat143)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1357190 RS:0000886 SS.MNS-(Adh1-D2Mit5)/Mco XCO:0000022 controlled sodium content diet 2 2 % 1357195 RS:0000895 SS.MNS-(Aldoc-D10Mco1)/Jr XCO:0000022 controlled sodium content diet 2 2 % 1641859 RS:0001539 SS.MNS-(D10Bra1-D10Mit11)/Jr XCO:0000022 controlled sodium content diet 2 2 % 631587 RS:0000892 SS.MNS-(D10M11Mit119-D10Mit11)/Jr XCO:0000022 controlled sodium content diet 0.2 0.2 % 631587 RS:0000892 SS.MNS-(D10M11Mit119-D10Mit11)/Jr XCO:0000022 controlled sodium content diet 2 2 % 1357183 RS:0000893 SS.MNS-(D10Mco10-Aldoc)/Jr XCO:0000022 controlled sodium content diet 2 2 % 631586 RS:0000888 SS.MNS-(D10Mco14-D10Mit11)/Jr XCO:0000022 controlled sodium content diet 2 2 % 2289916 RS:0001541 SS.MNS-(D10Mco15-D10Mit11)/Jr XCO:0000022 controlled sodium content diet 2 2 % 2289824 RS:0001544 SS.MNS-(D10Mco30-D10Got101)/Mco XCO:0000022 controlled sodium content diet 2 2 % 2289822 RS:0001545 SS.MNS-(D10Mco30-D10Got112)/Mco XCO:0000022 controlled sodium content diet 2 2 % 2289820 RS:0001546 SS.MNS-(D10Mco30-D10Got91)/1Mco XCO:0000022 controlled sodium content diet 2 2 % 2289826 RS:0001547 SS.MNS-(D10Mco30-D10Got91)/2Mco XCO:0000022 controlled sodium content diet 2 2 % 2289821 RS:0001548 SS.MNS-(D10Mco30-D10Got91)/3Mco XCO:0000022 controlled sodium content diet 2 2 % 2289827 RS:0001543 SS.MNS-(D10Mco30-D10Mco31)/Jr XCO:0000022 controlled sodium content diet 2 2 % 1641869 RS:0001549 SS.MNS-(D10Mco31-D10Mit11)/Jr XCO:0000022 controlled sodium content diet 2 2 % 2289819 RS:0001550 SS.MNS-(D10Mco62-D10Got99)/Mco XCO:0000022 controlled sodium content diet 2 2 % 2289823 RS:0001551 SS.MNS-(D10Mco62-D10Mco30)/Mco XCO:0000022 controlled sodium content diet 2 2 % 1641871 RS:0001542 SS.MNS-(D10Mco62-D10Mco31)/Jr XCO:0000022 controlled sodium content diet 2 2 % 1641860 RS:0001552 SS.MNS-(D10Mco62-D10Mit1)/Jr XCO:0000022 controlled sodium content diet 2 2 % 2289917 RS:0001553 SS.MNS-(D10Mco70-D10Mit11)/Jr XCO:0000022 controlled sodium content diet 2 2 % 631606 RS:0001540 SS.MNS-(D10Rat13-D10Mit11)/Jr XCO:0000022 controlled sodium content diet 2 2 % 2289913 RS:0001554 SS.MNS-(D10Rat13-D10Rat12)/Jr XCO:0000022 controlled sodium content diet 2 2 % 2289825 RS:0001555 SS.MNS-(D10Rat24-D10Mco31)/Jr XCO:0000022 controlled sodium content diet 2 2 % 7421649 RS:0003595 SS.MNS-(D2Chm153-D2Chm410)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 7421649 RS:0003595 SS.MNS-(D2Chm153-D2Chm410)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 7421647 RS:0003594 SS.MNS-(D2Chm161-D2Chm410)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 7421647 RS:0003594 SS.MNS-(D2Chm161-D2Chm410)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1358177 RS:0000898 SS.MNS-(D2Chm25-D2Mit14)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 1358177 RS:0000898 SS.MNS-(D2Chm25-D2Mit14)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1358169 RS:0000899 SS.MNS-(D2Chm25-D2Rat131)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1358172 RS:0000900 SS.MNS-(D2Chm25-Fgg)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 1358172 RS:0000900 SS.MNS-(D2Chm25-Fgg)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 7421643 RS:0003592 SS.MNS-(D2Chm254-D2Chm161)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 7421643 RS:0003592 SS.MNS-(D2Chm254-D2Chm161)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551774 RS:0003675 SS.MNS-(D2Chm33-Tm2sf1),LEW-(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551774 RS:0003675 SS.MNS-(D2Chm33-Tm2sf1),LEW-(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551772 RS:0003674 SS.MNS-(D2Chm33-Tm2sf1),LEW-(D10Rat194-D10Chm243),LEW-(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551772 RS:0003674 SS.MNS-(D2Chm33-Tm2sf1),LEW-(D10Rat194-D10Chm243),LEW-(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551776 RS:0003676 SS.MNS-(D2Chm33-Tm2sf1),LEW-(D10Rat194-D10Chm243)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551776 RS:0003676 SS.MNS-(D2Chm33-Tm2sf1),LEW-(D10Rat194-D10Chm243)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551778 RS:0003677 SS.MNS-(D2Chm33-Tm2sf1),LEW-(D3Rat2-D3Chm79)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551778 RS:0003677 SS.MNS-(D2Chm33-Tm2sf1),LEW-(D3Rat2-D3Chm79)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 7421654 RS:0003597 SS.MNS-(D2Chm366-D2Rat52)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 7421654 RS:0003597 SS.MNS-(D2Chm366-D2Rat52)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 7421638 RS:0003590 SS.MNS-(D2Chm381-D2Chm225)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 7421638 RS:0003590 SS.MNS-(D2Chm381-D2Chm225)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 7421651 RS:0003596 SS.MNS-(D2Chm442-D2Chm410)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 7421651 RS:0003596 SS.MNS-(D2Chm442-D2Chm410)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1358165 RS:0000902 SS.MNS-(D2Chm51-D2Rat341)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551759 RS:0003670 SS.MNS-(D2Chm90-D2Rat38),LEW-(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551759 RS:0003670 SS.MNS-(D2Chm90-D2Rat38),LEW-(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551761 RS:0003671 SS.MNS-(D2Chm90-D2Rat38),LEW-(D10Got112-Igfbp4)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551761 RS:0003671 SS.MNS-(D2Chm90-D2Rat38),LEW-(D10Got112-Igfbp4)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 7421636 RS:0003589 SS.MNS-(D2Chm90-D2Rat38)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 7421636 RS:0003589 SS.MNS-(D2Chm90-D2Rat38)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 7421634 RS:0003588 SS.MNS-(D2Got93-D2Rat222)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 7421634 RS:0003588 SS.MNS-(D2Got93-D2Rat222)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 728172 RS:0000889 SS.MNS-(D2Mit6-Adh1)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 728172 RS:0000889 SS.MNS-(D2Mit6-Adh1)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1357984 RS:0000901 SS.MNS-(D2Mit6-D2Rat166)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 1357984 RS:0000901 SS.MNS-(D2Mit6-D2Rat166)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1357978 RS:0000903 SS.MNS-(D2Mit6-D2Rat303)/Ayd XCO:0000116 Kreb's solution perfusate 1357978 RS:0000903 SS.MNS-(D2Mit6-D2Rat303)/Ayd XCO:0000121 NG-nitroarginine methyl ester 100 100 umol/l 1357978 RS:0000903 SS.MNS-(D2Mit6-D2Rat303)/Ayd XCO:0000191 angiotensin II 0.3 300 umol/l 1357978 RS:0000903 SS.MNS-(D2Mit6-D2Rat303)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 1357978 RS:0000903 SS.MNS-(D2Mit6-D2Rat303)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1357978 RS:0000903 SS.MNS-(D2Mit6-D2Rat303)/Ayd XCO:0000145 phenylephrine 1 100 mmol/l 1357978 RS:0000903 SS.MNS-(D2Mit6-D2Rat303)/Ayd XCO:0000312 potassium chloride solution 40 40 mmol/l 7421640 RS:0003591 SS.MNS-(D2Rat155-D2Chm161)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 7421640 RS:0003591 SS.MNS-(D2Rat155-D2Chm161)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551766 RS:0003673 SS.MNS-(D2Rat155-D2Chm419),LEW-(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551766 RS:0003673 SS.MNS-(D2Rat155-D2Chm419),LEW-(D10Chm10-D10Rat11)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 8551763 RS:0003672 SS.MNS-(D2Rat155-D2Chm419),LEW-(D10Rat194-D10Chm243)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 8551763 RS:0003672 SS.MNS-(D2Rat155-D2Chm419),LEW-(D10Rat194-D10Chm243)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 7421645 RS:0003593 SS.MNS-(D2Rat155-D2Chm419)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 7421645 RS:0003593 SS.MNS-(D2Rat155-D2Chm419)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1358156 RS:0000904 SS.MNS-(D2Rat183-D2Chm113)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 1358156 RS:0000904 SS.MNS-(D2Rat183-D2Chm113)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1358167 RS:0000905 SS.MNS-(D2Wox27-Adh1)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 1358167 RS:0000905 SS.MNS-(D2Wox27-Adh1)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 728170 RS:0000890 SS.MNS-(Mme-D2Mit14)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1357979 RS:0000906 SS.MNS-(Mme-D2Rat131)/Ayd XCO:0000022 controlled sodium content diet 0.2 0.2 % 1357979 RS:0000906 SS.MNS-(Mme-D2Rat131)/Ayd XCO:0000022 controlled sodium content diet 2 2 % 1579697 RS:0001556 SS.SHR-(D13Rat63-D13Mit1)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 1579703 RS:0001559 SS.SHR-(D2Rat61-D2Mco18)/Mco XCO:0000099 control condition 2314530 RS:0002200 SS.SHR-(D8Uia1-D8Rat90)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 11354926 RS:0004203 SS.SHR-(D9Mco110-D9Got111)/Bj XCO:0000022 controlled sodium content diet 0.3 0.3 % 11354926 RS:0004203 SS.SHR-(D9Mco110-D9Got111)/Bj XCO:0000022 controlled sodium content diet 2 2 % 11354928 RS:0004204 SS.SHR-(D9Mco110-D9Mco114)/Bj XCO:0000022 controlled sodium content diet 0.3 0.3 % 11354928 RS:0004204 SS.SHR-(D9Mco110-D9Mco114)/Bj XCO:0000022 controlled sodium content diet 2 2 % 11354903 RS:0004201 SS.SHR-(D9Mco110-D9Mco121)/Bj XCO:0000022 controlled sodium content diet 0.3 0.3 % 11354903 RS:0004201 SS.SHR-(D9Mco110-D9Mco121)/Bj XCO:0000022 controlled sodium content diet 2 2 % 11354901 RS:0004200 SS.SHR-(D9Mco110-D9Mco124)/Bj XCO:0000022 controlled sodium content diet 0.3 0.3 % 11354901 RS:0004200 SS.SHR-(D9Mco110-D9Mco124)/Bj XCO:0000022 controlled sodium content diet 2 2 % 11354924 RS:0004202 SS.SHR-(D9Mco113-D9Mco124)/Bj XCO:0000022 controlled sodium content diet 0.3 0.3 % 11354924 RS:0004202 SS.SHR-(D9Mco113-D9Mco124)/Bj XCO:0000022 controlled sodium content diet 2 2 % 11354930 RS:0004205 SS.SHR-(D9Mco115-D9Mco124)/Bj XCO:0000022 controlled sodium content diet 0.3 0.3 % 11354930 RS:0004205 SS.SHR-(D9Mco115-D9Mco124)/Bj XCO:0000022 controlled sodium content diet 2 2 % 6903925 RS:0003337 SS.SHR-(D9Mco72-D9Mco105)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 6903925 RS:0003337 SS.SHR-(D9Mco72-D9Mco105)/Mco XCO:0000022 controlled sodium content diet 2 2 % 6903922 RS:0003336 SS.SHR-(D9Mco72-D9Mco106)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 6903922 RS:0003336 SS.SHR-(D9Mco72-D9Mco106)/Mco XCO:0000022 controlled sodium content diet 2 2 % 6903917 RS:0003334 SS.SHR-(D9Mco72-D9Mco109)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 6903917 RS:0003334 SS.SHR-(D9Mco72-D9Mco109)/Mco XCO:0000022 controlled sodium content diet 2 2 % 2303152 RS:0002201 SS.SHR-(D9Mco72-D9Mco93)/Mco XCO:0000022 controlled sodium content diet 2 2 % 6903914 RS:0003333 SS.SHR-(D9Mco72-D9Rat55)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 6903914 RS:0003333 SS.SHR-(D9Mco72-D9Rat55)/Mco XCO:0000022 controlled sodium content diet 2 2 % 6903912 RS:0003332 SS.SHR-(D9Mco72-D9Rat89)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 6903912 RS:0003332 SS.SHR-(D9Mco72-D9Rat89)/Mco XCO:0000022 controlled sodium content diet 2 2 % 6903920 RS:0003335 SS.SHR-(D9Mco72-D9Uia4)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 6903920 RS:0003335 SS.SHR-(D9Mco72-D9Uia4)/Mco XCO:0000022 controlled sodium content diet 2 2 % 2303150 RS:0002202 SS.SHR-(D9Mco74-D9Rat64)/Mco XCO:0000022 controlled sodium content diet 2 2 % 6903928 RS:0003338 SS.SHR-(D9Rat7-D9Got111)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 6903928 RS:0003338 SS.SHR-(D9Rat7-D9Got111)/Mco XCO:0000022 controlled sodium content diet 2 2 % 6903934 RS:0003340 SS.SHR-(D9Rat7-D9Mco91)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 6903934 RS:0003340 SS.SHR-(D9Rat7-D9Mco91)/Mco XCO:0000022 controlled sodium content diet 2 2 % 2303153 RS:0002203 SS.SHR-(D9Rat7-D9Mco93)/Mco XCO:0000022 controlled sodium content diet 2 2 % 6903932 RS:0003339 SS.SHR-(D9Rat7-D9Rat52)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 6903932 RS:0003339 SS.SHR-(D9Rat7-D9Rat52)/Mco XCO:0000022 controlled sodium content diet 2 2 % 6903936 RS:0003341 SS.SHR-(D9Rat7-D9Rat84)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 6903936 RS:0003341 SS.SHR-(D9Rat7-D9Rat84)/Mco XCO:0000022 controlled sodium content diet 2 2 % 2303149 RS:0002204 SS.SHR-(D9Wox16-D9Mco73)/Mco XCO:0000022 controlled sodium content diet 2 2 % 2303151 RS:0002205 SS.SHR-(D9Wox16-D9Mco77)/Mco XCO:0000022 controlled sodium content diet 2 2 % 2303154 RS:0002206 SS.SHR-(D9Wox16-D9Mco85)/Mco XCO:0000022 controlled sodium content diet 2 2 % 1579702 RS:0001561 SS.SHR-(D9Wox16-D9Rat64)/Mco XCO:0000022 controlled sodium content diet 2 2 % 2303148 RS:0002207 SS.SHR-(D9Wox16-D9Rat76)/Mco XCO:0000022 controlled sodium content diet 2 2 % 1299869 RS:0000909 SS.SR-(Cyp11b1)/Jr XCO:0000022 controlled sodium content diet 0.2 0.2 % 1299869 RS:0000909 SS.SR-(Cyp11b1)/Jr XCO:0000022 controlled sodium content diet 1 1 % 1299869 RS:0000909 SS.SR-(Cyp11b1)/Jr XCO:0000022 controlled sodium content diet 2 2 % 1299869 RS:0000909 SS.SR-(Cyp11b1)/Jr XCO:0000022 controlled sodium content diet 4 4 % 737864 RS:0000914 SS.SR-(D13Mit9-D13Mit1)/Jr XCO:0000182 controlled exposure to ambient light 737864 RS:0000914 SS.SR-(D13Mit9-D13Mit1)/Jr XCO:0000183 controlled exposure to darkness 737864 RS:0000914 SS.SR-(D13Mit9-D13Mit1)/Jr XCO:0000022 controlled sodium content diet 0.2 0.2 % 737864 RS:0000914 SS.SR-(D13Mit9-D13Mit1)/Jr XCO:0000022 controlled sodium content diet 1 1 % 737864 RS:0000914 SS.SR-(D13Mit9-D13Mit1)/Jr XCO:0000022 controlled sodium content diet 2 2 % 737864 RS:0000914 SS.SR-(D13Mit9-D13Mit1)/Jr XCO:0000022 controlled sodium content diet 4 4 % 737864 RS:0000914 SS.SR-(D13Mit9-D13Mit1)/Jr XCO:0000022 controlled sodium content diet 8 8 % 737867 RS:0000910 SS.SR-(D13N1-D13Mit1)/Jr XCO:0000022 controlled sodium content diet 0.2 0.2 % 737867 RS:0000910 SS.SR-(D13N1-D13Mit1)/Jr XCO:0000022 controlled sodium content diet 2 2 % 737867 RS:0000910 SS.SR-(D13N1-D13Mit1)/Jr XCO:0000022 controlled sodium content diet 4 4 % 7771589 RS:0003598 SS.SR-(D2Rat352-rs63922710)/Opaz XCO:0000022 controlled sodium content diet 8 8 % 2306823 RS:0002214 SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 2306823 RS:0002214 SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco XCO:0000022 controlled sodium content diet 2 2 % 2306823 RS:0002214 SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco XCO:0000022 controlled sodium content diet 4 4 % 2306820 RS:0002213 SS.SR-(D3Arb14-D3Mco36)/Mco XCO:0000022 controlled sodium content diet 0.3 0.3 % 2306820 RS:0002213 SS.SR-(D3Arb14-D3Mco36)/Mco XCO:0000022 controlled sodium content diet 2 2 % 2306820 RS:0002213 SS.SR-(D3Arb14-D3Mco36)/Mco XCO:0000022 controlled sodium content diet 4 4 % 1559044 RS:0001562 SS.SR-(D3Mco19-D3Mco5)/Jr XCO:0000022 controlled sodium content diet 0.2 0.2 % 1559044 RS:0001562 SS.SR-(D3Mco19-D3Mco5)/Jr XCO:0000022 controlled sodium content diet 2 2 % 1582187 RS:0001563 SS.SR-(D3Mco24-D3Got130)/Jr XCO:0000022 controlled sodium content diet 0.4 0.4 % 1582187 RS:0001563 SS.SR-(D3Mco24-D3Got130)/Jr XCO:0000022 controlled sodium content diet 2 2 % 1582192 RS:0001564 SS.SR-(D3Mco36-D3Got159)/Jr XCO:0000022 controlled sodium content diet 0.4 0.4 % 1582192 RS:0001564 SS.SR-(D3Mco36-D3Got159)/Jr XCO:0000022 controlled sodium content diet 2 2 % 1582185 RS:0001565 SS.SR-(D3Mco36-D3Got166)/Jr XCO:0000022 controlled sodium content diet 0.4 0.4 % 1582185 RS:0001565 SS.SR-(D3Mco36-D3Got166)/Jr XCO:0000022 controlled sodium content diet 2 2 % 1582188 RS:0001566 SS.SR-(D3Mco36-D3Mco46)/Jr XCO:0000022 controlled sodium content diet 0.4 0.4 % 1582188 RS:0001566 SS.SR-(D3Mco36-D3Mco46)/Jr XCO:0000022 controlled sodium content diet 2 2 % 1582189 RS:0001567 SS.SR-(D3Mco39-D3Got130)/Jr XCO:0000022 controlled sodium content diet 0.4 0.4 % 1582189 RS:0001567 SS.SR-(D3Mco39-D3Got130)/Jr XCO:0000022 controlled sodium content diet 2 2 % 1582194 RS:0001568 SS.SR-(D3Mco78-D3Got130)/Jr XCO:0000022 controlled sodium content diet 0.4 0.4 % 1582194 RS:0001568 SS.SR-(D3Mco78-D3Got130)/Jr XCO:0000022 controlled sodium content diet 2 2 % 2306816 RS:0002208 SS.SR-(D7Mco19-D7Mco7)/Jr XCO:0000022 controlled sodium content diet 0.3 0.3 % 2306816 RS:0002208 SS.SR-(D7Mco19-D7Mco7)/Jr XCO:0000022 controlled sodium content diet 2 2 % 2306816 RS:0002208 SS.SR-(D7Mco19-D7Mco7)/Jr XCO:0000022 controlled sodium content diet 4 4 % 4107057 RS:0002422 SS.SR-(D7Mco7-D7Rat81)/Jr XCO:0000022 controlled sodium content diet 0.3 0.3 % 4107057 RS:0002422 SS.SR-(D7Mco7-D7Rat81)/Jr XCO:0000022 controlled sodium content diet 2 2 % 1299879 RS:0000911 SS.SR-(D7Mco7-D7Wox19)/Jr XCO:0000022 controlled sodium content diet 0.3 0.3 % 1299879 RS:0000911 SS.SR-(D7Mco7-D7Wox19)/Jr XCO:0000022 controlled sodium content diet 2 2 % 4107052 RS:0002420 SS.SR-(D7Rat16-D7Mgh5)/Jr XCO:0000022 controlled sodium content diet 0.3 0.3 % 4107052 RS:0002420 SS.SR-(D7Rat16-D7Mgh5)/Jr XCO:0000022 controlled sodium content diet 2 2 % 4107055 RS:0002423 SS.SR-(D7Rat16-D7Rat176)/Jr XCO:0000022 controlled sodium content diet 0.3 0.3 % 4107055 RS:0002423 SS.SR-(D7Rat16-D7Rat176)/Jr XCO:0000022 controlled sodium content diet 2 2 % 4107048 RS:0002421 SS.SR-(D7Rat16-D7Rat189)/Jr XCO:0000022 controlled sodium content diet 0.3 0.3 % 4107048 RS:0002421 SS.SR-(D7Rat16-D7Rat189)/Jr XCO:0000022 controlled sodium content diet 2 2 % 1299868 RS:0000912 SS.SR-(D7Uia1-D7Mco7)/Jr XCO:0000022 controlled sodium content diet 0.3 0.3 % 1299868 RS:0000912 SS.SR-(D7Uia1-D7Mco7)/Jr XCO:0000022 controlled sodium content diet 2 2 % 737868 RS:0000913 SS.SR-(Syt2-D13Mit1)/Jr XCO:0000022 controlled sodium content diet 0.2 0.2 % 737868 RS:0000913 SS.SR-(Syt2-D13Mit1)/Jr XCO:0000022 controlled sodium content diet 2 2 % 737868 RS:0000913 SS.SR-(Syt2-D13Mit1)/Jr XCO:0000022 controlled sodium content diet 4 4 % 7771600 RS:0003599 SS.SR-(rs106870553-rs63922710)/Opaz XCO:0000022 controlled sodium content diet 8 8 % 7365043 RS:0003553 SS.SR-(rs65785750-rs106808193)/Opaz XCO:0000022 controlled sodium content diet 8 8 % 7365040 RS:0003552 SS.SR-(rs65785750-rs13452155)/Opaz XCO:0000022 controlled sodium content diet 8 8 % 737907 RS:0000915 SS.SR-Inha/Jr XCO:0000022 controlled sodium content diet 2 2 % 1357179 RS:0000920 SS.WKY-(D2N35-Mme),MNS-(D10Mit11-D10M11Mit119)/Mco XCO:0000022 controlled sodium content diet 0.2 0.2 % 1357179 RS:0000920 SS.WKY-(D2N35-Mme),MNS-(D10Mit11-D10M11Mit119)/Mco XCO:0000022 controlled sodium content diet 2 2 % 631607 RS:0000919 SS.WKY-(D2N35-Mme)/Mco XCO:0000022 controlled sodium content diet 0.2 0.2 % 631607 RS:0000919 SS.WKY-(D2N35-Mme)/Mco XCO:0000022 controlled sodium content diet 2 2 % 13432151 RS:0004552 SS.ZUC-Leprfa+/+/Slc XCO:0000092 17 beta-estradiol 0.5 0.5 mg 13432151 RS:0004552 SS.ZUC-Leprfa+/+/Slc XCO:0000095 bilateral ovariectomy 13432151 RS:0004552 SS.ZUC-Leprfa+/+/Slc XCO:0000099 control condition 13432151 RS:0004552 SS.ZUC-Leprfa+/+/Slc XCO:0000553 everolimus 0.83 0.83 mg/kg/d 13432151 RS:0004552 SS.ZUC-Leprfa+/+/Slc XCO:0000102 fasting 13432151 RS:0004552 SS.ZUC-Leprfa+/+/Slc XCO:0000101 vehicle control condition 13432148 RS:0004550 SS.ZUC-Leprfa-/-/Slc XCO:0000092 17 beta-estradiol 0.5 0.5 mg 13432148 RS:0004550 SS.ZUC-Leprfa-/-/Slc XCO:0000628 atorvastatin 6 6 mg/kg/d 13432148 RS:0004550 SS.ZUC-Leprfa-/-/Slc XCO:0000628 atorvastatin 20 20 mg/kg/d 13432148 RS:0004550 SS.ZUC-Leprfa-/-/Slc XCO:0000095 bilateral ovariectomy 13432148 RS:0004550 SS.ZUC-Leprfa-/-/Slc XCO:0000099 control condition 13432148 RS:0004550 SS.ZUC-Leprfa-/-/Slc XCO:0000553 everolimus 0.83 0.83 mg/kg/d 13432148 RS:0004550 SS.ZUC-Leprfa-/-/Slc XCO:0000102 fasting 13432148 RS:0004550 SS.ZUC-Leprfa-/-/Slc XCO:0000101 vehicle control condition 0.5 0.5 % 13432148 RS:0004550 SS.ZUC-Leprfa-/-/Slc XCO:0000101 vehicle control condition 634365 RS:0000922 SS/Hsd XCO:0000586 Gnai2 antisense oligonucleotide 4.17 4.17 ug/d 634365 RS:0000922 SS/Hsd XCO:0000959 Guanabenz 50 50 ug 634365 RS:0000922 SS/Hsd XCO:0000337 air-jet exposure 1 1.5 lb/in2 634365 RS:0000922 SS/Hsd XCO:0000599 aldosterone 22.5 22.5 ng/hr 634365 RS:0000922 SS/Hsd XCO:0000956 artificial cerebrospinal fluid with 0.14 M sodium 4.4 4.6 ul/hr 634365 RS:0000922 SS/Hsd XCO:0000957 artificial cerebrospinal fluid with 0.15 M sodium 4.4 4.6 ul/hr 634365 RS:0000922 SS/Hsd XCO:0000958 artificial cerebrospinal fluid with 0.16 M sodium 4.4 4.6 ul/hr 634365 RS:0000922 SS/Hsd XCO:0000099 control condition 634365 RS:0000922 SS/Hsd XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 634365 RS:0000922 SS/Hsd XCO:0000795 controlled sodium chloride content diet 4 4 % 634365 RS:0000922 SS/Hsd XCO:0000022 controlled sodium content diet 0.3 0.3 % 634365 RS:0000922 SS/Hsd XCO:0000022 controlled sodium content diet 0.4 0.4 % 634365 RS:0000922 SS/Hsd XCO:0000022 controlled sodium content diet 4 4 % 634365 RS:0000922 SS/Hsd XCO:0000022 controlled sodium content diet 8 8 % 634365 RS:0000922 SS/Hsd XCO:0000102 fasting 634365 RS:0000922 SS/Hsd XCO:0000587 intracerebroventricular cannula implantation 634365 RS:0000922 SS/Hsd XCO:0000585 scrambled control oligodeoxynucleotide 4.17 4.17 ug/d 634365 RS:0000922 SS/Hsd XCO:0000100 sham surgical control condition 634365 RS:0000922 SS/Hsd XCO:0000373 surgical denervation 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000831 2% dimethyl sulfoxide in artificial cerebrospinal fluid 300 300 nl/min 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000218 4-alpha-phorbol 12,13-didecanoate 2.5 2.5 mg/kg 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000121 NG-nitroarginine methyl ester 100 100 umol/l 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000143 acetylcholine 0 95 umol/l 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000143 acetylcholine 0.001 9.5 umol/l 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000143 acetylcholine 0.001 95 umol/l 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000143 acetylcholine 3.16 3.16 umol/l 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000143 acetylcholine 31.6 31.6 umol/l 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000226 apamin 100 100 ug/kg 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000360 arterial catheter implantation 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000438 candesartan 0.5 0.5 ug/min 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000227 charybdotoxin 100 100 ug/kg 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000099 control condition 0.15 0.15 % 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000099 control condition 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000029 controlled carbohydrate content diet 53 53 % 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000029 controlled carbohydrate content diet 69 69 % 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000025 controlled fat content diet 12 12 % 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000025 controlled fat content diet 14 14 % 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000812 controlled hemorrhage 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000030 controlled protein content diet 19 19 % 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000030 controlled protein content diet 33 33 % 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000795 controlled sodium chloride content diet 0.1 0.1 % 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000795 controlled sodium chloride content diet 8 8 % 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000022 controlled sodium content diet 0.15 0.15 % 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000022 controlled sodium content diet 4 4 % 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000219 dihydrocapsaicin 30 30 ug/kg 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000654 kynurenate 0.14 0.14 ug/min 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000107 pentobarbital 50 50 mg/kg 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000145 phenylephrine 1 1 umol/l 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000145 phenylephrine 2 2 umol/l 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000145 phenylephrine 31.6 31.6 umol/l 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000312 potassium chloride solution 100 100 mmol/l 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000224 ruthenium red 3 3 mg/kg 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000142 sodium nitroprusside 0 9.5 umol/l 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000142 sodium nitroprusside 0.316 0.316 umol/l 2308886 RS:0002215 SS/HsdMcwiCrl XCO:0000142 sodium nitroprusside 3.16 3.16 umol/l 10041 RS:0000817 SS/Jr XCO:0000960 10% CO2, 20% O2, 70% N2 10 10 % 10041 RS:0000817 SS/Jr XCO:0000960 10% CO2, 20% O2, 70% N2 10041 RS:0000817 SS/Jr XCO:0000116 Kreb's solution perfusate 10041 RS:0000817 SS/Jr XCO:0000121 NG-nitroarginine methyl ester 100 100 umol/l 10041 RS:0000817 SS/Jr XCO:0000337 air-jet exposure 2 2 lb/in2 10041 RS:0000817 SS/Jr XCO:0000918 ambient air 10041 RS:0000817 SS/Jr XCO:0000191 angiotensin II 0.3 300 umol/l 10041 RS:0000817 SS/Jr XCO:0000631 atropine 1 1 mg/kg 10041 RS:0000817 SS/Jr XCO:0000268 balloon angioplasty 10041 RS:0000817 SS/Jr XCO:0000099 control condition 10041 RS:0000817 SS/Jr XCO:0000584 controlled cecal material content oral gavage 2 2 ml 10041 RS:0000817 SS/Jr XCO:0000182 controlled exposure to ambient light 10041 RS:0000817 SS/Jr XCO:0000183 controlled exposure to darkness 10041 RS:0000817 SS/Jr XCO:0000576 controlled meropenem content drinking water 50 50 mg/kg/d 10041 RS:0000817 SS/Jr XCO:0000583 controlled omeprazole content oral gavage 50 50 ml/kg/d 10041 RS:0000817 SS/Jr XCO:0000795 controlled sodium chloride content diet 0.3 0.3 % 10041 RS:0000817 SS/Jr XCO:0000795 controlled sodium chloride content diet 2 2 % 10041 RS:0000817 SS/Jr XCO:0000795 controlled sodium chloride content diet 8 8 % 10041 RS:0000817 SS/Jr XCO:0000022 controlled sodium content diet 0.2 0.2 % 10041 RS:0000817 SS/Jr XCO:0000022 controlled sodium content diet 0.3 0.3 % 10041 RS:0000817 SS/Jr XCO:0000022 controlled sodium content diet 0.4 0.4 % 10041 RS:0000817 SS/Jr XCO:0000022 controlled sodium content diet 1 1 % 10041 RS:0000817 SS/Jr XCO:0000022 controlled sodium content diet 2 2 % 10041 RS:0000817 SS/Jr XCO:0000022 controlled sodium content diet 4 4 % 10041 RS:0000817 SS/Jr XCO:0000022 controlled sodium content diet 8 8 % 10041 RS:0000817 SS/Jr XCO:0000022 controlled sodium content diet 10041 RS:0000817 SS/Jr XCO:0000574 controlled vancomycin content drinking water 50 50 mg/kg/d 10041 RS:0000817 SS/Jr XCO:0000107 pentobarbital 20 20 mg/kg 10041 RS:0000817 SS/Jr XCO:0000108 pentobarbital, sodium 20 20 mg/kg 10041 RS:0000817 SS/Jr XCO:0000145 phenylephrine 1 100 mmol/l 10041 RS:0000817 SS/Jr XCO:0000145 phenylephrine 5 50 ug/min 10041 RS:0000817 SS/Jr XCO:0000312 potassium chloride solution 40 40 mmol/l 10041 RS:0000817 SS/Jr XCO:0000254 sodium ion solution 800 800 mmol/l 10041 RS:0000817 SS/Jr XCO:0000142 sodium nitroprusside 10 100 ug/min 1582190 RS:0001481 SS/JrHsd XCO:0000092 17 beta-estradiol 5 5 mg 1582190 RS:0001481 SS/JrHsd XCO:0000092 17 beta-estradiol 10 10 ug/d 1582190 RS:0001481 SS/JrHsd XCO:0000095 bilateral ovariectomy 1582190 RS:0001481 SS/JrHsd XCO:0000629 carbenoxolone 100 100 mg/kg/d 1582190 RS:0001481 SS/JrHsd XCO:0000099 control condition 1582190 RS:0001481 SS/JrHsd XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 1582190 RS:0001481 SS/JrHsd XCO:0000795 controlled sodium chloride content diet 4 4 % 1582190 RS:0001481 SS/JrHsd XCO:0000022 controlled sodium content diet 0.1 0.1 % 1582190 RS:0001481 SS/JrHsd XCO:0000022 controlled sodium content diet 8 8 % 1582190 RS:0001481 SS/JrHsd XCO:0000917 distilled water 1582190 RS:0001481 SS/JrHsd XCO:0000916 gelled diet 200 200 g/kg/d 1582190 RS:0001481 SS/JrHsd XCO:0000823 peanut oil 0.2 0.2 ml 1582190 RS:0001481 SS/JrHsd XCO:0000100 sham surgical control condition 61499 RS:0000811 SS/JrHsdMcwi XCO:0000156 0.9% sodium chloride solution 61499 RS:0000811 SS/JrHsdMcwi XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 61499 RS:0000811 SS/JrHsdMcwi XCO:0000137 FAPGG 0.6 0.6 mmol/l 61499 RS:0000811 SS/JrHsdMcwi XCO:0000116 Kreb's solution perfusate 61499 RS:0000811 SS/JrHsdMcwi XCO:0000121 NG-nitroarginine methyl ester 5 5 mg/kg 61499 RS:0000811 SS/JrHsdMcwi XCO:0000121 NG-nitroarginine methyl ester 100 100 umol/l 61499 RS:0000811 SS/JrHsdMcwi XCO:0000143 acetylcholine 0 30 umol/l 61499 RS:0000811 SS/JrHsdMcwi XCO:0000143 acetylcholine 0.1 0.1 ug/kg/min 61499 RS:0000811 SS/JrHsdMcwi XCO:0000143 acetylcholine 0.2 0.2 ug/kg/min 61499 RS:0000811 SS/JrHsdMcwi XCO:0000012 air carbon dioxide content 7 7 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000012 air carbon dioxide content 7 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000126 angiotensin 5 5 ng/kg/min 61499 RS:0000811 SS/JrHsdMcwi XCO:0000126 angiotensin 10 10 ng/kg/min 61499 RS:0000811 SS/JrHsdMcwi XCO:0000126 angiotensin 25 25 ng/kg/min 61499 RS:0000811 SS/JrHsdMcwi XCO:0000126 angiotensin 50 50 ng/kg/min 61499 RS:0000811 SS/JrHsdMcwi XCO:0000191 angiotensin II 3 3 ng/kg/min 61499 RS:0000811 SS/JrHsdMcwi XCO:0000191 angiotensin II 20 20 ng/kg/min 61499 RS:0000811 SS/JrHsdMcwi XCO:0000191 angiotensin II 100 100 ng/kg/min 61499 RS:0000811 SS/JrHsdMcwi XCO:0000191 angiotensin II 200 200 ng/kg/min 61499 RS:0000811 SS/JrHsdMcwi XCO:0000522 common peroneal nerve direct electrical stimulation 3 3 V 61499 RS:0000811 SS/JrHsdMcwi XCO:0000099 control condition 0.4 0.4 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000099 control condition 61499 RS:0000811 SS/JrHsdMcwi XCO:0000010 controlled air oxygen content 12 12 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000010 controlled air oxygen content 12 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000215 controlled calcium ion content physiological salt solution perfusate 0 0 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000382 controlled captopril content drinking water 100 100 mg/kg/d 61499 RS:0000811 SS/JrHsdMcwi XCO:0000466 controlled ex vivo artery perfusion pressure 60 60 mmHg 61499 RS:0000811 SS/JrHsdMcwi XCO:0000182 controlled exposure to ambient light 61499 RS:0000811 SS/JrHsdMcwi XCO:0000183 controlled exposure to darkness 61499 RS:0000811 SS/JrHsdMcwi XCO:0000168 controlled in situ renal perfusion pressure 125 130 mmHg 61499 RS:0000811 SS/JrHsdMcwi XCO:0000168 controlled in situ renal perfusion pressure 150 150 mmHg 61499 RS:0000811 SS/JrHsdMcwi XCO:0000168 controlled in situ renal perfusion pressure 170 175 mmHg 61499 RS:0000811 SS/JrHsdMcwi XCO:0000383 controlled losartan content drinking water 20 20 mg/kg/d 61499 RS:0000811 SS/JrHsdMcwi XCO:0000383 controlled losartan content drinking water 50 50 mg/kg/d 61499 RS:0000811 SS/JrHsdMcwi XCO:0000146 controlled oxygen content Kreb's solution perfusate 61499 RS:0000811 SS/JrHsdMcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000795 controlled sodium chloride content diet 0.4 0.4 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000795 controlled sodium chloride content diet 1 1 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000795 controlled sodium chloride content diet 4 4 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000795 controlled sodium chloride content diet 8 8 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000022 controlled sodium content diet 0 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000022 controlled sodium content diet 0.1 0.1 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000022 controlled sodium content diet 0.4 0.4 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000022 controlled sodium content diet 1 1 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000022 controlled sodium content diet 4 4 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000022 controlled sodium content diet 4 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000022 controlled sodium content diet 8 8 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000384 controlled tempol content drinking water 15 15 mg/kg/d 61499 RS:0000811 SS/JrHsdMcwi XCO:0000152 drug dose time series 61499 RS:0000811 SS/JrHsdMcwi XCO:0000102 fasting 61499 RS:0000811 SS/JrHsdMcwi XCO:0000124 furosemide 10 10 mg/kg 61499 RS:0000811 SS/JrHsdMcwi XCO:0000109 isoflurane 1 2 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000134 methacholine 0 11.06 mg/kg 61499 RS:0000811 SS/JrHsdMcwi XCO:0000138 methylene blue 10 10 umol/l 61499 RS:0000811 SS/JrHsdMcwi XCO:0000642 monocrotaline 40 40 mg/kg 61499 RS:0000811 SS/JrHsdMcwi XCO:0000642 monocrotaline 40 40 61499 RS:0000811 SS/JrHsdMcwi XCO:0000127 norepinephrine 0.1 0.1 ng/kg/min 61499 RS:0000811 SS/JrHsdMcwi XCO:0000127 norepinephrine 0.2 0.2 ng/kg/min 61499 RS:0000811 SS/JrHsdMcwi XCO:0000127 norepinephrine 0.5 0.5 ng/kg/min 61499 RS:0000811 SS/JrHsdMcwi XCO:0000127 norepinephrine 0.5 0.5 ug/kg/min 61499 RS:0000811 SS/JrHsdMcwi XCO:0000127 norepinephrine 1 1 ng/kg/min 61499 RS:0000811 SS/JrHsdMcwi XCO:0000127 norepinephrine 1 1 ug/kg/min 61499 RS:0000811 SS/JrHsdMcwi XCO:0000127 norepinephrine 3 3 ug/kg/min 61499 RS:0000811 SS/JrHsdMcwi XCO:0000118 perfusate suspended 61499 RS:0000811 SS/JrHsdMcwi XCO:0000145 phenylephrine 0 300 umol/l 61499 RS:0000811 SS/JrHsdMcwi XCO:0000145 phenylephrine 1 1 umol/l 61499 RS:0000811 SS/JrHsdMcwi XCO:0000145 phenylephrine 10 10 umol/l 61499 RS:0000811 SS/JrHsdMcwi XCO:0000157 physical restraint 20 30 min/d 61499 RS:0000811 SS/JrHsdMcwi XCO:0000147 physiological salt solution perfusate 61499 RS:0000811 SS/JrHsdMcwi XCO:0000150 potassium ion 80 80 mmol/l 61499 RS:0000811 SS/JrHsdMcwi XCO:0000003 resting on treadmill 61499 RS:0000811 SS/JrHsdMcwi XCO:0000005 running on treadmill 1.6 1.6 m/min 61499 RS:0000811 SS/JrHsdMcwi XCO:0000153 sample resting period 61499 RS:0000811 SS/JrHsdMcwi XCO:0000142 sodium nitroprusside 0 3 umol/l 61499 RS:0000811 SS/JrHsdMcwi XCO:0000055 tactile electric shock exposure 2 2 % 61499 RS:0000811 SS/JrHsdMcwi XCO:0000101 vehicle control condition 61499 RS:0000811 SS/JrHsdMcwi XCO:0000004 walking on treadmill 0.8 0.8 m/min 737912 RS:0000923 SS/JrIpcv XCO:0000022 controlled sodium content diet 0.3 0.3 % 631695 RS:0000925 SS/JrRkb XCO:0000022 controlled sodium content diet 0.2 0.2 % 631695 RS:0000925 SS/JrRkb XCO:0000022 controlled sodium content diet 4 4 % 2325202 RS:0002409 SS/JrSeac XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2325202 RS:0002409 SS/JrSeac XCO:0000293 99mTc-sestamibi 37 37 MBq/l 2325202 RS:0002409 SS/JrSeac XCO:0000116 Kreb's solution perfusate 2325202 RS:0002409 SS/JrSeac XCO:0000099 control condition 2325202 RS:0002409 SS/JrSeac XCO:0000146 controlled oxygen content Kreb's solution perfusate 2325202 RS:0002409 SS/JrSeac XCO:0000022 controlled sodium content diet 0.3 0.3 % 2325202 RS:0002409 SS/JrSeac XCO:0000022 controlled sodium content diet 8 8 % 2325202 RS:0002409 SS/JrSeac XCO:0000102 fasting 2325202 RS:0002409 SS/JrSeac XCO:0000087 specific pathogen-free condition 724573 RS:0000924 SS/JrTol XCO:0000099 control condition 724573 RS:0000924 SS/JrTol XCO:0000022 controlled sodium content diet 0.3 0.3 % 724573 RS:0000924 SS/JrTol XCO:0000022 controlled sodium content diet 2 2 % 724573 RS:0000924 SS/JrTol XCO:0000035 housing in pairs 6903879 RS:0003328 SS/NEisSlc XCO:0000156 0.9% sodium chloride solution 0.3 0.3 ml 6903879 RS:0003328 SS/NEisSlc XCO:0000156 0.9% sodium chloride solution 6903879 RS:0003328 SS/NEisSlc XCO:0000303 adrenalectomy 6903879 RS:0003328 SS/NEisSlc XCO:0000567 adrenomedulin 9.6 9.6 ug/d 6903879 RS:0003328 SS/NEisSlc XCO:0000567 adrenomedulin 400 400 ng/hr 6903879 RS:0003328 SS/NEisSlc XCO:0000438 candesartan 1 1 mg/kg/d 6903879 RS:0003328 SS/NEisSlc XCO:0000592 cilazapril 10 10 mg/kg/d 6903879 RS:0003328 SS/NEisSlc XCO:0000652 controlled E4177 content drinking water 1.66 1.66 mg/kg/d 6903879 RS:0003328 SS/NEisSlc XCO:0000652 controlled E4177 content drinking water 25 25 ug/ml 6903879 RS:0003328 SS/NEisSlc XCO:0000650 controlled cilazapril content drinking water 0.16 0.16 mg/kg/d 6903879 RS:0003328 SS/NEisSlc XCO:0000650 controlled cilazapril content drinking water 0.94 0.94 mg/kg/d 6903879 RS:0003328 SS/NEisSlc XCO:0000650 controlled cilazapril content drinking water 2.5 2.5 ug/ml 6903879 RS:0003328 SS/NEisSlc XCO:0000650 controlled cilazapril content drinking water 12.5 12.5 ug/ml 6903879 RS:0003328 SS/NEisSlc XCO:0000795 controlled sodium chloride content diet 0.3 0.3 % 6903879 RS:0003328 SS/NEisSlc XCO:0000795 controlled sodium chloride content diet 8 8 % 6903879 RS:0003328 SS/NEisSlc XCO:0000022 controlled sodium content diet 0.3 0.3 % 6903879 RS:0003328 SS/NEisSlc XCO:0000022 controlled sodium content diet 8 8 % 6903879 RS:0003328 SS/NEisSlc XCO:0000384 controlled tempol content drinking water 0.5 0.5 mmol/l 6903879 RS:0003328 SS/NEisSlc XCO:0000372 dexamethasone 20 20 ug/d 6903879 RS:0003328 SS/NEisSlc XCO:0000551 hydralazine 4 4 mg/ml 6903879 RS:0003328 SS/NEisSlc XCO:0000107 pentobarbital 20 20 mg/kg 6903879 RS:0003328 SS/NEisSlc XCO:0000055 tactile electric shock exposure 500 500 mA 6903879 RS:0003328 SS/NEisSlc XCO:0000272 tempol 4 4 mol/l 6903879 RS:0003328 SS/NEisSlc XCO:0000570 tolvaptan 0.05 0.05 % 6903879 RS:0003328 SS/NEisSlc XCO:0000101 vehicle control condition 151356957 RS:0005133 Sah:SD XCO:0000099 control condition 2314928 RS:0002216 Slc:W XCO:0000566 controlled ipragliflozin content diet 0.008 0.008 % 2314928 RS:0002216 Slc:W XCO:0000101 vehicle control condition 151347873 RS:0005130 Slc:ZUC-Leprfa+ XCO:0000686 Intralipid 20 10 10 ml/kg 151347873 RS:0005130 Slc:ZUC-Leprfa+ XCO:0000099 control condition 151347873 RS:0005130 Slc:ZUC-Leprfa+ XCO:0000102 fasting 12859278 RS:0004403 Slc:ZUC-Leprfa-/- XCO:0000686 Intralipid 20 10 10 ml/kg 12859278 RS:0004403 Slc:ZUC-Leprfa-/- XCO:0000099 control condition 12859278 RS:0004403 Slc:ZUC-Leprfa-/- XCO:0000102 fasting 12859278 RS:0004403 Slc:ZUC-Leprfa-/- XCO:0000789 methylcellulose 0.5 0.5 % 12859278 RS:0004403 Slc:ZUC-Leprfa-/- XCO:0000684 nateglinide 50 50 mg/kg 1579693 RS:0001576 T2DN/Mcwi XCO:0000099 control condition 1579693 RS:0001576 T2DN/Mcwi XCO:0000102 fasting 68147 RS:0000931 THE/Utp XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 68147 RS:0000931 THE/Utp XCO:0000102 fasting 68147 RS:0000931 THE/Utp XCO:0000087 specific pathogen-free condition 68148 RS:0000932 TLE/Utp XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 68148 RS:0000932 TLE/Utp XCO:0000102 fasting 68148 RS:0000932 TLE/Utp XCO:0000087 specific pathogen-free condition 1302623 RS:0000934 TM/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302623 RS:0000934 TM/Kyo XCO:0000102 fasting 1302623 RS:0000934 TM/Kyo XCO:0000087 specific pathogen-free condition 1302655 RS:0000938 TO/Hkm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302655 RS:0000938 TO/Hkm XCO:0000102 fasting 1302655 RS:0000938 TO/Hkm XCO:0000087 specific pathogen-free condition 68152 RS:0000937 TO/Hok XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 68152 RS:0000937 TO/Hok XCO:0000102 fasting 68152 RS:0000937 TO/Hok XCO:0000087 specific pathogen-free condition 1302702 RS:0000940 TRM/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302702 RS:0000940 TRM/Kyo XCO:0000102 fasting 1302702 RS:0000940 TRM/Kyo XCO:0000087 specific pathogen-free condition 1302679 RS:0000941 TRMR/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302679 RS:0000941 TRMR/Kyo XCO:0000102 fasting 1302679 RS:0000941 TRMR/Kyo XCO:0000087 specific pathogen-free condition 1302674 RS:0000953 VF/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302674 RS:0000953 VF/Kyo XCO:0000102 fasting 1302674 RS:0000953 VF/Kyo XCO:0000087 specific pathogen-free condition 8655992 RS:0003774 W-LeprfaNin XCO:0000458 controlled retinyl palmitate content diet 2.6 2.6 mg/kg 8655992 RS:0003774 W-LeprfaNin XCO:0000458 controlled retinyl palmitate content diet 26 26 mg/kg 8655992 RS:0003774 W-LeprfaNin XCO:0000458 controlled retinyl palmitate content diet 52 52 mg/kg 8655992 RS:0003774 W-LeprfaNin XCO:0000458 controlled retinyl palmitate content diet 129 129 mg/kg 8655992 RS:0003774 W-LeprfaNin XCO:0000102 fasting 41404661 RS:0004852 W/Jpe XCO:0000099 control condition 41404661 RS:0004852 W/Jpe XCO:0000102 fasting 41404661 RS:0004852 W/Jpe XCO:0000103 glucose solution 1.75 1.75 g/kg 1302672 RS:0000963 W/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302672 RS:0000963 W/Kyo XCO:0000099 control condition 1302672 RS:0000963 W/Kyo XCO:0000102 fasting 1302672 RS:0000963 W/Kyo XCO:0000005 running on treadmill 15 15 m/min 1302672 RS:0000963 W/Kyo XCO:0000087 specific pathogen-free condition 8655977 RS:0003771 W/Nin XCO:0000458 controlled retinyl palmitate content diet 2.6 2.6 mg/kg 8655977 RS:0003771 W/Nin XCO:0000458 controlled retinyl palmitate content diet 26 26 mg/kg 8655977 RS:0003771 W/Nin XCO:0000458 controlled retinyl palmitate content diet 52 52 mg/kg 8655977 RS:0003771 W/Nin XCO:0000458 controlled retinyl palmitate content diet 129 129 mg/kg 8655977 RS:0003771 W/Nin XCO:0000102 fasting 152995284 RS:0005145 W/Nov XCO:0000099 control condition 152995284 RS:0005145 W/Nov XCO:0000944 controlled alendronate content drinking water 0.84 0.84 mg/kg/d 152995284 RS:0005145 W/Nov XCO:0000955 controlled glucosamine - alendronate content drinking water 1.26 1.26 mg/kg/d 152995284 RS:0005145 W/Nov XCO:0000945 controlled taxifolin content drinking water 5.06 5.06 mg/kg/d 61008 RS:0000967 WAG XCO:0000732 CC531 cells 5 5 X 10E6 61008 RS:0000967 WAG XCO:0000099 control condition 61008 RS:0000967 WAG XCO:0000750 diclofenac 40 40 mg/kg 61008 RS:0000967 WAG XCO:0000449 diestrus 61008 RS:0000967 WAG XCO:0000447 estrus 61008 RS:0000967 WAG XCO:0000448 metestrus 61008 RS:0000967 WAG XCO:0000749 phosphoramidon 250 250 mg 61008 RS:0000967 WAG XCO:0000450 proestrus 61008 RS:0000967 WAG XCO:0000101 vehicle control condition 1 1 ml 8655639 RS:0003766 WAG/Nov XCO:0000099 control condition 8655639 RS:0003766 WAG/Nov XCO:0000912 controlled exposure to red light 20 20 W 8655639 RS:0003766 WAG/Nov XCO:0000433 controlled sucrose content drinking water 4 4 % 8655639 RS:0003766 WAG/Nov XCO:0000713 desmopressin 100 100 ug/kg 8655639 RS:0003766 WAG/Nov XCO:0000799 ether 8655639 RS:0003766 WAG/Nov XCO:0000738 lipopolysaccharide 500 500 mg/kg 8655639 RS:0003766 WAG/Nov XCO:0000738 lipopolysaccharide 500 500 ug/kg 8655639 RS:0003766 WAG/Nov XCO:0000159 physical restraint in tube type rodent restrainer 8655639 RS:0003766 WAG/Nov XCO:0000155 sodium chloride solution 1 1 ml 8655639 RS:0003766 WAG/Nov XCO:0000722 solid food deprivation 8655639 RS:0003766 WAG/Nov XCO:0000101 vehicle control condition 2 2 ml/kg 737946 RS:0000968 WAG/OlaHsd XCO:0000732 CC531 cells 5 5 X 10E6 737946 RS:0000968 WAG/OlaHsd XCO:0000749 phosphoramidon 250 250 mg 737946 RS:0000968 WAG/OlaHsd XCO:0000101 vehicle control condition 1 1 ml 737924 RS:0000969 WAG/Rij XCO:0000156 0.9% sodium chloride solution 0.4 0.4 ml 737924 RS:0000969 WAG/Rij XCO:0000156 0.9% sodium chloride solution 1 1 ml 737924 RS:0000969 WAG/Rij XCO:0000646 Azoxymethane 15 15 mg/kg 737924 RS:0000969 WAG/Rij XCO:0000099 control condition 2303640 RS:0002248 WAG/RijCmcr XCO:0000815 leg-out partial body irradiation 11 13 Gy 2303640 RS:0002248 WAG/RijCmcr XCO:0000815 leg-out partial body irradiation 11.5 13 Gy 2303640 RS:0002248 WAG/RijCmcr XCO:0000814 partial body irradiation 10 12.75 Gy 2303640 RS:0002248 WAG/RijCmcr XCO:0000814 partial body irradiation 10.5 13 Gy 2303640 RS:0002248 WAG/RijCmcr XCO:0000816 partial-body irradiation with 5% bone marrow sparing 12.25 13 Gy 2303640 RS:0002248 WAG/RijCmcr XCO:0000816 partial-body irradiation with 5% bone marrow sparing 12.75 13 Gy 2303640 RS:0002248 WAG/RijCmcr XCO:0000813 total body irradiation 7 7 Gy 2303640 RS:0002248 WAG/RijCmcr XCO:0000813 total body irradiation 7 8 Gy 2303640 RS:0002248 WAG/RijCmcr XCO:0000817 whole thorax lung irradiation 11 13 Gy 2303640 RS:0002248 WAG/RijCmcr XCO:0000817 whole thorax lung irradiation 11 14 Gy 2303640 RS:0002248 WAG/RijCmcr XCO:0000817 whole thorax lung irradiation 13 16.5 Gy 2312498 RS:0002249 WAG/RijCrl XCO:0000793 BTB14431 0.6 0.6 mg/kg/d 2312498 RS:0002249 WAG/RijCrl XCO:0000793 BTB14431 3.4 3.4 mg/kg/d 2312498 RS:0002249 WAG/RijCrl XCO:0000732 CC531 cells 0.1 0.1 x 10E6 cells 2312498 RS:0002249 WAG/RijCrl XCO:0000732 CC531 cells 25 25 X 10E3 2312498 RS:0002249 WAG/RijCrl XCO:0000788 S4MH cells 250 250 X 10E3 2312498 RS:0002249 WAG/RijCrl XCO:0000792 emodin 5 5 mg/kg/d 2312498 RS:0002249 WAG/RijCrl XCO:0000792 emodin 10 10 mg/kg/d 2312498 RS:0002249 WAG/RijCrl XCO:0000800 iron oxide nanoparticles 2.6 2.6 mg 2312498 RS:0002249 WAG/RijCrl XCO:0000210 partial hepatectomy 2312498 RS:0002249 WAG/RijCrl XCO:0000147 physiological salt solution perfusate 2 2 ml/d 2312498 RS:0002249 WAG/RijCrl XCO:0000100 sham surgical control condition 1357953 RS:0000970 WAG/RijHfr XCO:0000732 CC531 cells 25 25 X 10E3 1357953 RS:0000970 WAG/RijHfr XCO:0000743 Haemophilus 1357953 RS:0000970 WAG/RijHfr XCO:0000099 control condition 10042 RS:0000971 WAG/RijKyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 10042 RS:0000971 WAG/RijKyo XCO:0000099 control condition 10042 RS:0000971 WAG/RijKyo XCO:0000102 fasting 10042 RS:0000971 WAG/RijKyo XCO:0000158 physical restraint in mechanical restrainer 10042 RS:0000971 WAG/RijKyo XCO:0000087 specific pathogen-free condition 634369 RS:0000976 WBN/KobSlc XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 634369 RS:0000976 WBN/KobSlc XCO:0000030 controlled protein content diet 634369 RS:0000976 WBN/KobSlc XCO:0000102 fasting 634369 RS:0000976 WBN/KobSlc XCO:0000103 glucose solution 634369 RS:0000976 WBN/KobSlc XCO:0000087 specific pathogen-free condition 61007 RS:0000982 WF XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 61007 RS:0000982 WF XCO:0000395 controlled 4-nitroquinoline N-oxide content drinking water 0.001 0.001 % 1641878 RS:0001579 WF.BBDR-(Clcn1-D4Rat228)/Wor XCO:0000235 Poly I:C 2.5 2.5 ug/g 1641878 RS:0001579 WF.BBDR-(Clcn1-D4Rat228)/Wor XCO:0000231 anti-RT6.1 antibody 1357196 RS:0000985 WF.BBDR-(D4Arb29-D4Rat265)/Wor XCO:0000235 Poly I:C 2.5 2.5 ug/g 1357196 RS:0000985 WF.BBDR-(D4Arb29-D4Rat265)/Wor XCO:0000231 anti-RT6.1 antibody 1 1 ml 1357172 RS:0000986 WF.BBDR-(D4Arb29-D4Rat44)/Wor XCO:0000235 Poly I:C 2.5 2.5 ug/g 1357172 RS:0000986 WF.BBDR-(D4Arb29-D4Rat44)/Wor XCO:0000231 anti-RT6.1 antibody 1 1 ml 1357176 RS:0000987 WF.BBDR-(D4Arb29-D4Rat96)/Wor XCO:0000235 Poly I:C 2.5 2.5 ug/g 1357176 RS:0000987 WF.BBDR-(D4Arb29-D4Rat96)/Wor XCO:0000231 anti-RT6.1 antibody 1 1 ml 1357192 RS:0000988 WF.BBDR-(D4Got39-D4Rat44)/Wor XCO:0000235 Poly I:C 2.5 2.5 ug/g 1357192 RS:0000988 WF.BBDR-(D4Got39-D4Rat44)/Wor XCO:0000231 anti-RT6.1 antibody 1 1 ml 1641852 RS:0001580 WF.BBDR-(D4Got48-D4Got43)/Wor XCO:0000235 Poly I:C 2.5 2.5 ug/g 1641852 RS:0001580 WF.BBDR-(D4Got48-D4Got43)/Wor XCO:0000231 anti-RT6.1 antibody 1357193 RS:0000989 WF.BBDR-(D4Got51-D4Rat44)/Wor XCO:0000238 Kilham rat virus 10000000 10000000 PFU 1357193 RS:0000989 WF.BBDR-(D4Got51-D4Rat44)/Wor XCO:0000235 Poly I:C 1 1 ug/g 1357193 RS:0000989 WF.BBDR-(D4Got51-D4Rat44)/Wor XCO:0000235 Poly I:C 2.5 2.5 ug/g 1357193 RS:0000989 WF.BBDR-(D4Got51-D4Rat44)/Wor XCO:0000231 anti-RT6.1 antibody 1 1 ml 1357193 RS:0000989 WF.BBDR-(D4Got51-D4Rat44)/Wor XCO:0000231 anti-RT6.1 antibody 25 25 ug 1357187 RS:0000990 WF.BBDR-(D4Rat16-D4Got39)/Wor XCO:0000235 Poly I:C 2.5 2.5 ug/g 1357187 RS:0000990 WF.BBDR-(D4Rat16-D4Got39)/Wor XCO:0000231 anti-RT6.1 antibody 1 1 ml 1641868 RS:0001581 WF.BBDR-(D4Rat93-D4Rat228)/Wor XCO:0000235 Poly I:C 2.5 2.5 ug/g 1641868 RS:0001581 WF.BBDR-(D4Rat93-D4Rat228)/Wor XCO:0000231 anti-RT6.1 antibody 1357194 RS:0000991 WF.BBDR-(D4Rat96-D4Rat44)/Wor XCO:0000235 Poly I:C 2.5 2.5 ug/g 1357194 RS:0000991 WF.BBDR-(D4Rat96-D4Rat44)/Wor XCO:0000231 anti-RT6.1 antibody 1 1 ml 1357194 RS:0000991 WF.BBDR-(D4Rat96-D4Rat44)/Wor XCO:0000231 anti-RT6.1 antibody 1359010 RS:0000992 WF.BBDR-ART2a/Wor XCO:0000238 Kilham rat virus 10000000 10000000 PFU 1359010 RS:0000992 WF.BBDR-ART2a/Wor XCO:0000235 Poly I:C 1 1 ug/g 1359010 RS:0000992 WF.BBDR-ART2a/Wor XCO:0000231 anti-RT6.1 antibody 25 25 ug 728389 RS:0000994 WF.COP-(D2Mit29-D2Rat201)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 5134951 RS:0002609 WF.COP-(D7Rat39-D7Uwm12)/1Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 5134953 RS:0002610 WF.COP-(D7Rat39-D7Uwm12)/2Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 1358921 RS:0000999 WF.DA-(D19Mit1-D19Mit6)/Kop XCO:0000395 controlled 4-nitroquinoline N-oxide content drinking water 10 10 mg/l 4892563 RS:0002541 WF.WKY-(D5Rat26-D5Uwm42)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 6907061 RS:0003350 WF.WKY-(D5Uwm67-D5Uwm78)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 6907080 RS:0003354 WF.WKY-(D5Uwm67-D5Uwm81)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 6907054 RS:0003347 WF.WKY-(D5Uwm67-D5Uwm98)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 6907063 RS:0003351 WF.WKY-(D5Uwm76-D5Got18)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 6907057 RS:0003348 WF.WKY-(D5Uwm76-D5Uwm61)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 6907084 RS:0003355 WF.WKY-(D5Uwm76-D5Uwm92)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 6907059 RS:0003349 WF.WKY-(D5Uwm76-D5Uwm98)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 6907104 RS:0003363 WF.WKY-(D5Uwm77-D5Uwm91)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 6907087 RS:0003356 WF.WKY-(D5Uwm78-D5Uwm84)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 6907090 RS:0003357 WF.WKY-(D5Uwm78-D5Uwm93)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 6907076 RS:0003352 WF.WKY-(D5Uwm78-D5Uwm98)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 6907100 RS:0003362 WF.WKY-(D5Uwm82-D5Uwm91)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 6907098 RS:0003361 WF.WKY-(D5Uwm82-D5Uwm92)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 6907096 RS:0003360 WF.WKY-(D5Uwm85-D5Uwm92)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 6907094 RS:0003359 WF.WKY-(D5Uwm87-D5Uwm92)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 6907092 RS:0003358 WF.WKY-(D5Uwm88-D5Uwm92)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 6907078 RS:0003353 WF.WKY-(D5Uwm95-D5Uwm98)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 634359 RS:0001000 WF.WKY-(D5Wox7-D5Uwm37)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 5134683 RS:0002604 WF.WKY-(D7Rat171-D7Rat128)/1Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 5134685 RS:0002605 WF.WKY-(D7Rat171-D7Rat128)/2Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 5134692 RS:0002608 WF.WKY-(D7Rat171-D7Rat45)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 5134687 RS:0002606 WF.WKY-(D7Rat51-D7Rat128)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 5134689 RS:0002607 WF.WKY-(D7Uwm25-D7Rat128)/Uwm XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 1641864 RS:0001590 WF/CrCrli XCO:0000393 1,2-dimethylhydrazine 20 20 mg/kg/week 734761 RS:0001004 WF/Kga XCO:0000395 controlled 4-nitroquinoline N-oxide content drinking water 10 10 mg/l 1302622 RS:0001005 WF/Kop XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302622 RS:0001005 WF/Kop XCO:0000102 fasting 1302622 RS:0001005 WF/Kop XCO:0000087 specific pathogen-free condition 737917 RS:0001006 WF/Mol XCO:0000319 artificial aortocaval fistula 737917 RS:0001006 WF/Mol XCO:0000383 controlled losartan content drinking water 10 10 mg/kg/d 737917 RS:0001006 WF/Mol XCO:0000893 controlled ramipril content drinking water 3 3 mg/kg/d 737917 RS:0001006 WF/Mol XCO:0000100 sham surgical control condition 737917 RS:0001006 WF/Mol XCO:0000101 vehicle control condition 737908 RS:0000984 WF/NHsd XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 737908 RS:0000984 WF/NHsd XCO:0000266 Freund's complete adjuvant 100 100 ul 737908 RS:0000984 WF/NHsd XCO:0000291 peripheral myelin protein 2 peptide 58-81 100 100 ug 737908 RS:0000984 WF/NHsd XCO:0000292 peripheral nerve myelin 2 2 mg 13508588 RS:0001013 WI XCO:0000099 control condition 13508588 RS:0001013 WI XCO:0000420 controlled in utero environment 13508588 RS:0001013 WI XCO:0000615 embolism injection of middle cerebral artery 13508588 RS:0001013 WI XCO:0000109 isoflurane 1.5 1.5 % 13508588 RS:0001013 WI XCO:0000614 rolipram 3 3 mg/kg 13508588 RS:0001013 WI XCO:0000069 standard diet 50 50 % of calories 13508588 RS:0001013 WI XCO:0000069 standard diet 100 100 % of calories 13508588 RS:0001013 WI XCO:0000006 swimming 13508588 RS:0001013 WI XCO:0000526 swimming with water weights 13508588 RS:0001013 WI XCO:0000101 vehicle control condition 13825199 RS:0004673 WI-Mc4rm1Hubr XCO:0000099 control condition 2304222 RS:0002254 WIAR/Iar XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2304222 RS:0002254 WIAR/Iar XCO:0000102 fasting 2304222 RS:0002254 WIAR/Iar XCO:0000087 specific pathogen-free condition 1302694 RS:0001018 WKA/Seac XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302694 RS:0001018 WKA/Seac XCO:0000102 fasting 1302694 RS:0001018 WKA/Seac XCO:0000087 specific pathogen-free condition 1302687 RS:0001019 WKAH/HkmSlc XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302687 RS:0001019 WKAH/HkmSlc XCO:0000102 fasting 1302687 RS:0001019 WKAH/HkmSlc XCO:0000087 specific pathogen-free condition 68184 RS:0001594 WKAH/Hok XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 68184 RS:0001594 WKAH/Hok XCO:0000102 fasting 68184 RS:0001594 WKAH/Hok XCO:0000087 specific pathogen-free condition 631276 RS:0001023 WKHA/Cfd XCO:0000319 artificial aortocaval fistula 631276 RS:0001023 WKHA/Cfd XCO:0000100 sham surgical control condition 61103 RS:0000742 WKY XCO:0000156 0.9% sodium chloride solution 3 3 ml 61103 RS:0000742 WKY XCO:0000156 0.9% sodium chloride solution 50 50 mg/kg 61103 RS:0000742 WKY XCO:0000156 0.9% sodium chloride solution 61103 RS:0000742 WKY XCO:0000525 benazepril 10 10 mg/kg/d 61103 RS:0000742 WKY XCO:0000541 bosentan 100 100 mg/kg/d 61103 RS:0000742 WKY XCO:0000099 control condition 61103 RS:0000742 WKY XCO:0000031 controlled calcium content diet 0.6 0.6 % 61103 RS:0000742 WKY XCO:0000031 controlled calcium content diet 1.2 1.2 % 61103 RS:0000742 WKY XCO:0000015 controlled calorie content diet 30 30 % of calories 61103 RS:0000742 WKY XCO:0000015 controlled calorie content diet 100 100 % of calories 61103 RS:0000742 WKY XCO:0000246 controlled cholesterol content diet 1 1 % 61103 RS:0000742 WKY XCO:0000677 controlled enalapril content drinking water 50 50 mg/kg 61103 RS:0000742 WKY XCO:0000677 controlled enalapril content drinking water 50 50 mg/l 61103 RS:0000742 WKY XCO:0000023 controlled ethanol content drinking water 10 10 % 61103 RS:0000742 WKY XCO:0000420 controlled in utero environment 30 30 % of calories 61103 RS:0000742 WKY XCO:0000420 controlled in utero environment 100 100 % of calories 61103 RS:0000742 WKY XCO:0000022 controlled sodium content diet 0.4 0.4 % 61103 RS:0000742 WKY XCO:0000022 controlled sodium content diet 1.4 1.4 % 61103 RS:0000742 WKY XCO:0000750 diclofenac 10 10 mg/kg 61103 RS:0000742 WKY XCO:0000750 diclofenac 20 20 mg/kg 61103 RS:0000742 WKY XCO:0000750 diclofenac 40 40 mg/kg 61103 RS:0000742 WKY XCO:0000542 enalapril 10 10 mg/kg/d 61103 RS:0000742 WKY XCO:0000542 enalapril 50 50 mg/l 61103 RS:0000742 WKY XCO:0000325 ethanol 20 20 % 61103 RS:0000742 WKY XCO:0000124 furosemide 10 10 mg/kg/d 61103 RS:0000742 WKY XCO:0000124 furosemide 10 10 ml/kg/d 61103 RS:0000742 WKY XCO:0000124 furosemide 61103 RS:0000742 WKY XCO:0000531 gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector 40000000000 40000000000 PFU 61103 RS:0000742 WKY XCO:0000531 gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector 40000000000 40000000000 61103 RS:0000742 WKY XCO:0000530 gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector 40000000000 40000000000 PFU 61103 RS:0000742 WKY XCO:0000530 gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector 40000000000 40000000000 61103 RS:0000742 WKY XCO:0000421 in utero condition 30 30 % of calories 61103 RS:0000742 WKY XCO:0000130 ketamine 80 80 mg/kg 61103 RS:0000742 WKY XCO:0000549 left anterior descending coronary artery occlusion 61103 RS:0000742 WKY XCO:0000593 puromycin aminonucleoside 50 50 mg/kg 61103 RS:0000742 WKY XCO:0000593 puromycin aminonucleoside 50 50 mg/l 61103 RS:0000742 WKY XCO:0000548 ramipril 1 1 mg/kg/d 61103 RS:0000742 WKY XCO:0000594 saralasin 0.3 0.3 mg/kg/hr 61103 RS:0000742 WKY XCO:0000100 sham surgical control condition 61103 RS:0000742 WKY XCO:0000069 standard diet 61103 RS:0000742 WKY XCO:0000241 streptozotocin 35 35 mg/kg 61103 RS:0000742 WKY XCO:0000241 streptozotocin 60 60 mg/kg 61103 RS:0000742 WKY XCO:0000112 unilateral nephrectomy 61103 RS:0000742 WKY XCO:0000101 vehicle control condition 1 1 61103 RS:0000742 WKY XCO:0000101 vehicle control condition 61103 RS:0000742 WKY XCO:0000021 water 61103 RS:0000742 WKY XCO:0000131 xylazine 10 10 mg/kg 7241267 RS:0003413 WKY-Chr YSHR/Akr XCO:0000159 physical restraint in tube type rodent restrainer 1598804 RS:0001597 WKY.GHS-(D1Rat32-D1Mit32) XCO:0000031 controlled calcium content diet 1.2 1.2 % 7257722 RS:0003522 WKY.SHR-(D1Mgh14-D1Rat77)/Iwai XCO:0000182 controlled exposure to ambient light 7257722 RS:0003522 WKY.SHR-(D1Mgh14-D1Rat77)/Iwai XCO:0000183 controlled exposure to darkness 7257722 RS:0003522 WKY.SHR-(D1Mgh14-D1Rat77)/Iwai XCO:0000022 controlled sodium content diet 8 8 % 631592 RS:0001040 WKY.SHR-(D1Rat236-D1M7Mit206)/Njs XCO:0000099 control condition 631591 RS:0001041 WKY.SHR-(D1Rat56-D1M7Mit206)/Njs XCO:0000099 control condition 629482 RS:0001039 WKY.SHR-(D1Wox19-D1Mit2)/Njs XCO:0000099 control condition 629482 RS:0001039 WKY.SHR-(D1Wox19-D1Mit2)/Njs XCO:0000114 left nephrectomy 631601 RS:0001064 WKY.SHRSP-(Asgr1-Vamp2)/Bbb XCO:0000099 control condition 631601 RS:0001064 WKY.SHRSP-(Asgr1-Vamp2)/Bbb XCO:0000022 controlled sodium content diet 4889414 RS:0002493 WKY.SHRSP-(D1Rat171-D1Wox33)/Izm XCO:0000307 cold ambient air exposure 4 4 degrees C 4889414 RS:0002493 WKY.SHRSP-(D1Rat171-D1Wox33)/Izm XCO:0000099 control condition 4889414 RS:0002493 WKY.SHRSP-(D1Rat171-D1Wox33)/Izm XCO:0000183 controlled exposure to darkness 4889414 RS:0002493 WKY.SHRSP-(D1Rat171-D1Wox33)/Izm XCO:0000284 controlled visible light exposure 4889414 RS:0002493 WKY.SHRSP-(D1Rat171-D1Wox33)/Izm XCO:0000158 physical restraint in mechanical restrainer 728139 RS:0001045 WKY.SHRSP-(D1Rat200-D1Rat216)(Shbg-Atp1b2)/Bbb XCO:0000164 controlled sodium content drinking water 1 1 % 631694 RS:0001046 WKY.SHRSP-(D1Rat200-D1Rat216)/Bbb XCO:0000164 controlled sodium content drinking water 1 1 % 1302675 RS:0001051 WKY.SHRSP-(D1Smu13-D1Smu11)/Izm XCO:0000307 cold ambient air exposure 4 4 degrees C 1302675 RS:0001051 WKY.SHRSP-(D1Smu13-D1Smu11)/Izm XCO:0000099 control condition 1302636 RS:0001054 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm XCO:0000337 air-jet exposure 1302636 RS:0001054 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm XCO:0000191 angiotensin II 20 20 ng 1302636 RS:0001054 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm XCO:0000438 candesartan 1 1 ug 1302636 RS:0001054 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm XCO:0000307 cold ambient air exposure 4 4 degrees C 1302636 RS:0001054 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm XCO:0000099 control condition 1302636 RS:0001054 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm XCO:0000310 guanethidine 50 50 mg/kg/d 1302636 RS:0001054 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm XCO:0000320 hexamethonium 40 40 mg/kg 1302636 RS:0001054 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm XCO:0000145 phenylephrine 3 3 ug 1302636 RS:0001054 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm XCO:0000058 room temperature 1302636 RS:0001054 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm XCO:0000155 sodium chloride solution 1302636 RS:0001054 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm XCO:0000101 vehicle control condition 2 2 ul 631280 RS:0001059 WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc XCO:0000099 control condition 631280 RS:0001059 WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc XCO:0000182 controlled exposure to ambient light 631280 RS:0001059 WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc XCO:0000183 controlled exposure to darkness 631280 RS:0001059 WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc XCO:0000164 controlled sodium content drinking water 1 1 % 631281 RS:0001062 WKY.SHRSP-(Fst-Pklr)/Gcrc XCO:0000099 control condition 631281 RS:0001062 WKY.SHRSP-(Fst-Pklr)/Gcrc XCO:0000182 controlled exposure to ambient light 631281 RS:0001062 WKY.SHRSP-(Fst-Pklr)/Gcrc XCO:0000183 controlled exposure to darkness 631281 RS:0001062 WKY.SHRSP-(Fst-Pklr)/Gcrc XCO:0000164 controlled sodium content drinking water 1 1 % 631600 RS:0001065 WKY.SHRSP-(Mt1pa-D1Rat200)/Bbb XCO:0000099 control condition 631600 RS:0001065 WKY.SHRSP-(Mt1pa-D1Rat200)/Bbb XCO:0000164 controlled sodium content drinking water 1 1 % 629495 RS:0001066 WKY.SHRSP-(Mt1pa-D1Rat57)/Bbb XCO:0000099 control condition 629495 RS:0001066 WKY.SHRSP-(Mt1pa-D1Rat57)/Bbb XCO:0000164 controlled sodium content drinking water 1 1 % 1302689 RS:0001063 WKY.SHRSP-(Ntrk3-D1Smu13)/Izm XCO:0000307 cold ambient air exposure 4 4 degrees C 1302689 RS:0001063 WKY.SHRSP-(Ntrk3-D1Smu13)/Izm XCO:0000099 control condition 631693 RS:0001044 WKY.SHRSP-(Shbg-Atp1b2)/Bbb XCO:0000164 controlled sodium content drinking water 1 1 % 1579699 RS:0001600 WKY.WKHA-(D5Rat45-D5Rat245)/Cfd XCO:0000319 artificial aortocaval fistula 1579699 RS:0001600 WKY.WKHA-(D5Rat45-D5Rat245)/Cfd XCO:0000100 sham surgical control condition 1581635 RS:0001601 WKY/Bbb XCO:0000099 control condition 1581635 RS:0001601 WKY/Bbb XCO:0000022 controlled sodium content diet 1581635 RS:0001601 WKY/Bbb XCO:0000164 controlled sodium content drinking water 1 1 % 631275 RS:0001068 WKY/Cfd XCO:0000319 artificial aortocaval fistula 631275 RS:0001068 WKY/Cfd XCO:0000100 sham surgical control condition 2304329 RS:0002272 WKY/Ezo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2304329 RS:0002272 WKY/Ezo XCO:0000102 fasting 2304329 RS:0002272 WKY/Ezo XCO:0000087 specific pathogen-free condition 734760 RS:0000761 WKY/Gcrc XCO:0000099 control condition 734760 RS:0000761 WKY/Gcrc XCO:0000182 controlled exposure to ambient light 734760 RS:0000761 WKY/Gcrc XCO:0000183 controlled exposure to darkness 734760 RS:0000761 WKY/Gcrc XCO:0000164 controlled sodium content drinking water 1 1 % 734760 RS:0000761 WKY/Gcrc XCO:0000155 sodium chloride solution 1 1 % 734760 RS:0000761 WKY/Gcrc XCO:0000101 vehicle control condition 1302709 RS:0001071 WKY/Hcm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302709 RS:0001071 WKY/Hcm XCO:0000102 fasting 1302709 RS:0001071 WKY/Hcm XCO:0000087 specific pathogen-free condition 631286 RS:0000771 WKY/Izm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 631286 RS:0000771 WKY/Izm XCO:0000337 air-jet exposure 631286 RS:0000771 WKY/Izm XCO:0000191 angiotensin II 20 20 ng 631286 RS:0000771 WKY/Izm XCO:0000438 candesartan 1 1 ug 631286 RS:0000771 WKY/Izm XCO:0000307 cold ambient air exposure 4 4 degrees C 631286 RS:0000771 WKY/Izm XCO:0000099 control condition 0 0 631286 RS:0000771 WKY/Izm XCO:0000099 control condition 631286 RS:0000771 WKY/Izm XCO:0000183 controlled exposure to darkness 631286 RS:0000771 WKY/Izm XCO:0000025 controlled fat content diet 5 5 % 631286 RS:0000771 WKY/Izm XCO:0000025 controlled fat content diet 26 26 % 631286 RS:0000771 WKY/Izm XCO:0000032 controlled potassium content diet 0.44 0.44 % 631286 RS:0000771 WKY/Izm XCO:0000032 controlled potassium content diet 0.75 0.75 % 631286 RS:0000771 WKY/Izm XCO:0000032 controlled potassium content diet % 631286 RS:0000771 WKY/Izm XCO:0000284 controlled visible light exposure 631286 RS:0000771 WKY/Izm XCO:0000102 fasting 0 0 631286 RS:0000771 WKY/Izm XCO:0000102 fasting 631286 RS:0000771 WKY/Izm XCO:0000320 hexamethonium 40 40 mg/kg 631286 RS:0000771 WKY/Izm XCO:0000245 insulin 50000 50000 pmol/l 631286 RS:0000771 WKY/Izm XCO:0000256 isoproterenol 200 200 nmol/l 631286 RS:0000771 WKY/Izm XCO:0000145 phenylephrine 3 3 ug 631286 RS:0000771 WKY/Izm XCO:0000158 physical restraint in mechanical restrainer 631286 RS:0000771 WKY/Izm XCO:0000058 room temperature 631286 RS:0000771 WKY/Izm XCO:0000087 specific pathogen-free condition 631286 RS:0000771 WKY/Izm XCO:0000101 vehicle control condition 2 2 ul 70454 RS:0000714 WKY/N XCO:0000099 control condition 70454 RS:0000714 WKY/N XCO:0000103 glucose solution 2 2 g/kg 1358112 RS:0000731 WKY/NCrl XCO:0000137 FAPGG 0.6 0.6 mmol/l 1358112 RS:0000731 WKY/NCrl XCO:0000116 Kreb's solution perfusate 1358112 RS:0000731 WKY/NCrl XCO:0000143 acetylcholine 0 30 umol/l 1358112 RS:0000731 WKY/NCrl XCO:0000012 air carbon dioxide content 7 7 % 1358112 RS:0000731 WKY/NCrl XCO:0000012 air carbon dioxide content 7 % 1358112 RS:0000731 WKY/NCrl XCO:0000126 angiotensin 5 5 ng/kg/min 1358112 RS:0000731 WKY/NCrl XCO:0000126 angiotensin 10 10 ng/kg/min 1358112 RS:0000731 WKY/NCrl XCO:0000126 angiotensin 25 25 ng/kg/min 1358112 RS:0000731 WKY/NCrl XCO:0000126 angiotensin 50 50 ng/kg/min 1358112 RS:0000731 WKY/NCrl XCO:0000191 angiotensin II 90 90 ng 1358112 RS:0000731 WKY/NCrl XCO:0000255 anti-glomerular basement membrane antibody 500 500 ul 1358112 RS:0000731 WKY/NCrl XCO:0000830 artificial cerebrospinal fluid 200 200 nl 1358112 RS:0000731 WKY/NCrl XCO:0000438 candesartan 0.05 0.05 ug 1358112 RS:0000731 WKY/NCrl XCO:0000438 candesartan 0.5 0.5 ug 1358112 RS:0000731 WKY/NCrl XCO:0000099 control condition 1358112 RS:0000731 WKY/NCrl XCO:0000010 controlled air oxygen content 12 12 % 1358112 RS:0000731 WKY/NCrl XCO:0000010 controlled air oxygen content 12 % 1358112 RS:0000731 WKY/NCrl XCO:0000182 controlled exposure to ambient light 1358112 RS:0000731 WKY/NCrl XCO:0000183 controlled exposure to darkness 1358112 RS:0000731 WKY/NCrl XCO:0000146 controlled oxygen content Kreb's solution perfusate 1358112 RS:0000731 WKY/NCrl XCO:0000148 controlled oxygen content physiological salt solution perfusate 0 0 % 1358112 RS:0000731 WKY/NCrl XCO:0000148 controlled oxygen content physiological salt solution perfusate 5 5 % 1358112 RS:0000731 WKY/NCrl XCO:0000148 controlled oxygen content physiological salt solution perfusate 10 10 % 1358112 RS:0000731 WKY/NCrl XCO:0000148 controlled oxygen content physiological salt solution perfusate 95 95 % 1358112 RS:0000731 WKY/NCrl XCO:0000022 controlled sodium content diet 0 % 1358112 RS:0000731 WKY/NCrl XCO:0000022 controlled sodium content diet 0.4 0.4 % 1358112 RS:0000731 WKY/NCrl XCO:0000022 controlled sodium content diet 4 4 % 1358112 RS:0000731 WKY/NCrl XCO:0000022 controlled sodium content diet 8 8 % 1358112 RS:0000731 WKY/NCrl XCO:0000463 dark phase of controlled light/dark cycle 1358112 RS:0000731 WKY/NCrl XCO:0000152 drug dose time series 1358112 RS:0000731 WKY/NCrl XCO:0000102 fasting 1358112 RS:0000731 WKY/NCrl XCO:0000124 furosemide 10 10 mg/kg 1358112 RS:0000731 WKY/NCrl XCO:0000275 glucose 2 2 g/kg 1358112 RS:0000731 WKY/NCrl XCO:0000462 light phase of controlled light/dark cycle 1358112 RS:0000731 WKY/NCrl XCO:0000134 methacholine 0 11.06 mg/kg 1358112 RS:0000731 WKY/NCrl XCO:0000138 methylene blue 10 10 umol/l 1358112 RS:0000731 WKY/NCrl XCO:0000127 norepinephrine 0.1 0.1 ng/kg/min 1358112 RS:0000731 WKY/NCrl XCO:0000127 norepinephrine 0.2 0.2 ng/kg/min 1358112 RS:0000731 WKY/NCrl XCO:0000127 norepinephrine 0.5 0.5 ng/kg/min 1358112 RS:0000731 WKY/NCrl XCO:0000127 norepinephrine 1 1 ng/kg/min 1358112 RS:0000731 WKY/NCrl XCO:0000118 perfusate suspended 1358112 RS:0000731 WKY/NCrl XCO:0000145 phenylephrine 0 300 umol/l 1358112 RS:0000731 WKY/NCrl XCO:0000145 phenylephrine 1 1 umol/l 1358112 RS:0000731 WKY/NCrl XCO:0000145 phenylephrine 10 10 umol/l 1358112 RS:0000731 WKY/NCrl XCO:0000150 potassium ion 80 80 mmol/l 1358112 RS:0000731 WKY/NCrl XCO:0000003 resting on treadmill 1358112 RS:0000731 WKY/NCrl XCO:0000005 running on treadmill 1.6 1.6 m/min 1358112 RS:0000731 WKY/NCrl XCO:0000562 salidroside 40 40 mg/kg 1358112 RS:0000731 WKY/NCrl XCO:0000153 sample resting period 1358112 RS:0000731 WKY/NCrl XCO:0000142 sodium nitroprusside 0 3 umol/l 1358112 RS:0000731 WKY/NCrl XCO:0000791 standard condition 1358112 RS:0000731 WKY/NCrl XCO:0000101 vehicle control condition 1358112 RS:0000731 WKY/NCrl XCO:0000004 walking on treadmill 0.8 0.8 m/min 61119 RS:0001036 WKY/NCrlCrlj XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 61119 RS:0001036 WKY/NCrlCrlj XCO:0000099 control condition 61119 RS:0001036 WKY/NCrlCrlj XCO:0000102 fasting 61119 RS:0001036 WKY/NCrlCrlj XCO:0000087 specific pathogen-free condition 61097 RS:0001072 WKY/NCruk XCO:0000099 control condition 61097 RS:0001072 WKY/NCruk XCO:0000010 controlled air oxygen content 10 10 % 61097 RS:0001072 WKY/NCruk XCO:0000245 insulin 50000 50000 pmol/l 61097 RS:0001072 WKY/NCruk XCO:0000256 isoproterenol 200 200 nmol/l 61097 RS:0001072 WKY/NCruk XCO:0000249 left kidney transplant 61097 RS:0001072 WKY/NCruk XCO:0000114 left nephrectomy 61097 RS:0001072 WKY/NCruk XCO:0000113 right nephrectomy 61105 RS:0000916 WKY/NHsd XCO:0000156 0.9% sodium chloride solution 0.9 0.9 % 61105 RS:0000916 WKY/NHsd XCO:0000090 7,12-dimethyltetraphene (DMBA) 65 65 mg/kg 61105 RS:0000916 WKY/NHsd XCO:0000268 balloon angioplasty 61105 RS:0000916 WKY/NHsd XCO:0000099 control condition 61105 RS:0000916 WKY/NHsd XCO:0000022 controlled sodium content diet 8 8 % 61105 RS:0000916 WKY/NHsd XCO:0000102 fasting 61105 RS:0000916 WKY/NHsd XCO:0000103 glucose solution 2 2 g/kg 61105 RS:0000916 WKY/NHsd XCO:0000157 physical restraint 61105 RS:0000916 WKY/NHsd XCO:0000159 physical restraint in tube type rodent restrainer 61105 RS:0000916 WKY/NHsd XCO:0000016 standard rat chow 61105 RS:0000916 WKY/NHsd XCO:0000534 sunitinib 0.5 0.5 ml 61105 RS:0000916 WKY/NHsd XCO:0000534 sunitinib 7 7 mg/kg/d 61105 RS:0000916 WKY/NHsd XCO:0000101 vehicle control condition 0.5 0.5 ml 38549343 RS:0004797 WKY/NIcoCrlf XCO:0000739 housing in trios 38549343 RS:0004797 WKY/NIcoCrlf XCO:0000744 housing with Haemophilus H21-infected subject 38549343 RS:0004797 WKY/NIcoCrlf XCO:0000745 housing with Haemophilus H35-infected subject 38549343 RS:0004797 WKY/NIcoCrlf XCO:0000746 housing with Pasteurella pneumotropica-infected subject 38549343 RS:0004797 WKY/NIcoCrlf XCO:0000747 housing with Pasteurellaceae-infected subject 1302614 RS:0001073 WKY/NMna XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302614 RS:0001073 WKY/NMna XCO:0000102 fasting 1302614 RS:0001073 WKY/NMna XCO:0000087 specific pathogen-free condition 1566432 RS:0001602 WKY/NMolTac XCO:0000099 control condition 1566432 RS:0001602 WKY/NMolTac XCO:0000102 fasting 10046 RS:0001074 WKY/OlaHsd XCO:0000159 physical restraint in tube type rodent restrainer 1302599 RS:0001076 WKY/Ta XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302599 RS:0001076 WKY/Ta XCO:0000102 fasting 1302599 RS:0001076 WKY/Ta XCO:0000087 specific pathogen-free condition 737895 RS:0001070 WKY/Ztm XCO:0000099 control condition 70455 RS:0001078 WKYO/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 70455 RS:0001078 WKYO/Kyo XCO:0000102 fasting 70455 RS:0001078 WKYO/Kyo XCO:0000087 specific pathogen-free condition 127338473 RS:0004961 WM/Nem XCO:0000099 control condition 127338473 RS:0004961 WM/Nem XCO:0000884 trypan blue 0 0 mg/kg 127338473 RS:0004961 WM/Nem XCO:0000884 trypan blue 20 20 mg/kg 127338473 RS:0004961 WM/Nem XCO:0000884 trypan blue 30 30 mg/kg 127338473 RS:0004961 WM/Nem XCO:0000884 trypan blue 40 40 mg/kg 127338473 RS:0004961 WM/Nem XCO:0000884 trypan blue 60 60 mg/kg 127338473 RS:0004961 WM/Nem XCO:0000884 trypan blue 120 120 mg/kg 10045 RS:0001082 WN/N XCO:0000099 control condition 1302664 RS:0001083 WNA/Nshm XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302664 RS:0001083 WNA/Nshm XCO:0000102 fasting 1302664 RS:0001083 WNA/Nshm XCO:0000087 specific pathogen-free condition 67935 RS:0000065 WOKW XCO:0000099 control condition 67935 RS:0000065 WOKW XCO:0000103 glucose solution 2 2 g/kg 737957 RS:0001087 WOKW/K XCO:0000099 control condition 737957 RS:0001087 WOKW/K XCO:0000103 glucose solution 2 2 g/kg 2314935 RS:0002275 WST.F344-Kmch/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2314935 RS:0002275 WST.F344-Kmch/Kyo XCO:0000102 fasting 2314935 RS:0002275 WST.F344-Kmch/Kyo XCO:0000087 specific pathogen-free condition 2304242 RS:0002278 WTC-Kcnq1dfkKyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2304242 RS:0002278 WTC-Kcnq1dfkKyo XCO:0000102 fasting 2304242 RS:0002278 WTC-Kcnq1dfkKyo XCO:0000087 specific pathogen-free condition 2304221 RS:0002277 WTC-swh/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2304221 RS:0002277 WTC-swh/Kyo XCO:0000102 fasting 2304221 RS:0002277 WTC-swh/Kyo XCO:0000087 specific pathogen-free condition 2303792 RS:0002282 WTC.ZI-Atrnzi/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 2303792 RS:0002282 WTC.ZI-Atrnzi/Kyo XCO:0000102 fasting 2303792 RS:0002282 WTC.ZI-Atrnzi/Kyo XCO:0000087 specific pathogen-free condition 10047 RS:0001090 WTC/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 10047 RS:0001090 WTC/Kyo XCO:0000102 fasting 10047 RS:0001090 WTC/Kyo XCO:0000087 specific pathogen-free condition 9831158 RS:0003865 Y59/Zgd XCO:0000474 alendronate 40 40 mg/kg/d 9831158 RS:0003865 Y59/Zgd XCO:0000474 alendronate 100 100 mg/kg/d 9831158 RS:0003865 Y59/Zgd XCO:0000472 chrysin 100 100 mg/kg/d 9831158 RS:0003865 Y59/Zgd XCO:0000325 ethanol 0.5 0.5 % 9831158 RS:0003865 Y59/Zgd XCO:0000473 naringenin 100 100 mg/kg/d 9831158 RS:0003865 Y59/Zgd XCO:0000471 quercetin 100 100 mg/kg/d 9831158 RS:0003865 Y59/Zgd XCO:0000468 vitamin A 80 80 mg/kg/d 1302726 RS:0001103 ZI/Kyo XCO:0000156 0.9% sodium chloride solution 25 25 ml/kg 1302726 RS:0001103 ZI/Kyo XCO:0000102 fasting 1302726 RS:0001103 ZI/Kyo XCO:0000087 specific pathogen-free condition 634381 RS:0000610 iNP/Iusm XCO:0000099 control condition 634381 RS:0000610 iNP/Iusm XCO:0000023 controlled ethanol content drinking water 10 10 % 634381 RS:0000610 iNP/Iusm XCO:0000021 water 634380 RS:0000635 iP/Iusm XCO:0000099 control condition 634380 RS:0000635 iP/Iusm XCO:0000023 controlled ethanol content drinking water 10 10 % 634380 RS:0000635 iP/Iusm XCO:0000021 water